0001213900-15-006402.txt : 20150819 0001213900-15-006402.hdr.sgml : 20150819 20150819172731 ACCESSION NUMBER: 0001213900-15-006402 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 11 CONFORMED PERIOD OF REPORT: 20150630 FILED AS OF DATE: 20150819 DATE AS OF CHANGE: 20150819 FILER: COMPANY DATA: COMPANY CONFORMED NAME: OxySure Systems Inc CENTRAL INDEX KEY: 0001413797 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 710960725 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-54137 FILM NUMBER: 151064920 BUSINESS ADDRESS: STREET 1: 10880 JOHN W. ELLIOTT ROAD STREET 2: SUITE 600 CITY: Frisco STATE: TX ZIP: 75034 BUSINESS PHONE: (972) 294-6450 MAIL ADDRESS: STREET 1: 10880 JOHN W. ELLIOTT ROAD STREET 2: SUITE 600 CITY: Frisco STATE: TX ZIP: 75034 10-Q 1 f10q0615_oxysure.htm QUARTERLY REPORT

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 30, 2015

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Commission File Number: 000-54137

OXYSURE SYSTEMS, INC.

(Exact name of registrant as specified in its charter)

Delaware		71-0960725
(State or other jurisdiction of		(IRS Employer
incorporation or organization)		Identification No.)

10880 John W. Elliott Drive, Suite 600, Frisco, TX 75033

(Address of principal executive offices)

(972) 294-6450

(Registrant’s telephone number)

N/A

(Former name, former address and former fiscal year, if changed since last report)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☐	Accelerated filer	☐
Non-accelerated filer	☐	Smaller reporting company	☒
(Do not check if a smaller reporting company)

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

Our common stock is traded in the over-the-counter market and quoted on the OTCQB under the symbol “OXYS.”

The number of shares outstanding of the registrant’s class of $0.0004 par value common stock as of August 18, 2015 was 32,003,034.

INDEX

		Page
		Number
PART I - FINANCIAL INFORMATION

Item 1.	Condensed Financial Statements	F-1
	Condensed Balance Sheets – June 30, 2015 (unaudited) and December 31, 2014	F-1
	Condensed Statements of Operations – For the three and six months ended June 30, 2015 and 2014 (unaudited)	F-2
	Condensed Statements of Cash Flows – For six months ended June 30, 2015 and 2014 (unaudited)	F-3
	Condensed Notes to Financial Statements	F-4 – F-13
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	2
Item 3.	Quantitative and Qualitative Disclosures about Market Risk	7
Item 4.	Controls and Procedures	7

PART II - OTHER INFORMATION

Item 1.	Legal Proceedings	8
Item 1A.	Risk Factors	8
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	8
Item 3.	Defaults upon Senior Securities	8
Item 4.	Mine Safety Disclosures	8
Item 5.	Other Information	8
Item 6.	Exhibits	8

SIGNATURES		9

PART I - FINANCIAL INFORMATION

ITEM 1. CONDENSED FINANCIAL STATEMENTS

OXYSURE SYSTEMS INC.
CONDENSED BALANCE SHEETS

	June 30,			December 31,
	2015			2014
	(Unaudited)

ASSETS
Current assets
Cash and cash equivalents	$	875,941		$	647,093
Restricted cash		2,000,000			-
Accounts receivable, net		711,148			369,575
Inventories		422,551			277,346
License fee receivable		448,308			463,308
Prepaid expenses and other current assets		91,747			53,588
Total current assets		4,549,695			1,810,910

Property and equipment, net		88,617			91,537
Intangible assets, net		347,650			362,764
Other assets		296,605			246,237

TOTAL ASSETS	$	5,282,567		$	2,511,448

LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities
Accounts payable and accrued expenses	$	810,784		$	558,338
Related party payable		200,000			154,850
Capital leases - current		-			149
Notes payable - current, net of discount		43,723			40,897
Convertible notes payable, net of discount		981,475			606,932
Derivative liability		249,200			31,010
Total current liabilities		2,285,182			1,392,176

Long-term liabilities
Notes payable		-			44,484
Total long-term liabilities		-			44,484

TOTAL LIABILITIES		2,285,182			1,436,660

COMMITMENTS AND CONTINGENCY

STOCKHOLDERS’ EQUITY
Preferred stock, par value $0.0005 per share; 25,000,000 shares authorized;
518,750 Series A convertible preferred shares issued and outstanding as of June 30, 2015 and 593,750 shares issued and outstanding as of December 31, 2014.		258			296
900 Series B convertible preferred shares issued and outstanding as of June 30, 2015 and 1,145 shares issued and outstanding as of December 31, 2014.		1			1
770,000 Series C convertible preferred shares issued and outstanding as of June 30, 2015 and 0 shares issued and outstanding as of December 31, 2014.		385			-
1,050,000 Series D convertible preferred shares issued and outstanding as of June 30, 2015 and 0 shares issued and outstanding as of December 31, 2014.		525			-
531,666 Series E convertible preferred shares issued and outstanding as of June 30, 2015 and 0 shares issued and outstanding as of December 31, 2014.		266			-
Common stock, par value $0.0004 per share; 100,000,000 shares authorized;
31,224,000 shares of voting common stock issued and outstanding as of June 30, 2015 and 28,438,631 shares issued and outstanding as of December 31, 2014		12,492			11,377
Stock subscription receivable		(1,231,666	)		-
Additional Paid-in Capital		24,854,869			19,104,322
Accumulated deficit		(20,639,745	)		(18,041,208	)

TOTAL STOCKHOLDERS’ EQUITY		2,997,385			1,074,788

TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY	$	5,282,567		$	2,511,448

See accompanying notes to financial statements

F-1

OXYSURE SYSTEMS INC.

STATEMENTS OF OPERATIONS

(Unaudited)

	For the three months ended June 30,						For the six months ended June 30,
	2015			2014			2015			2014

Revenues, net	$	1,046,019		$	678,111		$	1,670,533		$	1,034,340
Cost of goods sold		409,183			264,856			745,039			470,446
Gross profit		636,836			413,255			925,494			563,894

Operating expenses
Research and development	$	297,456		$	275,974		$	510,801		$	277,515
Sales and marketing		329,393			154,044			794,139			241,993
Other general and administrative		621,066			259,230			1,243,350			604,987
Total operating expenses		1,247,915			689,248			2,548,290			1,124,495

Loss from operating expenses		(611,079	)		(275,993	)		(1,622,796	)		(560,600	)

Other income (expenses)
Interest expense		(561,791	)		(85,980	)		(892,945	)		(193,587	)
Change in value of derivative liabilities		119,933			-			122,584			-
Derivative expense		(204,272	)		-			(204,272	)		-
Other income (expense)		(1,225	)		42,465			(1,108	)		58,360
Total other income (expenses)		(647,355	)		(43,515	)		(975,741	)		(135,227	)

Net loss	$	(1,258,434	)	$	(319,508	)	$	(2,598,537	)	$	(695,828	)

Basic and diluted net loss per common share	$	(0.04	)	$	(0.01	)	$	(0.09	)	$	(0.03	)

Weighted average common shares outstanding:
Basic and diluted		30,215,788			25,996,642			29,587,327			25,956,948

See accompanying notes to financial statements

F-2

OXYSURE SYSTEMS INC.

STATEMENTS OF CASH FLOWS

(Unaudited)

	For the six months ended
	June 30,
	2015			2014

CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$	(2,598,537	)	$	(695,828	)
Adjustments to reconcile net loss to net cash from operating activities:
Depreciation and amortization expense		21,934			24,853
Amortization of debt discount and beneficial conversion features		803,870			121,140
Gain on forgiveness of debt		(37,714	)		-
Gain on extinguishment of debt		-			(42,525	)
Excess derivative over proceeds		204,272			-
Derivative liability fair value adjustment		(122,584	)		-
Expenses paid on behalf of related parties		137,150			-
Expenses paid by related parties		-			4,374
Warrants issued for services		8,883			-
Stock based compensation		106,911			17,588
Common stock issued for services		62,670			-
Changes in operating assets and liabilities:
Accounts receivable		(341,573	)		(363,543	)
Inventories		(145,205	)		1,804
License fees receivable		15,000			36,692
Prepaid expenses and other current assets		(38,159	)		62,509
Other assets		(50,368	)		-
Accounts payable and accrued liabilities		282,345			304,405
Deferred revenue		-			(2,976	)

NET CASH USED IN OPERATING ACTIVITIES		(1,691,105	)		(531,507	)

CASH FLOWS FROM INVESTING ACTIVITIES
Purchase of property and equipment		(3,900	)		(70,651	)
Purchase of intangible assets		-			(198	)

NET CASH USED IN INVESTING ACTIVITIES		(3,900	)		(70,849	)

CASH FLOWS FROM FINANCING ACTIVITIES
Common stock subscribed and issued for cash		80,001			10,672
Preferred stock issued for cash and warrants		2,650,001			-
Cash received from related parties		-			9,800
Payments made to related parties		(92,000	)		(108,300	)
Cash received from convertible notes payable		1,461,000			247,500
Payments made on convertible notes payable		(175,000	)		(192,000	)
Payments on capital leases		(149	)		(1,008	)

NET CASH PRODUCED BY FINANCING ACTIVITIES		3,923,853			(33,336	)

Net change in cash and cash equivalents		2,228,848			(635,692	)

Cash and cash equivalents, at beginning of period		647,093			657,673

Cash and cash equivalents, at end of period	$	2,875,941		$	21,981

Supplemental disclosure of cash flow information:
Cash paid during the period for:
Interest	$	-		$	-
Income taxes	$	-		$	-

Supplemental non-cash investing and financing activities:
Conversion of preferred stock to common	$	246		$	-
Conversion of convertible notes payable		804,138			-
Beneficial conversion feature		808,532			-
Initial value of the derivative		165,200			-

See accompanying notes to financial statements

F-3

OXYSURE® SYSTEMS, INC.

NOTES TO CONDENSED FINANCIAL STATEMENTS

June 30, 2015

(Unaudited)

NOTE 1 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

A summary of significant accounting policies of OxySure® Systems, Inc. (“OxySure” or the “Company”) is presented to assist in understanding the Company’s financial statements. The accounting policies presented in these footnotes conform to accounting principles generally accepted in the United States of America and have been consistently applied in the preparation of the accompanying financial statements. These financial statements and notes are representations of the Company’s management who are responsible for their integrity and objectivity.

Basis of Presentation - The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reported period. Actual results could differ from those estimates. The interim financial statements include all adjustments which, in the opinion of management, are necessary in order to make the financial statements not misleading.

The accompanying Condensed Financial Statements have been prepared in accordance with United States generally accepted accounting principles (“GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X promulgated by the Securities and Exchange Commission (“SEC”) and therefore do not contain all of the information and footnotes required by GAAP and the SEC for annual financial statements. The Company's Condensed Financial Statements reflect all adjustments that management believes are necessary for the fair presentation of their financial position, results of operations, comprehensive loss and cash flows for the periods presented. The information at December 31, 2014 in the Company's Condensed Balance Sheet included in this quarterly report was derived from the audited Balance Sheet included in the Company's Annual Report on Form 10-K for the year ended December 31, 2014 filed with the SEC on March 31, 2015. Where applicable, the Company's 2014 Annual Report on Form 10-K is referred to in this quarterly report as the “2014 Annual Report.” This quarterly report should be read in conjunction with the 2014 Annual Report.

Deferred Revenue and Income - We defer revenue and income when we invoice a customer or a customer makes a payment and the requirements of revenue recognition have not been met (i.e. persuasive evidence of an arrangement exists, shipment from a company warehouse has occurred, the price is fixed or determinable and collectability is reasonably assured). Deferred Revenue was $0 for each of the periods ended June 30, 2015 and December 31, 2014, respectively.

Inventory – Our inventory consists of raw material and components for our portable oxygen systems as well as completed products and accessories. Inventories are computed using the lower of cost or market, which approximates actual cost on a first-in first-out basis. Inventory components are parts, work-in-process and finished goods. Finished goods are reported as inventories until the point of title transfer to the customer.

Inventories as at June 30, 2015 and December 31, 2014 consisted of the following:

	June 30,		December 31,
	2015		2014

Parts inventory	$	181,863	$	133,477
Work in process		41,994		41,114
Finished goods		198,694		102,755
Total inventories	$	422,551	$	277,346

F-4

OXYSURE® SYSTEMS, INC.

NOTES TO CONDENSED FINANCIAL STATEMENTS

June 30, 2015

(Unaudited)

NOTE 1 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)

Cash and Cash Equivalents - We invest our cash in deposits and money market funds with major financial institutions. We place our cash investments in instruments that meet high credit quality standards, as specified in our investment policy guidelines. These guidelines also limit the amount of credit exposure to any one issue, issuer or type of instrument.

Fair Value of Financial Instruments - Our financial instruments consist principally of cash and cash equivalents, accounts receivable and accounts payable. We believe that the recorded values of all of our other financial instruments approximate their fair values because of their nature and respective maturity dates or durations. The fair value of our long-term debt is determined by using estimated market prices. Assets and liabilities measured at fair value are categorized based on whether or not the inputs are observable in the market and the degree that the inputs are observable. The categorization of financial instruments within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement. The hierarchy is prioritized into three levels (with Level 3 being the lowest) defined as follows:

Level 1: Inputs are based on quoted market prices for identical assets or liabilities in active markets at the measurement date.

Level 2: Inputs include quoted prices for similar assets or liabilities in active markets and/or quoted prices for identical or similar assets or liabilities in markets that are not active near the measurement date.

Level 3: Inputs include management’s best estimate of what market participants would use in pricing the asset or liability at the measurement date. The inputs are unobservable in the market and significant to the instrument’s valuation.

The fair value of the majority of our cash equivalents was determined based on “Level 1” inputs. We do not have any marketable securities in the “Level 2” and “Level 3” category. We believe that the recorded values of all our other financial instruments approximate their current fair values because of their nature and respective relatively short maturity dates or durations.

Property and Equipment – Property and equipment are recorded at cost with depreciation and amortization provided over the shorter of the remaining lease term or the estimated useful life of the improvement ranging from three to seven years. Renewals and betterments that materially extend the life of an asset are capitalized. Expenditures for maintenance and repairs are charged to expense when incurred. Furniture and fixtures are depreciated over five years. Machinery and equipments are depreciated over five to seven years. Software is depreciated over three years. Leasehold improvements are computed using the shorter of the estimated useful lives of the assets or the lease terms. Depreciation expense was $3,478 and $5,155 for the three month periods ended June 30, 2015 and 2014, respectively. Depreciation expense was $6,820 and $9,786 for the six month periods ended June 30, 2015 and 2014, respectively.

Other Long-Lived Assets – We have two types of intangible assets – patents and trademarks. Intangible assets are carried at cost, net of accumulated amortization. Amortization expense for patents and trademarks was $7,557 and $7,558 for the three month periods ended June 30, 2015 and 2014, respectively. Amortization expense for patents and trademarks was $15,114 and $15,066 for the six month periods ended June 30, 2015 and 2014, respectively

Intangible assets with definite useful lives and other long-lived assets are tested for impairment if certain impairment indicators are identified. Management evaluates the recoverability of its identifiable intangible assets in accordance with applicable accounting guidance, which requires the assessment of these assets for recoverability when events or circumstances indicate a potential impairment exists. If impairment is indicated based on a comparison of the assets’ carrying values and the undiscounted cash flows, the impairment loss is measured as the amount by which the carrying amount of the assets exceeds the fair value of the assets. Impairment charges for patents were $0 for each of the three month periods ended June 30, 2015 and 2014.

5-Year amortization expense for patents and trademarks is as follows:

2015	$	30,232
2016		30,232
2017		30,232
2018		30,232
Thereafter		226,723
	$	347,650

F-5

OXYSURE® SYSTEMS, INC.

NOTES TO CONDENSED FINANCIAL STATEMENTS

June 30, 2015

(Unaudited)

NOTE 1 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)

Other Assets– We record Other Assets net of accumulated amortization. Amortization expense for Other Assets was $21,911 and $10,051 for the three month periods ended June 30, 2015 and 2014, respectively. Amortization expense for Other Assets was $42,034 and $37,562 for the six month periods ended June 30, 2015 and 2014, respectively.

Capitalization of software: The Company accounts for internal-use software and website development costs, including the development of its partner marketplaces in accordance with ASC 350-50 (Intangibles – Website cost). The Company capitalizes internal costs consisting of payroll and direct payroll-related costs of employees who devote time to the development of internal-use software, as well as any external direct costs. It amortizes these costs over their estimated useful lives, which typically range between three to five years. The Company’s judgment is required in determining the point at which various projects enter the stages at which costs may be capitalized, in assessing the ongoing value of the capitalized costs, and in determining the estimated useful lives over which the costs are amortized. The estimated life is based on management’s judgment as to the product life cycle.

Amortization expense for websites and URLs was $9,654 and $9,654 for the three month periods ended June 30, 2015 and 2014, respectively. Amortization expense for websites and URLs was $19,309 and $19,309 for the six month periods ended June 30, 2015 and 2014, respectively.

Research and Development Costs – Costs associated with the development of our products are charged to expense as incurred. Research and development expense was $297,456 and $275,974 for the three month periods ended June 30, 2015 and 2014, respectively. Research and development expense was $510,801 and $277,515 for the six month periods ended June 30, 2015 and 2014, respectively.

Equity Warrants - We issued warrants to purchase shares of our common stock in connection with convertible notes. In accordance with ASC 470-20, Debt with conversions and other options, the proceeds from the notes were allocated based on the relative fair values of the notes without the warrants issued in conjunction with the notes and of the warrants themselves at the time of issuance. We record the fair value of the warrants at the time of issuance as additional paid in capital and as a debt discount to the notes. We amortize this debt discount as interest expense over the life of the note. Additionally, as a result of issuing the warrants with the convertible notes, a beneficial conversion option is recorded as a debt discount reflecting the incremental conversion option intrinsic value of the conversion option provided to the holders of the notes. We also amortize this debt discount as interest expense over the life of the notes. The intrinsic value of each conversion option was calculated as the difference between the effective conversion price and the fair value of the common stock, multiplied by the number of shares into which the note is convertible.

Stock-Based Compensation – We account for share-based payments, including grants of stock options to employees, consultants and non-employees; moreover, we issue warrants to the consultants and related parties. We are required to estimate the fair value of share-based awards and warrants on the date of grant. The value of the award is principally recognized as expense ratably over the requisite service periods. We have estimated the fair value of stock options and warrants as of the date of grant or assumption using the Black-Scholes option pricing model.

F-6

OXYSURE® SYSTEMS, INC.

NOTES TO CONDENSED FINANCIAL STATEMENTS

June 30, 2015

(Unaudited)

NOTE 1 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)

For the three month periods ended June 30, 2015 and 2014, stock based compensation expense was approximately $58,611 and $0, respectively, which consisted primarily of stock-based compensation expense related to stock options issued to the employees and recognized under GAAP. For the six month periods ended June 30, 2015 and 2014, stock based compensation expense was approximately $106,911 and $17,588, respectively.

Shipping and Handling Costs - Shipping and handling charges to customers are included in net revenues, and the associated costs incurred are recorded in cost of revenues.

Advertising Costs - Advertising costs are charged to operations when incurred. We incurred $329,393 and $154,044 in advertising and promotion costs during the three month periods ended June 30, 2015 and 2014, respectively. Advertising and promotion costs during the six month periods ended June 30, 2015 and 2014 were $794,139 and $241,993, respectively.

Net Income (Loss) Per Share - Basic earnings (loss) per share is computed based on the weighted average number of common shares outstanding. However, basic loss per share excludes anti-dilutive securities. Diluted earnings per share is computed based on the weighted average number of common shares outstanding, increased by the number of additional shares that would have been outstanding had the potentially dilutive common shares been issued, and reduced by the number of shares the Company could have repurchased from the proceeds from issuance of the potentially dilutive shares. Potentially dilutive shares of common stock include stock options and other stock-based awards granted under stock-based compensation plans and shares committed to be purchased under the employee stock purchase plan. As of June 30, 2015 there were 18,268,932 potentially dilutive shares.

Recent Accounting Pronouncements

We have reviewed recent accounting pronouncements and concluded that they are either not applicable to our business or that no material effect is expected on the financial statements as a result of future adoption.

F-7

OXYSURE® SYSTEMS, INC.

NOTES TO CONDENSED FINANCIAL STATEMENTS

June 30, 2015

(Unaudited)

NOTE 2 – NOTES PAYABLE

We have issued warrants for the purchase of shares of our restricted common stock in connection with raising equity and debt financing and for other professional services. The fair value of warrants issued is determined in accordance with Codification topic 470-20.

Frisco Promissory Note. On March 22, 2011 we entered into an Amended and Restated Performance Agreement with the Frisco Economic Development Corporation (“FEDC”) pursuant to an economic incentive package. In terms of the Amended and Restated Performance Agreement, the FEDC provided us with economic assistance in the form of the renewal and extension a forgivable loan of $213,000 (the “Frisco Note”) together with performance credits over 5 years, commencing on March 22, 2011 and ending on the earlier to occur of: (i) the full payment of the economic incentives; or (ii) March 31, 2016.

The Frisco Note requires varying annual principal payments through December 2015. The Frisco Note is non-interest bearing; however, interest has been imputed at 12.34% per annum. The unamortized discount at June 30, 2015 was $8,000, and the net amount of the Frisco Note as at June 30, 2015 was $44,000.

Future principal payments of the Frisco Note payable are as follows:

2015			52,000
Total		$	52,000

During the three months ended June 30, 2015 we issued seven convertible notes with a total principal value of $1,147,500 for $966,000 in cash. The notes contained original issuance discounts for a total of $181,000, and interest rates ranging from 10% to 12%. The maturity dates of the notes range from November 25, 2015 to May 4, 2017. The creditors have the option at any time to convert the principal and any accrued interest into common stock of the Company at a weighted average discount rate of approximately thirty percent off the market price of the Company’s common stock, as calculated at June 30, 2015.

F-8

OXYSURE® SYSTEMS, INC.

NOTES TO CONDENSED FINANCIAL STATEMENTS

June 30, 2015

(Unaudited)

During the quarter, we issued warrants associated with notes. In accordance with ASC 470-20, Debt with conversions and other options, the proceeds from the notes were allocated based on the relative fair values of the notes without the warrants issued in conjunction with the notes and of the warrants themselves at the time of issuance. As a result of issuing the warrants with subordinated convertible promissory notes, beneficial conversion options were recorded as debt discounts reflecting the incremental conversion option intrinsic value benefits totaling $400,196, at the time of issuance provided to the holders of the notes, which we also amortize as interest expense over the life of the notes. We recorded interest expense in the amounts of $638,190 and $0 for the three months ended June 30, 2015 and 2014, respectively in connection with all the notes issued with warrants that contained beneficial conversion features.

NOTE 3 - SHAREHOLDERS’ EQUITY

Preferred Shares Rights

We have 25,000,000 shares of preferred stock authorized, par value $0.0005 per share.

Series A Convertible Preferred Stock: As of June 30, 2015, the Company had authorized the issuance of 3,143,237 shares of preferred stock designated as Series A Convertible Preferred Stock (“Series A Preferred”). The original issue price of the Series A Preferred is $1.00 per share. There were 518,750 and 593,750 Series A Preferred shares issued and outstanding as of June 30, 2015 and December 31, 2014, respectively.

During the three months ended June 30, 2015 the Company did not issue any shares of the Series A Preferred, and no shares of the Series A Preferred have been converted into common stock.

Series B Convertible Preferred Stock: As of June 30, 2015, we had 3,500 shares of preferred stock designated as Series B Convertible Preferred Stock (“Series B Preferred”). The original issue price of the Series B Preferred is $1,000 per share. There were 900 and 1,145 Series B Preferred shares issued and outstanding as of June 30, 2015 and December 31, 2014, respectively.

During the three months ended June 30, 2015 the Company did not issue any shares of the Series B Preferred and 75 shares of Series B Preferred were converted into 204,188 shares of our common stock.

Series C Convertible Preferred Stock: As of June 30, 2015, we had 770,000 shares of preferred stock designated as Series C Convertible Preferred Stock (“Series C Preferred”). The original issue price of the Series C Preferred is $2.00 per share. There were 770,000 and 0 Series C Preferred shares issued and outstanding as of June 30, 2015 and December 31, 2014, respectively.

During the three months ended June 30, 2015 the Company issued 770,000 shares of the Series C Preferred and no shares of Series C Preferred were converted into common stock.

Series D Convertible Preferred Stock: As of June 30, 2015, we had 1,050,000 shares of preferred stock designated as Series D Convertible Preferred Stock (“Series D Preferred”). The original issue price of the Series D Preferred is $2.00 per share. There were 1,050,000 and 0 shares of the Series D Preferred issued and outstanding as of June 30, 2015 and December 31, 2014, respectively.

During the three months ended June 30, 2015 the Company issued 1,050,000 shares of the Series D Preferred and no shares of Series D Preferred were converted into common stock.

Series E Convertible Preferred Stock: As of June 30, 2015, we had 531,666 shares of preferred stock designated as Series E Convertible Preferred Stock (“Series E Preferred”). The original issue price of the Series E Preferred is $1.00 per share. There were 531,666 and 0 shares of the Series E Preferred issued and outstanding as of June 30, 2015 and December 31, 2014, respectively.

During the three months ended June 30, 2015 the Company issued 531,666 shares of the Series E Preferred and no shares of Series E Preferred were converted into common stock.

Common Stock

The Company has authorized 100,000,000 shares of $0.0004 par value common stock.

During the three months ended June 30, 2015:

	(1)	We issued 133,333 shares of common stock for $80,000 in cash.
	(2)	We issued 204,188 shares of common stock pursuant to the cashless conversion of 75 shares of Series B Preferred;
	(3)	We issued 1,256,453 shares of common stock pursuant to the conversion of convertible notes;
	(4)	We issued 770,000 shares of the Series C Preferred for which we received $700,000 in cash and recorded a stock subscription receivable for the remaining $700,000;
	(5)	We issued 1,050,000 shares of the Series D Preferred for $2,000,000 in cash held in escrow, to be released upon our uplisting to a national exchange;
	(6)	We recorded $58,611 for the computed fair value of options issued to employees, non-employee directors, and consultants, net of cancellations and forfeitures; and
	(7)	We recorded $400,196 in connection with beneficial conversion features.

As of June 30, 2015 we had approximately 31,244,000 shares of common stock issued and outstanding.

F-9

OXYSURE® SYSTEMS, INC.

NOTES TO CONDENSED FINANCIAL STATEMENTS

June 30, 2015

(Unaudited)

NOTE 4 - STOCK OPTIONS AND WARRANTS

Equity Incentive Plans

In April 2004, our Board of Directors and the stockholders at that time approved the adoption of a Voting Stock Option Plan (“the Plan”), which provides for the issuance of stock options to eligible employees, consultants, Board members and Advisory Board members of the Company to acquire up to a maximum of 5,000,000 shares of common stock.

Our Board of Directors, which determines the number of options that will be granted, the effective dates of the grants, the option process and the vesting schedules, administers the Plan. In the absence of an established market for the common stock of the Company, the Board of Directors determines the fair market value of our common stock. Options generally expire between five and ten years from the date of grant and automatically terminate 90 days after such optionee ceases to be an eligible individual under the Plan other than by reason of death or disability.

The portion of options granted that is not exercisable on the date the optionee ceases to be an eligible individual under the Plan by reason other than death, shall terminate and be forfeited to the Company on the date of such cessation. An optionee has no right as a stockholder with respect to any shares covered by the options granted to him until a certificate representing such shares is issued to them.

Stock Options

The following table summarizes information about the number and weighted average of the options that were forfeited or expired under the Plan as at June 30, 2015:

	Employee				Non-Employee
			Weighted				Weighted
	Number		Average		Number		Average		Combined
	Of		Exercise		Of		Exercise		Total
Outstanding at March 31, 2015		2,513,838	$	0.41		-	$	-		2,513,838
Granted		-	$	-		-	$	-		-
Exercised		-	$	-		-	$	-		-
Forfeited/Cancelled		-	$	-		-	$	-		-
Outstanding at June 30, 2015		2,513,838	$	0.41		-	$	-		2,513,838

The number of stock options exercisable at June 30, 2015 was 1,627,296.

F-10

OXYSURE® SYSTEMS, INC.

NOTES TO CONDENSED FINANCIAL STATEMENTS

June 30, 2015

(Unaudited)

NOTE 4 - STOCK OPTIONS AND WARRANTS (CONTINUED)

We used the following assumptions to estimate the fair value of options granted under the Plan for the three and six months ended June 30, 2015 and 2014:

	Equity Incentive Plans						Equity Incentive Plans
	for the Three Months Ended June 30,						for the Six Months Ended June 30,
	2015			2014			2015			2014

Expected terms (in years)		5-10			5-10			5-10			5-10
Volatility (weighted ave.)		83.79	%		40.45	%		83.79	%		40.45	%
Risk-free interest rate		.85% - 1.74%			1.50% - 1.80%			.85% - 1.74%			1.44% - 1.80%
Expected dividend rate		0	%		0	%		0	%		0	%

The expected term of stock options represents the weighted average period the stock options are expected to remain outstanding. The expected term is based on the observed and expected time to exercise and post-vesting cancellations of options by optionees. We use historical volatility in deriving our expected volatility assumption because it believes that future volatility over the expected term of the stock options is not likely to differ from the past.

The expected dividend assumption is based on our history and expectation of dividend payouts. The fair value of the shares of common stock underlying the stock options has historically been determined by the board of directors. On or before February 2012, when our common stock commenced trading on the over the counter bulletin board (OTCQB), there has been no public market for our common stock. Consequently, the board of directors has historically determined the fair value of the common stock at the time of grant of the option by considering a number of objective and subjective factors including valuation of comparable companies, operating and financial performance, the lack of liquidity of capital stock and general and industry specific economic outlook, amongst other factors.

FASB ASC 718 requires forfeitures to be estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates. The Company only records stock-based compensation expense for awards that are expected to vest. While we generally consider historical forfeitures in its estimates, judgment is also required in estimating the amount of stock-based awards that are expected to be forfeited. The Company’s estimates for forfeitures may differ from actual forfeitures. If actual results differ significantly from these estimates, stock-based compensation expense and its results of operations could be materially impacted when the Company records a true-up for the difference in the period that the awards vest. We adjust stock-based compensation expense based on our actual forfeitures on an annual basis, if necessary.

Stock compensation cost, using the graded vesting attribute method in accordance with Codification topic 718, is recognized over the requisite service period, generally 5 years, during which each tranche of shares is earned (zero, one, two, three, and four years). The value of each tranche is generally amortized on a straight-line basis. For the three months ended June 30, 2015 and 2014, stock based compensation expense was approximately $58,611 and $0, respectively, which consisted primarily of stock-based compensation expense related to stock options recognized under GAAP issued to employees. For each of the three months ended June 30, 2015 and 2014, the number of options exercised was 0.

Compensation expense is recognized only for the portion of stock options that are expected to vest, assuming an expected forfeiture rate in determining stock-based compensation expense, which could affect the stock-based compensation expense recorded if there is a significant difference between actual and estimated forfeiture rates. As of June 30, 2015, total unrecognized compensation cost related to stock-based awards granted to employees and non-employee directors was $323,715.

F-11

OXYSURE® SYSTEMS, INC.

NOTES TO CONDENSED FINANCIAL STATEMENTS

June 30, 2015

(Unaudited)

NOTE 4 - STOCK OPTIONS AND WARRANTS (CONTINUED)

Warrants.

The following table summarizes our warrant activities for the three months ended June 30, 2015:

			Weighted
	Number		Average
	Of		Exercise
	Warrants		Price
Outstanding at March 31, 2015		3,304,260	$	1.28
Granted		1,659,696	$	1.11
Exercised		-	$	-
Forfeited/Cancelled		-	$	-
Outstanding at June 30, 2015		4,963,956	$	1.22

The number of warrants exercisable at June 30, 2015 was 4,963,956.

NOTE 5 – RELATED PARTY TRANSACTIONS

A summary of the related party financings and notes as at June 30, 2015 is as follows:

Related party	Julian Ross (1)
Amount	$	200,000
Stated interest rate		0	%
Maturity		n/a

(1) Our CEO, Mr. Ross provides us shareholder cash advances and other consideration from time to time to fund working capital.

F-12

OXYSURE® SYSTEMS, INC.

NOTES TO CONDENSED FINANCIAL STATEMENTS

June 30, 2015

(Unaudited)

NOTE 6 – OFF BALANCE SHEET ARRANGEMENTS AND CONTRACTUAL OBLIGATIONS

We have not entered into any transactions with unconsolidated entities whereby we have financial guarantees, subordinated retained interests, or other contingent arrangements that expose us to material continuing risks, contingent liabilities, or any other obligation under a variable interest in an unconsolidated entity that provides financing, liquidity, market risk or credit risk support to us.

NOTE 7 – FAIR VALUE MEASUREMENTS

Changes related to derivatives for the six months ended June 30, 2015 are as follows:

Balance as of December 31, 2014	$	31,010
Additions related to embedded derivative of convertible notes issued		369,472
Gain on decrease in value of derivative liabilities		(122,584	)
Conversions		(28,698	)
Balance as of June 30, 2015	$	249,200

During the six month period the Company recorded derivatives related to convertible notes of $369,472 of which $204,272 exceed the proceeds of the convertible notes and was recorded as a derivative expense. The Company also converted $28,698 and recorded a gain on the change in the fair value of the derivative of $122,584.

NOTE 8 – SEGMENT INFORMATION

We are organized as, and operate in, one reportable segment: the development, distribution and sale of specialty respiratory products and related medical products, accessories, and services. Our chief operating decision-maker is our Chief Executive Officer. Our Chief Executive Officer reviews financial information presented for purposes of evaluating financial performance and allocating resources, accompanied by information about revenue by geographic regions. Our assets are primarily located in the United States of America and not allocated to any specific region and we do not measure the performance of our geographic regions based upon asset-based metrics. Therefore, geographic information is presented only for revenue. Revenue by geographic region is based on the ship to address on our customer orders.

The following presents total revenue by geographic region for the three month periods ended June 30, 2015 and 2014:

	Three Months Ended June 30,				Six Months Ended June 30,
	2015		2014		2015		2014

United States - product sales	$	1,044,066	$	677,508	$	1,668,580	$	979,110
ROW - product sales		1,953		603		1,953		37,730
ROW - license fees/service revenue		-		-		-		17,500
Totals	$	1,046,019	$	678,111	$	1,670,533	$	1,034,340

NOTE 9 – GOING CONCERN

Our financial statements are prepared using accounting principles generally accepted in the United States of America applicable to a going concern, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business. Historically we have been suffering from recurring loss from operations. We have an accumulated deficit of $20,639,745 and $18,041,208 at June 30, 2015 and December 31, 2014, respectively, and stockholders’ equity of $2,997,385 and $1,074,787 as of June 30, 2015 and December 31, 2014, respectively. We require substantial additional funds to manufacture and commercialize our products. Our management is actively seeking additional sources of equity and/or debt financing; however, there is no assurance that any additional funding will be available.

In view of the matters described above, recoverability of a major portion of the recorded asset amounts shown in the accompanying June 30, 2015 balance sheet is dependent upon continued operations of the Company, which in turn is dependent upon the Company’s ability to meet its financing requirements on a continuing basis, to maintain present financing, and to generate cash from future operations. These factors, among others, raise substantial doubt about our ability to continue as a going concern. The financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or amounts and classification of liabilities that might be necessary should we be unable to continue in existence.

F-13

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The following discussion and analysis summarizes the significant factors affecting our results of operations, financial conditions and liquidity position for the three months ended June 30, 2015 and 2014, and should be read in conjunction with our financial statements, including the notes thereto, appearing elsewhere in this report.

Forward-Looking Statements

Statements and information included in this Quarterly Report on Form 10-Q that are not purely historical, including, without limitation, statements that relate to the Company's expectations with regard to the future impact on the Company's results from new products in development, are forward-looking statements within the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. When used in this report, words such as “believe,” “expect,” “intend,” “goal,” “plan,” “pursue,” “likely,” “believe,” “project,” “anticipate,” “intend,” “estimate,” “evaluate,” “opinion,” “may,” “could,” “future,” “potential,” “probable,” “if,” “will” and similar expressions generally identify forward-looking statements. These statements are subject to risks and uncertainties.

Forward-looking statements in this Quarterly Report on Form 10-Q represent our beliefs, projections and predictions about future events. These statements are necessarily subjective and involve known and unknown risks, uncertainties and other important factors that could cause our actual results, performance or achievements, or industry results, to differ materially from any future results, performance or achievement described in or implied by such statements. Actual results may differ materially from the expected results described in our forward-looking statements, including with respect to the correct measurement and identification of factors affecting our business or the extent of their likely impact, the accuracy and completeness of publicly available information relating to the factors upon which our business strategy is based, or the success of our business. The factors or uncertainties that could cause actual results, performance or achievement to differ materially from forward-looking statements contained in this report can be found in our filings with the Securities and Exchange Commission, including our filings on Form 10-K.

Highlights

Financial highlights:

●	Total revenue increased 54% to $1,046,019 for the three months ended June 30, 2015 as compared to $678,111 for the prior period;

●	Total revenue increased 62% to $1,670,533 for the six months ended June 30, 2015 as compared to $1,034,340 for the prior period;

●	Gross profit increased 54% to $636,836 for the three months ended June 30, 2015 as compared to $413,255 for the prior period;

●	Gross profit increased 64% to $925,494 for the six months ended June 30, 2015 as compared to $563,894 for the prior period;

●	Total cash equivalents increased 344% to $2,875,941 at June 30, 2015 from $647,093 at December 31, 2014;

●	Working capital surplus increased 441% to $2,264,512 at June 30, 2015 from $418,734 at December 31, 2014;

●	Total assets increased 110% to $5,282,567 at June 30, 2015 from $2,511,448 at December 31, 2014; and

●	Stockholder equity increased 179% to $2,997,385 at June 30, 2015 from $1,074,788 at December 31, 2014.

Non-financial highlights and milestones:

●	We signed a distribution agreement with Z-Medica, LLC, a leading developer of hemostatic devices like QuikClot Combat Gauze®;

●	We were selected as Supplier of Backup Support, Medical Equipment for Health Services at Special Olympics World Games Los Angeles 2015 (LA2015); our OxySure Model 615 emergency oxygen device was deployed into all the competition venues and medical operations of the Games, along with Automated External Defibrillators (AEDs) and OxySure branded pulse oximeters supplied by us;

●	We appointed three new Territory Managers in Minneapolis, Philadelphia, and San Antonio. These appointments followed other appointments during 1Q2015 by us of Territory Managers in Michigan, Georgia, Colorado, Western Pennsylvania, Arizona, and North Texas;

●	We signed a distribution agreement with Team Life of New Jersey, an established organization in emergency health training and products with three locations in Middlesex, Cherry Hill and Colts Neck, New Jersey; and

●	We unveiled plans for a medical drone solution to be utilized in aerial operations in support of emergency response and services, disaster response and recovery, search and rescue, and humanitarian relief efforts.

Overview

OxySure Systems, Inc. was formed on January 15, 2004 as a Delaware “C” Corporation for the purpose of developing products with the capability of generating medical grade oxygen “on demand,” without the necessity of storing oxygen in compressed tanks. Our technology, process and methodologies involve the creation of medically pure (USP) oxygen from two dry, inert powders. We believe that other available chemical oxygen generating technologies contain hazards that make them commercially unviable for broad-based emergency use by lay rescuers or the general public. Our launch product is the OxySure Model 615 portable emergency oxygen system. We believe that the OxySure Model 615 is currently the only product on the market that can be safely pre-positioned in public and private venues for emergency administration of medical oxygen by lay persons, without the need for training.

To date, we have been issued 9 patents and we have other patents pending on this process and technology that we believe is revolutionizing the emergency/short duration oxygen supply marketplace. We believe that OxySure makes the delivery devices lighter, safer, more affordable and easier to use. We believe our products can improve access to emergency oxygen that affects the survival, recovery and safety of individuals in several areas of need: (1) Public and private places and settings where medical emergencies can occur; (2) Individuals at risk for cardiac, respiratory or general medical distress needing immediate help prior to emergency medical care arrival; and (3) Those requiring immediate protection and escape from exposure situations or oxygen-deficient situations in industrial, mining, military, or other “Immediately Dangerous to Life or Health” (IDLH) environments.

The OxySure Model 615 emergency oxygen device was cleared by the Food and Drug Administration (“FDA”) (510k, Class II) for over-the-counter purchase in December 2005. We believe it bridges the gap between the onset of a medical emergency and the time first responders arrive on the scene. We believe it allows a lay rescuer – a bystander or loved one – to administer medical oxygen during those first, critical minutes after an emergency occurs, improving medical outcomes and saving lives in the process. In March 2014 we also received CE Marking approval for Model 615, allowing us to begin commercializing it in the European Union.

We have since diversified our product portfolio to provide include solutions focused on the emergency medical preparedness and respiratory needs of our education, commercial and government customers. Our solutions include Automated External Defibrillators (AEDs) and accessories, resuscitation equipment, and respiratory and monitoring equipment and supplies.

The OxySure Strategy

The following summarizes the principal elements of our strategy:

●

We launched the OxySure Model 615 into the K-12 education market in the United States, and we subsequently diversified into other institutional markets, such as colleges, churches and places of worship, manufacturing facilities and other commercial and municipal buildings. We plan to continue to pursue institutional customers in these and other vertical markets, both in the United States and internationally.

●

We believe that Model 615 is a natural complement and companion product to an Automated External Defibrillator (AED). We plan to continue to market Model 615 as a companion product to AEDs, and our goal in the foreseeable future is to pursue the placement of the OxySure Model 615 next to as many AEDs as possible, in the United States as well as internationally. According to Frost & Sullivan, there are approximately We believe in the long term, however, Model 615 has the potential to become a standard issue item for public and private settings, just like a fire extinguisher.

●	We plan to continue to leverage our core competencies in oxygen, breathing technologies, research and manufacturing to pursue revenue opportunities in new vertical markets, including the military.

●	We plan to continue to build our sales force by recruiting dedicated sales professionals focusing on business to business sales, former first responders, paramedics and firefighters as well individuals from other medical, first aid and safety sales areas to market our products and craft solutions for our customers.

●	Our channel strategy includes leveraging distribution partnerships to enhance market penetration, and we plan to increase our efforts to partner with distributors, including distributors of AEDs, safety products and medical devices. We plan to invest resources in training and tools for our distribution partners’ sales, systems and support organizations, in order to improve the overall efficiency and effectiveness of these partnerships.

●

We plan to continue our increasing efforts to promote market awareness and education of our products and their critical need, and our efforts may include partnerships with industry, medical thought leaders, and community and advocacy organizations.

●

We plan to market to “at risk” markets – people with conditions such as asthma and other respiratory and medical conditions where supplemental or emergency oxygen is either required or desired – by way of direct to consumer campaigns utilizing television, print and online media to increase sales, awareness and brand recognition.

●	We plan to pursue market catalysts such as a legislative agenda for state and federal mandates, medical reimbursement for at risk markets, and insurance underwriting benefits and discounts for product users.

●

We plan to continue to diversify our product offerings through the addition of complimentary or additive products and solutions that enhance our core product usability, feasibility, appeal or application, or that enhances our ability to access or add value to existing and new customers. In addition, we plan to continue our development efforts focused on developing new products incorporating our core “oxygen from powder” technology for other vertical markets, such as aviation, mining, and sports and recreation as applicable.

●	We plan to pursue strategic alliances where applicable to accelerate our growth and access to new customers, sales channels, markets and products.

Results of Operations

You should read the selected financial data set forth below along with our discussion and our financial statements and the related notes. We have derived the financial data from our unaudited financial statements. We believe the financial data shown in the table below include all adjustments consisting only of normal recurring adjustments, that we consider necessary for a fair presentation of such information. Operating results for the period are not necessarily indicative of the results that may be expected in the future.

Results for the Three Months Ended June 30, 2015 Compared to the Three Months Ended June 30, 2014 (unaudited)

	Three Months Ended
	June 30
	2015			2014

Net loss	$	(1,258,436	)	$	(319,508	)
Shares used in computing basic and diluted loss per share amounts (weighted ave.)		30,215,788			25,996,642
Net loss per share:
Basic and diluted	$	(0.04	)	$	(0.01	)

Revenues

We had $1,046,019 in revenues from operations for the three months ended June 30, 2015 as compared to revenues of $678,111 for the three months ended June 30, 2014. The increase in revenues is primarily attributable to an increase in US product sales and military products.

Expenses

Total expenses for the three months ended June 30, 2015 were $2,423,159, which amount includes $1,247,913 of operating expenses, $409,183 in cost of goods sold, $561,791 in interest expense, and $204,272 in derivative expense, as compared to total expenses for the three months ended June 30, 2014 of $1,040,084, which amount includes $689,248 of operating expenses, $264,856 in cost of goods sold, and $85,980 in interest expense. The increase in total selling, general and administrative expenses is primarily attributable to an increase in advertising and promotional expense, an increase in other general and administrative expense, an increase in interest expense and derivative expense, and an increase in research and development expense. The increase in interest expense is primarily attributable to an increase in interest expense related to convertible notes.

Research and Development

Research and development expenses of $297,456 and $275,974 were incurred in the three months periods ended June 30, 2015 and 2014, respectively. The increase in research and development expense is primarily attributable to an increase in research and development expense associated with products for military markets.

Net Income (Loss)

Net loss for the three months ended June 30, 2015 was $1,258,438 and basic and diluted net loss per share was $(0.04) as compared to a net loss for the three months ended June 30, 2014 of $319,508 and basic and diluted net loss per share of $(0.01). The increase in net loss during the three months ended June 30, 2015 as compared to the three months ended June 30, 2014 is primarily due to the combined effect of an increase in research and development expense, an increase in interest expense and derivative expense, an increase in sales and marketing expense and an increase in other general and administrative expenses, offset by an increase in revenues and gross profit.

Results for the Six Months Ended June 30, 2015 Compared to the Six Months Ended June 30, 2014 (unaudited)

	Six Months Ended
	June 30
	2015			2014

Net loss	$	(2,598,537	)	$	(695,828	)
Shares used in computing basic and diluted loss per share amounts (weighted ave.)		29,587,327			25,956,948
Net loss per share:
Basic and diluted	$	(0.09	)	$	(0.03	)

Revenues

We had $1,670,533 in revenues from operations for the six months ended June 30, 2015 as compared to revenues of $1,034,340 for the six months ended June 30, 2014. The increase in revenues is primarily attributable to an increase in US product sales and military products.

Expenses

Total expenses for the six months ended June 30, 2015 were $4,390,546, which amount includes $2,548,290 of operating expenses, $745,039 in cost of goods sold, $892,945 in interest expense, and $204,272 in derivative expense, and as compared to total expenses for the six months ended June 30, 2014 of $1,788,528, which amount includes $1,124,494 of operating expenses, $470,447 in cost of goods sold, and $193,587 in interest expense. The increase in total selling, general and administrative expenses is primarily attributable to an increase in advertising and promotional expense, an increase in other general and administrative expense, an increase in interest expense, an increase in derivative expense, and an increase in research and development expense. The increase in interest expense is primarily attributable to an increase in interest expense related to convertible notes.

Research and Development

Research and development expenses of $510,801 and $277,515 were incurred in the six months periods ended June 30, 2015 and 2014, respectively. The increase in research and development expense is primarily attributable to an increase in research and development expense associated with products for military markets.

Net Income (Loss)

Net loss for the six months ended June 30, 2015 was $2,598,537 and basic and diluted net loss per share was $(0.09) as compared to a net loss for the six months ended June 30, 2014 of $695,828 and basic and diluted net loss per share of $(0.02). The increase in net loss during the six months ended June 30, 2015 as compared to the six months ended June 30, 2014 is primarily due to the combined effect of an increase in research and development expense, an increase in interest expense, an increase in derivative expense, an increase in sales and marketing expense and an increase in other general and administrative expenses, offset by an increase in revenues and gross profit.

Liquidity and Capital Resources

We had a cash balance of approximately $2,875,941 as of June 30, 2015, as compared to $647,093 as of December 31, 2014. Of this amount, $2,000,000 is held in a U.S. based third party escrow account, and is to be released upon an uplisting of our Company to a national stock exchange. The remainder of our funds is kept in financial institutions located in the United States of America.

We had a working capital surplus of $2,264,512 as of June 30, 2015 as compared to a working capital surplus of $418,734 as of December 31, 2014.

We had total notes payable of $1,159,832 and $647,829 as of June 30, 2015 and December 31, 2014, respectively. The increase in Notes Payable was primarily due to an increase new convertible notes payable offset by partial note conversions into common stock and note forgiveness related to an economic incentive received from the City of Frisco.

We generally provide our customers with terms of up to 30 days on our accounts receivable. In some cases we require prepayment, depending on history or credit review. Further, we generally require pre-payment on orders shipped to international destinations. Our accounts receivable, net of allowances, were $711,148 and $369,575 as at June 30, 2015 and December 31, 2014, respectively.

Since inception, we have been engaged primarily in product research and development, obtaining certain regulatory approvals, investigating markets for our products, developing manufacturing and supply chain partners, developing our production capability, and developing distribution, licensing and other channel relationships. In the course of funding research and development activities, we have sustained operating losses since inception and have an accumulated deficit of $20,639,745 at June 30, 2015.

We completed product development of our launch product, the OxySure Model 615 and launched sales thereof in 2008. We have and will continue to use significant capital to manufacture and commercialize our products. These factors raise doubt about our ability to continue as a going concern. In this regard, management is proposing to raise any necessary additional funds not provided by operations through loans or through additional sales of our common stock.

During the remainder of 2015 and 2016, we will need additional capital to market and sell our products, and to further develop and enhance our current product offerings, introduce new products and address unanticipated competitive threats, technical problems, economic conditions or other requirements. We estimate that we will require approximately $3.7 million over the next 12 months to remain viable. There is no assurance that we will be successful in raising this additional capital or in achieving profitable operations. The financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or amounts and classification of liabilities that might result from this uncertainty. However, there can be no assurance that any additional financing will be available to us. Additional equity financing may involve substantial dilution to our then existing stockholders. In the event we are unable to raise additional capital, we may be required to substantially reduce or curtail our activities.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

We are a smaller reporting company as defined by Rule 12b-2 of the Securities Exchange Act of 1934 and are not required to provide information under this item.

ITEM 4. CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

Our President and Chief Financial Officer has evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934) as of the end of period covered by this report. Based upon such evaluation, the President and Chief Financial Officer concluded that our disclosure controls and procedures were not effective to ensure that the information required to be disclosed by us in the reports that we file or submit under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and is accumulated and communicated to our management, including our President and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure.

Changes in Internal Control Over Financial Reporting

There were no changes in our internal control over financial reporting during the period covered by this report that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

PART II - OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

The Company is subject to litigation in the normal course of business, none of which management believes will have a material adverse effect on the Company’s financial statements.

On or about December 13 of 2013, Wall Street Buy Sell Hold, Inc., (“WSBSH”) filed a lawsuit against the Company in the New York Supreme Court, Nassau County. The suit seeks damages in the form of money, stock and warrants for breach of a marketing agreement entered into on October 22, 2012 and another entered into on March 11, 2013. We have answered the complaint and filed a counterclaim against WSBSH seeking the return of all moneys and shares we paid or transferred to WSBSH, as well as punitive damages for fraud.

On May 8, 2015, we filed a lawsuit against Wall Street Buy Sell Hold, Inc., and its principals Christopher and Jerry Castaldo in federal court in the Eastern District of Texas. The suit arises out of certain agreements made between the defendants and us. These and/or similar agreements are also the subject of parallel breach of contract actions between us and WSBSH in the 2013 suit in New York state.

The core of the Texas federal suit is that WSBSH attempted to contract to provide broker/dealer services despite the fact that, unbeknownst to us, its principal was a disgraced former broker who was not licensed to provide such services under state and federal law. Irrespective of the defendants' failed performance, the Texas suit seeks the return of the compensation and shares we paid and rescission of their illegal contracts, which are voidable at the option of the innocent party, as well as our attorney's fees.

On June 30, 2015, we issued $2.7 million in convertible preferred stock (“Series C, Series D and Series E Preferred Stock”) and $.3 million in 2 convertible notes (“Convertible Notes”). On July 14, 2015, a lawsuit was filed by Alpha Capital Anstalt (“Alpha”) against us and Adar Bays LLC, Union Capital LLC, JSJ Investments LLC, Group 10 Holdings LLC, and Macallan Partners LLC (the “Noteholders”) in the United States District Court for the Southern District of New York (the “Court”). Alpha is one of the holders of our Series B convertible preferred stock (“Series B Preferred”). In its complaint, Alpha claims that the issuance of the Series C, D and E Preferred Stock and of the Convertible Notes without allowing the Alpha the opportunity to invest constitutes, and that future conversions of the Series, C, D and E Preferred Stock and of the Convertible Notes into our common stock could constitute, a breach of contract under the terms of the Series B Preferred Stock and the terms of the stock purchase agreements pursuant to which the Alpha acquired its Series B Preferred Stock. Alpha asked for preliminary and permanent injunctive relief and monetary damages. On July16, 2015, the Court, upon hearing oral arguments from us and Plaintiff and ruling from the bench, denied Alpha preliminary injunctive relief. We believe this lawsuit to be an attempt by Alpha to extract more favorable terms from us and that it has no merit, and we intend to vigorously contest any remaining claims that might remain.

ITEM 1A. RISK FACTORS

We are a smaller reporting company as defined by Rule 12b-2 of the Securities Exchange Act of 1934 and are not required to provide information under this item.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

None.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

None.

ITEM 4. MINE SAFETY DISCLOSURES

Not applicable.

ITEM 5. OTHER INFORMATION

None.

ITEM 6. EXHIBITS

The following Exhibits are filed herein:

No.		Title

31.1		Certification of President Pursuant to the Securities Exchange Act of 1934, Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

31.2		Certification of Chief Financial Officer Pursuant to the Securities Exchange Act of 1934, Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

32		Certifications Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

DATED: August 19, 2015	OXYSURE SYSTEMS, INC.

	/s/ Julian T. Ross
	BY: Julian T. Ross
	ITS: President and Chief Financial Officer
	(Principal Executive Officer, Principal Financial Officer and Principal Accounting Officer)

EX-31.1 2 f10q0615ex31i_oxysure.htm

Exhibit 31.1

CERTIFICATION OF PRESIDENT

PURSUANT TO THE SECURITIES EXCHANGE ACT OF 1934,

RULES 13a-14(a) AND 15d-14(a)

AS ADOPTED PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Julian T. Ross, certify that:

1.	I have reviewed this Quarterly Report on Form 10-Q for the period ended June 30, 2015 of OxySure Systems, Inc.

Based upon my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report.

3.	Based upon my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report.

The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

Designed such disclosure control and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c.	Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting.

5.	The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrants’ board of directors (or persons performing the equivalent functions):

a.	All significant deficiencies and material weakness in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b.	Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: August 19, 2015

/s/ Julian T. Ross
Julian T. Ross,
President

EX-31.2 3 f10q0615ex31ii_oxysure.htm

Exhibit 31.2

CERTIFICATION OF CHIEF FINANCIAL OFFICER

PURSUANT TO THE SECURITIES EXCHANGE ACT OF 1934,

RULES 13a-14(a) AND 15d-14(a)

AS ADOPTED PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Julian T. Ross, certify that:

1.	I have reviewed this Quarterly Report on Form 10-Q for the period ended June 30, 2015 of OxySure Systems, Inc.

3.	Based upon my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report.

c.	Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

5.	The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrants’ board of directors (or persons performing the equivalent functions):

a.	All significant deficiencies and material weakness in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b.	Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: August 19, 2015

/s/ Julian T. Ross
Julian T. Ross,
Chief Financial Officer

EX-32 4 f10q0615ex32i_oxysure.htm

Exhibit 32

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of OxySure Systems, Inc. (the “Company”) on Form 10-Q for the period ending June 30, 2015 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Julian T. Ross, President and Chief Financial Officer of the Company, respectively, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

1.	The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2.	The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

Date: August 19, 2015

/s/ Julian T. Ross
Julian T. Ross,
President and Chief Financial Officer

GRAPHIC 5 image_001.jpg GRAPHIC begin 644 image_001.jpg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end EX-101.INS 6 oxys-20150630.xml XBRL INSTANCE FILE 0001413797 2004-04-30 0001413797 2004-04-01 2004-04-30 0001413797 oxys:FriscoPromissoryNoteMember 2011-03-22 0001413797 oxys:FriscoPromissoryNoteMember 2011-03-20 2011-03-22 0001413797 2013-12-31 0001413797 2014-04-01 2014-06-30 0001413797 us-gaap:MinimumMember 2014-04-01 2014-06-30 0001413797 us-gaap:MaximumMember 2014-04-01 2014-06-30 0001413797 country:US 2014-04-01 2014-06-30 0001413797 oxys:RowMember 2014-04-01 2014-06-30 0001413797 oxys:RowProductSalesMember 2014-04-01 2014-06-30 0001413797 us-gaap:ComputerSoftwareIntangibleAssetMember 2014-04-01 2014-06-30 0001413797 2014-01-01 2014-06-30 0001413797 us-gaap:MinimumMember 2014-01-01 2014-06-30 0001413797 us-gaap:MaximumMember 2014-01-01 2014-06-30 0001413797 country:US 2014-01-01 2014-06-30 0001413797 oxys:RowMember 2014-01-01 2014-06-30 0001413797 oxys:RowProductSalesMember 2014-01-01 2014-06-30 0001413797 us-gaap:ComputerSoftwareIntangibleAssetMember 2014-01-01 2014-06-30 0001413797 us-gaap:ConvertibleNotesPayableMember 2014-01-01 2014-06-30 0001413797 2014-06-30 0001413797 2014-12-31 0001413797 us-gaap:WarrantMember 2014-12-31 0001413797 us-gaap:EmployeeStockOptionMember 2014-12-31 0001413797 us-gaap:SeriesAPreferredStockMember 2014-12-31 0001413797 us-gaap:SeriesBPreferredStockMember 2014-12-31 0001413797 us-gaap:SeriesCPreferredStockMember 2014-12-31 0001413797 us-gaap:SeriesDPreferredStockMember 2014-12-31 0001413797 us-gaap:SeriesEPreferredStockMember 2014-12-31 0001413797 oxys:EmployeeMember us-gaap:EmployeeStockOptionMember 2014-12-31 0001413797 oxys:NonEmployeeStockOptionMember us-gaap:EmployeeStockOptionMember 2014-12-31 0001413797 2015-04-01 2015-06-30 0001413797 us-gaap:MinimumMember 2015-04-01 2015-06-30 0001413797 us-gaap:MaximumMember 2015-04-01 2015-06-30 0001413797 country:US 2015-04-01 2015-06-30 0001413797 oxys:RowMember 2015-04-01 2015-06-30 0001413797 oxys:RowProductSalesMember 2015-04-01 2015-06-30 0001413797 us-gaap:ComputerSoftwareIntangibleAssetMember 2015-04-01 2015-06-30 0001413797 us-gaap:SeriesCPreferredStockMember 2015-04-01 2015-06-30 0001413797 us-gaap:SeriesDPreferredStockMember 2015-04-01 2015-06-30 0001413797 us-gaap:SeriesEPreferredStockMember 2015-04-01 2015-06-30 0001413797 2015-01-01 2015-06-30 0001413797 us-gaap:MinimumMember 2015-01-01 2015-06-30 0001413797 us-gaap:MaximumMember 2015-01-01 2015-06-30 0001413797 country:US 2015-01-01 2015-06-30 0001413797 oxys:RowMember 2015-01-01 2015-06-30 0001413797 oxys:RowProductSalesMember 2015-01-01 2015-06-30 0001413797 us-gaap:ComputerSoftwareIntangibleAssetMember 2015-01-01 2015-06-30 0001413797 us-gaap:ConvertibleNotesPayableMember 2015-01-01 2015-06-30 0001413797 us-gaap:WarrantMember 2015-01-01 2015-06-30 0001413797 us-gaap:EmployeeStockOptionMember 2015-01-01 2015-06-30 0001413797 us-gaap:SeriesBPreferredStockMember 2015-01-01 2015-06-30 0001413797 oxys:EmployeeMember us-gaap:EmployeeStockOptionMember 2015-01-01 2015-06-30 0001413797 oxys:NonEmployeeStockOptionMember us-gaap:EmployeeStockOptionMember 2015-01-01 2015-06-30 0001413797 us-gaap:ChiefExecutiveOfficerMember 2015-01-01 2015-06-30 0001413797 us-gaap:NotesPayableOtherPayablesMember 2015-01-01 2015-06-30 0001413797 us-gaap:LeaseholdImprovementsMember us-gaap:MinimumMember 2015-01-01 2015-06-30 0001413797 us-gaap:LeaseholdImprovementsMember us-gaap:MaximumMember 2015-01-01 2015-06-30 0001413797 us-gaap:FurnitureAndFixturesMember 2015-01-01 2015-06-30 0001413797 us-gaap:MachineryAndEquipmentMember us-gaap:MinimumMember 2015-01-01 2015-06-30 0001413797 us-gaap:MachineryAndEquipmentMember us-gaap:MaximumMember 2015-01-01 2015-06-30 0001413797 us-gaap:ComputerSoftwareIntangibleAssetMember us-gaap:MinimumMember 2015-01-01 2015-06-30 0001413797 us-gaap:ComputerSoftwareIntangibleAssetMember us-gaap:MaximumMember 2015-01-01 2015-06-30 0001413797 2015-06-30 0001413797 oxys:FriscoPromissoryNoteMember 2015-06-30 0001413797 us-gaap:ConvertibleNotesPayableMember 2015-06-30 0001413797 us-gaap:WarrantMember 2015-06-30 0001413797 us-gaap:EmployeeStockOptionMember 2015-06-30 0001413797 us-gaap:SeriesAPreferredStockMember 2015-06-30 0001413797 us-gaap:SeriesBPreferredStockMember 2015-06-30 0001413797 us-gaap:SeriesCPreferredStockMember 2015-06-30 0001413797 us-gaap:SeriesDPreferredStockMember 2015-06-30 0001413797 us-gaap:SeriesEPreferredStockMember 2015-06-30 0001413797 oxys:EmployeeMember us-gaap:EmployeeStockOptionMember 2015-06-30 0001413797 oxys:NonEmployeeStockOptionMember us-gaap:EmployeeStockOptionMember 2015-06-30 0001413797 us-gaap:ChiefExecutiveOfficerMember 2015-06-30 0001413797 us-gaap:NotesPayableOtherPayablesMember 2015-06-30 0001413797 oxys:FriscoPromissoryNoteMember us-gaap:MaximumMember 2015-06-30 0001413797 oxys:FriscoPromissoryNoteMember us-gaap:MinimumMember 2015-06-30 0001413797 us-gaap:CommonStockMember us-gaap:SeriesAPreferredStockMember 2015-06-30 0001413797 us-gaap:CommonStockMember us-gaap:SeriesBPreferredStockMember 2015-06-30 0001413797 2015-08-18 xbrli:shares iso4217:USD iso4217:USDxbrli:shares xbrli:pure OxySure Systems Inc 0001413797 false --12-31 10-Q 2015-06-30 Q2 2015 Smaller Reporting Company 32003034

657673

21981

647093

875941

369575

711148

277346

422551

463308 448308

53588

91747

1810910

4549695

91537

88617

362764

347650

246237

296605

2511448

5282567

558338

810784

154850

200000

149

40897

43723

606932

981475

31010

249200

1392176

2285182

44484

1436660

2285182

296

258

385

525

266

11377

12492

-1231666

19104322

24854869

-18041208

-20639745

1074788

2997385

2511448

5282567

0.0005

1.00

1000

25000000

3143237

593750

1145

518750

900

770000

1050000

531666

593750

1145

518750

900

770000

1050000

531666

0.0004

100000000

28438631

31224000

28438631

31224000

678111

1034340

1046019

1670533

264856

470446

409183

745039

413255

563894

636836

925494

275974

277515

297456

510801

154044

241993

329393

794139

259230

604987

621066

1243350

689248

1124495

1247915

2548290

-275993

-560600

-611079

-1622796

85980

193587

561791

892945

638190

119933

122584

204272

42465

58360

-1225

-1108

-43515

-135227

-647355

-975741

-319508

-695828

-1258434

-2598537

-0.01

-0.03

-0.04

-0.09

25996642

25956948

30215788

29587327

24853

21934

121140

803870

-37714

42525

-204272

122584

137150 4374

8883

17588

58611

106911

-62670

363543

341573

-1804

145205

-36692 -15000

-62509

38159

50368

304405

282345

-2976

-531507

-1691105

70651

3900

198

-70849

-3900

10672

80001

-2650001

-9800

108300 92000

247500

1461000

192000

175000

1008

149

-33336

3923853

-635692

2228848

246

804138

808532

165200

<p style="color: #000000; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; font-family: 'times new roman', serif; margin: 0px;">NOTE 1 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED) <p style="color: #000000; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; font-family: 'times new roman', serif; margin: 0px; text-align: justify; text-indent: 0.5in;">  <p style="color: #000000; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; font-family: 'times new roman', serif; margin: 0px; text-align: justify;">Other Assets– We record Other Assets net of accumulated amortization. Amortization expense for Other Assets was $21,911 and $10,051 for the three month periods ended June 30, 2015 and 2014, respectively. Amortization expense for Other Assets was $42,034 and $37,562 for the six month periods ended June 30, 2015 and 2014, respectively. <p style="color: #000000; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; font-family: 'times new roman', serif; margin: 0px; text-indent: 0.5in;">  <p style="color: #000000; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; font-family: 'times new roman', serif; margin: 0px; text-align: justify;">Capitalization of software: The Company accounts for internal-use software and website development costs, including the development of its partner marketplaces in accordance with ASC 350-50 (Intangibles – Website cost). The Company capitalizes internal costs consisting of payroll and direct payroll-related costs of employees who devote time to the development of internal-use software, as well as any external direct costs. It amortizes these costs over their estimated useful lives, which typically range between three to five years. The Company’s judgment is required in determining the point at which various projects enter the stages at which costs may be capitalized, in assessing the ongoing value of the capitalized costs, and in determining the estimated useful lives over which the costs are amortized. The estimated life is based on management’s judgment as to the product life cycle. <p style="color: #000000; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; font-family: 'times new roman', serif; margin: 0px; text-align: justify;">  <p style="color: #000000; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; font-family: 'times new roman', serif; margin: 0px; text-align: justify;">Amortization expense for websites and URLs was $9,654 and $9,654 for the three month periods ended June 30, 2015 and 2014, respectively. Amortization expense for websites and URLs was $19,309 and $19,309 for the six month periods ended June 30, 2015 and 2014, respectively. <p style="color: #000000; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; font-family: 'times new roman', serif; margin: 0px; text-align: justify; text-indent: 0.5in;">  <p style="color: #000000; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; font-family: 'times new roman', serif; margin: 0px; text-align: justify;">Research and Development Costs – Costs associated with the development of our products are charged to expense as incurred.  Research and development expense was $297,456 and $275,974 for the three month periods ended June 30, 2015 and 2014, respectively. Research and development expense was $510,801 and $277,515 for the six month periods ended June 30, 2015 and 2014, respectively. <p style="color: #000000; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; font-family: 'times new roman', serif; margin: 0px; text-indent: 0.5in;">  <p style="color: #000000; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; font-family: 'times new roman', serif; margin: 0px; text-align: justify;">Equity Warrants - We issued warrants to purchase shares of our common stock in connection with convertible notes. In accordance with ASC 470-20, Debt with conversions and other options, the proceeds from the notes were allocated based on the relative fair values of the notes without the warrants issued in conjunction with the notes and of the warrants themselves at the time of issuance. We record the fair value of the warrants at the time of issuance as additional paid in capital and as a debt discount to the notes.  We amortize this debt discount as interest expense over the life of the note.  Additionally, as a result of issuing the warrants with the convertible notes, a beneficial conversion option is recorded as a debt discount reflecting the incremental conversion option intrinsic value of the conversion option provided to the holders of the notes. We also amortize this debt discount as interest expense over the life of the notes.  The intrinsic value of each conversion option was calculated as the difference between the effective conversion price and the fair value of the common stock, multiplied by the number of shares into which the note is convertible. <p style="color: #000000; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; font-family: 'times new roman', serif; margin: 0px; text-indent: 0.5in;">  <p style="color: #000000; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; font-family: 'times new roman', serif; margin: 0px; text-align: justify;">Stock-Based Compensation – We account for share-based payments, including grants of stock options to employees, consultants and non-employees; moreover, we issue warrants to the consultants and related parties.  We are required to estimate the fair value of share-based awards and warrants on the date of grant. The value of the award is principally recognized as expense ratably over the requisite service periods. We have estimated the fair value of stock options and warrants as of the date of grant or assumption using the Black-Scholes option pricing model. <p style="color: #000000; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; font-family: 'times new roman', serif; margin: 0px; text-align: justify;">   <p style="color: #000000; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; font-family: 'times new roman', serif; margin: 0px; text-align: justify;">For the three month periods ended June 30, 2015 and 2014, stock based compensation expense was approximately $58,611 and $0, respectively, which consisted primarily of stock-based compensation expense related to stock options issued to the employees and recognized under GAAP. For the six month periods ended June 30, 2015 and 2014, stock based compensation expense was approximately $106,911 and $17,588, respectively. <p style="color: #000000; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; font-family: 'times new roman', serif; margin: 0px; text-indent: 0.5in;">  <p style="color: #000000; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; font-family: 'times new roman', serif; margin: 0px; text-align: justify;">Shipping and Handling Costs - Shipping and handling charges to customers are included in net revenues, and the associated costs incurred are recorded in cost of revenues. <p style="color: #000000; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; font-family: 'times new roman', serif; margin: 0px; text-indent: 0.5in;">  <p style="color: #000000; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; font-family: 'times new roman', serif; margin: 0px; text-align: justify;">Advertising Costs - Advertising costs are charged to operations when incurred.  We incurred $329,393 and $154,044 in advertising and promotion costs during the three month periods ended June 30, 2015 and 2014, respectively. Advertising and promotion costs during the six month periods ended June 30, 2015 and 2014 were $794,139 and $241,993, respectively. <p style="color: #000000; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; font-family: 'times new roman', serif; margin: 0px; text-indent: 0.5in;">  <p style="color: #000000; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; font-family: 'times new roman', serif; margin: 0px; text-align: justify;">Net Income (Loss) Per Share - Basic earnings (loss) per share is computed based on the weighted average number of common shares outstanding. However, basic loss per share excludes anti-dilutive securities. Diluted earnings per share is computed based on the weighted average number of common shares outstanding, increased by the number of additional shares that would have been outstanding had the potentially dilutive common shares been issued, and reduced by the number of shares the Company could have repurchased from the proceeds from issuance of the potentially dilutive shares. Potentially dilutive shares of common stock include stock options and other stock-based awards granted under stock-based compensation plans and shares committed to be purchased under the employee stock purchase plan. As of June 30, 2015 there were 18,268,932 potentially dilutive shares. <p style="color: #000000; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; font-family: 'times new roman', serif; margin: 0px; text-align: justify;">   <p style="color: #000000; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; font-family: 'times new roman', serif; margin: 0px;">Recent Accounting Pronouncements <p style="color: #000000; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; font-family: 'times new roman', serif; margin: 0px; text-indent: 0.5in;">  <p style="color: #000000; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; font-family: 'times new roman', serif; margin: 0px; text-align: justify;">We have reviewed recent accounting pronouncements and concluded that they are either not applicable to our business or that no material effect is expected on the financial statements as a result of future adoption.

<p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; margin: 0px;">NOTE 3 - SHAREHOLDERS’ EQUITY <p style="color: #000000; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; font-family: 'times new roman', serif; margin: 0px; text-indent: 0.5in;">  <p style="color: #000000; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; font-family: 'times new roman', serif; margin: 0px; text-align: justify;">Preferred Shares Rights <p style="color: #000000; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; font-family: 'times new roman', serif; margin: 0px; text-align: justify; text-indent: 0.5in;">  <p style="color: #000000; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; font-family: 'times new roman', serif; margin: 0px; text-align: justify;">We have 25,000,000 shares of preferred stock authorized, par value $0.0005 per share. <p style="color: #000000; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; font-family: 'times new roman', serif; margin: 0px; text-indent: 0.5in;">  <p style="color: #000000; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; font-family: 'times new roman', serif; margin: 0px; text-align: justify;">Series A Convertible Preferred Stock: As of June 30, 2015, the Company had authorized the issuance of 3,143,237 shares of preferred stock designated as Series A Convertible Preferred Stock (“Series A Preferred”). The original issue price of the Series A Preferred is $1.00 per share. There were 518,750 and 593,750 Series A Preferred shares issued and outstanding as of June 30, 2015 and December 31, 2014, respectively. <p style="color: #000000; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; font-family: 'times new roman', serif; margin: 0px; text-indent: 0.5in;">  <p style="color: #000000; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; font-family: 'times new roman', serif; margin: 0px; text-align: justify;">During the three months ended June 30, 2015 the Company did not issue any shares of the Series A Preferred, and no shares of the Series A Preferred have been converted into common stock. <p style="color: #000000; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; font-family: 'times new roman', serif; margin: 0px; text-indent: 0.5in;">  <p style="color: #000000; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; font-family: 'times new roman', serif; margin: 0px; text-align: justify;">Series B Convertible Preferred Stock: As of June 30, 2015, we had 3,500 shares of preferred stock designated as Series B Convertible Preferred Stock (“Series B Preferred”). The original issue price of the Series B Preferred is $1,000 per share. There were 900 and 1,145 Series B Preferred shares issued and outstanding as of June 30, 2015 and December 31, 2014, respectively. <p style="color: #000000; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; font-family: 'times new roman', serif; margin: 0px; text-indent: 0.5in;">  <p style="color: #000000; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; font-family: 'times new roman', serif; margin: 0px; text-indent: 0.5in;"> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;">During the three months ended June 30, 2015 the Company did not issue any shares of the Series B Preferred and 75 shares of Series B Preferred were converted into 204,188 shares of our common stock. <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify; text-indent: 0.5in;">  <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;">Series C Convertible Preferred Stock: As of June 30, 2015, we had 770,000 shares of preferred stock designated as Series C Convertible Preferred Stock (“Series C Preferred”). The original issue price of the Series C Preferred is $2.00 per share. There were 770,000 and 0 Series C Preferred shares issued and outstanding as of June 30, 2015 and December 31, 2014, respectively. <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-indent: 36pt;">  <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; margin: 0px; text-align: justify;">During the three months ended June 30, 2015 the Company issued 770,000 shares of the Series C Preferred and no shares of Series C Preferred were converted into common stock. <p style="color: #000000; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; font-family: 'times new roman', serif; margin: 0px; text-indent: 0.5in;">  <p style="color: #000000; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; font-family: 'times new roman', serif; margin: 0px; text-align: justify;">Series D Convertible Preferred Stock: As of June 30, 2015, we had 1,050,000 shares of preferred stock designated as Series D Convertible Preferred Stock (“Series D Preferred”). The original issue price of the Series D Preferred is $2.00 per share. There were 1,050,000 and 0 shares of the Series D Preferred issued and outstanding as of June 30, 2015 and December 31, 2014, respectively. <p style="color: #000000; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; font-family: 'times new roman', serif; margin: 0px; text-indent: 0.5in;">  <p style="color: #000000; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; font-family: 'times new roman', serif; margin: 0px; text-align: justify;">During the three months ended June 30, 2015 the Company issued 1,050,000 shares of the Series D Preferred and no shares of Series D Preferred were converted into common stock. <p style="color: #000000; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; font-family: 'times new roman', serif; margin: 0px; text-align: justify;">  <p style="color: #000000; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; font-family: 'times new roman', serif; margin: 0px; text-align: justify;">Series E Convertible Preferred Stock: As of June 30, 2015, we had 531,666 shares of preferred stock designated as Series E Convertible Preferred Stock (“Series E Preferred”). The original issue price of the Series E Preferred is $1.00 per share. There were 531,666 and 0 shares of the Series E Preferred issued and outstanding as of June 30, 2015 and December 31, 2014, respectively. <p style="color: #000000; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; font-family: 'times new roman', serif; margin: 0px; text-indent: 0.5in;">  <p style="color: #000000; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; font-family: 'times new roman', serif; margin: 0px; text-align: justify;">During the three months ended June 30, 2015 the Company issued 531,666 shares of the Series E Preferred and no shares of Series E Preferred were converted into common stock. <p style="color: #000000; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; font-family: 'times new roman', serif; margin: 0px;">  <p style="color: #000000; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; font-family: 'times new roman', serif; margin: 0px; text-align: justify;">Common Stock <p style="color: #000000; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; font-family: 'times new roman', serif; margin: 0px; text-indent: 0.5in;">  <p style="color: #000000; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; font-family: 'times new roman', serif; margin: 0px; text-align: justify;">The Company has authorized 100,000,000 shares of $0.0004 par value common stock. <p style="color: #000000; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; font-family: 'times new roman', serif; margin: 0px; text-indent: 0.5in;">  <p style="color: #000000; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; font-family: 'times new roman', serif; margin: 0px; text-align: justify;">During the three months ended June 30, 2015: <p style="color: #000000; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; font-family: 'times new roman', serif; margin: 0px; text-align: justify; text-indent: 0.5in;">  <p style="color: #000000; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; font-family: 'times new roman', serif; margin: 0px; text-align: justify; text-indent: 0.5in;"> <table style="width: 1584px; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman', times, serif; font-size: 10pt; word-spacing: 0px; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"> <tr style="vertical-align: top;"> <td style="width: 24px; line-height: 15.3333320617676px;"> </td> <td style="width: 24px; line-height: 15.3333320617676px;">(1)</td> <td style="text-align: justify; line-height: 15.3333320617676px;">We issued 133,333 shares of common stock for $80,000 in cash.</td> </tr> <tr style="vertical-align: top;"> <td style="line-height: 15.3333320617676px;"> </td> <td style="line-height: 15.3333320617676px;">(2)</td> <td style="text-align: justify; line-height: 15.3333320617676px;">We issued 204,188 shares of common stock pursuant to the cashless conversion of 75 shares of Series B Preferred;</td> </tr> <tr style="vertical-align: top;"> <td style="line-height: 15.3333320617676px;"> </td> <td style="line-height: 15.3333320617676px;">(3)</td> <td style="text-align: justify; line-height: 15.3333320617676px;">We issued 1,256,453 shares of common stock pursuant to the conversion of convertible notes;</td> </tr> <tr style="vertical-align: top;"> <td style="line-height: 15.3333320617676px;"> </td> <td> <p style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: 15.3333320617676px; font-family: 'times new roman', times, serif; margin: 0px;">(4) </td> <td> <p style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: 15.3333320617676px; font-family: 'times new roman', times, serif; margin: 0px; text-align: justify;">We issued 770,000 shares of the Series C Preferred for for which we received $700,000 in cash and recorded a stock subscription receivable for the remaining $700,000; </td> </tr> <tr style="vertical-align: top;"> <td style="line-height: 15.3333320617676px;"> </td> <td>(5)</td> <td style="text-align: justify;">We issued 1,050,000 shares of the Series D Preferred for $2,000,000 in cash held in escrow, to be released upon our uplisting to a national exchange;</td> </tr> <tr style="vertical-align: top;"> <td style="line-height: 15.3333320617676px;"> </td> <td style="line-height: 15.3333320617676px;">(6)</td> <td style="text-align: justify; line-height: 15.3333320617676px;">We recorded $58,611 for the computed fair value of options issued to employees, non-employee directors, and consultants, net of cancellations and forfeitures; and</td> </tr> <tr style="vertical-align: top;"> <td style="line-height: 15.3333320617676px;"> </td> <td style="line-height: 15.3333320617676px;">(7)</td> <td style="text-align: justify; line-height: 15.3333320617676px;">We recorded $400,196 in connection with beneficial conversion features.</td> </tr> </table> <p style="color: #000000; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; font-family: 'times new roman', serif; margin: 0px; text-align: justify; text-indent: 0.5in;"> <p style="color: #000000; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; font-family: 'times new roman', serif; margin: 0px; text-align: justify; text-indent: 0.5in;">  <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;">As of June 30, 2015 we had approximately 31,244,000 shares of common stock issued and outstanding.

<div><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">NOTE 4 - STOCK OPTIONS AND WARRANTS<p style="font: 10pt/normal 'times new roman', serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"> <p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">Equity Incentive Plans<p style="font: 10pt/normal 'times new roman', serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"> <p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">In April 2004, our Board of Directors and the stockholders at that time approved the adoption of a Voting Stock Option Plan (“the Plan”), which provides for the issuance of stock options to eligible employees, consultants, Board members and Advisory Board members of the Company to acquire up to a maximum of 5,000,000 shares of common stock.<p style="font: 10pt/normal 'times new roman', serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"> <p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">Our Board of Directors, which determines the number of options that will be granted, the effective dates of the grants, the option process and the vesting schedules, administers the Plan. In the absence of an established market for the common stock of the Company, the Board of Directors determines the fair market value of our common stock. Options generally expire between five and ten years from the date of grant and automatically terminate 90 days after such optionee ceases to be an eligible individual under the Plan other than by reason of death or disability.<p style="font: 10pt/normal 'times new roman', serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"> <p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">The portion of options granted that is not exercisable on the date the optionee ceases to be an eligible individual under the Plan by reason other than death, shall terminate and be forfeited to the Company on the date of such cessation. An optionee has no right as a stockholder with respect to any shares covered by the options granted to him until a certificate representing such shares is issued to them.<p style="font: 10pt/normal 'times new roman', serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"> <p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">Stock Options<p style="font: 10pt/normal 'times new roman', serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"> <p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">The following table summarizes information about the number and weighted average of the options that were forfeited or expired under the Plan as at June 30, 2015:<p style="font: 10pt/normal 'times new roman', serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"> <table style="font: 10pt/normal calibri, helvetica, sans-serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom;"><td> </td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', serif;"> </td><td style="text-align: center; font-family: 'times new roman', serif; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="6">Employee</td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', serif;"> </td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', serif;"> </td><td style="text-align: center; font-family: 'times new roman', serif; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="6">Non-Employee</td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', serif;"> </td><td style="padding-bottom: 1.5pt;"> </td><td colspan="2"> </td><td style="padding-bottom: 1.5pt;"> </td></tr><tr style="vertical-align: bottom;"><td> </td><td> </td><td colspan="2"> </td><td> </td><td style="font-family: 'times new roman', serif;"> </td><td style="text-align: center; font-family: 'times new roman', serif;" colspan="2">Weighted</td><td style="font-family: 'times new roman', serif;"> </td><td> </td><td colspan="2"> </td><td> </td><td style="font-family: 'times new roman', serif;"> </td><td style="text-align: center; font-family: 'times new roman', serif;" colspan="2">Weighted</td><td style="font-family: 'times new roman', serif;"> </td><td> </td><td colspan="2"> </td><td> </td></tr><tr style="vertical-align: bottom;"><td> </td><td style="font-family: 'times new roman', serif;"> </td><td style="text-align: center; font-family: 'times new roman', serif;" colspan="2">Number</td><td style="font-family: 'times new roman', serif;"> </td><td style="font-family: 'times new roman', serif;"> </td><td style="text-align: center; font-family: 'times new roman', serif;" colspan="2">Average</td><td style="font-family: 'times new roman', serif;"> </td><td style="font-family: 'times new roman', serif;"> </td><td style="text-align: center; font-family: 'times new roman', serif;" colspan="2">Number</td><td style="font-family: 'times new roman', serif;"> </td><td style="font-family: 'times new roman', serif;"> </td><td style="text-align: center; font-family: 'times new roman', serif;" colspan="2">Average</td><td style="font-family: 'times new roman', serif;"> </td><td style="font-family: 'times new roman', serif;"> </td><td style="text-align: center; font-family: 'times new roman', serif;" colspan="2">Combined</td><td style="font-family: 'times new roman', serif;"> </td></tr><tr style="vertical-align: bottom;"><td> </td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', serif;"> </td><td style="text-align: center; font-family: 'times new roman', serif; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Of</td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', serif;"> </td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', serif;"> </td><td style="text-align: center; font-family: 'times new roman', serif; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Exercise</td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', serif;"> </td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', serif;"> </td><td style="text-align: center; font-family: 'times new roman', serif; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Of</td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', serif;"> </td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', serif;"> </td><td style="text-align: center; font-family: 'times new roman', serif; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Exercise</td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', serif;"> </td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', serif;"> </td><td style="text-align: center; font-family: 'times new roman', serif; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Total</td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', serif;"> </td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="width: 627px; padding-bottom: 4pt; font-family: 'times new roman', serif;">Outstanding at March 31, 2015</td><td style="width: 16px; padding-bottom: 4pt; font-family: 'times new roman', serif;"> </td><td style="width: 16px; text-align: left; font-family: 'times new roman', serif; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;"> </td><td style="width: 142px; text-align: right; font-family: 'times new roman', serif; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">2,513,838</td><td style="width: 16px; text-align: left; padding-bottom: 4pt; font-family: 'times new roman', serif;"> </td><td style="width: 16px; padding-bottom: 4pt; font-family: 'times new roman', serif;"> </td><td style="width: 16px; text-align: left; font-family: 'times new roman', serif; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">$</td><td style="width: 142px; text-align: right; font-family: 'times new roman', serif; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">0.41</td><td style="width: 16px; text-align: left; padding-bottom: 4pt; font-family: 'times new roman', serif;"> </td><td style="width: 16px; padding-bottom: 4pt; font-family: 'times new roman', serif;"> </td><td style="width: 16px; text-align: left; font-family: 'times new roman', serif; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;"> </td><td style="width: 141px; text-align: right; font-family: 'times new roman', serif; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">-</td><td style="width: 15px; text-align: left; padding-bottom: 4pt; font-family: 'times new roman', serif;"> </td><td style="width: 15px; padding-bottom: 4pt; font-family: 'times new roman', serif;"> </td><td style="width: 15px; text-align: left; font-family: 'times new roman', serif; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">$</td><td style="width: 141px; text-align: right; font-family: 'times new roman', serif; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">-</td><td style="width: 15px; text-align: left; padding-bottom: 4pt; font-family: 'times new roman', serif;"> </td><td style="width: 15px; padding-bottom: 4pt; font-family: 'times new roman', serif;"> </td><td style="width: 15px; text-align: left; font-family: 'times new roman', serif; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;"> </td><td style="width: 141px; text-align: right; font-family: 'times new roman', serif; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">2,513,838</td><td style="width: 15px; text-align: left; padding-bottom: 4pt; font-family: 'times new roman', serif;"> </td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="font-family: 'times new roman', serif;">Granted</td><td style="font-family: 'times new roman', serif;"> </td><td style="text-align: left; font-family: 'times new roman', serif;"> </td><td style="text-align: right; font-family: 'times new roman', serif;">-</td><td style="text-align: left; font-family: 'times new roman', serif;"> </td><td style="font-family: 'times new roman', serif;"> </td><td style="text-align: left; font-family: 'times new roman', serif;">$</td><td style="text-align: right; font-family: 'times new roman', serif;">-</td><td style="text-align: left; font-family: 'times new roman', serif;"> </td><td style="font-family: 'times new roman', serif;"> </td><td style="text-align: left; font-family: 'times new roman', serif;"> </td><td style="text-align: right; font-family: 'times new roman', serif;">-</td><td style="text-align: left; font-family: 'times new roman', serif;"> </td><td style="font-family: 'times new roman', serif;"> </td><td style="text-align: left; font-family: 'times new roman', serif;">$</td><td style="text-align: right; font-family: 'times new roman', serif;">-</td><td style="text-align: left; font-family: 'times new roman', serif;"> </td><td style="font-family: 'times new roman', serif;"> </td><td style="text-align: left; font-family: 'times new roman', serif;"> </td><td style="text-align: right; font-family: 'times new roman', serif;">-</td><td style="text-align: left; font-family: 'times new roman', serif;"> </td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="font-family: 'times new roman', serif;">Exercised</td><td style="font-family: 'times new roman', serif;"> </td><td style="text-align: left; font-family: 'times new roman', serif;"> </td><td style="text-align: right; font-family: 'times new roman', serif;">-</td><td style="text-align: left; font-family: 'times new roman', serif;"> </td><td style="font-family: 'times new roman', serif;"> </td><td style="text-align: left; font-family: 'times new roman', serif;">$</td><td style="text-align: right; font-family: 'times new roman', serif;">-</td><td style="text-align: left; font-family: 'times new roman', serif;"> </td><td style="font-family: 'times new roman', serif;"> </td><td style="text-align: left; font-family: 'times new roman', serif;"> </td><td style="text-align: right; font-family: 'times new roman', serif;">-</td><td style="text-align: left; font-family: 'times new roman', serif;"> </td><td style="font-family: 'times new roman', serif;"> </td><td style="text-align: left; font-family: 'times new roman', serif;">$</td><td style="text-align: right; font-family: 'times new roman', serif;">-</td><td style="text-align: left; font-family: 'times new roman', serif;"> </td><td style="font-family: 'times new roman', serif;"> </td><td style="text-align: left; font-family: 'times new roman', serif;"> </td><td style="text-align: right; font-family: 'times new roman', serif;">-</td><td style="text-align: left; font-family: 'times new roman', serif;"> </td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="padding-bottom: 1.5pt; font-family: 'times new roman', serif;">Forfeited/Cancelled</td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', serif;"> </td><td style="text-align: left; font-family: 'times new roman', serif; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;"> </td><td style="text-align: right; font-family: 'times new roman', serif; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">-</td><td style="text-align: left; padding-bottom: 1.5pt; font-family: 'times new roman', serif;"> </td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', serif;"> </td><td style="text-align: left; font-family: 'times new roman', serif; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">$</td><td style="text-align: right; font-family: 'times new roman', serif; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">-</td><td style="text-align: left; padding-bottom: 1.5pt; font-family: 'times new roman', serif;"> </td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', serif;"> </td><td style="text-align: left; font-family: 'times new roman', serif; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;"> </td><td style="text-align: right; font-family: 'times new roman', serif; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">-</td><td style="text-align: left; padding-bottom: 1.5pt; font-family: 'times new roman', serif;"> </td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', serif;"> </td><td style="text-align: left; font-family: 'times new roman', serif; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">$</td><td style="text-align: right; font-family: 'times new roman', serif; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">-</td><td style="text-align: left; padding-bottom: 1.5pt; font-family: 'times new roman', serif;"> </td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', serif;"> </td><td style="text-align: left; font-family: 'times new roman', serif; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;"> </td><td style="text-align: right; font-family: 'times new roman', serif; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">-</td><td style="text-align: left; padding-bottom: 1.5pt; font-family: 'times new roman', serif;"> </td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="padding-bottom: 4pt; font-family: 'times new roman', serif;">Outstanding at June 30, 2015</td><td style="padding-bottom: 4pt; font-family: 'times new roman', serif;"> </td><td style="text-align: left; font-family: 'times new roman', serif; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;"> </td><td style="text-align: right; font-family: 'times new roman', serif; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">2,513,838</td><td style="text-align: left; padding-bottom: 4pt; font-family: 'times new roman', serif;"> </td><td style="padding-bottom: 4pt; font-family: 'times new roman', serif;"> </td><td style="text-align: left; font-family: 'times new roman', serif; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">$</td><td style="text-align: right; font-family: 'times new roman', serif; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">0.41</td><td style="text-align: left; padding-bottom: 4pt; font-family: 'times new roman', serif;"> </td><td style="padding-bottom: 4pt; font-family: 'times new roman', serif;"> </td><td style="text-align: left; font-family: 'times new roman', serif; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;"> </td><td style="text-align: right; font-family: 'times new roman', serif; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">-</td><td style="text-align: left; padding-bottom: 4pt; font-family: 'times new roman', serif;"> </td><td style="padding-bottom: 4pt; font-family: 'times new roman', serif;"> </td><td style="text-align: left; font-family: 'times new roman', serif; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">$</td><td style="text-align: right; font-family: 'times new roman', serif; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">-</td><td style="text-align: left; padding-bottom: 4pt; font-family: 'times new roman', serif;"> </td><td style="padding-bottom: 4pt; font-family: 'times new roman', serif;"> </td><td style="text-align: left; font-family: 'times new roman', serif; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;"> </td><td style="text-align: right; font-family: 'times new roman', serif; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">2,513,838</td><td style="text-align: left; padding-bottom: 4pt; font-family: 'times new roman', serif;"> </td></tr></table><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"> <p style="font: 10pt/normal 'times new roman', serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">The number of stock options exercisable at June 30, 2015 was 1,627,296.<p style="font: 10pt/normal 'times new roman', serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"> <p style="font: 10pt/normal 'times new roman', serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">We used the following assumptions to estimate the fair value of options granted under the Plan for the three and six months ended June 30, 2015 and 2014:<p style="font: 10pt/normal 'times new roman', serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"> <table style="width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman', times, serif; word-spacing: 0px; border-collapse: collapse; widows: 1; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom;"><td style="font-size: 10pt;"> </td><td style="font: 10pt/normal 'times new roman', serif; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', serif; text-align: center; font-stretch: normal;" colspan="6">Equity Incentive Plans</td><td style="font: 10pt/normal 'times new roman', serif; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', serif; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', serif; text-align: center; font-stretch: normal;" colspan="6">Equity Incentive Plans</td><td style="font: 10pt/normal 'times new roman', serif; font-stretch: normal;"> </td></tr><tr style="vertical-align: bottom;"><td style="font-size: 10pt;"> </td><td style="font: 10pt/normal 'times new roman', serif; padding-bottom: 1.5pt; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', serif; text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;" colspan="6">for the Three Months Ended June 30,</td><td style="font: 10pt/normal 'times new roman', serif; padding-bottom: 1.5pt; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', serif; padding-bottom: 1.5pt; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', serif; text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;" colspan="6">for the Six Months Ended June 30,</td><td style="font: 10pt/normal 'times new roman', serif; padding-bottom: 1.5pt; font-stretch: normal;"> </td></tr><tr style="vertical-align: bottom;"><td style="font-size: 10pt;"> </td><td style="font: 10pt/normal 'times new roman', serif; padding-bottom: 1.5pt; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', serif; text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;" colspan="2">2015</td><td style="font: 10pt/normal 'times new roman', serif; padding-bottom: 1.5pt; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', serif; padding-bottom: 1.5pt; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', serif; text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;" colspan="2">2014</td><td style="font: 10pt/normal 'times new roman', serif; padding-bottom: 1.5pt; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', serif; padding-bottom: 1.5pt; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', serif; text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;" colspan="2">2015</td><td style="font: 10pt/normal 'times new roman', serif; padding-bottom: 1.5pt; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', serif; padding-bottom: 1.5pt; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', serif; text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;" colspan="2">2014</td><td style="font: 10pt/normal 'times new roman', serif; padding-bottom: 1.5pt; font-stretch: normal;"> </td></tr><tr style="vertical-align: bottom;"><td style="font-size: 10pt;"> </td><td style="font-size: 10pt;"> </td><td style="font-size: 10pt;" colspan="2"> </td><td style="font-size: 10pt;"> </td><td style="font-size: 10pt;"> </td><td style="font-size: 10pt;" colspan="2"> </td><td style="font-size: 10pt;"> </td><td style="font-size: 10pt;"> </td><td style="font-size: 10pt;" colspan="2"> </td><td style="font-size: 10pt;"> </td><td style="font-size: 10pt;"> </td><td style="font-size: 10pt;" colspan="2"> </td><td style="font-size: 10pt;"> </td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="font: 10pt/normal 'times new roman', serif; text-align: left; text-indent: 0pt; padding-left: 0pt; font-stretch: normal;">Expected terms (in years)</td><td style="font: 10pt/normal 'times new roman', serif; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', serif; text-align: left; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', serif; text-align: right; font-stretch: normal;">5-10</td><td style="font: 10pt/normal 'times new roman', serif; text-align: left; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', serif; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', serif; text-align: left; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', serif; text-align: right; font-stretch: normal;">5-10</td><td style="font: 10pt/normal 'times new roman', serif; text-align: left; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', serif; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', serif; text-align: left; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', serif; text-align: right; font-stretch: normal;">5-10</td><td style="font: 10pt/normal 'times new roman', serif; text-align: left; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', serif; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', serif; text-align: left; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', serif; text-align: right; font-stretch: normal;">5-10</td><td style="font: 10pt/normal 'times new roman', serif; text-align: left; font-stretch: normal;"> </td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="font: 10pt/normal 'times new roman', serif; width: 565px; text-indent: 0pt; padding-left: 0pt; font-stretch: normal;">Volatility (weighted ave.)</td><td style="font: 10pt/normal 'times new roman', serif; width: 16px; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', serif; width: 16px; text-align: left; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', serif; width: 204px; text-align: right; font-stretch: normal;">83.79</td><td style="font: 10pt/normal 'times new roman', serif; width: 16px; text-align: left; font-stretch: normal;">%</td><td style="font: 10pt/normal 'times new roman', serif; width: 16px; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', serif; width: 16px; text-align: left; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', serif; width: 204px; text-align: right; font-stretch: normal;">40.45</td><td style="font: 10pt/normal 'times new roman', serif; width: 16px; text-align: left; font-stretch: normal;">%</td><td style="font: 10pt/normal 'times new roman', serif; width: 16px; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', serif; width: 16px; text-align: left; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', serif; width: 203px; text-align: right; font-stretch: normal;">83.79</td><td style="font: 10pt/normal 'times new roman', serif; width: 15px; text-align: left; font-stretch: normal;">%</td><td style="font: 10pt/normal 'times new roman', serif; width: 15px; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', serif; width: 15px; text-align: left; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', serif; width: 203px; text-align: right; font-stretch: normal;">40.45</td><td style="font: 10pt/normal 'times new roman', serif; width: 15px; text-align: left; font-stretch: normal;">%</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="font: 10pt/normal 'times new roman', serif; text-align: left; text-indent: 0pt; padding-left: 0pt; font-stretch: normal;">Risk-free interest rate</td><td style="font: 10pt/normal 'times new roman', serif; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', serif; text-align: left; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', serif; text-align: right; font-stretch: normal;">.85% - 1.74%</td><td style="font: 10pt/normal 'times new roman', serif; text-align: left; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', serif; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', serif; text-align: left; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', serif; text-align: right; font-stretch: normal;">1.50% - 1.80%</td><td style="font: 10pt/normal 'times new roman', serif; text-align: left; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', serif; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', serif; text-align: left; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', serif; text-align: right; font-stretch: normal;">.85% - 1.74%</td><td style="font: 10pt/normal 'times new roman', serif; text-align: left; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', serif; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', serif; text-align: left; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', serif; text-align: right; font-stretch: normal;">1.44% - 1.80%</td><td style="font: 10pt/normal 'times new roman', serif; text-align: left; font-stretch: normal;"> </td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="font: 10pt/normal 'times new roman', serif; text-align: left; text-indent: 0pt; padding-left: 0pt; font-stretch: normal;">Expected dividend rate</td><td style="font: 10pt/normal 'times new roman', serif; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', serif; text-align: left; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', serif; text-align: right; font-stretch: normal;">0</td><td style="font: 10pt/normal 'times new roman', serif; text-align: left; font-stretch: normal;">%</td><td style="font: 10pt/normal 'times new roman', serif; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', serif; text-align: left; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', serif; text-align: right; font-stretch: normal;">0</td><td style="font: 10pt/normal 'times new roman', serif; text-align: left; font-stretch: normal;">%</td><td style="font: 10pt/normal 'times new roman', serif; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', serif; text-align: left; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', serif; text-align: right; font-stretch: normal;">0</td><td style="font: 10pt/normal 'times new roman', serif; text-align: left; font-stretch: normal;">%</td><td style="font: 10pt/normal 'times new roman', serif; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', serif; text-align: left; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', serif; text-align: right; font-stretch: normal;">0</td><td style="font: 10pt/normal 'times new roman', serif; text-align: left; font-stretch: normal;">%</td></tr></table><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">  <p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">The expected term of stock options represents the weighted average period the stock options are expected to remain outstanding. The expected term is based on the observed and expected time to exercise and post-vesting cancellations of options by optionees.  We use historical volatility in deriving our expected volatility assumption because it believes that future volatility over the expected term of the stock options is not likely to differ from the past.<p style="font: 10pt/normal 'times new roman', serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"> <p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">The expected dividend assumption is based on our history and expectation of dividend payouts.  The fair value of the shares of common stock underlying the stock options has historically been determined by the board of directors. On or before February 2012, when our common stock commenced trading on the over the counter bulletin board (OTCQB), there has been no public market for our common stock. Consequently, the board of directors has historically determined the fair value of the common stock at the time of grant of the option by considering a number of objective and subjective factors including valuation of comparable companies, operating and financial performance, the lack of liquidity of capital stock and general and industry specific economic outlook, amongst other factors.  <p style="font: 10pt/normal 'times new roman', serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"> <p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">FASB ASC 718 requires forfeitures to be estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates. The Company only records stock-based compensation expense for awards that are expected to vest. While we generally consider historical forfeitures in its estimates, judgment is also required in estimating the amount of stock-based awards that are expected to be forfeited. The Company’s estimates for forfeitures may differ from actual forfeitures. If actual results differ significantly from these estimates, stock-based compensation expense and its results of operations could be materially impacted when the Company records a true-up for the difference in the period that the awards vest. We adjust stock-based compensation expense based on our actual forfeitures on an annual basis, if necessary.<p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"> <p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">Stock compensation cost, using the graded vesting attribute method in accordance with Codification topic 718, is recognized over the requisite service period, generally 5 years, during which each tranche of shares is earned (zero, one, two, three, and four years).  The value of each tranche is generally amortized on a straight-line basis.  For the three months ended June 30, 2015 and 2014, stock based compensation expense was approximately $58,611 and $0, respectively, which consisted primarily of stock-based compensation expense related to stock options recognized under GAAP issued to employees.  For each of the three months ended June 30, 2015 and 2014, the number of options exercised was 0.<p style="font: 10pt/normal 'times new roman', serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"> <p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">Compensation expense is recognized only for the portion of stock options that are expected to vest, assuming an expected forfeiture rate in determining stock-based compensation expense, which could affect the stock-based compensation expense recorded if there is a significant difference between actual and estimated forfeiture rates. As of June 30, 2015, total unrecognized compensation cost related to stock-based awards granted to employees and non-employee directors was $323,715.<p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">  <p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">Warrants.<p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"> <p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">The following table summarizes our warrant activities for the three months ended June 30, 2015:<p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"> <table style="width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman', times, serif; word-spacing: 0px; border-collapse: collapse; widows: 1; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom;"><td style="font-size: 10pt;"> </td><td style="font-size: 10pt;"> </td><td style="font-size: 10pt;" colspan="2"> </td><td style="font-size: 10pt;"> </td><td style="font: 10pt/normal 'times new roman', serif; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', serif; text-align: center; font-stretch: normal;" colspan="2">Weighted</td><td style="font: 10pt/normal 'times new roman', serif; font-stretch: normal;"> </td></tr><tr style="vertical-align: bottom;"><td style="font-size: 10pt;"> </td><td style="font: 10pt/normal 'times new roman', serif; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', serif; text-align: center; font-stretch: normal;" colspan="2">Number</td><td style="font: 10pt/normal 'times new roman', serif; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', serif; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', serif; text-align: center; font-stretch: normal;" colspan="2">Average</td><td style="font: 10pt/normal 'times new roman', serif; font-stretch: normal;"> </td></tr><tr style="vertical-align: bottom;"><td style="font-size: 10pt;"> </td><td style="font: 10pt/normal 'times new roman', serif; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', serif; text-align: center; font-stretch: normal;" colspan="2">Of</td><td style="font: 10pt/normal 'times new roman', serif; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', serif; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', serif; text-align: center; font-stretch: normal;" colspan="2">Exercise</td><td style="font: 10pt/normal 'times new roman', serif; font-stretch: normal;"> </td></tr><tr style="vertical-align: bottom;"><td style="font-size: 10pt;"> </td><td style="font: 10pt/normal 'times new roman', serif; padding-bottom: 1.5pt; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', serif; text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;" colspan="2">Warrants</td><td style="font: 10pt/normal 'times new roman', serif; padding-bottom: 1.5pt; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', serif; padding-bottom: 1.5pt; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', serif; text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;" colspan="2">Price</td><td style="font: 10pt/normal 'times new roman', serif; padding-bottom: 1.5pt; font-stretch: normal;"> </td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="font: 10pt/normal 'times new roman', serif; width: 1191px; text-indent: 0pt; padding-bottom: 1.5pt; padding-left: 0pt; font-stretch: normal;">Outstanding at March 31, 2015</td><td style="font: 10pt/normal 'times new roman', serif; width: 16px; padding-bottom: 1.5pt; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', serif; width: 16px; text-align: left; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', serif; width: 142px; text-align: right; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;">3,304,260</td><td style="font: 10pt/normal 'times new roman', serif; width: 16px; text-align: left; padding-bottom: 1.5pt; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', serif; width: 15px; padding-bottom: 1.5pt; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', serif; width: 15px; text-align: left; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;">$</td><td style="font: 10pt/normal 'times new roman', serif; width: 141px; text-align: right; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;">1.28</td><td style="font: 10pt/normal 'times new roman', serif; width: 15px; text-align: left; padding-bottom: 1.5pt; font-stretch: normal;"> </td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="font: 10pt/normal 'times new roman', serif; text-indent: 0pt; padding-left: 0pt; font-stretch: normal;">Granted</td><td style="font: 10pt/normal 'times new roman', serif; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', serif; text-align: left; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', serif; text-align: right; font-stretch: normal;">1,659,696</td><td style="font: 10pt/normal 'times new roman', serif; text-align: left; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', serif; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', serif; text-align: left; font-stretch: normal;">$</td><td style="font: 10pt/normal 'times new roman', serif; text-align: right; font-stretch: normal;">1.11</td><td style="font: 10pt/normal 'times new roman', serif; text-align: left; font-stretch: normal;"> </td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="font: 10pt/normal 'times new roman', serif; text-indent: 0pt; padding-left: 0pt; font-stretch: normal;">Exercised</td><td style="font: 10pt/normal 'times new roman', serif; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', serif; text-align: left; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', serif; text-align: right; font-stretch: normal;">-</td><td style="font: 10pt/normal 'times new roman', serif; text-align: left; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', serif; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', serif; text-align: left; font-stretch: normal;">$</td><td style="font: 10pt/normal 'times new roman', serif; text-align: right; font-stretch: normal;">-</td><td style="font: 10pt/normal 'times new roman', serif; text-align: left; font-stretch: normal;"> </td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="font: 10pt/normal 'times new roman', serif; text-indent: 0pt; padding-bottom: 1.5pt; padding-left: 0pt; font-stretch: normal;">Forfeited/Cancelled</td><td style="font: 10pt/normal 'times new roman', serif; padding-bottom: 1.5pt; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', serif; text-align: left; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', serif; text-align: right; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;">-</td><td style="font: 10pt/normal 'times new roman', serif; text-align: left; padding-bottom: 1.5pt; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', serif; padding-bottom: 1.5pt; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', serif; text-align: left; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;">$</td><td style="font: 10pt/normal 'times new roman', serif; text-align: right; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-stretch: normal;">-</td><td style="font: 10pt/normal 'times new roman', serif; text-align: left; padding-bottom: 1.5pt; font-stretch: normal;"> </td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="font: 10pt/normal 'times new roman', serif; text-indent: 0pt; padding-bottom: 4pt; padding-left: 0pt; font-stretch: normal;">Outstanding at June 30, 2015</td><td style="font: 10pt/normal 'times new roman', serif; padding-bottom: 4pt; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', serif; text-align: left; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', serif; text-align: right; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;">4,963,956</td><td style="font: 10pt/normal 'times new roman', serif; text-align: left; padding-bottom: 4pt; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', serif; padding-bottom: 4pt; font-stretch: normal;"> </td><td style="font: 10pt/normal 'times new roman', serif; text-align: left; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;">$</td><td style="font: 10pt/normal 'times new roman', serif; text-align: right; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-stretch: normal;">1.22</td><td style="font: 10pt/normal 'times new roman', serif; text-align: left; padding-bottom: 4pt; font-stretch: normal;"> </td></tr></table><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"> <p style="font: 10pt/normal 'times new roman', serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">The number of warrants exercisable at June 30, 2015 was 4,963,956.</div>

<div><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">NOTE 5 – RELATED PARTY TRANSACTIONS<p style="font: 10pt/normal 'times new roman', serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"> <p style="font: 10pt/normal 'times new roman', serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">A summary of the related party financings and notes as at June 30, 2015 is as follows:<p style="font: 10pt/normal 'times new roman', serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"> <table style="font: 10pt/normal 'times new roman', times, serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom;"><td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">Related party</td><td style="padding-bottom: 1.5pt;"> </td><td style="text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Julian Ross (1)</td><td style="padding-bottom: 1.5pt;"> </td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="width: 1379px;">Amount</td><td style="width: 16px;"> </td><td style="width: 16px; text-align: left;">$</td><td style="width: 141px; text-align: right;">200,000</td><td style="width: 15px; text-align: left;"> </td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: left;">Stated interest rate</td><td> </td><td style="text-align: left;"> </td><td style="text-align: right;">0</td><td style="text-align: left;">%</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td>Maturity</td><td> </td><td style="text-align: left;"> </td><td style="text-align: right;">n/a</td><td style="text-align: left;"> </td></tr></table><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"> <p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">(1) Our CEO, Mr. Ross provides us shareholder cash advances and other consideration from time to time to fund working capital.</div>

NOTE 8 – SEGMENT INFORMATION   We are organized as, and operate in, one reportable segment: the development, distribution and sale of specialty respiratory products and related medical products, accessories, and services. Our chief operating decision-maker is our Chief Executive Officer. Our Chief Executive Officer reviews financial information presented for purposes of evaluating financial performance and allocating resources, accompanied by information about revenue by geographic regions. Our assets are primarily located in the United States of America and not allocated to any specific region and we do not measure the performance of our geographic regions based upon asset-based metrics. Therefore, geographic information is presented only for revenue. Revenue by geographic region is based on the ship to address on our customer orders.   The following presents total revenue by geographic region for the three month periods ended June 30, 2015 and 2014:   <table style="width: 100%; border-collapse: collapse;" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom;"> <td style="font-size: 10pt;"> </td> <td style="padding-bottom: 1.5pt; font: 10pt times new roman, times, serif;"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center; font: 10pt times new roman, times, serif;" colspan="6">Three Months Ended June 30,</td> <td style="padding-bottom: 1.5pt; font: 10pt times new roman, times, serif;"> </td> <td style="padding-bottom: 1.5pt; font: 10pt times new roman, times, serif;"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center; font: 10pt times new roman, times, serif;" colspan="6">Six Months Ended June 30,</td> <td style="padding-bottom: 1.5pt; font: 10pt times new roman, times, serif;"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="font-size: 10pt;"> </td> <td style="padding-bottom: 1.5pt; font: 10pt times new roman, times, serif;"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center; font: 10pt times new roman, times, serif;" colspan="2">2015</td> <td style="padding-bottom: 1.5pt; font: 10pt times new roman, times, serif;"> </td> <td style="padding-bottom: 1.5pt; font: 10pt times new roman, times, serif;"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center; font: 10pt times new roman, times, serif;" colspan="2">2014</td> <td style="padding-bottom: 1.5pt; font: 10pt times new roman, times, serif;"> </td> <td style="padding-bottom: 1.5pt; font: 10pt times new roman, times, serif;"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center; font: 10pt times new roman, times, serif;" colspan="2">2015</td> <td style="padding-bottom: 1.5pt; font: 10pt times new roman, times, serif;"> </td> <td style="padding-bottom: 1.5pt; font: 10pt times new roman, times, serif;"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center; font: 10pt times new roman, times, serif;" colspan="2">2014</td> <td style="padding-bottom: 1.5pt; font: 10pt times new roman, times, serif;"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="font-size: 10pt;"> </td> <td style="font-size: 10pt;"> </td> <td style="font-size: 10pt;" colspan="2"> </td> <td style="font-size: 10pt;"> </td> <td style="font-size: 10pt;"> </td> <td style="font-size: 10pt;" colspan="2"> </td> <td style="font-size: 10pt;"> </td> <td style="font-size: 10pt;"> </td> <td style="font-size: 10pt;" colspan="2"> </td> <td style="font-size: 10pt;"> </td> <td style="font-size: 10pt;"> </td> <td style="font-size: 10pt;" colspan="2"> </td> <td style="font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="width: 52%; text-align: left; font: 10pt times new roman, times, serif;">United States - product sales</td> <td style="width: 1%; font: 10pt times new roman, times, serif;"> </td> <td style="width: 1%; text-align: left; font: 10pt times new roman, times, serif;">$</td> <td style="width: 9%; text-align: right; font: 10pt times new roman, times, serif;">1,044,066</td> <td style="width: 1%; text-align: left; font: 10pt times new roman, times, serif;"> </td> <td style="width: 1%; font: 10pt times new roman, times, serif;"> </td> <td style="width: 1%; text-align: left; font: 10pt times new roman, times, serif;">$</td> <td style="width: 9%; text-align: right; font: 10pt times new roman, times, serif;">677,508</td> <td style="width: 1%; text-align: left; font: 10pt times new roman, times, serif;"> </td> <td style="width: 1%; font: 10pt times new roman, times, serif;"> </td> <td style="width: 1%; text-align: left; font: 10pt times new roman, times, serif;">$</td> <td style="width: 9%; text-align: right; font: 10pt times new roman, times, serif;">1,668,580</td> <td style="width: 1%; text-align: left; font: 10pt times new roman, times, serif;"> </td> <td style="width: 1%; font: 10pt times new roman, times, serif;"> </td> <td style="width: 1%; text-align: left; font: 10pt times new roman, times, serif;">$</td> <td style="width: 9%; text-align: right; font: 10pt times new roman, times, serif;">979,110</td> <td style="width: 1%; text-align: left; font: 10pt times new roman, times, serif;"> </td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="text-align: left; font: 10pt times new roman, times, serif;">ROW - product sales</td> <td style="font: 10pt times new roman, times, serif;"> </td> <td style="text-align: left; font: 10pt times new roman, times, serif;"> </td> <td style="text-align: right; font: 10pt times new roman, times, serif;">1,953</td> <td style="text-align: left; font: 10pt times new roman, times,;"> </td> <td style="font: 10pt times new roman, times, serif;"> </td> <td style="text-align: left; font: 10pt times new roman, times, serif;"> </td> <td style="text-align: right; font: 10pt times new roman, times, serif;">603</td> <td style="text-align: left; font: 10pt times new roman, times, serif;"> </td> <td style="font: 10pt times new roman, times, serif;"> </td> <td style="text-align: left; font: 10pt times new roman, times, serif;"> </td> <td style="text-align: right; font: 10pt times new roman, times, serif;">1,953</td> <td style="text-align: left; font: 10pt times new roman, times, serif;"> </td> <td style="font: 10pt times new roman, times, serif;"> </td> <td style="text-align: left; font: 10pt times new roman, times, serif;"> </td> <td style="text-align: right; font: 10pt times new roman, times, serif;">37,730</td> <td style="text-align: left; font: 10pt times new roman, times, serif;"> </td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="padding-bottom: 1.5pt; text-align: left; font: 10pt times new roman, times, serif;">ROW - license fees/service revenue</td> <td style="padding-bottom: 1.5pt; font: 10pt times new roman, times, serif;"> </td> <td style="border-bottom: black 1.5pt solid; text-align: left; font: 10pt times new roman, times, serif;"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; font: 10pt times new roman, times, serif;">-</td> <td style="padding-bottom: 1.5pt; text-align: left; font: 10pt times new roman, times, serif;"> </td> <td style="padding-bottom: 1.5pt; font: 10pt times new roman, times, serif;"> </td> <td style="border-bottom: black 1.5pt solid; text-align: left; font: 10pt times new roman, times, serif;"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; font: 10pt times new roman, times, serif;">-</td> <td style="padding-bottom: 1.5pt; text-align: left; font: 10pt times new roman, times, serif;"> </td> <td style="padding-bottom: 1.5pt; font: 10pt times new roman, times, serif;"> </td> <td style="border-bottom: black 1.5pt solid; text-align: left; font: 10pt times new roman, times, serif;"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; font: 10pt times new roman, times, serif;">-</td> <td style="padding-bottom: 1.5pt; text-align: left; font: 10pt times new roman, times, serif;"> </td> <td style="padding-bottom: 1.5pt; font: 10pt times new roman, times, serif;"> </td> <td style="border-bottom: black 1.5pt solid; text-align: left; font: 10pt times new roman, times, serif;"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; font: 10pt times new roman, times, serif;">17,500</td> <td style="padding-bottom: 1.5pt; text-align: left; font: 10pt times new roman, times, serif;"> </td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="padding-bottom: 4pt; font: 10pt times new roman, times, serif; padding-left: 10pt;">Totals</td> <td style="padding-bottom: 4pt; font: 10pt times new roman, times, serif;"> </td> <td style="border-bottom: black 4pt double; text-align: left; font: 10pt times new roman, times, serif;">$</td> <td style="border-bottom: black 4pt double; text-align: right; font: 10pt times new roman, times, serif;">1,046,019</td> <td style="padding-bottom: 4pt; text-align: left; font: 10pt times new roman, times, serif;"> </td> <td style="padding-bottom: 4pt; font: 10pt times new roman, times, serif;"> </td> <td style="border-bottom: black 4pt double; text-align: left; font: 10pt times new roman, times, serif;">$</td> <td style="border-bottom: black 4pt double; text-align: right; font: 10pt times new roman, times, serif;">678,111</td> <td style="padding-bottom: 4pt; text-align: left; font: 10pt times new roman, times, serif;"> </td> <td style="padding-bottom: 4pt; font: 10pt times new roman, times, serif;"> </td> <td style="border-bottom: black 4pt double; text-align: left; font: 10pt times new roman, times, serif;">$</td> <td style="border-bottom: black 4pt double; text-align: right; font: 10pt times new roman, times, serif;">1,670,533</td> <td style="padding-bottom: 4pt; text-align: left; font: 10pt times new roman, times, serif;"> </td> <td style="padding-bottom: 4pt; font: 10pt times new roman, times, serif;"> </td> <td style="border-bottom: black 4pt double; text-align: left; font: 10pt times new roman, times, serif;">$</td> <td style="border-bottom: black 4pt double; text-align: right; font: 10pt times new roman, times, serif;">1,034,340</td> <td style="padding-bottom: 4pt; text-align: left; font: 10pt times new roman, times, serif;"> </td> </tr> </table>

Basis of Presentation - The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reported period. Actual results could differ from those estimates. The interim financial statements include all adjustments which, in the opinion of management, are necessary in order to make the financial statements not misleading. The accompanying Condensed Financial Statements have been prepared in accordance with United States generally accepted accounting principles (“GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X promulgated by the Securities and Exchange Commission (“SEC”) and therefore do not contain all of the information and footnotes required by GAAP and the SEC for annual financial statements. The Company's Condensed Financial Statements reflect all adjustments that management believes are necessary for the fair presentation of their financial position, results of operations, comprehensive loss and cash flows for the periods presented. The information at December 31, 2014 in the Company's Condensed Balance Sheet included in this quarterly report was derived from the audited Balance Sheet included in the Company's Annual Report on Form 10-K for the year ended December 31, 2014 filed with the SEC on March 31, 2015. Where applicable, the Company's 2014 Annual Report on Form 10-K is referred to in this quarterly report as the “2014 Annual Report.” This quarterly report should be read in conjunction with the 2014 Annual Report.

<div>Deferred Revenue and Income - We defer revenue and income when we invoice a customer or a customer makes a payment and the requirements of revenue recognition have not been met (i.e. persuasive evidence of an arrangement exists, shipment from a company warehouse has occurred, the price is fixed or determinable and collectability is reasonably assured). Deferred Revenue was $0 for each of the periods ended June 30, 2015 and December 31, 2014, respectively.</div>

<div>Cash and Cash Equivalents - We invest our cash in deposits and money market funds with major financial institutions.  We place our cash investments in instruments that meet high credit quality standards, as specified in our investment policy guidelines. These guidelines also limit the amount of credit exposure to any one issue, issuer or type of instrument.</div>

<div>Property and Equipment – Property and equipment are recorded at cost with depreciation and amortization provided over the shorter of the remaining lease term or the estimated useful life of the improvement ranging from three to seven years. Renewals and betterments that materially extend the life of an asset are capitalized. Expenditures for maintenance and repairs are charged to expense when incurred. Furniture and fixtures are depreciated over five years. Machinery and equipments are depreciated over five to seven years. Software is depreciated over three years.  Leasehold improvements are computed using the shorter of the estimated useful lives of the assets or the lease terms.  Depreciation expense was $3,478 and $5,155 for the three month periods ended June 30, 2015 and 2014, respectively. Depreciation expense was $6,820 and $9,786 for the six month periods ended June 30, 2015 and 2014, respectively.</div>

Other Assets– We record Other Assets net of accumulated amortization. Amortization expense for Other Assets was $21,911 and $10,051 for the three month periods ended June 30, 2015 and 2014, respectively. Amortization expense for Other Assets was $42,034 and $37,562 for the six month periods ended June 30, 2015 and 2014, respectively. Capitalization of software: The Company accounts for internal-use software and website development costs, including the development of its partner marketplaces in accordance with ASC 350-50 (Intangibles – Website cost). The Company capitalizes internal costs consisting of payroll and direct payroll-related costs of employees who devote time to the development of internal-use software, as well as any external direct costs. It amortizes these costs over their estimated useful lives, which typically range between three to five years. The Company’s judgment is required in determining the point at which various projects enter the stages at which costs may be capitalized, in assessing the ongoing value of the capitalized costs, and in determining the estimated useful lives over which the costs are amortized. The estimated life is based on management’s judgment as to the product life cycle. Amortization expense for websites and URLs was $9,654 and $9,654 for the three month periods ended June 30, 2015 and 2014, respectively. Amortization expense for websites and URLs was $19,309 and $19,309 for the six month periods ended June 30, 2015 and 2014, respectively.

<div>Research and Development Costs – Costs associated with the development of our products are charged to expense as incurred.  Research and development expense was $297,456 and $275,974 for the three month periods ended June 30, 2015 and 2014, respectively. Research and development expense was $510,801 and $277,515 for the six month periods ended June 30, 2015 and 2014, respectively.</div>

<div>Equity Warrants - We issued warrants to purchase shares of our common stock in connection with convertible notes. In accordance with ASC 470-20, Debt with conversions and other options, the proceeds from the notes were allocated based on the relative fair values of the notes without the warrants issued in conjunction with the notes and of the warrants themselves at the time of issuance. We record the fair value of the warrants at the time of issuance as additional paid in capital and as a debt discount to the notes.  We amortize this debt discount as interest expense over the life of the note.  Additionally, as a result of issuing the warrants with the convertible notes, a beneficial conversion option is recorded as a debt discount reflecting the incremental conversion option intrinsic value of the conversion option provided to the holders of the notes. We also amortize this debt discount as interest expense over the life of the notes.  The intrinsic value of each conversion option was calculated as the difference between the effective conversion price and the fair value of the common stock, multiplied by the number of shares into which the note is convertible.</div>

<div>Shipping and Handling Costs - Shipping and handling charges to customers are included in net revenues, and the associated costs incurred are recorded in cost of revenues.</div>

<div>Advertising Costs - Advertising costs are charged to operations when incurred.  We incurred $329,393 and $154,044 in advertising and promotion costs during the three month periods ended June 30, 2015 and 2014, respectively. Advertising and promotion costs during the six month periods ended June 30, 2015 and 2014 were $794,139 and $241,993, respectively.</div>

Net Income (Loss) Per Share - Basic earnings (loss) per share is computed based on the weighted average number of common shares outstanding. However, basic loss per share excludes anti-dilutive securities. Diluted earnings per share is computed based on the weighted average number of common shares outstanding, increased by the number of additional shares that would have been outstanding had the potentially dilutive common shares been issued, and reduced by the number of shares the Company could have repurchased from the proceeds from issuance of the potentially dilutive shares. Potentially dilutive shares of common stock include stock options and other stock-based awards granted under stock-based compensation plans and shares committed to be purchased under the employee stock purchase plan. As of June 30, 2015 there were 18,268,932 potentially dilutive shares.

<div><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><table style="font: 10pt/normal calibri, helvetica, sans-serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="width: 1365.67px; text-align: left; padding-left: 10pt; font-family: 'times new roman', serif;">2015</td><td style="width: 16px; font-family: 'times new roman', serif;"> </td><td style="width: 16px; text-align: left; font-family: 'times new roman', serif;">$</td><td style="width: 141px; text-align: right; font-family: 'times new roman', serif;">30,232</td><td style="width: 15px; text-align: left; font-family: 'times new roman', serif;"> </td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: left; padding-left: 10pt; font-family: 'times new roman', serif;">2016</td><td style="font-family: 'times new roman', serif;"> </td><td style="text-align: left; font-family: 'times new roman', serif;"> </td><td style="text-align: right; font-family: 'times new roman', serif;">30,232</td><td style="text-align: left; font-family: 'times new roman', serif;"> </td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="text-align: left; padding-left: 10pt; font-family: 'times new roman', serif;">2017</td><td style="font-family: 'times new roman', serif;"> </td><td style="text-align: left; font-family: 'times new roman', serif;"> </td><td style="text-align: right; font-family: 'times new roman', serif;">30,232</td><td style="text-align: left; font-family: 'times new roman', serif;"> </td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: left; padding-left: 10pt; font-family: 'times new roman', serif;">2018</td><td style="font-family: 'times new roman', serif;"> </td><td style="text-align: left; font-family: 'times new roman', serif;"> </td><td style="text-align: right; font-family: 'times new roman', serif;">30,232</td><td style="text-align: left; font-family: 'times new roman', serif;"> </td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="text-align: left; padding-bottom: 1.5pt; font-family: 'times new roman', serif;">Thereafter</td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', serif;"> </td><td style="text-align: left; font-family: 'times new roman', serif; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;"> </td><td style="text-align: right; font-family: 'times new roman', serif; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">226,723</td><td style="text-align: left; padding-bottom: 1.5pt; font-family: 'times new roman', serif;"> </td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: left; padding-bottom: 4pt;"> </td><td style="padding-bottom: 4pt; font-family: 'times new roman', serif;"> </td><td style="text-align: left; font-family: 'times new roman', serif; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">$</td><td style="text-align: right; font-family: 'times new roman', serif; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">347,650</td><td style="text-align: left; padding-bottom: 4pt; font-family: 'times new roman', serif;"> </td></tr></table></div>

<table style="width: 100%; border-collapse: collapse;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom;"><td style="font-size: 10pt;"> </td><td style="padding-bottom: 1.5pt; font: 10pt times new roman, times, serif;"> </td><td style="border-bottom: black 1.5pt solid; text-align: center; font: 10pt times new roman, times, serif;" colspan="6">Three Months Ended June 30,</td><td style="padding-bottom: 1.5pt; font: 10pt times new roman, times, serif;"> </td><td style="padding-bottom: 1.5pt; font: 10pt times new roman, times, serif;"> </td><td style="border-bottom: black 1.5pt solid; text-align: center; font: 10pt times new roman, times, serif;" colspan="6">Six Months Ended June 30,</td><td style="padding-bottom: 1.5pt; font: 10pt times new roman, times, serif;"> </td></tr><tr style="vertical-align: bottom;"><td style="font-size: 10pt;"> </td><td style="padding-bottom: 1.5pt; font: 10pt times new roman, times, serif;"> </td><td style="border-bottom: black 1.5pt solid; text-align: center; font: 10pt times new roman, times, serif;" colspan="2">2015</td><td style="padding-bottom: 1.5pt; font: 10pt times new roman, times, serif;"> </td><td style="padding-bottom: 1.5pt; font: 10pt times new roman, times, serif;"> </td><td style="border-bottom: black 1.5pt solid; text-align: center; font: 10pt times new roman, times, serif;" colspan="2">2014</td><td style="padding-bottom: 1.5pt; font: 10pt times new roman, times, serif;"> </td><td style="padding-bottom: 1.5pt; font: 10pt times new roman, times, serif;"> </td><td style="border-bottom: black 1.5pt solid; text-align: center; font: 10pt times new roman, times, serif;" colspan="2">2015</td><td style="padding-bottom: 1.5pt; font: 10pt times new roman, times, serif;"> </td><td style="padding-bottom: 1.5pt; font: 10pt times new roman, times, serif;"> </td><td style="border-bottom: black 1.5pt solid; text-align: center; font: 10pt times new roman, times, serif;" colspan="2">2014</td><td style="padding-bottom: 1.5pt; font: 10pt times new roman, times, serif;"> </td></tr><tr style="vertical-align: bottom;"><td style="font-size: 10pt;"> </td><td style="font-size: 10pt;"> </td><td style="font-size: 10pt;" colspan="2"> </td><td style="font-size: 10pt;"> </td><td style="font-size: 10pt;"> </td><td style="font-size: 10pt;" colspan="2"> </td><td style="font-size: 10pt;"> </td><td style="font-size: 10pt;"> </td><td style="font-size: 10pt;" colspan="2"> </td><td style="font-size: 10pt;"> </td><td style="font-size: 10pt;"> </td><td style="font-size: 10pt;" colspan="2"> </td><td style="font-size: 10pt;"> </td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="width: 52%; text-align: left; font: 10pt times new roman, times, serif;">United States - product sales</td><td style="width: 1%; font: 10pt times new roman, times, serif;"> </td><td style="width: 1%; text-align: left; font: 10pt times new roman, times, serif;">$</td><td style="width: 9%; text-align: right; font: 10pt times new roman, times, serif;">1,044,066</td><td style="width: 1%; text-align: left; font: 10pt times new roman, times, serif;"> </td><td style="width: 1%; font: 10pt times new roman, times, serif;"> </td><td style="width: 1%; text-align: left; font: 10pt times new roman, times, serif;">$</td><td style="width: 9%; text-align: right; font: 10pt times new roman, times, serif;">677,508</td><td style="width: 1%; text-align: left; font: 10pt times new roman, times, serif;"> </td><td style="width: 1%; font: 10pt times new roman, times, serif;"> </td><td style="width: 1%; text-align: left; font: 10pt times new roman, times, serif;">$</td><td style="width: 9%; text-align: right; font: 10pt times new roman, times, serif;">1,668,580</td><td style="width: 1%; text-align: left; font: 10pt times new roman, times, serif;"> </td><td style="width: 1%; font: 10pt times new roman, times, serif;"> </td><td style="width: 1%; text-align: left; font: 10pt times new roman, times, serif;">$</td><td style="width: 9%; text-align: right; font: 10pt times new roman, times, serif;">979,110</td><td style="width: 1%; text-align: left; font: 10pt times new roman, times, serif;"> </td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: left; font: 10pt times new roman, times, serif;">ROW - product sales</td><td style="font: 10pt times new roman, times, serif;"> </td><td style="text-align: left; font: 10pt times new roman, times, serif;"> </td><td style="text-align: right; font: 10pt times new roman, times, serif;">1,953</td><td style="font: 10pt times new roman, times, serif;"> </td><td style="text-align: left; font: 10pt times new roman, times, serif;"> </td><td style="text-align: right; font: 10pt times new roman, times, serif;">603</td><td style="text-align: left; font: 10pt times new roman, times, serif;"> </td><td style="font: 10pt times new roman, times, serif;"> </td><td style="text-align: left; font: 10pt times new roman, times, serif;"> </td><td style="text-align: right; font: 10pt times new roman, times, serif;">1,953</td><td style="text-align: left; font: 10pt times new roman, times, serif;"> </td><td style="font: 10pt times new roman, times, serif;"> </td><td style="text-align: left; font: 10pt times new roman, times, serif;"> </td><td style="text-align: right; font: 10pt times new roman, times, serif;">37,730</td><td style="text-align: left; font: 10pt times new roman, times, serif;"> </td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="padding-bottom: 1.5pt; text-align: left; font: 10pt times new roman, times, serif;">ROW - license fees/service revenue</td><td style="padding-bottom: 1.5pt; font: 10pt times new roman, times, serif;"> </td><td style="border-bottom: black 1.5pt solid; text-align: left; font: 10pt times new roman, times, serif;"> </td><td style="border-bottom: black 1.5pt solid; text-align: right; font: 10pt times new roman, times, serif;">-</td><td style="padding-bottom: 1.5pt; text-align: left; font: 10pt times new roman, times, serif;"> </td><td style="padding-bottom: 1.5pt; font: 10pt times new roman, times, serif;"> </td><td style="border-bottom: black 1.5pt solid; text-align: left; font: 10pt times new roman, times, serif;"> </td><td style="border-bottom: black 1.5pt solid; text-align: right; font: 10pt times new roman, times, serif;">-</td><td style="padding-bottom: 1.5pt; text-align: left; font: 10pt times new roman, times, serif;"> </td><td style="padding-bottom: 1.5pt; font: 10pt times new roman, times, serif;"> </td><td style="border-bottom: black 1.5pt solid; text-align: left; font: 10pt times new roman, times, serif;"> </td><td style="border-bottom: black 1.5pt solid; text-align: right; font: 10pt times new roman, times, serif;">-</td><td style="padding-bottom: 1.5pt; text-align: left; font: 10pt times new roman, times, serif;"> </td><td style="padding-bottom: 1.5pt; font: 10pt times new roman, times, serif;"> </td><td style="border-bottom: black 1.5pt solid; text-align: left; font: 10pt times new roman, times, serif;"> </td><td style="border-bottom: black 1.5pt solid; text-align: right; font: 10pt times new roman, times, serif;">17,500</td><td style="padding-bottom: 1.5pt; text-align: left; font: 10pt times new roman, times, serif;"> </td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="padding-bottom: 4pt; font: 10pt times new roman, times, serif; padding-left: 10pt;">Totals</td><td style="padding-bottom: 4pt; font: 10pt times new roman, times, serif;"> </td><td style="border-bottom: black 4pt double; text-align: left; font: 10pt times new roman, times, serif;">$</td><td style="border-bottom: black 4pt double; text-align: right; font: 10pt times new roman, times, serif;">1,046,019</td><td style="padding-bottom: 4pt; text-align: left; font: 10pt times new roman, times, serif;"> </td><td style="padding-bottom: 4pt; font: 10pt times new roman, times, serif;"> </td><td style="border-bottom: black 4pt double; text-align: left; font: 10pt times new roman, times, serif;">$</td><td style="border-bottom: black 4pt double; text-align: right; font: 10pt times new roman, times, serif;">678,111</td><td style="padding-bottom: 4pt; text-align: left; font: 10pt times new roman, times, serif;"> </td><td style="padding-bottom: 4pt; font: 10pt times new roman, times, serif;"> </td><td style="border-bottom: black 4pt double; text-align: left; font: 10pt times new roman, times, serif;">$</td><td style="border-bottom: black 4pt double; text-align: right; font: 10pt times new roman, times, serif;">1,670,533</td><td style="padding-bottom: 4pt; text-align: left; font: 10pt times new roman, times, serif;"> </td><td style="padding-bottom: 4pt; font: 10pt times new roman, times, serif;"> </td><td style="border-bottom: black 4pt double; text-align: left; font: 10pt times new roman, times, serif;">$</td><td style="border-bottom: black 4pt double; text-align: right; font: 10pt times new roman, times, serif;">1,034,340</td><td style="padding-bottom: 4pt; text-align: left; font: 10pt times new roman, times, serif;"> </td></tr></table>

133477

181863

41114

41994

102755

198694

30232

226723

347650

5155

9786

3478

6820

7558

9654

15066

19309

7557

9654

15114

19309

37562 42034

17588

58611

106911

154044

241993

329393

794139

18268932

P3Y

P7Y

P5Y

P7Y

P3Y

P5Y

52000

213000

(i) the full payment of the economic incentives; or (ii) March 31, 2016.

P5Y 0.1234 0.12 0.10

181000

8000

1147500

44000

966000

0.01

400196

3500 204188

770000

1050000

531666

400196

1256453

58611 133333 80000

700000

2000000

700000

3304260

2513838

4963956

2513838

1.28

0.41

1.22

0.41

1659696

1.11

P5Y

P10Y

P5Y

P10Y

P5Y

P10Y

P5Y

P10Y

0.4045

0.8379

0.0150

0.0180

0.0144

0.0180

0.0085

0.0174

0.0085

0.0174

0.00

5000000

P10Y P5Y P90D P5Y

323175

1627296

4963956

200000

0.00

n/a

678111

677508

603

1034340

979110

17500

37730

1046019

1044066

1953

1670533

1668580

1953

<p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;">NOTE 7 – FAIR VALUE MEASUREMENTS <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;">  <p style="color: #000000; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; font-family: 'times new roman', serif; margin: 0px; text-align: justify;">Changes related to derivatives for the six months ended June 30, 2015 are as follows: <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;">  <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;">  <table style="width: 1175px; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman', times, serif; word-spacing: 0px; border-collapse: collapse; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="width: 915px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 8pt; line-height: normal; font-family: 'times new roman', times, serif;">Balance as of December 31, 2014</td> <td style="width: 12px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 8pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">$</td> <td style="width: 235px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 8pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: right;">31,010</td> <td style="width: 13px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 8pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;"> </td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">Additions related to embedded derivative of convertible notes issued</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 8pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;"> </td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 8pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: right;">369,472</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 8pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;"> </td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 8pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">Gain on decrease in value of derivative liabilities</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 8pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;"> </td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 8pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: right;">(122,584</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 8pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">)</td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 8pt; line-height: normal; font-family: 'times new roman', times, serif; padding-bottom: 1pt;">Conversions</td> <td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: right;"> </td> <td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: right;">(28,698</td> <td style="padding-bottom: 1pt; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 8pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">)</td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 8pt; line-height: normal; font-family: 'times new roman', times, serif; padding-bottom: 2.5pt;">Balance as of June 30, 2015</td> <td style="border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: right;">$</td> <td style="border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: right;">249,200</td> <td style="padding-bottom: 2.5pt; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 8pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;"> </td> </tr> </table> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify; text-indent: 0.5in;">  <p style="color: #000000; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; font-family: 'times new roman', serif; margin: 0px; text-align: justify;">During the six month period the Company recorded derivatives related to convertible notes of $369,472 of which $204,272 exceed the proceeds of the convertible notes and was recorded as a derivative expense. The Company also converted $28,698 and recorded a gain on the change in the fair value of the derivative of $122,584.

<p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;">  <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;">  <table style="width: 1175px; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman', times, serif; word-spacing: 0px; border-collapse: collapse; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="width: 915px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 8pt; line-height: normal; font-family: 'times new roman', times, serif;">Balance as of December 31, 2014</td> <td style="width: 12px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 8pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">$</td> <td style="width: 235px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 8pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: right;">31,010</td> <td style="width: 13px; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 8pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;"> </td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">Additions related to embedded derivative of convertible notes issued</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 8pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;"> </td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 8pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: right;">369,472</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 8pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;"> </td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 8pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">Gain on decrease in value of derivative liabilities</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 8pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;"> </td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 8pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: right;">(122,584</td> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 8pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">)</td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 8pt; line-height: normal; font-family: 'times new roman', times, serif; padding-bottom: 1pt;">Conversions</td> <td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: right;"> </td> <td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: right;">(28,698</td> <td style="padding-bottom: 1pt; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 8pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;">)</td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 8pt; line-height: normal; font-family: 'times new roman', times, serif; padding-bottom: 2.5pt;">Balance as of June 30, 2015</td> <td style="border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: right;">$</td> <td style="border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: right;">249,200</td> <td style="padding-bottom: 2.5pt; font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 8pt; line-height: normal; font-family: 'times new roman', times, serif; text-align: left;"> </td> </tr> </table> <div> </div>

-122584

369472

2000000

-28698 (1) Our CEO, Mr. Ross provides us shareholder cash advances and other consideration from time to time to fund working capital.

EX-101.SCH 7 oxys-20150630.xsd XBRL SCHEMA FILE 001 - Document - Document and Entity Information link:presentationLink link:definitionLink link:calculationLink 002 - Statement - Condensed Balance Sheets link:presentationLink link:definitionLink link:calculationLink 003 - Statement - Condensed Balance Sheets (Parenthetical) link:presentationLink link:definitionLink link:calculationLink 004 - Statement - Statements of Operations (Unaudited) link:presentationLink link:definitionLink link:calculationLink 005 - Statement - Statements of Cash Flows (Unaudited) link:presentationLink link:definitionLink link:calculationLink 006 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:definitionLink link:calculationLink 007 - Disclosure - Notes Payable link:presentationLink link:definitionLink link:calculationLink 008 - Disclosure - Shareholders' Equity link:presentationLink link:definitionLink link:calculationLink 009 - Disclosure - Stock Options and Warrants link:presentationLink link:definitionLink link:calculationLink 010 - Disclosure - Related Party Transactions link:presentationLink link:definitionLink link:calculationLink 011 - Disclosure - Off Balance Sheet Arrangements and Contractual Obligations link:presentationLink link:definitionLink link:calculationLink 012 - Disclosure - Fair Value Measurements link:presentationLink link:definitionLink link:calculationLink 013 - Disclosure - Segment Information link:presentationLink link:definitionLink link:calculationLink 014 - Disclosure - Going Concern link:presentationLink link:definitionLink link:calculationLink 015 - Disclosure - Summary of Significant Accounting Policies (Policies) link:presentationLink link:definitionLink link:calculationLink 016 - Disclosure - Summary of Significant Accounting Policies (Tables) link:presentationLink link:definitionLink link:calculationLink 017 - Disclosure - Notes Payable (Tables) link:presentationLink link:definitionLink link:calculationLink 018 - Disclosure - Stock Options and Warrants (Tables) link:presentationLink link:definitionLink link:calculationLink 019 - Disclosure - Related Party Transactions (Tables) link:presentationLink link:definitionLink link:calculationLink 020 - Disclosure - Fair Value Measurements (Tables) link:presentationLink link:definitionLink link:calculationLink 021 - Disclosure - Segment Information (Tables) link:presentationLink link:definitionLink link:calculationLink 022 - Disclosure - Summary of Significant Accounting Policies (Details) link:presentationLink link:definitionLink link:calculationLink 023 - Disclosure - Summary of Significant Accounting Policies (Details 1) link:presentationLink link:definitionLink link:calculationLink 024 - Disclosure - Summary of Significant Accounting Policies (Details Textual) link:presentationLink link:definitionLink link:calculationLink 025 - Disclosure - Notes Payable (Details) link:presentationLink link:definitionLink link:calculationLink 026 - Disclosure - Notes Payable (Details Textual) link:presentationLink link:definitionLink link:calculationLink 027 - Disclosure - Shareholders' Equity (Details) link:presentationLink link:definitionLink link:calculationLink 028 - Disclosure - Stock Options and Warrants (Details) link:presentationLink link:definitionLink link:calculationLink 029 - Disclosure - Stock Options and Warrants (Details 1) link:presentationLink link:definitionLink link:calculationLink 030 - Disclosure - Stock Options and Warrants (Details 2) link:presentationLink link:definitionLink link:calculationLink 031 - Disclosure - Stock Options and Warrants (Details Textual) link:presentationLink link:definitionLink link:calculationLink 032 - Disclosure - Related Party Transactions (Details) link:presentationLink link:definitionLink link:calculationLink 033 - Disclosure - Fair Value Measurements (Details) link:presentationLink link:definitionLink link:calculationLink 034 - Disclosure - Fair Value Measurements (Details Textual) link:presentationLink link:definitionLink link:calculationLink 035 - Disclosure - Segment Information (Details) link:presentationLink link:definitionLink link:calculationLink 036 - Disclosure - Going Concern (Details) link:presentationLink link:definitionLink link:calculationLink EX-101.CAL 8 oxys-20150630_cal.xml XBRL CALCULATION FILE EX-101.DEF 9 oxys-20150630_def.xml XBRL DEFINITION FILE EX-101.LAB 10 oxys-20150630_lab.xml XBRL LABEL FILE Document and Entity Information [Abstract] Document and Entity Information [Abstract] Entity Registrant Name Entity Registrant Name Entity Central Index Key Entity Central Index Key Amendment Flag Amendment Flag Current Fiscal Year End Date Current Fiscal Year End Date Document Type Document Type Document Period End Date Document Period End Date Document Fiscal Period Focus Document Fiscal Period Focus Document Fiscal Year Focus Document Fiscal Year Focus Entity Filer Category Entity Filer Category Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Balance Sheets [Abstract] Statement of Financial Position [Abstract] Statement [Table] Class of Stock [Axis] Class of Stock [Axis] Class of Stock [Domain] Class of Stock [Domain] Series A Preferred Stock [Member] Series A convertible preferred shares Series B Preferred Stock [Member] Series B convertible preferred shares Series C Preferred Stock [Member] Series C convertible preferred shares Series D Preferred Stock [Member] Series D convertible preferred shares Series E Preferred Stock [Member] Series E convertible preferred shares Statement [Line Items] Assets [Abstract] ASSETS Assets, Current [Abstract] Current assets Cash and Cash Equivalents, at Carrying Value Total cash equivalents Cash and cash equivalents Cash and cash equivalents, at beginning of period Cash and cash equivalents, at end of period Restricted Cash and Cash Equivalents, Current Restricted cash Accounts Receivable, Net, Current Accounts receivable, net Inventory, Net Total inventories Inventories Total inventories License Fee Receivable Current License fee receivable License Fee Receivable Current. Prepaid Expense and Other Assets, Current Prepaid expenses and other current assets Assets, Current Total current assets Total current assets Property, Plant and Equipment, Net Property and equipment, net Total property and equipment, net Property, Plant and Equipment, Net, Beginning Balance Property, Plant and Equipment, Net, Ending Balance Intangible Assets, Net (Excluding Goodwill) Intangible assets, net Intangible assets, net Other Assets, Noncurrent Other assets Other assets Assets TOTAL ASSETS TOTAL ASSETS LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT) LIABILITIES AND STOCKHOLDERS' EQUITY Liabilities, Current [Abstract] Current liabilities Accounts Payable and Accrued Liabilities, Current Accounts payable and accrued expenses Total accounts payable and accrued expenses Accounts Payable, Related Parties, Current Related party payable Capital Lease Obligations, Current Capital leases balance Capital leases - current Notes Payable, Current Short-term notes payable Notes payable - current, net of discount Total short-term notes payable Notes payable, current Current portion of notes payable, net Convertible Notes Payable Convertible notes payable, net of discount Derivative Liability, Current Derivative liability Balance as of December 31, 2014 Balance as of June 30, 2015 Liabilities, Current Total current liabilities Total current liabilities Long-Term Debt and Capital Lease Obligations [Abstract] Long-term liabilities Notes Payable, Noncurrent Amount Notes payable Notes payable, noncurrent Long-term portion of notes payable, net Total long-term notes payable Long-Term Debt and Capital Lease Obligations Total long-term liabilities Total long-term liabilities Liabilities TOTAL LIABILITIES TOTAL LIABILITIES Commitments and Contingencies COMMITMENTS AND CONTINGENCY Stockholders Equity Attributable To Parent [Abstract] STOCKHOLDERS' EQUITY Preferred Stock, Value, Issued Preferred stock value Common Stock, Value, Issued Common stock, par value $0.0004 per share; 100,000,000 shares authorized;31,224,000 shares of voting common stock issued and outstanding as of June 30, 2015 and 28,438,631 shares issued and outstanding as of December 31, 2014 Other Additional Capital Stock subscription receivable Additional Paid In Capital Additional Paid-in Capital Additional Paid-in Capital Additional Paid in Capital, Beginning Balance Additional Paid in Capital, Ending Balance Retained Earnings (Accumulated Deficit) Accumulated deficit Accumulated deficit Accumulated deficit - beginning of the period Accumulated deficit - end of the period Accumulated deficit Stockholders' Equity Attributable to Parent Stockholders' deficit Stockholders' Equity TOTAL STOCKHOLDERS' EQUITY Beginning Balance Ending Balance Beginning Balance Liabilities and Equity TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY Preferred Stock, Par Or Stated Value Per Share Series B Preferred stock, par value Preferred stock, par value Preferred Stock, Shares Authorized Series A Preferred stock, shares authorized Preferred stock, shares authorized Preferred Stock, Shares Issued Preferred Stock, shares issued Series A convertible preferred stock, shares issued Preferred Stock, Shares Issued, Total Preferred Stock, Shares Outstanding Series A convertible preferred stock, shares outstanding Preferred stock, shares outstanding Preferred Stock, Shares Outstanding, Beginning Balance Preferred Stock, Shares Outstanding, Ending Balance Common Stock, Par Or Stated Value Per Share Common stock, par value Common Stock, Shares Authorized Common stock, shares authorized Common Stock, Shares, Issued Common stock, Shares issued Voting common stock, shares issued Common Stock, Shares, Issued, Total Common Stock, Shares, Outstanding Common stock, Shares outstanding Voting common stock, shares outstanding Common Stock, Shares, Outstanding, Beginning Balance Common Stock, Shares, Outstanding, Ending Balance Income Statement [Abstract] Income Statement [Abstract] Revenues, net Total revenues Revenues, net Revenues, net Cost Of Goods Sold Cost of goods sold Cost of goods sold Gross Profit Gross profit Gross profit Operating Expenses [Abstract] Operating expenses Research and Development Expense Research and development Research and development expense Selling and Marketing Expense Sales and marketing Other General and Administrative Expense Other general and administrative Operating Expenses Total operating expenses Total operating expenses Operating Income (Loss) Loss from operating expenses Loss from operating expenses Nonoperating Income (Expense) [Abstract] Other income (expenses) Interest Expense Interest expense Interest expense Interest expense Interest expense Unrealized Gain (Loss) on Derivatives Change in value of derivative liabilities Derivative, Loss on Derivative Derivative expense Nonoperating Gains (Losses) Other income (expense) Other income (expense) Nonoperating Income (Expense) Total other income (expenses) Total other income (expenses) Net Income (Loss) Attributable to Parent Net loss Net loss Net loss Net loss, as reported Earnings Per Share, Basic and Diluted Basic and diluted net loss per common share Earnings Per Share, Basic and Diluted, Other Disclosures [Abstract] Weighted average common shares outstanding: Weighted Average Number of Shares Outstanding, Basic and Diluted Basic and diluted Statement of Cash Flows [Abstract] Net Cash Provided by (Used in) Operating Activities [Abstract] CASH FLOWS FROM OPERATING ACTIVITIES: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Adjustments to reconcile net loss to net cash from operating activities: Depreciation, Depletion and Amortization Depreciation and amortization expense Amortization of Debt Discount (Premium) Amortization of debt discount and beneficial conversion features Debt Instrument, Decrease, Forgiveness Gain on forgiveness of debt Gains (Losses) on Extinguishment of Debt Gain on extinguishment of debt Gain on extinguishment of debt Excess Derivative Over Proceeds Excess derivative over proceeds Excess derivative over proceeds. Excess derivative over proceeds Derivative, Gain (Loss) on Derivative, Net Derivative liability fair value adjustment Derivative liability fair value adjustment Expenses Paid On Behalf Of Related Parties Expenses paid on behalf of related parties Expenses paid on behalf of related parties. Expenses Paid By Related Parties Expenses paid by related parties Expenses paid by related parties. Issuance of Stock and Warrants for Services or Claims Warrants issued for services Share-based Compensation Stock based compensation expense Issuance of common stock for compensation Issuance of common stock options to employees as compensation Stock based compensation Common Stock Issued During Period Value Issued For Services Common stock issued for services Common stock issued for services. Common stock issued for services Increase (Decrease) in Operating Capital [Abstract] Changes in operating assets and liabilities: Increase (Decrease) in Accounts Receivable Accounts receivable Increase (Decrease) in Inventories Inventories Increase Decrease In License Fee Receivable Current License fees receivable License fees receivable. License fees receivable Increase (Decrease) in Prepaid Expenses, Other Prepaid expenses and other current assets Increase (Decrease) in Other Current Assets Other assets Increase (Decrease) in Accounts Payable and Accrued Liabilities Accounts payable and accrued liabilities Increase (Decrease) in Deferred Revenue Deferred revenue Net Cash Provided by (Used in) Operating Activities NET CASH USED IN OPERATING ACTIVITIES NET CASH USED IN OPERATING ACTIVITIES Net Cash Provided by (Used in) Investing Activities [Abstract] CASH FLOWS FROM INVESTING ACTIVITIES Payments to Acquire Property, Plant, and Equipment Purchase of property and equipment Payments to Acquire Intangible Assets Purchase of intangible assets Purchase of intangible assets Net Cash Provided by (Used in) Investing Activities NET CASH USED IN INVESTING ACTIVITIES NET CASH USED IN INVESTING ACTIVITIES Net Cash Provided by (Used in) Financing Activities [Abstract] CASH FLOWS FROM FINANCING ACTIVITIES Proceeds from Issuance of Common Stock Common stock subscribed and issued for cash Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants Preferred stock issued for cash and warrants Revenue from Related Parties Cash received from related parties Payments To Related Parties Payments made to related parties Payments to related parties. Payments made to related parties Proceeds from Convertible Debt Cash received from convertible notes payable Repayments of Convertible Debt Payments made on convertible notes payable Reduction of Short-term Capital Lease Obligations Payments on capital leases Payments on capital leases Net Cash Provided by (Used in) Financing Activities NET CASH USED IN FINANCING ACTIVITIES NET CASH USED IN FINANCING ACTIVITIES Cash and Cash Equivalents, Period Increase (Decrease) Net change in cash and cash equivalents Net change in cash and cash equivalents Supplemental Cash Flow Information [Abstract] Supplemental disclosure of cash flow information: Cash Paid During Period [Abstract] Cash paid during the period for: Interest Paid, Net Interest Income Taxes Paid, Net Income taxes Noncash Investing and Financing Items [Abstract] Supplemental non-cash investing and financing activities: Conversion of Stock, Amount Issued Conversion of preferred stock to common Debt Conversion, Converted Instrument, Amount Conversion of convertible notes payable Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature Beneficial conversion feature Initial Value Of Derivative Initial value of the derivative Initial value of the derivative. Summary of Significant Accounting Policies [Abstract] Accounting Policies [Abstract] Significant Accounting Policies [Text Block] SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Notes Payable [Abstract] Notes Payable [Abstract] Debt Disclosure [Text Block] NOTES PAYABLE Shareholders' Equity [Abstract] Equity [Abstract] Stockholders Equity Note Disclosure [Text Block] SHAREHOLDERS' EQUITY Stock Options and Warrants [Abstract] Disclosure of Compensation Related Costs, Share-based Payments [Abstract] Disclosure Of Compensation Related Costs, Share-Based Payments [Text Block] STOCK OPTIONS AND WARRANTS Related Party Transactions [Abstract] Related Party Transactions [Abstract] Related Party Transactions Disclosure [Text Block] RELATED PARTY TRANSACTIONS Off Balance Sheet Arrangements and Contractual Obligations [Abstract] Off Balance Sheet Arrangements and Contractual Obligations [Abstract] Off Balance Sheet Arrangements and Contractual Obligations [Text Block] OFF BALANCE SHEET ARRANGEMENTS AND CONTRACTUAL OBLIGATIONS Disclosure on off balance sheet arrangements and contractual obligations entered into by the entity during the period. Fair Value Measurements [Abstract] Fair Value Disclosures [Text Block] FAIR VALUE MEASUREMENTS Segment Information [Abstract] Segment Information [Abstract] Segment Reporting Disclosure [Text Block] SEGMENT INFORMATION Going Concern [Abstract] Going Concern [Abstract] Going Concern. Going Concern [Text Block] GOING CONCERN Basis Of Accounting, Policy [Policy Text Block] Basis of Presentation Revenue Recognition, Deferred Revenue [Policy Text Block] Deferred Revenue and Income Inventory, Policy [Policy Text Block] Inventory Cash and Cash Equivalents, Policy [Policy Text Block] Cash and Cash Equivalents Fair Value Of Financial Instruments, Policy [Policy Text Block] Fair Value of Financial Instruments Property, Plant and Equipment, Policy [Policy Text Block] Property and Equipment Impairment or Disposal of Long-Lived Assets, Including Intangible Assets, Policy [Policy Text Block] Other Long-Lived Assets Other Assets [Policy Text Block] Other assets Disclosure of accounting policy for recording of other assets net of accumulated amortization. Research and Development Expense, Policy [Policy Text Block] Research and Development Costs Equity Warrants Policy [Policy Text Block] Equity Warrants Disclosure for accounting policy of equity warrants. Share-Based Compensation, Option and Incentive Plans Policy [Policy Text Block] Stock-Based Compensation Shipping and Handling Cost, Policy [Policy Text Block] Shipping and Handling Costs Advertising Costs, Policy [Policy Text Block] Advertising Costs Earnings Per Share, Policy [Policy Text Block] Net Income (Loss) Per Share New Accounting Pronouncements, Policy [Policy Text Block] Recent Accounting Pronouncements Schedule of Inventory, Current [Table Text Block] Schedule of inventories Finite-lived Intangible Assets Amortization Expense [Table Text Block] Schedule of finite-lived intangible assets amortization expense Schedule of Long-term Debt Instruments [Table] Schedule of Long-term Debt Instruments [Table] Long-term Debt, Type [Axis] Long-term Debt, Type [Axis] Long-term Debt, Type [Domain] Long-term Debt, Type [Domain] Notes Payable, Other Payables [Member] Frisco EDC [Member] Frisco Note payable [Member] Debt Instrument [Line Items] Debt Instrument [Line Items] Schedule of Maturities of Long-term Debt [Table Text Block] Future principal payments of Frisco note payable Schedule Of Share-Based Compensation, Stock Options, Activity [Table Text Block] Summary of option activity Schedule Of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Summary of assumptions to estimate the fair value of options granted Schedule Of Other Share-Based Compensation, Activity [Table Text Block] Summary of warrant activity Schedule Of Related Party Transactions [Table Text Block] Summary of the related party financings and notes payable Schedule of Derivative Liabilities at Fair Value [Table Text Block] Schedule of changes related to derivatives Schedule of Segment Reporting Information, by Segment [Table Text Block] Components of revenue by geographic region Inventory, Net [Abstract] Inventories: Summary of Inventories Inventory, Raw Materials, Gross Parts inventory Inventory, Work in Process, Gross Work in process Inventory, Finished Goods, Gross Finished goods Finite-Lived Intangible Assets, Amortization Expense, Next Twelve Months 2015 Finite-Lived Intangible Assets, Amortization Expense, Year Two 2016 Finite-Lived Intangible Assets, Amortization Expense, Year Three 2017 Finite-Lived Intangible Assets, Amortization Expense, Year Four 2018 Finite-Lived Intangible Assets, Amortization Expense, after Year Five Thereafter Finite-Lived Intangible Assets, Net Finite-lived intangible assets, Net Finite-Lived Intangible Total Schedule Of Property, Plant and Equipment [Table] Schedule of Property, Plant and Equipment [Table] Property, Plant and Equipment, Type [Axis] Property, Plant and Equipment, Type [Axis] Property, Plant and Equipment, Type [Domain] Property, Plant and Equipment, Type [Domain] Furniture and Fixtures [Member] Furniture and Fixtures [Member] EX-101.PRE 11 oxys-20150630_pre.xml XBRL PRESENTATION FILE EXCEL 12 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0````(`)V+$T?G?S$WN0$``)T7```3````6T-O;G1E;G1?5'EP97-= M+GAM;,V8RT[#,!!%?Z7*%C6N'=ZBW5"V@`0_8))I8S6.+=M]_3UV"@BJ@EJ@ MTMWDT3N>>Y-QSJ(WSVM+OK?23>N'61V"O6;,ES5IZ7-CJ8W*Q#@M0[QU4V9E M.9-38F(P.&>E:0.UH1]2CVQT\[`@YU1%O=N-D'H/,VEMHTH9E&G9HJVVNO;- M9*)*JDPYUW%)'J(UG40]ZSU*%^ZECBW8JF&=L#GR/.GL?PR]=20K7Q,%W>0^ MK!ORN_PWRKOSF"9RWH2#C-_>7>ZHZ6I\K>R;U=TJ=O'QMV$65;^7P_;"GY(I MG89FV^F7%>G^E\^R]1(7NAD[N51;!HNCC2F=::W?]W=`[T;/N=$1(')1#@.0H0'*<@N0X`\EQ#I+C`B3')4B.*Y`QW8OG*\M"_V/Z'D4X$G1H>)%]2-F`Q+M*;V"^GH`A3&^.R6:E((C M-Z."N[_8_`)02P,$%`````@`G8L31PQUTFF.`0``J18``!H```!X;"]?&?/ODKC;671NJN@^S]^;:ANWP M?Y]5,?9;8T)1N<:&AZYW[;!Z[GQCX_#I2]/;XF)+9SC/E\9/YV2'W<_9L^-I MG_GCB;+9B_6EB_OLK?.74#D7@QE?]#!L,"S?>O>?[;OSN2[<8U>\-JZ-?U28 MKPTRDP[B=!!#@B0=))"@>3IH#@E:I(,6D*!E.F@)"5JE@U:0H'4Z:`T)VJ2# M-I`@RA49C-&;%;T9HSC-&;U;T9HS> MK.C-&+U9T9LQ>K.B-V/T%D5OP>@MBMZ"T5L4O05T5Z)=EF#T%D5OP>@MBMZ" MT5L4O06CMTST#I7U[O06V/&RO9&4Z-S-$Z@94^95'9$P;,@ M=2X?A:'E*69@CPFBZ&ZB30:.+LTBU$DB.%YH7F2H7-CO]88A/CE4,<8?\DW2 M(!K[*N=Y+@4')[2*K@4WVNK$LI?L,1,=):#6H75U7>A'NUM/M<7X+#.:MZHLJ=@,*:BC>R;8(GY MNJ(YI>=.4E`+C.O8US?76MRAL7[2D_YQCSX;"=;Q*C="+-1B"L+8:+QTHR5R MI\VS34MWJ$NQYMYT>S>G_FS`'L"B/YX%2S`"E`N8%7_HLA]49:MH>9:Y=2:Z MU^;1IHC.CL--L#S6L?6S.(T&PQ)!IR8RW$P6/*UI3=@2R0 M72/8PE3@]NYQ42[.KFWYHFG_&:T!1]-A]S8;3CX>P!GNMHX=S?V7?;^G-25O M3W^Z.1V"KYM[J_`[AMFF5;]_`&=P`.?T+9Y3KWLE)N?\Z@W?[67=[J3N/GI!W[ZB7\ MXI4;-O\J1G\!4$L#!!0````(`)V+$T>EMN_:/P$``&D#```1````9&]C4')O M<',O8V]R92YX;6S-D\%.PS`,AE\%]=ZEW3084=<#($Y,0F((Q"TDWA;6)E'B MJ>O;DWFE9GCTUH%'#>%B7URWZG8&<'7 MX2@'U;>GOW]ZH`Q+NLI]T'U5TS2C9D)U<>"GNAL4FT""B,AJH+FV#J8 M)U^=7R:W=\O[I!QG^33-9FE^OOJOP$4$L#!!0````(`)V+$T>97)PC$`8``)PG```3```` M>&PO=&AE;64O=&AE;64Q+GAM;.U:6W/:.!1^[Z_0>&?V;0O&-H&VM!-S:7;; MM)F$[4X?A1%8C6QY9)&$?[]'-A#+E@WMDDVZFSP$+.G[SD5'Y^@X>?/N+F+H MAHB4\GA@V2_;UKNW+][@5S(D$4$P&:>O\,`*I4Q>M5II`,,X?+&A`T%116F]?(+3E'S/X%/F7/Z3H=,H%N,!M8('_.;Z?D3EJ(X53"Q,!J M9S]6:\?1TDB`@LE]E`6Z2?:CTQ4(,@T[.IU8SG9\]L3MGXS*VG0T;1K@X_%X M.+;+THMP'`3@4;N>PIWT;+^D00FTHVG09-CVVJZ1IJJ-4T_3]WW?ZYMHG`J- M6T_3:W?=TXZ)QJW0>`V^\4^'PZZ)QJO0=.MI)B?]KFNDZ19H0D;CZWH2%;7E M0-,@`%AP=M;,T@.67BGZ=90:V1V[W4%<\%CN.8D1_L;%!-9ITAF6-$9RG9`% M#@`WQ-%,4'RO0;:*X,*2TER0UL\IM5`:")K(@?5'@B'%W*_]]9>[R:0S>IU] M.LYKE']IJP&G[;N;SY/\<^CDGZ>3UTU"SG"\+`GQ^R-;88C'(CN]WV6'WV3T=N(]>IP+,BUY1& M)$6?R"VZY!$XM4D-,A,_")V&F&I0'`*D"3&6H8;XM,:L$>`3?;>^",C?C8CW MJV^:/5>A6$G:A/@01AKBG'/F<]%L^P>E1M'V5;SCFED)O816:I^JAS0^J!XR"@7QN1X^Y7IX"C>6QKQ0KH)[`?_1VC?" MJ_B"P#E_+GW/I>^Y]#VATK\>WZV22$KYI9+2,6D$N!LT$DN/R+RO`JQ`GH9%LE"0AMNZ5/U2I77Y:^Y*+@\6^3IKZ%T/BS/^3Q?Y[3-"S-#MW)+ZK:4 MOK4F.$KTL@'37[]EUVY".E,%.70[@:0KX#;;J=W#HX MGIB1N0K34I!OP_GIQ7@:XCG9!+E]F%=MY]C1T?OGP5&PH^\\EAW'B/*B(>ZA MAIC/PT.'>7M?F&>5QE`T%&ULK"0L1K=@N-?Q+!3@9&`MH`>#KU$"\E)58#%; MQ@,KD*)\3(Q%Z'#GEUQ?X]&2X]NF9;5NKREW&6TB4CG":9@39ZO*WF6QP54= MSU5;\K"^:CVT%4[/_EFMR)\,$4X6"Q)(8Y07IDJB\QE3ON>;G*YZ M(G;ZEW?!8/+]<,E'#^4[YU_T74.N?O;=X_INDSM(3)QYQ1$!=$4"(Y4U#VT%SU&\Z.9X!ZSAW.;>KC"1:S_6-8>^3+?.7#; M.MX#7N83+$.D?L%]BHJ`$:MBOKJO3_DEG#NT>_&!()O\UMND]MW@#'S4JUJE M9"L1/TL'?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPY MC0IO0=5`Y3_;U`UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$ M%`````@`G8L31]8:CWI-`@``?`H```T```!X;"]S='EL97,N>&ULS59;:]LP M%/XK0AFCA1';*4UI:QM&(3#8RJ!YZ%N1;=D6Z.+)5U!$NEJAO/J],2,U1/186Y7LF%9$CIJ2R\ MNI(89;79Q*@W\_VYQQ#A,`YYPQ9,U2`5#5<1O!@@X/;?B0Q'\.GLZY]&J-LO MP(V3;Y.)_W1^NXN?V85S"!S'CRR"P?P2>B\GG?KZV:X-VF/XP5M/@30NU%5T?5W2@K.L!/KH(7H9H?H@SWT<8AZ M5E`*29ZUORF$5`-80K#"4I%T$_DK4;7$K>HJV&OS?0J//?)[:CI]UD8UN@0_ M.CU'![?0?<,2+!?VP_AZ21=7AZ_,OIUP1^;'5LT1$DZ0'-/:/JVT^>>5]CXU M=8IJOWZC,J]K#!O=9ZOW#"A(&D(5X;T$9/X6[HULNM46QKZC.;-V;#EV5:%$ M_PIN1=%D&4DM!G"#/0"G:&TTX3RK-KK6%-9,I),6[Z>E=W0-5$" M??)5Q]+NT7K?N?F]L7>WQMRQAUII-[>+I/*^F8]&+J^@%NZ-:4#CL]+86GB\ MM.N1*4N9PXG)VQJT'_'Q>#:RH(271KM*-BYYHKG_H;G&@BA!KU<-J(77R M_IV;EU+!#5B'8"::YJNH89$\J(0IX?QI(3T4BV2"E^8>!C=LVWQLI0H7T_$T M&0789JE7EN6F@!ZVJJ3[_O0@8064HE5^A9/=?'>1I'S"^:QGA-=N)-P["@PW MF,B]_`DK<;M(Q@D3K3=G4GFP)\+#)VO:1NHULA)62NO\,BRW>[.66M;R5Y@W M7KG*W'\V5OXRV@NUS*U1JAL5'G2#\`ONSQV*>Q<]\G#T(0YX,OG1?=A M.Y=X8L^+M`\5!1T;78!V4+"/0@F=`^O6X@B!$P+_?P([N!(6Z%0R`LJV04N/ M"0F+TN&O8U\O\((5D85*/PK M=OJCQ323T8=D]&$L#":_PSCV00RB?!?6X@)HK+ M(_I&A(D%BE-W><3=O5GCG*(&-3?F\%Y41E'49QXKNWM1$XJBAO.(X7^Y=`)> M2#6,$36;1\R.(]@*'GPKU`!%S>81LV/5,SXI:CA_H>'(HRAJ.']14484/Z(H M:CB/&+X7E8WICY<:GL4,WXM**8I*GD4DW[>%A['*J.191/*=6[C/(44-6HN( MY'M1&94\HY)GL3(>JP81JS*J>A91??`CB2.HXMGLJ3U\[@BQ*98:BM`ONPZ/ M#6<>FF@\]+_"R304RG!]@8WU(@G=+S:ZK5+'>.]2?S&BZQ%[\J9M?O\;4$L# M!!0````(`)V+$T=II'Y[0@(``(X'```8````>&PO=V]R:W-H965T&UL?57;CILP$/T5Q`E_'MR^JFIBH[D*R]DD)@Q9_C&/3F7$8_R1HHOD)<"+` MF0"S_Q+01$`S`20FTS$RD]<7+'%9<#8$?#R,'NLS!SND=J[21K-1YI_*3"CK MHXR+Z*'=3(CCB(`+!)@1D?(]"T"?P!$Z=/BOP,E%(+\`\F:`#!TMZ(F?GGCI MB:$G"WIJ;8"+R/P"J5<@=>BY)3`B4H/HQAU.`,JWN5\F\\IDCLS&DG$16[]` M[A7('3JPKXH'LG)7-EZ)C2]<_N-[?@\B]0 M2P,$%`````@`G8L31[O;#*NS!```F!<``!@```!X;"]W;W)KLOC6S]O5P*)M_U]6^/M_/S?S]B^^[EVW7?[%8+1?7<9O=H3JVN_HX:ZKG M^_DOYNZ!0B\9%'_MJG,[>3_KS3_6]8_^PQ^;^WG1>ZCVU5/77Z),+V_50[7? M]U=*D?\9+_I_S'[@]/W[U7\;TDWV'\NV>JCW?^\VW3:Y+>:S3?5^J_'"9J^"UEUJ9OWU8` MR\5;?YU1LKY(8"JY53PH"KQ*%BG^U02H)F`8C]/QI(]'=3P.XVDZWK(D+A(_ M2(Z#)'@;R;!,I,R1+V(F&U+=D'3CF)N+Q$["I+KJ__0X5HUC91S/XE@1QQMC M*+"LK<@:7;3>ZFZV`.LH4[84TXY@ M;J3.!%-$D]G%/4XU`A72D4!0(4*%X`R?'D46C46?\9,AHI%^D/LQ(A"2=[;@ MAA2=`^\R=#,Z'@U(1\0=@:R:Z%S!UTS3D8/L'.G`-9*XR(D[:FXV*P2P3JR: M%()-E*+,OC8Z=@V)4P0SS#`Z4(TD*G*B&HG4M.=]()Z4U%D;$',YZ5`UDJK( MJ3IJIO2&V[-D="2Y:BP%FZM6':Q&DA4CCR29:2AFPNC$-!*9Q)$Y:J:)$WI` M[D9"DXH0IZ:1V.2]P]I('L9@R(L2E#I7N#B!WFW+I&,3)#:)8Q,D#X$B MB*VAZ-`4.8Z#SDV0W"3.S5%SLUD$<9S_H_(F_=05$D(&<:@3!251+"<* M2E!\@<)A]*),-:D)!1G(=?.H4P5E/V9Y/X9:/Q8]!N%*"E,_03[7U6/F%EAR MRHI[X,]V9(KPPXX,=:2A1)K-[4N=56@_7=6HDP4E62RG'2IWG);?!VJBF,M& M9Q3*WLGF9E1G%(;/SX=.%52H(N9#N;'CLQ%EB6>>D>C$(84XF4Q(IP.93\\% MZ75,2AWSN2!9GM,:O@VCER;)TLP=CY1YHB1O;;*IZH5$\M"7J2JW+)!+5:\V MDM7FHV0+(7$R>H9[*E^K/LGG9'=O98]UU]6%X M:/IN[ZMSZ];RX/CB\?NOKT_AS\^C!^]1]02P,$ M%`````@`G8L31_B&%,+<`@``'0T``!@```!X;"]W;W)K-+Q_D@?1ZCM; MV355Z$-+PLO%:[O3(+T7(>7>,V52/:OI)MT(GM(OQ"9RO&C,0J?E7BW$_&@8%_ MD_+=3'YL%B$Q#*(6:V52<'TYB96H:Y-)[_QG3/I_3Q,X'5^R?[/E:OPWWHN5 MK']7&[77M"0,-F++C[5ZE>?O8JPA-0G7LN[M=[`^]DHVEY`P:/C'<*U:>ST/ M=])D#,,#V!C`K@'T?D`\!L1.0#20V;J^@V[X,0[<_.9T%NO.KIIF;%Y=#)Y1LGS(&$3B:-8(8KX*HGT_E<(AD(P&Y],(6('8I`4 M5M):"7DBA*0.R:>R&YH8I8DA3>+0#))TL@U+B?TX/`\(;X@2E"B!1$[ASPE> MN`.^^E1V0Y.B-"FDR1R:%)1-"4$;](CRABE#F3+(E#M,&=@IIHPE$`D*69'$ M1193G"A'B7)(5#A$^:-$4'B?J$")"D"49GA\B<:7L*+2J:@$H"DM\M2M!Y&5 M\51V0V-L&',N`GARXEH7>0P(T]TC\G@IA1TN/!EP(Z2($[H]'C53UA(\,8B( MTL1C@Q3W00J-$#88&AP"`T5W8'`+I-`#T]*3`;L!BT*-)=! M]\%AH,Z%B28'V0/?B9^\VU5M'[Q)I<_$]N2ZE5()G8X\Z41[_:YRG=1BJ\PP MU^-N.+T/$R4/EY>1ZQO1\A]02P,$%`````@`G8L31QN3(553!```V1(``!@` M``!X;"]W;W)KZ^=;N8^QF M/ZKRV#[.]UUW>LBR=KN/5='>UZ=X3&]>ZJ8JNO38O&;MJ8G%;C"JRDP*8;.J M.!SGR\4P]J59+NJWKCP5Q_@0/&RE[R(#XZQ#/[U[$L>T\I\C\7IQ\Q>\/;^W?OOPUT4_K/11O7=?GW8=?M4[9B/MO% ME^*M[+[6Y]_CA8/I'6[KLAU^9]NWMJNK=Y/YK"I^C-?#<;B>QS?:7#:QS>0%T,U(>!_JF!OACH_QO!7`P,BI"-W(?*Y457+!=-?9XUXW2?BKZK MX,&DN=GV@\-4#.]2[=HT^GWI8)%][_U<(*L1(F\A\C,DIY`/)UF*?TU"/..F$4JMV&"ZNTTH*G9UAZAM*SB-X(,3=QM`C@43IK M"I-6>X.\Y13FM!$*U6K#!'5":\MSLRPW2[DYQ,V2,%99KU#2:PK3H*1!C9!3 M6)!&!XVX49BQRH>)MG0L-T?;VO/VGK7WM#9H"E:>3FA(#=!<4+> M@%*4F")P*;D`!G.D0.N#U!YSI+BT=KT,A",3.8768:)'@97/)Y"4I,(D)0EU M9P$$7JIK#MBO0MS0.0<$*Z4+%M-DD,8**R;D!7CY!:J_?F*C`UZ`@2JPQPI\ MP:!D(;4#+A05S3MO`MX?!:B+TVP>9 M8P8GI9DL.R^>0-738_4$JF1W4FA)/S5_#?R<$R]ZX&A.'N?DF`Y/]'$C.#)O M6FJ+%9WUEG0+=P'U9M)7Q-12X249J"9[K,E`]?'.:J?PI\B:`VIE\/:8<[C@ MC--8F#D@*).VC@F2O#8#%6>\PZXNF,]KJF]@I3%+!JD@&#Q!.0=,4N>-#GQ>25YF994IO%FM+I@PFTH<2\PR0D8_MLP`<,?(1.PB8\0R2NT!+*K MAXFE+'GYDU3^L%BM))4@)208AQ?]FD&FV0W6:KP3<<@TNTY)W`B\3V.#QIV0 MW?QOKV+S.IR8M+-M_7;L^B+=C%Y/99Z&0QDTOH*'-3#C.3QLQC.7#_?+Q:EX MC7\6S>OAV,Z>ZZZKJ^%,X*6NNY@(B/N4^CX6N^M#&5^Z_M:E^V8\>1D?NOKT M?I!T/M<7BHZI_-KNR;">_CH=3\SC= MM>WY83YO-KOR6#3?JG-YZKYYJ>ICT7:W]>N\.==EL1VFL/^U/YO9XT;\=C4?^W*@_5Q^.4II\/?NQ?=VW_8+YFPP6?^_+C^;F>M*+?ZZJG_W-G]O'J>DUE(=RT_9- M%-W'>[DN#X>^I2[ROV.C7S%[Q]OKS]9_']+MY#\73;FN#O_LM^VN4VNFDVWY M4KP=VA_5QQ_EF(/K&]Q4AV;X/]F\-6UU_'293H[%K\OG_C1\?ER^\3*Z80<> M'?CJ<(V#'61TD"\'.V1Z43;D]5O1%LM%77U,ZLM@G(M^S.E!NI[;]`^'CAJ^ MZS)KNJ?OR]PNYN]].Z/)ZF+"-R9TM9AWC5\C,(JP8N7.]P'6VL(+CB`P!QG\ MY38'A_TM]+>#O[WU-U$?7$S\8'(:3&;L\N#$1[D`PRQW@0,6Y*`@IQ/*L'\& M_3.=4*1S=3%Q-SJ9"C,5A[U;7$1-9@ M-0&J"5I-'JD)>@3%>[(X3`[#Y"H,F3B=7,>Q[#@Q5K0"2*%[!1H=A8 M]IP(E2`%@5``(TX,<")3%@9P:J,XH)XHS=[J3O0L)G!'F M$6D@D8F)1!HV&6<^-9J8-N05.LFDQ&)$D&8$F1@2H]'=/!=+SDO!G%$D!&:297D" M3XSQQ!I/HO0`.DD@E\>"2`U:QNYF$MP+P@QCS;!X?UV--G>"G)$L,6,9(XP! MPN*%O&*-,`XL-IX

)]132A0@?,>%<6#:AN]TX5=((!):#(XAB9HHLLSMR=I/M8B5-^C]Z(P\@0@CV/D"6`9V7@+AU8F50H* M!IX`X'%<28L&GN0LMZ_)HR14,W9_B?U.,!L%L)%C-HJ&'C.'8$.L"="QJTZ3 MQ9?%>+2@&E3UJ=5E7F:]R>-^0G;.9ZDS(8MQ:P%N.<:MU1P-WN4V)A.PXVY3 M2S#08MY:UGN()!:(Q1BU`*.24I$X[`*`E-1H8YY9?3Y%DAH=C!\+\*.JX]'H MKM=M8K583!0+B"(Q42PZ@+(D"5A8#`L+8"$Q+*QF0#`=*E(#@!E@`0/BD\B5 MU?419=W;8#SCYC='Q<>R?AV.T)O)IGH[M?VI[,W3ZS']$_='S='S%3VL+X?M M7\TL%^?BM?RKJ%_WIV;R7+5M=1R.FU^JJBT[F>9;UQ>[LMA>;P[E2]M?^NZZ MOARY7V[:ZOSY"\+U9XSE_U!+`P04````"`"=BQ-'C`6.KJ(!``"Q`P``&``` M`'AL+W=O*D4YM&?6'MLHP+B`U^G?%[#7<5)?@!GFO7DS#,6(]L5U`)Z\:F7 M]T?&7-6!%NX.>S#AID&KA0^F;9GK+8@Z@;1B/,L^,2VDH661?$^V+'#P2AIX MLL0-6@O[]PP*QQ/=T9OC6;:=CPY6%FS!U5*#<1(-L=",YC1`KX)6%T MJS.)VB^(+]'X49]H%B6`@LI'!A&V*SR"4I$H)/XS<[ZEC,#U^<;^+54;U%^$ M@T=4OV7MNR`VHZ2&1@S*/^/X'>82#I&P0N722JK!>=0W""5:O$Z[-&D?IYM# M/L.V`7P&\`5PGR7A4Z(D\ZOPHBPLCL1.K>U%?,'=D8=&5-&9ZDYW0:@+WFNY MV]\7[!J)YICS%,/7,4L$"^Q+"KZ5XLS_@_-M^'Y3X3[!]^\4?MDFR#<)\D20 MKPGR[$.)6S$?BV2KGFJP;1H=1RH<3!K4E7>9S@>>WN0MO"QZT<)/85MI'+F@ M#R^;^M\@>@A2LKL#)5WX/XNAH/'Q^#F<[312D^&QOWV0Y9>6_P!02P,$%``` M``@`G8L31TA+9GJ@`0``L0,``!@```!X;"]W;W)KO&EEW(EVWO='QES5@1;N#GLPX:9!JX4/IFV9ZRV( M.H&T8CS+OC`MI*%ED7Q/MBQP\$H:>++$#5H+^_<,"L<3W='9\2S;SD<'*PNV MX&JIP3B)AEAH3O1^=SSG,2(%_)8PNM691.T7Q)=H_*Q/-(L20$'E(X,(VQ4> M0*E(%!*_WCC?4T;@^CRS/Z9J@_J+[(-0%[[79?IO.?I3=[#RZ(7+?P2MI7&D0OZ\+*I_PVBAR`ENSM0TH7_LQ@*&A^/7\/9 M3B,U&1[[^8,LO[3\!U!+`P04````"`"=BQ-'OM#T3*(!``"Q`P``&````'AL M+W=OVF?6'MLHP+B`U^G?%[#7<5*_`#/,.7-F&(H1[:OK`#QYT\JX(^V\[P^, MN:H#+=P-]F#"38-6"Q],VS+76Q!U`FG%>);=,2VDH661?,^V+'#P2AIXML0- M6@O[]P0*QR/=T:OC1;:=CPY6%FS!U5*#<1(-L=`/N<,IC1`KX)6%TJS.) MVL^(K]'X41]I%B6`@LI'!A&V"SR!4I$H)/XS<[ZGC,#U^82;B-AA)MV:=(^3C=[/L.V M`7P&\`7PD"7A4Z(D\ZOPHBPLCL1.K>U%?,'=@8=&5-&9ZDYW0:@+WDNYR^\* M=HE$<\QIBN'KF"6"!?8E!=]*<>+_P?DV?+^I<)_@^P\*[[<)\DV"/!'D'P@> M/I6X%?/E4Q*VZJD&VZ;1<:3"P:1!77F7Z7Q,C\C>P\NB%RW\%+:5QI$S^O"R MJ?\-HH<@);NYI:0+_V^^L'67YI^0]02P,$%`````@` MG8L31P;TZ/:A`0``L0,``!@```!X;"]W;W)KPUW%2]P+, M,._-FV$H1K0OK@/PY%4KXTZT\[X_,N:J#K1P=]B#"3<-6BU\,&W+7&]!U`FD M%>-9]HEI(0TMB^1[LF6!@U?2P),E;M!:V#]G4#B>Z([>',^R[7QTL+)@"ZZ6 M&HR3:(B%YD0?=L?S/D:D@)\21K_UB691`BBH?&008;O"(R@5 MB4+BWS/G6\H(7)]O[%]3M4']13AX1/5+UKX+8C-*:FC$H/PSCM]@+N$0"2M4 M+JVD&IQ'?8-0HL7KM$N3]G&ZR>]GV#:`SP"^`.ZS)'Q*E&1^$5Z4A<61V*FU MO8@ON#ORT(@J.E/=Z2X(=<%[+7>'KH#3'G*<8OHY9(EA@7U+PK11G_@^< M;\/S385Y@N?O%/XG_WZ38)\(]N\(^(<2MV+R#TG8JJ<:;)M&QY$*!Y,&=>5= MIO.!IS=Y"R^+7K3P0]A6&D&UL;5/13NP@$/T5T@^0+MM5L^DV<34W]S[< MQ/B@SVP[;8G`5*!;_7N!=FO5O@`SS#ES9ACR`5=2VT/2.M?M*;5E M"XK;*^Q`^YL:C>+.FZ:AMC/`JPA2DK(TO::*"YT4>?0]FB+'WDFAX=$0VRO% MS<<1)`Z'9)-<'$^B:5UPT"*G,ZX2"K05J(F!^I#<;?;'+$3$@&<<;^,]-([0E)W3^96/_ M:T0'7DIZM4M(Z__/;$BH73C>^+,91VHT'':7#S+_TN(34$L#!!0````(`)V+ M$T<"IDA:H@$``+$#```9````>&PO=V]R:W-H965T_-F&/(![:MK`3QYU\JX(VV][PZ,N;(%+=P-=F#"38U6"Q],VS#761!5`FG% M>);=,BVDH46>?,^VR+'W2AIXML3U6@O[]P0*AR/=T*OC13:MCPY6Y&S&55*# M<1(-L5`?Z%+G%@=BQM9V( M+[@Y\-"(,CI3W>DN"'7!>RDV^_N<72+1%',:8_@R9HY@@7U.P==2G/A_<+X. MWZXJW";X]I/";^L$NU6"72+8+0ENLR\EKL5\+9(M>JK!-FET'"FQ-VE0%]YY M.A]X>I./\"+O1`._A&VD<>2,/KQLZG^-Z"%(R6[VE+3A_\R&@MK'XUTXVW&D M1L-C=_T@\R\M_@%02P,$%`````@`G8L31RR@X6R@`0``L0,``!D```!X;"]W M;W)K&UL;5/!;N0@#/T5E`\H&9+I5J-,I$Y75?>P M4M7#[IE)G`05T-\#J"E*0L36^IXD(G91%]SZ8L<'!2:'@VQ`Y* M+:#L7'+0LZ(*KA0)M!6IBH#DF][O#*0\1,>"/@-&NSB1H M/R.^!N-7?4S2(`$D5"XP<+]=X`&D#$0^\;\KYT?*`%R?9_;'6*U7?^86'E#^ M%;7KO-@T(34T?)#N!<WK*"7 M0'2-.4TQ;!VS1%#/OJ1@6RE.[!N<;<.S3859A&>?%&;;!/DF01X)\D\$^9<2 MMV+V7Y+054\5F#:.CB45#CH.ZLJ[3.<]BV_R$5X6/6_A-S>MT):G-/B&=_S^+(:%QX?C#G\TT4I/AL)\_R/)+RW=02P,$%`````@`G8L3 M1QE+?OVB`0``L0,``!D```!X;"]W;W)K&UL;5/! M;N,@$/T5Q`<4VTG3;N18:KJJVL-*50_=,[''-BHP+N"X^_<%[+ANUQ=@AGEO MW@Q#/J!YLRV`(Q]*:GN@K7/=GC%;MJ"XO<(.M+^IT2CNO&D:9CL#O(H@)5F6 M)#NFN-"TR*/OV10Y]DX*#<^&V%XI;OX=0>)PH"F].%Y$T[K@8$7.9EPE%&@K M4!,#]8'>I?OC-D3$@%+\2AF`R_.%_2%6Z]6?N(5[E']%Y5HO-J&D@IKWTKW@\`A3"=>!L$1IXTK* MWCI4%P@EBG^,N]!Q'\:;33K!U@'9!,AFP&T2A8^)HLS?W/$B-S@0,[:VX^$% MTWWF&U$&9ZP[WGFAUGO/1;K;Y>P'-.L%VE6`;";;?"&Y_E+@6\^M'$K;HJ0+3Q-&QI,1>QT%=>.?I MO,OBFWR%%WG'&_C#32.T)2=T_F5C_VM$!UY*O_SVQ(J%TXWOBS&4=J M-!QVEP\R_]+B$U!+`P04````"`"=BQ-'[\;6M*`!``"Q`P``&0```'AL+W=O MP%FF/?FS3#D`]HWUP)X\J&5<0?:>M_M&7-E M"UJX*^S`A)L:K18^F+9AKK,@J@32BO$LNV%:2$.+//E>;)%C[Y4T\&*)Z[46 M]L\1%`X'NJ&3XU4VK8\.5N1LQE52@W$2#;%0'^C=9G_`>U6]9 M^3:(S2BIH!:]\J\X/,&EA.M(6*)R:25E[SSJ"4*)%A_C+DW:A_&&3[!U`+\` M^`SXD27A8Z(D\T%X4>06!V+'UG8BON!FST,CRNA,=:>[(-0%[[G8W&8Y.T>B M2\QQC.'+F#F"!?8Y!5]+<>3_P/DZ?+NJ<)O@VR\*_Y-_MTJP2P2[+P3\6XEK M,=MO2=BBIQILDT;'D1)[DP9UX9VG\XZG-_D,+_).-/!3V$8:1T[HP\NF_M>( M'H*4[.J:DC;\G]E04/MXO`UG.X[4:'CLI@\R_]+B+U!+`P04````"`"=BQ-' M0"KP"V4"``!2"0``&0```'AL+W=OVDVS_OK9)6-8<7O"%,^>, M/1Z/\YN0[ZKB7`12VKN[#(W=RK+')QT4W=\5<9J$O;,OEOQQMQVX0D?$R\U:=*VXFH MR*/![E"WO%.UZ`+)CYMP2YYW)+40A_A=\YL:]0/K_%Z(=SOX>=B$L?6!-[S4 MEH*9YLI?>--8)J/\]T[ZJ6D-Q_T'^W>W7./^GBG^(IH_]4%7QMLX#`[\R"Z- M?A.W'_R^AJ4E+$6CW#72U1'?,KL?0 M,69`1(9]D*!(8D",`LLDD&1 M#!#X@4>8F<#;[$89%`,*/_00-!-[,I.I9$*13#)UBB'I3+(0F*U;0J<46>SK M(-#,I4!P6I,$4%!?!X&2&1V<_02D=C;9-P1:SNC@"X"`[,Y6O@X"K6=T\!U` M0()GJ:^#0'/G`%\#9)KCII3[.@@T=P[P34"F:4[CR3E`(/\<1*.:UW)YF+_N2WP^T.#]>,,,SJO@/4$L#!!0````(`)V+$T=4$<@0KP$` M`!8$```9````>&PO=V]R:W-H965T0' M*`YQTBYR+#6=JNUB4M6+[9K8QS\J<%S`E-NI44MNW5(WU/0:>!5(4E"6IGLJ>:>2(@^U M%UWD.%C1*7C1Q`Q2$0"_.QC-:DY\]C/BFU_\K(Y)ZB.`@-)Z!>Z&"SR!$%[(&;_/FI^6GKB> M7]6?0[$+QIZMLZ\*F":F@YH.PKSC^@+F%D+!$8<(O*0=C45XI"9'\ M8QH[%<9QVMEG,RU.8#.!+82'-`2?C$+,[]SR(M"VI<]5*P-,OIQ0O-F-.$82O,9D%0I[Y8L)C%B?U'9W'Z-IIP&^C;M?OV M6UP@BPID02#[TN+NIL489A\WV45-=A&!^QN3&.;AQH2N#DZ";L+]-*3$0877 ML*HN3^"1A8/_A!=YSQOXQ773*4/.:-WU"8=<(UIP4=([EZ5UCW19"*BMG]Z[ MN9[N[;2PV%]?X?)74/P#4$L#!!0````(`)V+$T>JED<8J@$``/(#```9```` M>&PO=V]R:W-H965T0/"#:[VS8KKZ5L MJJH]5(IR:,^L/;91@'$!K]._+V"OXZ;T`C/#O#=O8"@G-"^V!W#D54EM3UGO MW'"DU-8]*&[O<`#M3UHTBCOOFH[:P0!O(DA)RO+\`U5!9=[T*`5B5=<8U0H*U`30RTI^RA.)X/(2,F_!`P MV8U-@O8+XDMPOC6G+`\20$+M`@/WVQ4>0O47 M;N$1Y4_1N-Z+S3/20,M'Z9YQ^@I+"U%AC=+&E=2C=:AND(PH_CKO0L=]FD_V M]PLL#6`+@*T`]BD*GPM%F9^YXU5I<")FOMJ!AQ]XYH5:'[U6 M++\OZ340+3GG.8=MXB?+^%%WF:8)\DV$>" MW5\$_VG@D"0X)!2P=W>4RMF]*T(WCZ+`=''V+*EQU''2-]%UO!]8?-2W]*H< M>`??N>F$MN2"SH]&?,`6T8&7DM]Y+;W_@*LCH77!_.AM,\_D[#@<;C]L_>;5 M'U!+`P04````"`"=BQ-'!RO!C[X!``![!```&0```'AL+W=OI1F?!C M`=?T[0OH&K.E-P*'[^<-'(C$)0_><$7$W')$NN M@5?6]=8'<%7BE=N)U?U;^&:EWV9VK@6?%?K+&]2S9-4`,M M';E]5=,W6$K(O6"MN`E?5(_&*G&E)$C0]WED,HS3O%,\+K0X@2P$LA(>TI#X M;!32_$(MK4JM)J3GHQVH_X/9@;B#J'TPU!WV7*+&12\5R?8EOGBA!7.:,62# MR58$=NJK!8E9G,@_=!*G[Z(9[@)]MW7/_^._CPKL@\#^4XGY38DQ3!$WR:,F M>43@_L8DAGF(FQ11DR(B\'AC$L&0],8$;VZ'`-V%)C"H5J,,+;>)KGWV1,+M M^H!7Y4`[^$%UQZ1!9V7='0TWJ57*@DLEO7,%]^XE6!<<6NNG]VZNY^:8%U8- MUU9?WYOJ+U!+`P04````"`"=BQ-'9.THKJ(!``"Q`P``&0```'AL+W=O+'$#5H+^^<, M"L<3W=&;XU6VG8\.5A9LP=52@W$2#;'0G.C3[G@^Q(@4\%/"Z%9G$K5?$-^B M\;T^T2Q*``65CPPB;%=X!J4B44C\>^:\IXS`]?G&_C55&]1?A(-G5+]D[;L@ M-J.DAD8,RK_B^`WF$O)(6*%R:275X#SJ&X02+=ZG79JTC]--_CC#M@%\!O`% M\)@EX5.B)/.+\*(L+([$3JWM17S!W9&'1E31F>I.=T&H"]YKR?FN8-=(-,>< MIQB^BKE'L,"^I.!;*<[\/SC?AN\W%>X3?+_.GN?;!(=-@D,B./Q3(O]0XE;, M_D,2MNJI!MNFT7&DPL&D05UYE^E\XNE-[N%ET8L6?@C;2N/(!7UXV=3_!M%# MD)(]Y)1TX?\LAH+&Q^/G<+;32$V&Q_[V099?6OX%4$L#!!0````(`)V+$T<0 M6'MMHP$``+$#```9````>&PO=V]R:W-H965T0/"%[LW48KKZ5LJJHY1(IR:,^L/;91@'$!K]._#V"OXZ:^`#/,>_-F M&(H1S9OM`!QY5U+;4](YUQ\IM54'BML[[$'[FP:-XLZ;IJ6V-\#K"%*2LC0] M4,6%3LHB^EY,6>#@I-#P8H@=E.+F[QDDCJ=DE]P%P9&8J;4]#R^X M.S+?B"HX8]WQS@NUWGLM&@U$<\QYBF&KF-T203W[DH)MI3BS_^!L&YYM M*LPB/%MG/V3;!/DF01X)\G]*W'\I<2OF\"4)7?54@6GCZ%A2X:#CH*Z\RW0^ ML/@FG^%ET?,6GKEIA;;D@LZ_;.Q_@^C`2TGO]@GI_/]9#`F-"\=O_FRFD9H, MA_WM@RR_M/P`4$L#!!0````(`)V+$T>K*_#PHP$``+$#```9````>&PO=V]R M:W-H965TX33=R+#6MJO:P4M7# M[IG88QL5/"[@N/OW"]AQW=878(9Y;]X,0S:@>;,-@",?6K7V0!OGNCUCMFA` M"WN%';3^ID*CA?.FJ9GM#(@R@K1B/$ENF!:RI7D6?2\FS[!W2K;P8HCMM1;F MWQ$4#@>ZH1?'JZP;%QPLS]B,*Z6&UDILB8'J0.\V^V,:(F+`'PF#79Q)T'Y" M?`O&+P!%,)UX&P0&7C2HK>.M07""5:?(R[;.,^C#?I=H*M`_@$ MX#/@-HG"QT11YH-P(L\,#L2,K>U$>,'-GOM&%,$9ZXYW7JCUWG/.^2YCYT`T MQ1S'&+Z(V?K\.VJPFV$;Y?9;W;K!.DJ01H)TB\EWGXK M<2WFU["G)U34EC?\_LZ&@&PO=V]R:W-H965T@!HDHY4S M=1R@*$I`1]L^S#.W]RKS3%PU;WOV*@-U[3HJ_Q:,B_$8PO"^\=9>&FTW0)Z! MQ5>U'>M5*_I`LOH8?H&'4V(53O"K9:-:S0/+?A;BW2Y^5,MH3]3Q4Z"_VXKW1C8*`PJ5M,KUV]B_,[F M%F(;6`JNW&]07I46W=T2!AW]F,:V=^,XG21XMOD-:#:@Q0#)IP8\&_#&`"8R MU]=7JFF>23$&7*EW70/RIV9SI39O>4(1QFXV:!94TP:M-8\ M*DX>!5XDP``L%,A+@9P?/_BA/P![`[`+(`\!&\ABTJ1.TSL-W,%=@C>]>&08 MDS3UXQ`O#O'@;.H4DR9>U2%POR<;&I\*0N*'B;TPL0=F4Z:(G\K`_2YYHO'( M(I3&L1\G\>(D'IQX@Y,\O0."4!S##V$\J+VVO@K/0 MYKMR__Y:",U,9/1BFFO,=;&PO=V]R:W-H965T'56GG7D55\JNB70^O(I!7QHCX>P3*QT,8A]/$6W=I ME9E`58GFNG/'H)<=[P,!S2'\$N^/A5%8P:\.1KGH!R;[B?-W,_AQ/H21B0`4 M:F4A6TJG,7X#O!7@NP"ZX`]F8 M7XDB52GX&`AWM`,Q_V"\Q_H@:C-I]VW7=%"I9V\53K(2W8S177-T&OQ)D\\: MI/UG"/9"L#5(%@9Q\NPW2+P&B35(K4'O$D1QNHKI1/E"E$0XP7[.SLO9^3CK MX]B*'G!2+R?U@!)_=RR5:#A7H"VC)YVZ MU4_:/*#0*-/-=5^X6^X&B@_3FS4_G-4_4$L#!!0````(`)V+$T<)?"&C]0,` M`*D3```9````>&PO=V]R:W-H965T!R7!4_4C.+KNKJQ5943[-379_GOE_M3BI/JF_ZK(KFEX,N\Z1N/LNC7YU+E>P[ MHSSS:1`(/T_28K9<=&,_RN5"7^HL+=2/TJLN>9Z4_Z]4IJ]/,S)['_B9'D]U M.^`O%_[-;I_FJJA277BE.CS-GLG\A/\V" M-@>5J5W=NDB:QYM:JRQK/361_QN.MPI[.J^^OM+E6M\W>3F9K+.GDWJZ2A%"!V$ MG8-P7$EB\%CU&-EAB@YC3-GF2\3+9XA)FARFR:TT:6BFV6/X*`0+961,++?R MX(1S@X[M24348+2U/<4R$IB4@*0$(&6N,F&E8N;Q&6*2A(1)2)!$:%166B$D MY]*H+`09Y=_8(,(),>)M$2H0CMI&D%8$:)G3'%EA0AHP,QD;Q207%"<3PV1B M*QD9&R6.K2@TEB$71I$!3/(&:#"S89P$44`,:LB;;/2`N;5;)FKI`2BUD?=J M`$TRB@0Q$EH#F-EJ`(0$(C9=;1%.\BAR<'-L5P1PDR8W8J\0&K.8F>1L'.%A M8*IM,^#&G47&(6&QR=#VUS3_.'9L(`3NA<^$`HJF;`?0)/6(BBAF#AT0O%T1 M!H+%#A=XPR+A_5L>P9L)`;L)M]89`KGBX/Y.0(/GKH+A[DSD`VQQ)R2H%9H= M?@!-=C/!0W,%WX/:`!2)66`MWZ]@4W*XLQ*[M8*I1""'2BAN&PO M=V]R:W-H965TD/TP%8]"6X-+NDL[;?8FSJ M#@0U-ZH'Z79:I06U+M5';'H-M`D@P3%)TS46E,FD*D/M15>E.EG.)+QH9$Y" M4/V]!ZZ&79(EE\(K.W;6%W!5X@G7,`'2,"61AG:7W&;;?>$[0L,;@\',8N2] M'Y3Z\,E3LTM2;P$XU-8S4+>A8/.>6EJ56@U(QZ/MJ;_!;$O<0=2^&.8.>\ZH<=5S1=99B<^> M:.S9QQXR[\DW4P]V_),(610A@2#_(T*6"?)%@CP0K`*!C`1IMKJR&9LVLZ:5 M^_?299UB4:<(%,4?H_F53/$O&3R[@)X>X9GJ(Y,&'91U=QE.O%7*@F-,;]Q@ MG7LQ4\*AM3[&PO=V]R:W-H965TS$@OWW[=B4]Q.RD MZK=F+Z4./LJB:N;A7NO#?10UZ[TL17.G#K(R_VQ570IM'NM=U!QJ*38VJ"PB M@E`:E2*OPL7,CCW7BYDZZB*OY',=-,>R%/7?!UFHTSS$X7G@)=_M=3L0+6;1 M)6Z3E[)JSUU_U#>A\$!I`\@EP`6?QD0 M]P'Q)0#3+P-H'T!O#4CZ@.36@+0/2)V`J&N6;?6CT&(QJ]4IJ+OU<1#M,L3W MJ9G,=3MHY\[^9YK=F-'W!4GI+'IOB7K,0X3!EB:=G&C<0E(""$D!0Y@A*O$19FOK]F80-Y*2@G-23P]V5 MFWIIDA2S##O+-_5FBR<9=S7[9#PC&75RKGPRG,4)9W!I#"R-^9UF([WA(`&_ M?2]D($$&*'#:MNPPK;E?2D5WR$$]3:$&8EH8Y&0(D$-!%&$<#92-QXQ M33RYK)YZS'6F-.8X0ZZC86\MC,PBABT-$Z#N$5/$L*GA^/:E@&$CPH`3,>]% M0KU:"8Y'MS2&+08#'L,2-Q4$&BL)]@[LFP=AS,T#@)*QA0MO9`SM9.[F@4#9 M2!YXOV-^P[NK!PT&+`/[]W5@ZY7#*6`GBG8\&@`&P@!#(2/ M4<#&0/#M&XF,G%"@[>RV!0)QUU0G0$,QL#$0X+C#R0@%;`R$_D=+X`U/H+WL MM00``.0'JQ$179^>#V,F?HM[E51.\*FV.X?:PO%5*2T.([@SAWGRQ71X* MN=7M+3/W=?<-TSUH=3A_DEV^"Q?_`%!+`P04````"`"=BQ-'W5^\I<4$``"9 M&P``&0```'AL+W=OCA02+ M:U'^J@Y:U]Z?/#M5+[-#79^?Y_-J<]!Y6CT59WUJ?MD599[6S==R/Z_.I4ZW M7:,\FW/?#^9Y>CS-EHONW(]RN2@N=78\Z1^E5UWR/"W_6^FLN+[,V.SCQ,_C M_E"W)^;+Q?S6;GO,]:DZ%B>OU+N7V2M[3E0GZ13_'/6U&AU[K?FWHOC5?OEK M^S+S6P\ZTYNZ[2)M/M[U6F=9VU,3^??0Z6?,MN'X^*/W;]UP&_MO::771?;O M<5L?&K?^S-OJ77K)ZI_%];L>QJ#:#C=%5G7_O?QU'U> M^U_"CV:X`1\:\%L#=K^!&!H(UP9R:"`_&\@N-?U0ND0D:9TN%V5Q]]O1H%GU&C[2A'PJ65,)NRGFC8&; M"XY$HT"^4]-%&48=Y,E#V43TP$T'5#3@6$Z(-EA MO@\3[JQ,7)03]R%T'U+W1I)6(4Z2451K-UGR4#8Q'4'3$3'-(R/GZUX3CN)( MWV=Q@./$,$X,XH1&G)A>!ZX"J2R3OJ4_XI\/0D4FW7PR)A4%S((X9B$M`Y%B M$[6,C$HPSB4M6&=E`I0-XT44"-L`(*1?&:<#B'US`-QY`*[*!"@?#``3G@DP M`&8.0-"Z$NV?)12^%S!Z,^`Q-T-)4E:1'2,,HYM1=O/89A:#E`7NMSZ&:<8` MSDAMAR2SBD6A(H7AIDN0+A9CW=0Y1AJC3`M)44>.SMUT"=+=?6$N8B)P2@0Z%^FZ*0S!@MA1EP"= MI7P%9I``*S"SIE:#Z(Z;:2C,*D%9)9A>`M&+3$&ZW#+M3&-AS`FZW@)SD&XB.=RV.PBG MIC`X!04G+7FPX<37S5&8`*'%ML3HE!2=PK>L_25&HF3N12\QPB1%&"EZ29=3 M2K#`?&"S=M0E0&=+'8:<1*LSL^0EI9+A9AK*\ER0HHD4EZ3+,YP?-UT"=+;\ M8!A*NM(3MF=%$L-0?F%;*3&8)-A6DF>JE$N"2<&%N01V$$X]88!)"C#RL%12 M+#'3S3W)U`=FEJ3,$K8'J`KS0WUA^Z

N7=BY%/^7)Q3O?Z[[3<'T^5]U;4=9%W+T%V M15'KQHS_U%3)0:?;VY=,[^KV,&R.R_[-4?^E+LX?+\)N;^.6_P-02P,$%``` M``@`G8L31_915"JA`@``%0P``!D```!X;"]W;W)K&ULE9?=CMHP$(5?)55GO17ALP$&T2T]C`]NUK.X&R M[+'$WA#;F3DS<;X3F=E)MZ]FIY1-WNJJ,?-T9^U^FF5FM5.U-`]ZKQIW9Z/; M6EHW;;>9V;=*KD-2766;I%YH^BL*'A(A?I3J9JW'BFU]J M_>HG/];S-/<]J$JMK)>0[G)43ZJJO)*K_*<7_5_3)UZ/S^K?PN.Z]I?2J"== M_2[7=N>ZS=-DK3;R4-D7??JN^F<8>,&5KDSX358'8W5]3DF36KYUU[()UU-W M9YSW:3B!^P2^)$Q"WUV=T.57:>5BUNI3TG9;NY?^#=*4W3ZL_&)X['#/]6G< MZG$A\N$L.WJA/N:QB^&K&!:32TSF]"]%&!;A(""N!6B`!004$$&@>-?EZ*;+ M+F808IJNR(#$6(QQH0(6*D"AB,``"@R`0&2OAE!@^%&`L5V(."'F*$(&X*0(R*6(FP)0IZ( M[04V!2%71&S%V!6,7!$Q%F/8&<%^:ZP^Z&[,./+59U#K%ND^Z#[,&'N'@7P1RPD, MNT"P1[@0&':!8(]83F"&!6(X8CD1.;L@.HN(!*93H`_V+5K9U9%O+[?JIVRW M96.2I;;N\!C.>!NMK7*"^8-C=>?.Z)=)I3;6#T=NW':GUFYB]?Y\"+_\$UC\ M`U!+`P04````"`"=BQ-'I%L528@"``"5"@``&0```'AL+W=O34N&S=-=.R=I0D]BJILR#MS^+&N,?NW M)!4]SUWD7@(?Y;X0*N"EB=?SMF5-&E[2QF%D-W<7:):C4$$TXD])SOQF[*CD MUY1^JLFO[=SU50ZD(ANA)+!\G4A&JDHIR96_.M'KFHIX.[ZH_]!V9?IKS$E& MJ[_E5A0R6]]UMF2'CY7XH.>?I/,0*\$-K;A^.ILC%[2^4%RGQM_MNVST^]Q^ MF?@=#28$'2'H"?TZ,"'L".&5$#TE1!TALETA[@BQL8+7>M<[M\("IPFC9X>U MO_N`U:E"LUC^FXT*ZE^AO\F]XS)Z2D,T3;R3$NHPRQ83W&#&P1"RNH>@'N') M!/HL`BB+97!'-Q;([A'CT,CAI4C^5&209@AN5JCYX>UF!3XL$($"D1:(!@+( MV&T(8^X&A#&WPT(G?ZXS,!2#AF)`(#(,09C8,&2!65E@\N>8@:$1:&@$"(Q@ M@3$H,+8_(Q-08`)D,#:V]!X3Q,8YRBPP*PM,_APS,#0%#4T!0Q/#$(0QRE`& M8$+?,&2ADT,Z#PRI.P8JFCX@$3R0>%!WD?TY06#17*#`XJ1`H-`H%9D-:&4# MRE^`AK;@(HM"B_,"@<+(M`6!S*IBHY2_4&IM>3=W;DW87G<[W-G08R/4G[Z) M]AW5(E!WMA%?HEF&@/A*=6#ZCK_*I\D![\EOS/9EPYTU%;)3T/?YCE)!9.[^ MFZR)A>P1^TE%=D(-QW+,VJZIG0AZN#2!?2>:_@=02P,$%`````@`G8L31R1C M=TL&`@``308``!D```!X;"]W;W)K&UL=57;CILP M$/T5Q`<$;.X106JVJMJ'2JM]:)\=,`&MP=1VPO;O:QM"63*\Q/9XYIPSX\R0 MCUR\RX92Y7QTK)+!O:$7G@`^WU3_HJ''GK.B+^GBGCX\E%[L/PUEX;90Q>D7M+7-5V MM)[O2% M,F:0-/.?&?0_IPE<[Q_HWVRZ6OZ%2/K"V>^V4HU6Z[M.16MR8^J-C]_IG$-D M`$O.I/UURIM4O'N$N$Y'/J:U[>TZ3C>I/X?!`7@.P$M`9G5//%;E5Z)(D0L^ M.F(J[4#,"Z(CUG4HC=&F;>^T3JFM]R((XMR[&Z#9YSSYX)4/#K+%Q]/X"PD& M2;`%"#Z1)#!```($%B!<`_C)1N7D$UF??B;Q0QS[,%$($H7/1&A;CLDG6Q&A M`TYAE@ADB8!TT@U+])0.BJ,LSF*8*`:)8H`HVQ#%0#H(P2P)R)(`1=NI>@H" MI`#`CH(,!,@```P#F!:%^L`'(((=B)U60@!$N.TE]/2N818'6;3SK@CN*(0! MKFU'S$Z;?^JV+MYJ5`SD2G\2<6U[Z5RXTD/'SH::&ULE5;1D+T54+<$^(/0OPI M(>D)R5<52$\@ED+0):>2+=3H MJ8BB21Z<=*`>,^\P>(3)QIB%BTGQ&+)T(6A`!,KDX!1#3N?8=1&'E@L78YEX M\PB<$T!I.$Y@<+ M):!0`@A9^9H#F.A&.@@H0@"1V!)Q,3BYD;(4%$D!D<02@3`$%IF`(A,@0&IM M+Q=SA:*\Y(E"6.J?O`L2FP M$CXB#)BZL8407('0-TH0@FL0`HI0@NW4Q,[.B'"D-H>=F;NXSE)P=:[5K-V9 M*XCPUOS82#V=J]'AFO.(];EHC2_0]`D!XTM]+3+GZ$?X(C_0'?M%VUW9".^5 M2W4:FS-SR[EDRG[XH)9TKRYN0Z=B6ZF;J6JWW56FZTA^N-S,ANMA\1]02P,$ M%`````@`G8L31SF4@$ON`0``C`4``!D```!X;"]W;W)K&ULC53;CILP$/T5Q`>L"0381@1IR:IJ'RJM]J%]=F"X:'VAMA.V?U]? M"$NHJS8/L3T^Y\P9FW$QP`5O%/"Y#'LE1H/",FZ!XKE`Q^!Z9V6"XJ5 M7HH.R5$`;BR)$A1'488H'EA8%C;V(LJ"7Q09&+R(0%XHQ>)7!81/QW`7W@*O M0],U!@PZ?=X90;A`5\'V"2JWE@O)\Y?S.+K\TQC(P% M(%`KHX#U<(43$&*$=.*?L^9'2D-";$_TM(9D*R M$':N4N?,UO6,%2X+P:=`N+L8L;GRW2'1)U>;H#THNZR]WK9>_+D&R\^S-:+!Q.G?B.IUTCJ2?*X,>+#;(WX,'^YWLQK)%O. M\P]"[B7D_W95>3#9]I[0ZBNG(#K;_3*H^84I\RVNHLL#4]DNV<:S0Y79[OF0 M*8L1=_`-BVY@,CASI7O0=DK+N0)M,7K0)]?KIW%9$&B5F>9Z+MQKX1:*C[>W M;WF`R]]02P,$%`````@`G8L31UIJ4)OS`0``5@4``!D```!X;"]W;W)K&UL;91-CYLP$(;_"N+>!.=]9B">!J%N@6#RQ M`7KUY,PXQ5(=^240`P?LEBN\`"':2('_S)YWI$Y<[V_N;Z9;5?T)"WAAY'?7 MR%85&_I>`V<\$OG!IN\PMY!JPYH187Z]>A22T5N*[U'\9=>N-^MDGV2[.:J(P"MV8U(E)'9AX@[&:=(W)=DF.W)S,R`T@TH?P2A(ML5;D[AY!0.3K;A%`_?!R4[-5LVG&#UQZ?`+^9^"Z]F M8V^FR2JZC)!G9"[.75Z5`[[`3\PO72^\$Y/J^IE+^_M0;+A-L6645K]`U!+`P04````"`"=BQ-']*R5I^,!``#M!``` M&0```'AL+W=OJ]1P\'U9ML"(?.`#]'JGYH(1I9>B\>4@@%0VB5$?!T'J,]+U7I';V*LH M@?#QZH7<+O'5-JTS`+W)_R:LZ!KWL>(\$U$?O,3R< M,H.P@-\=C'(U1\;[F?-WL_A9';W`6``*I3(,1`]7>`)*#9$6_CMS?DJ:Q/7\ MQOYLJ]7NST3"$Z=_NDJUVFS@H0IJ0&,*24VF_J+Q(Q=DMQ4., M?$QCU]MQG';2_9SF3L!S`EX2\&1\$K(V?Q!%BESP$8GI:`=B_F!XP/H@2A.T M==L];53JZ+6(TBSWKX9HQIPF#%YAP@7A:_9%`KLD3O@N'4>9FR!R>HPL0?3% MX\Y-$#L)8DL0?R&(-D5.F,QB^AFSCS/LUDF<.LF=3AB$&YT)DZQT\R`?2P"\BFJZ7Z,R5[@I[=VO.%6@WP8.NM]5OS[*@4"LS MS?1<3.TX+10?;H_+\L(5_P%02P,$%`````@`G8L31TW8;222`@``*0D``!D` M``!X;"]W;W)K&ULE5;;DN(@$/V55#Y@`B&!:,54 M>=O:?=BJJ7G8?49%34T27$"=_?L%$F-$G'%?!#JG3WZYJ*OS-6\?,DA.'%\%;N]LH8HB*/>K]-6;-&EKP)!-M. MPBD<+R$R$(OX5;*S',P#D_R*\W>S^+&9A,#DP"JV5H:"ZN'$YJRJ#).._*GOZ*2S7GUN]RHOFQ4F_\_)UU-:2&<,TK:7^# M]5$J7E]'SR,DG4/R;(2T MG0Q1 MAYFUF'B`(?$M9'$/@3TBT@GT6<2^+&;QG;L38'Z/(,C)X4N2Y:@L02)$.U"7#4;C'$8II62I!@`)U=F=_C,,D@A(XJ'CI,0(H< M]9:^L"A!"?#7EWKK2SWU/3@(V$N`GU>8>`G($PJWF/16X01@["A\C\.$I"!S M%/;089REF1-V>8\;D1&$#P3.O.5EGO)B/\'(2S!Z7F!SP?IN#/"$Q!WHYCB- M4N?,S3TH#-R_]5-4RPXU5!<1@AZ("Q]`X]]H5Y%=B^ MR/6;+N6(Z>_"B]VFOWRW]HF);9:9$ST7;R=N% MXH?+PZ1_'17_`%!+`P04````"`"=BQ-'>EUDN\(!``!+!```&0```'AL+W=O MSCFJ:L530LO&IFK ME%S_>0:A^F.41/?$:W.IK4_@/,,3KVPDM*91+=)0'://R>'$/"(`?C;0F]D< M>>]GI=Y\\+T\1K&W``(*ZQ6X&VYP`B&\D-OX]ZCY;TM/G,_OZE]#M<[]F1LX M*?&K*6WMS,81*J'B5V%?5?\-QA(V7K!0PH0O*J[&*GFG1$CR]V%LVC#VPPIE M(VV=0$8"F0C)_PET)-`%`0_.0EU?N.5YIE6/]-"+CON6)P?J3J[PR7!08+?NB:UZ8@^>:+I=F&(/6Y'] M/J6[I:5'7!*G+-TM#>%9WSM^@1]<7YK6H+.R[@J%1E=*67":\=,F0K5[V5,@ MH+)^FKJY'B[[$%C5W9_N]/_(_P)02P,$%`````@`G8L31QGQ^QKV)0``9I\` M`!0```!X;"]S:&%R9613=')I;F=S+GAM;.T]V6XC1Y+/TU^1,&2,&BBI>9-J M>PRP):JM&5TCJMUK&/M0(I-2V<4JN@X=@WV8?]BG!79_;KYD(R*/RJK,*A9E M#^`Y8+A%LO*,B(P[H[Y.TXP]K\,H_<,7#UFV>?_N7;IXX&L_/8PW/((GJSA9 M^QE\3>[?I9N$^\OT@?-L';[K=3JC=VL_B+Y@>13\G//C.(^R/WS1'X^_^.;K M-/CFZ^R;DWB1KWF4,3]:LEF4!=D+.XO$F$$OY87J79HF_R/ZS MVE,VON'W`;:`(2[]-:^VNGI^F><)9_.7-./K%,9>U`QT#*M(_!!:+/DS^Q-_ ML?8!ZUS26D]#_[[Z=.6'J37[<9XDU"%(%S#T]]Q/$(#LQ,^LM@<'W=Y!OUL+ MH-N7C=6GVSGX@W$,\_BQ4\> MFQ-%LZL\2S,@,^ANX2D&I$,.!L(-%QD53BQX7"SS?*4OX M@L,8=R'W6,2S:KNSZ!%&CY/`/M7GP0*WS5:<&Z-46UTG?.,'2\:?-]@ZI<7' MV0,@9-&XT]LX`]PWM[E.@*\E@#,<%(&Q0;JIV0B@[SZ`%R MITT3FP!A%7(?`7R@@%9M=QEGO)A>-R-`L'C%EG#<<(D.`G\$*!/L(G.,K3U/ MX-P_`B]^Y!HRUJDKX[D!@.=Q='^0\63=U*BT1_=489MQ!++/SZ8?SL[/;L]F M-L:O+B[.;B]FE[=S-KT\8<=7E[=GEQ]GE\??6PSH]NKX3]]>G9_,;N:_9[,_ M?SJ[M=I(II,*I@/H9G"N<\[V.H>=3F?`@,R%.R:8`\N+L@+ZUXD#FRQHUZ;IX M3L`A"J@9^<-.(\M.QZ_I=/*:3K.=.M5*T/UK'[G"`\\"4`3>`L_:8^_:0<\X M1%M;6J>HY>EL;K9UU._L4^F5#])Z#:78\+S%)'7@:9A@GL&!0]%+9_\* MF!4IX(#`3Y&?P]GER[?UZE"_M7E@<1'0R.,UD(N:OT'EO^&@R>3<+?>/XY0$ MV7T<+U.6QJ&UC(])G()@2>*5S5'DA@$S]7(\!25V(52W):PDC$E5L0`)RIQ0 MD=9^\A//'+`6*LH]CS@:'*1$+-=!1'8,2EJWT(NW+O$<][=*XG6+MF(-@0#^ MOFIE(19T+@Z4DZEQ+*@_@$K&81PI[%"3L#4&AW0V](J:H9TKM!8H8=-N-Y>@ MZX0`I.KO'_PT6`C$!F&.@B>2+4EJJ\.*AZC:]3,/[A^PAP^\T@=0F(U+)^[] MUEF;SR39#:=A_-3R3!Y/Y]^RT_.KSW-V>G-UP:ZN9S=35'#8]/CV[#N2AM:: MILL?\S03"=O6N"<<),@B$$8]4?P: M+;F_B!]J*&!JMB'*NLNTHDJCW,$90@T!U4^25BDV77$_RQWRY:,/=(K/X^0> M""_B::J&K6O*GW%G>9`^$&^J:3U[7N!8!N7'L!9D-0O.ETVTKW5JMO(#I3'Z M&@GV1-($(X,,UG?''_QPA>M*##O#<=[*/>]>MK7_["?H5-$Z(L",I3QY!(O1 MUAA(U[GS4?P#^>-$A+,FX=IF7,%<4N0N!I&194?8-]B+35WL_F6/M=-%\,:G+Y2JIZ>:4Y#?$D*=[I MKQ'D@5V0Y6TY.]?^B^"@:W_)!1MM;.^885%GL#?/!>#9O2=V*OD?MF*X#;90 MUBZT=K!HZ_2J]8YYS,^`W=T'481L`&F97)*[#<#1U&WL2OQQF2'IY"Y1]?/6)'$+L M^NK\[-A%XE>W,]8%#:S]$&Q?>)D^S4[>,J'A3H5`D]X00]U)XU4&3(FSJ4-7 M(M[UQ._2()/FQJ>;\Q286,KVCKS1<$"_R8_8%G&0/22#^?G+_`\A\TF[.-T>GVH@;(KLEX#DFYGY!TI MF'3'WG`RJ6)]_A!L-HI)?@O_A"(4A"B?+HF1I<4O!PQ%D.3%^V@;O\4HE@@' MP=,;$+@59I'$$7Q>2)OK,VY#8`8,IS!$ZV0,( M'``?*%LP(0_HM`.7Q9T#5R)=$K`1YPF[RV'A9(XDHEL4,P1,@FR4KU8``\`? M@8_B00!*Q(L4%-`F+4Q%!"T"+@_)7EGER*+!IA!T<.AVMU^[V7[I80,/14XX M9]?3[Z]#ART!*U:),`UC!:# M2$/(BUGE,_P!]@V[0#@\@M@3:X]R6">P"-C+!C\IK0X869S?/Q1N?#RC]HBP M:M1"`N7GN0.^"@-_Q1[B)^"KBSVK\`L2$1,*A!`.$.7H6H"^N;"UL\IBD;2=HPPH7`)P%,3N M`(=C-&W/)33R*@[1N?+^#0T[[.&(;X1[:4]^92>%7F@("C<[?-*$G:(!Z-"U MB"I\((6LA$)-87M=KSL`3@@3(WWN'8U&M`JI3PM8BZ%@\,PGPHN3`'1D&`8G M)^)3&!`'2\U'XT^Z!?@UGL'01H,8K3[8*YDCWCK6`RV`+4UR.(D%=P`1Q*\"I'M1R\L M"]9<:+0$0<$;-+C('(=6RB37^X`/<9D]R'7*Y`$:'M!4<>!I@D4X8)>RH,H> M`@KD\F0A/$)B3.'LQ64M>&6>O_WU?]**PQ_(;>&'"QGEJM+TH4EG/^=@-.(Y M?+(9)1CD,3K5\#>D)4+`(<@\B_=,Y\>2V7C`$8#]T:^%*F\&]:7"X$DX"Q^6 M0&B!Y2>.IP9.S(*F%[)>BB520="[53#,"HW@['$N,&GQ43HJ/X)4+9AXT=,7 M!ERI(WQ9ISQ\Y,0>Z'`BQ:#S0IX!4%W+4A$?*`CK<6BJ-+\#R,$)$L+%#(%I MYDQ+\6J\CTK?(@BA8I4@;_#3LOL2/4ZK$`657`60``YR]VCDU<$`-_`8+`L5\"$.0=4K8T9IGT^(W#16;EIBD$$E M%B"KS]N6/*2I\&].,9`O&W6Q?;_]M?_U0WU MP[_]]?_>"DE5DJV\S.SM?JA;[74!0B9\8!A@"\0;AMV)-QX*DA\>]>FS8Y0V MN1KVF;"R-ZK&U"ZJC(F99;`D(T:``'\I4."&@U`OP*+9UE#0(ZF8DO$*YE&6 MXIK&/KR"QIXXD5:?E*H=::=Q/I-V/KR2=CY4:8<.I9MXCCJ"<%!%'+H&^,H9D-H"`KKCZO\;HR&Y#AOR-=NWV(ZCC8N`G*1R\GI2@7,\?!6Q-,YI M$LO)*XGEI#VQ%)L0Y.*$?GF\WQ35N)!0L_(ZNCEY#=W,7D\W0P#%:#3:E6H: M9S2I9O9*JIGMH./(+330S.RW2S,V`FK674?0=8/'^S7[W+1H(ZNST^UZ_WS^8(MDPN MC;#)$U3N,V6:XA`A^L,7I7#E%FW@JS?[_=*RO=YPY`V&M0NWIFT.CL+X@[=O MBO%;"R($$(7)E&VM@_U[XTX);CH:(YP&Y62':HZUMI(3CM>^R`L@QX.E#LN@ M:,W]")L]36!J80\\)-\,AY7$3QZ"[(Y4-$PM1N,&)%_N>QOM^-8.H;ED0];?05=$\9&AZ*G(C+H M]O$C>6.$<(N69!C*'%<9`5CQ@"S[K_"'-_OCRC*E@\7E6]CB*7!Q><7DR]Y% MS/T?5'/_6R3]V\X(:GRU*3;XN2:_I;YEDV,",^C9U?7MV=6ER*G_/+VYF5[: M]VK(/3%`]T1M%^4'.8O0I8J.P^O0C_"R'IN"_`D!7L`^B+H^Q'Y"#L`3A6,= M.B#P*)\6^<#P'W2"$8@?I1M!!<+(L\MD.K8)`YJ8B@4FG1"`"%#')O$R+O4B[A[B-;RH`E M!BGT5;YX@Y_4A0#$@AQ$58$`<2(Y;,&0+*M2'2*9V@WGF3]O$$=W/'M"M\8* M`4,;AB\OW$\,O_I2AAL(5"*JD60J,D![+&C@=>LU%EFLG!9+%QW0S:M! M)9*$%7,O?-_J')GKP@.,L$2J),$`?#LJ5HI*&.AX"7I/19#=X#@RUBR43SJ/ MA8=C@7YR3DFWQ=8-D,7L(5@SS"@(8=`%JAP4)D;9`PI_RD6N`:U-6^3E=([U M(2NS<0I74T"3)#'A(*5L*=`@T95?7+'V[U0D1IYS2H:L1L7DN2DS`-1H"]`" MI0AR7U8QYHC;OF4/"2MAB'K><-NWYOT)VR/=0X'7;JE=&#\_%'B2ORN_E5S5'\_ M52!Y=RS4#*M%93EEQ6#K:FY+/+DL=,Q#YXR5@T73&WN]HQ'%:/)4BL6"6'P@ MK+4APH`KK]6Q=6MDBI(K6"_'<)"J=!Y1#%2Z_%(9GAY/AEX#[[N%X\"7\.^R(;Q/X6WDT&!2/ M]+*)A6+.*PW6@8G,_Y&.N+E#FYPT!Q)RT&(+,CM6ZU^Z(Z4\Z;%C::*45%;' M_,#72I'D^`XS<*2Z6S25^0!"Q0&$0B9Y6RC?.DF-YH4YP5D#(+'P<+,(RB-+(:,OJ","@!.?F*VB*X4!BL5S3,`#+@VD(R?>O[H] M_O.'MZ0>)KS(?`+YO\E!S5R8.J:M!Q[#5OG/.1R;4*J8]GYL4!A0L'FMI3CVV)W509+[)$X'0/>(GOB1NFB2(-D_V9 MZX6]88*)7J3'?LR7]Y1E#-M10&1*&3UB;)(W^@(U ML)B0C!"5T(OI*;`QVC?Q+9CQC4*^PKL/+"OG!V#<*\U%K)A,7ID_HX6O)%L) M78EQ=8]P^_I+@L%!N71E4Z6:0N,@+9\#97R4!E^`//98GBJ"@+.$ZI:^YY)E M27"7@U:RYG`:VB;,CK&05)":">N:EQ,UXC4$E;8K`>091#\4^ING;O@(?P?W MX1\L(K5X,).-,>/:3Y`?[_^%)S'PN0CYV%/L"9W6DXY#@)K0"@79:IY=&C8P MW0)%>BS"EJ&3#16K@Q"XOX#PH>M&PC_+503G=0.78U=`@>`H1=L.T'"[KK@V MVA`8G3(.BN]\'Y4_'UU[-<3BIB0C\73XH@)]3PH%"&R][>` MM\`.\A=?7!+0&E63`U&(6%KF498;A+BG?77&[_D5>>+_7]\:84*MOS/P>J,.VP/SKE.AF+<7J_B;]#9DEM=#7H@*SJABF)=4U&L6Q@O]2F<4EL^ MRV[95"AD=CZ]G9VPZ^G-[??L]F9Z.<>+JE>7[NC$D.ZFU'=B4TDA+XH+):6B M7OHJB2)(2E1VW%4(4O.B`2N7!OMC'@;`'FZPR`*&7Z="@]K#Z`?Y\JD<1"5/ MG^SX"Y6-'[WSJ2MZ]X]G5QZ[2`[%@#ILD:="NDFWI8@Y+A^1/DJ%W:1R*(ZG MT(NDU:W^KG+T$\;)3\+@)AW>0O35:E6N",2F"5T0*"Y,@;%$6$3F<@6VU;WO M)(37C]1`*%>GI^S#]'QZ>3QC\V]GLUM&(:F/LW)5L!L@A$_3 MD$9$2*\?5.?DDON<\"P3!2CF8Q(_*4AYA'B*PV!)E(%.,>)63\C4P?I[DL,5 M%MD]V,S(/4BO-3/=$RZ3GA5YH5F7%-2`2AM=?C.!3A(/I`H:,SE94_K2FNA" M.?9)D/XDXEYJ$*-J`LU"5@_-%&NT2SB_HGXFN8;E.^XE=S.\#Y%D_P[4N\NN)_F(F'?(M6:9@UT M>#H]NV'?3<\_S=C%;#K_="-HQ4ED8W%?U=V#J9H9AC`M;EX7J"(L2[[`@$^; M,D/`_GH];S@9L+=OCHW;+?L]4'./)O!K>2OE;0.O'1QYO?)%K^KEUU+\2*M2 M)I"-K=M[Q$P=N4&2IJ3#[6%^3`]^X<]XVT;HF>KFC?;^5(<252O2TB43WP2, M5/C*[@6RW(L\I#T)F4KBR;V$/@8.88@RSG!1+A[ M7ZBJODPD$48]`H),072.`Z\0&J18^'L)#WTAW6CU`^%D8G^+#_, M7LCF"F!D],<"UI?Y(E/7L@4AK8%!+>B.H'CHH:G,\2X2<5`:5=]41>&_>`CX MRG#+P0D*\"`AB'B+"V4D-7@*:UQPL5GI:R3_L!V\E!5V\.$] MC\%2V,"I@E_O\>R+[:BR0>)VJ#1BU>TU2=F?(HICDIY%:YZN.?K%E%9GW'=3 M$5[EDQ1SR=`I6\;4?"V8O_+5Z)W*W`%[J=)TIUPJ6K`T@=8<;SNG,K,2_=^> MV=L$2)`:.-!VJP00%DZHAY05?4D?`I%;LEPF=#E=NMAS,,_6**P3S+6IFE1% MP(B,OB;,[TT9ZP?JD-$Y3=$$\CJ8D35"N*^:AD8%JG?*::4` M=D#_=>G^K[B'K%8S`E%[1*N9P+Q=L9IQQQOV^Z)%?^#U!QUF%36+174$H,'$ M8KVEAPU,]^,5UC,!!?9X=E-EMX*S'A%G+;6C(^BN5D`'DH,)A(2?BJ(W1GT% MNN6+@#2<9\#[-JV.;:G.`LBT6)3>I"T:SJT,W0?46=AVI2HL1KTQ=%:D*Z&! MBRA&H7?(M41X$%'[S1-1MT!5=CADWYJQ'J694U0IS='9HB];@Q3.$_H:5@LZ M$CM31H)/'M-JK5P2P;V.-^H?>>/!4-;3F`#9=$&SF=A&:8M$:BEBC`0[O%\H M*RK0?-[1T=CK3]1T7F<\\,:3\>LSMS_K8@<48<%T.:0Z2NH7=)5A"DA,:U_R,*WL)'*4A:*XBI+K"`CH#X*=*7<:60I_/,W5)02$86 M9=`($(YH:!*L1D%+*&LEUB2E*0N-BDU"A&5Y9*6BE*= MXL:]R+E6"#K#>/`<-GC"G@Y?Q?4-9K7WVRRI]B=56BPFN!>J>]X6Q$6"@=AZ*Z M]:E&CE&#D6I(YHEEE,>409VZYAXG(&![!)&32E\@-$JQK%'`1,K$K1*C330XH@F^=+L+CAM_G(GV&S0_^@VH?Y.&]*/7P(F\. M+-#I&$@[=";3^^D22T#U<\15H]DQK5QF^0KM59&SO&I/5_,EOZCN917'F:PK MHH+-L`"*%ZG$89A"1,%%@-)U?DH6\._3;0B5I1EH7>8Q$]1>B`^=Z(-:3$'\ M2JLE2WEC4I;89&#J0F`@D4CPW.%CCP(E"7^`Y9*O(Y8ITX)=43E@'9F2FK,V M`,2V2R#-'-Z;H,1]2^`I>UP#5=J*>L#)D<5)*%^!_&9/OBR#RY=%BI*L5=PX MF#G]5"!2O.T%N;NBU#_IK6*\55H(]GY6`48Z--TC?<`@Y;`*ID10"1.M(WJ5 M5=!0#4NA$*&\,P.GJ18DOE`KX2S8(Q["V0`W0]T7_ M:C=I`F)(*:72FV(%8#I-NMYD1$94O^\-QF/V.4ZHJIBZK`!*]-'1`/]T8813 MO)V`-PY$T?GN$;K2!D`>/6\\',K4X\#8V!X;H'-LB#9;#VS)_F!D`5`7,*4/ MLQ:E4JL-V4QK@5/"\,Q()VYS8=5T`^^?HZF)=^;>I&N?>F2TP)*E&-61U+9HUI` M1+ZV9PK#2%=6"DG#2C*K$%>"B2U2:;6+(!NUGV!]:NZA080+O*@]!*7TL!3#I%4$A#62X_@!&RC>) M*5A!(JS`%=VZ0$W$_#5"IZNX8H8V'9HJH(I"]T,V/*`WFKF*V`O')V!#*="8 M>LJ1+M-J_%?&'(!%]?H]_#8R/H^-SQ/UF?Q_XMI/KS?RQCWD5?W!V!L-;7?/ MO\O+OG(AC:_^L*K-[M8:?6-6;?YRJ=HMCVWN7E?8MFV[?Q?`_<A^)HJO>VB>8U5?NW3V5SU=]?V_R)5@G=Q MR=SBFFV'S%S>Z\4Q#)VX%8[_475Y<\]"7Y$ZB?56C38OQ''#YN^L191+0-1=G!!5O5:DC[8SA/]]'?;5UV$;,/'JNZPMBM M)&JW/&G_A!G:.V1-M^!?+3.<=^&]?Y=4Y[9YEVTTDD5CWF2K/?[+)4FVR=ZK M@SW:GW&D1'I3DE"[0_VJ?"`G,_W5\H%8^WP@MF,^$/M5\H%V4>I/,#\\3!O> M-VF,UO#*^8JB;KUVL*RC6R>\I*17GUHZ^J^P8=:U-FJ^SG98`XQ"Q78N\M=8 MV"U_QIL.[3"RW6B3H]E:N_'BSIKW=)X53E-@H\F]S#.73E#+DU!YJ^?6%PPZ MW8*HLI&I[.XS_[6]1$W^$"H_D<3K6-]ELWUXPCJG`@"A2*@MXA.V]9-$@7;_ MGP;/XAING6%U[7RGHU=XQE<6QN0U6!=3SM$LG$O?L&>ZW\F37+N*_B\?DOT7 MNX`#CD7,ZF;9=3A9$ZUNN`M_\0#F4E(-;.RPHC9#;%G%V`VZO?D`*N-^G4C6(PHM4OL^R_,>?SF).9NM?<@E^"6G_( M0#-"QM[=Y@>IX9>?'*\^PJJ33T)[:]X.%J?HJ@A"U<;;T?O!7&?QYJTE,FCZXK$BC#/?T*7:W[`70JF7SVA=9K M<34H7I42_53^)%-)BW65;I]I!O&:K+81;G.LN5OK>:<`MK*;;<0WH M?-U)&UW2V:_NS#6^G-0ED:QJJBJ-M:GZKR??G^*T.MM4J6U:B!I<]FO5U*BE M91%8I3KPF]:*P;L]SG;M7$7)]**"]J]` M$I5*['7$4;^#ROKK!G!4D]X)9C6XJZZK_*8'1+Q*NJQ[+;JCX1%5KE"M"ER[5`'MQ:Q]L/.0#D=HBR8[3],,1RX> MU`!1QV3JJ*-Y\"TK;8'%7SA^\^Y*4:=?0/\.?XFI_3?6#Z5ZLE8QMG)=Y**@ MU`U)04Z+/6%PA[6K^ZP1;654Q_:ID75!G(L M![\[$&,O8F*OG^(S]H\#6\'?7%41Z\.HJL MCNZ&8VT]K/N(0C*U1>3IV(YZS?5=7"67F@FU[L1^:BS!50I(85VM M1Y$O:R[9XD0-H49#)ZH>6#,$:!S:[9[L[8%)MX.A^NL/78=XLZ..]MD2`5#34E!WCVW6NZVL1PU!SEV!Q^I8 M<7U(NJ:#,X:ZW6%R:]9:L'9:#FFJ5K5,XB9^PBQ'BEK.*6I9VW)[V+*N:[G> M0(LM5CK4`M"XI?Y[=2F^:/0N3;-O_A]02P$"%`,4````"`"=BQ-'YW\Q-[D! M``"=%P``$P``````````````@`$`````6T-O;G1E;G1?5'EP97-=+GAM;%!+ M`0(4`Q0````(`)V+$T=(=07NQ0```"L"```+``````````````"``>H!``!? M&UL4$L!`A0#%`````@`G8L31Z6V[]H_`0``:0,``!$````````` M`````(`!:P<``&1O8U!R;W!S+V-O&UL4$L!`A0#%`````@`G8L31YE< MG",0!@``G"<``!,``````````````(`!V0@``'AL+W1H96UE+W1H96UE,2YX M;6Q02P$"%`,4````"`"=BQ-'UAJ/>DT"``!\"@``#0``````````````@`$: M#P``>&PO0F<,1@P,``'\,```/ M``````````````"``9(1``!X;"]W;W)K8F]O:RYX;6Q02P$"%`,4````"`"= MBQ-'::1^>T("``".!P``&```````````````@`%"%0``>&PO=V]R:W-H965T M&UL4$L!`A0#%`````@`G8L31[O;#*NS!```F!<``!@````` M`````````(`!NA<``'AL+W=O&PO=V]R:W-H965T&UL4$L! M`A0#%`````@`G8L31Q7Y6W,8!0``TA@``!@``````````````(`!/B0``'AL M+W=O,!8ZNH@$` M`+$#```8``````````````"``8PI``!X;"]W;W)KJ`!``"Q`P``&```````````````@`%D M*P``>&PO=V]R:W-H965T&UL4$L!`A0#%`````@`G8L31[[0 M]$RB`0``L0,``!@``````````````(`!.BT``'AL+W=O&PO=V]R:W-H965T M&UL4$L!`A0# M%`````@`G8L31RR@X6R@`0``L0,``!D``````````````(`!FC0``'AL+W=O M&PO=V]R:W-H965T&UL4$L!`A0#%`````@`G8L31T`J M\`ME`@``4@D``!D``````````````(`!(3H``'AL+W=O&PO=V]R:W-H965TJED<8J@$``/(#```9``````````````"``:,^``!X;"]W;W)K&UL4$L!`A0#%`````@`G8L31PP0``!D` M`````````````(`!A$```'AL+W=O&PO M=V]R:W-H965T&UL4$L!`A0#%`````@`G8L31ZLK\/"C`0``L0,``!D``````````````(`! M+$8``'AL+W=OL!``!@!0``&0``````````````@`$&2```>&PO=V]R:W-H965T&UL4$L!`A0#%``` M``@`G8L31PE\(:/U`P``J1,``!D``````````````(`!-4P``'AL+W=O&PO=V]R:W-H965T&UL4$L!`A0#%`````@`G8L31]U?O*7% M!```F1L``!D``````````````(`!A%4``'AL+W=O&PO=V]R:W-H965TD6Q5)B`(``)4*```9``````````````"``5A=``!X;"]W;W)K&UL4$L!`A0#%`````@`G8L31R1C=TL&`@``308``!D````` M`````````(`!%V```'AL+W=O&PO=V]R M:W-H965T&UL M4$L!`A0#%`````@`G8L31UIJ4)OS`0``5@4``!D``````````````(`!86<` M`'AL+W=O&PO=V]R:W-H965T&UL4$L!`A0#%`````@` MG8L31WI=9+O"`0``2P0``!D``````````````(`!;FX``'AL+W=O&PO XML 13 R33.htm IDEA: XBRL DOCUMENT v3.2.0.727

Fair Value Measurements (Details)
6 Months Ended

Jun. 30, 2015

USD ($)

Fair Value Measurements [Abstract]

Balance as of December 31, 2014 $ 31,010

Additions related to embedded derivative of convertible notes issued 369,472

Gain on decrease in value of derivative liabilities (122,584)

Conversions (28,698)

Balance as of June 30, 2015 $ 249,200

Notes Payable (Details) - Frisco Note payable [Member]	Jun. 30, 2015 USD ($)
Summary of future principal payments of Frisco note payable
2015	$ 52,000
Note payable, Total	$ 52,000

XML 16 R9.htm IDEA: XBRL DOCUMENT

Stock Options and Warrants

6 Months Ended

Jun. 30, 2015

Stock Options and Warrants [Abstract]

STOCK OPTIONS AND WARRANTS

NOTE 4 - STOCK OPTIONS AND WARRANTS

Equity Incentive Plans

Stock Options

The following table summarizes information about the number and weighted average of the options that were forfeited or expired under the Plan as at June 30, 2015:

	Employee				Non-Employee
			Weighted				Weighted
	Number		Average		Number		Average		Combined
	Of		Exercise		Of		Exercise		Total
Outstanding at March 31, 2015		2,513,838	$	0.41		-	$	-		2,513,838
Granted		-	$	-		-	$	-		-
Exercised		-	$	-		-	$	-		-
Forfeited/Cancelled		-	$	-		-	$	-		-
Outstanding at June 30, 2015		2,513,838	$	0.41		-	$	-		2,513,838

The number of stock options exercisable at June 30, 2015 was 1,627,296.

We used the following assumptions to estimate the fair value of options granted under the Plan for the three and six months ended June 30, 2015 and 2014:

	Equity Incentive Plans						Equity Incentive Plans
	for the Three Months Ended June 30,						for the Six Months Ended June 30,
	2015			2014			2015			2014

Expected terms (in years)		5-10			5-10			5-10			5-10
Volatility (weighted ave.)		83.79	%		40.45	%		83.79	%		40.45	%
Risk-free interest rate		.85% - 1.74%			1.50% - 1.80%			.85% - 1.74%			1.44% - 1.80%
Expected dividend rate		0	%		0	%		0	%		0	%

Warrants.

The following table summarizes our warrant activities for the three months ended June 30, 2015:

			Weighted
	Number		Average
	Of		Exercise
	Warrants		Price
Outstanding at March 31, 2015		3,304,260	$	1.28
Granted		1,659,696	$	1.11
Exercised		-	$	-
Forfeited/Cancelled		-	$	-
Outstanding at June 30, 2015		4,963,956	$	1.22

The number of warrants exercisable at June 30, 2015 was 4,963,956.

XML 17 R29.htm IDEA: XBRL DOCUMENT

Stock Options and Warrants (Details 1)	3 Months Ended		6 Months Ended
Stock Options and Warrants (Details 1)	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2015	Jun. 30, 2014
Summary of fair value of options granted were estimated at the date of grant using the Black-Scholes model
Volatility (weighted ave.)	83.79%	40.45%	83.79%	40.45%
Expected dividend rate	0.00%	0.00%	0.00%	0.00%
Minimum [Member]
Summary of fair value of options granted were estimated at the date of grant using the Black-Scholes model
Expected terms (in years)	5 years	5 years	5 years	5 years
Risk-free interest rate	0.85%	1.50%	0.85%	1.44%
Maximum [Member]
Summary of fair value of options granted were estimated at the date of grant using the Black-Scholes model
Expected terms (in years)	10 years	10 years	10 years	10 years
Risk-free interest rate	1.74%	1.80%	1.74%	1.80%

XML 18 R28.htm IDEA: XBRL DOCUMENT

Stock Options and Warrants (Details) - 6 months ended Jun. 30, 2015 - Stock Options [Member] - $ / shares	Total
Summary of option activity
Outstanding Options/Warrants, beginning balance	2,513,838
Granted
Granted, Weighted Average Exercise Price
Exercised
Exercised, Weighted Average Exercise Price
Forfeited/Cancelled
Forfeited/Cancelled, Weighted Average Exercise Price
Outstanding Options/Warrants, ending balance	2,513,838
Employee [Member]
Summary of option activity
Outstanding Options/Warrants, beginning balance	2,513,838
Outstanding Options/Warrants, Weighted Average Exercise Price, beginning balance	$ 0.41
Granted
Granted, Weighted Average Exercise Price
Exercised
Exercised, Weighted Average Exercise Price
Forfeited/Cancelled
Forfeited/Cancelled, Weighted Average Exercise Price
Outstanding Options/Warrants, ending balance	2,513,838
Outstanding Options/Warrants, Weighted Average Exercise Price, ending balance	$ 0.41
Non-Employee [Member]
Summary of option activity
Outstanding Options/Warrants, beginning balance
Outstanding Options/Warrants, Weighted Average Exercise Price, beginning balance
Granted
Granted, Weighted Average Exercise Price
Exercised
Exercised, Weighted Average Exercise Price
Forfeited/Cancelled
Forfeited/Cancelled, Weighted Average Exercise Price
Outstanding Options/Warrants, ending balance
Outstanding Options/Warrants, Weighted Average Exercise Price, ending balance

XML 19 R30.htm IDEA: XBRL DOCUMENT

Stock Options and Warrants (Details 2) - 6 months ended Jun. 30, 2015 - Warrant [Member] - $ / shares	Total
Summary of warrants activity
Outstanding Options/Warrants, beginning balance	3,304,260
Outstanding Options/Warrants, Weighted Average Exercise Price, beginning balance	$ 1.28
Granted	1,659,696
Granted, Weighted Average Exercise Price	$ 1.11
Exercised
Exercised, Weighted Average Exercise Price
Forfeited/Cancelled
Forfeited/Cancelled, Weighted Average Exercise Price
Outstanding Options/Warrants, ending balance	4,963,956
Outstanding Options/Warrants, Weighted Average Exercise Price, ending balance	$ 1.22

XML 20 R31.htm IDEA: XBRL DOCUMENT

Stock Options and Warrants (Details Textual) - USD ($)	1 Months Ended	3 Months Ended		6 Months Ended
Stock Options and Warrants (Details Textual) - USD ($)	Apr. 30, 2004	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2015	Jun. 30, 2014
Stock option and warrants (Textual)
Maximum number of shares acquired under voting stock option plan	5,000,000
Expiration period of option, Maximum	10 years
Expiration period of option, Minimum	5 years
Termination period of option for ineligible individual	90 days
Stock compensation expense recognition requisite service period				5 years
Stock based compensation expense		$ 58,611	$ 0	$ 106,911	$ 17,588
Number of stock options exercisable		1,627,296		1,627,296
Number of warrants exercisable		4,963,956		4,963,956
Stock Options [Member]
Stock option and warrants (Textual)
Unrecognized compensation costs related to non-vested stock option		$ 323,175		$ 323,175

XML 21 R8.htm IDEA: XBRL DOCUMENT

Shareholders' Equity

6 Months Ended

Jun. 30, 2015

Shareholders' Equity [Abstract]

SHAREHOLDERS' EQUITY

NOTE 3 - SHAREHOLDERS’ EQUITY

Preferred Shares Rights

We have 25,000,000 shares of preferred stock authorized, par value $0.0005 per share.

During the three months ended June 30, 2015 the Company did not issue any shares of the Series A Preferred, and no shares of the Series A Preferred have been converted into common stock.

During the three months ended June 30, 2015 the Company did not issue any shares of the Series B Preferred and 75 shares of Series B Preferred were converted into 204,188 shares of our common stock.

During the three months ended June 30, 2015 the Company issued 770,000 shares of the Series C Preferred and no shares of Series C Preferred were converted into common stock.

During the three months ended June 30, 2015 the Company issued 1,050,000 shares of the Series D Preferred and no shares of Series D Preferred were converted into common stock.

During the three months ended June 30, 2015 the Company issued 531,666 shares of the Series E Preferred and no shares of Series E Preferred were converted into common stock.

Common Stock

The Company has authorized 100,000,000 shares of $0.0004 par value common stock.

During the three months ended June 30, 2015:

	(1)	We issued 133,333 shares of common stock for $80,000 in cash.
	(2)	We issued 204,188 shares of common stock pursuant to the cashless conversion of 75 shares of Series B Preferred;
	(3)	We issued 1,256,453 shares of common stock pursuant to the conversion of convertible notes;
	(4)	We issued 770,000 shares of the Series C Preferred for for which we received $700,000 in cash and recorded a stock subscription receivable for the remaining $700,000;
	(5)	We issued 1,050,000 shares of the Series D Preferred for $2,000,000 in cash held in escrow, to be released upon our uplisting to a national exchange;
	(6)	We recorded $58,611 for the computed fair value of options issued to employees, non-employee directors, and consultants, net of cancellations and forfeitures; and
	(7)	We recorded $400,196 in connection with beneficial conversion features.

As of June 30, 2015 we had approximately 31,244,000 shares of common stock issued and outstanding.

- Definition

The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(d),(e))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21484-112644

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 310

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SAB TOPIC 4.E)

-URI http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21488-112644

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29-31)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 4

-Subparagraph (SAB TOPIC 4.C)

-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187143-122770

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21506-112644

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.3-04)

-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 30

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6405834&loc=d3e23285-112656

Reference 10: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21475-112644

Reference 11: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Preferred Stock

-URI http://asc.fasb.org/extlink&oid=6521494

Reference 12: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 13: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 11

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21564-112644

Reference 14: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 4

-Section E

Reference 15: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 4

-Section C

+ Details

XML 22 R32.htm IDEA: XBRL DOCUMENT

^[1]

^[1]

^[1]

[1]	(1) Our CEO, Mr. Ross provides us shareholder cash advances and other consideration from time to time to fund working capital.

XML 23 R2.htm IDEA: XBRL DOCUMENT

Condensed Balance Sheets - USD ($)	Jun. 30, 2015	Dec. 31, 2014
Current assets
Cash and cash equivalents	$ 875,941	$ 647,093
Restricted cash	2,000,000
Accounts receivable, net	711,148	$ 369,575
Inventories	422,551	277,346
License fee receivable	448,308	463,308
Prepaid expenses and other current assets	91,747	53,588
Total current assets	4,549,695	1,810,910
Property and equipment, net	88,617	91,537
Intangible assets, net	347,650	362,764
Other assets	296,605	246,237
TOTAL ASSETS	5,282,567	2,511,448
Current liabilities
Accounts payable and accrued expenses	810,784	558,338
Related party payable	$ 200,000	154,850
Capital leases - current		149
Notes payable - current, net of discount	$ 43,723	40,897
Convertible notes payable, net of discount	981,475	606,932
Derivative liability	249,200	31,010
Total current liabilities	$ 2,285,182	1,392,176
Long-term liabilities
Notes payable		44,484
Total long-term liabilities		44,484
TOTAL LIABILITIES	$ 2,285,182	$ 1,436,660
COMMITMENTS AND CONTINGENCY
STOCKHOLDERS' EQUITY
Common stock, par value $0.0004 per share; 100,000,000 shares authorized;31,224,000 shares of voting common stock issued and outstanding as of June 30, 2015 and 28,438,631 shares issued and outstanding as of December 31, 2014	$ 12,492	$ 11,377
Stock subscription receivable	(1,231,666)
Additional Paid-in Capital	24,854,869	$ 19,104,322
Accumulated deficit	(20,639,745)	(18,041,208)
TOTAL STOCKHOLDERS' EQUITY	2,997,385	1,074,788
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	5,282,567	2,511,448
Series A convertible preferred shares
STOCKHOLDERS' EQUITY
Preferred stock value	258	296
Series B convertible preferred shares
STOCKHOLDERS' EQUITY
Preferred stock value	1	$ 1
Series C convertible preferred shares
STOCKHOLDERS' EQUITY
Preferred stock value	385
Series D convertible preferred shares
STOCKHOLDERS' EQUITY
Preferred stock value	525
Series E convertible preferred shares
STOCKHOLDERS' EQUITY
Preferred stock value	$ 266

XML 24 R6.htm IDEA: XBRL DOCUMENT

Summary of Significant Accounting Policies

6 Months Ended

Jun. 30, 2015

Summary of Significant Accounting Policies [Abstract]

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

NOTE 1 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)

Shipping and Handling Costs - Shipping and handling charges to customers are included in net revenues, and the associated costs incurred are recorded in cost of revenues.

Recent Accounting Pronouncements

XML 25 R35.htm IDEA: XBRL DOCUMENT

Segment Information (Details) - USD ($)	3 Months Ended		6 Months Ended
Segment Information (Details) - USD ($)	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2015	Jun. 30, 2014
Components of revenue by geographic region
Total revenues	$ 1,046,019	$ 678,111	$ 1,670,533	$ 1,034,340
United States revenues [Member]
Components of revenue by geographic region
Total revenues	1,044,066	677,508	1,668,580	979,110
Row Product Sales [Member]
Components of revenue by geographic region
Total revenues	$ 1,953	$ 603	$ 1,953	37,730
ROW - license fees/service revenue [Member]
Components of revenue by geographic region
Total revenues				$ 17,500

XML 26 R22.htm IDEA: XBRL DOCUMENT

Summary of Significant Accounting Policies (Details) - USD ($)	Jun. 30, 2015	Dec. 31, 2014
Summary of Inventories
Parts inventory	$ 181,863	$ 133,477
Work in process	41,994	41,114
Finished goods	198,694	102,755
Total inventories	$ 422,551	$ 277,346

XML 27 R36.htm IDEA: XBRL DOCUMENT

Going Concern (Details) - USD ($)	Jun. 30, 2015	Dec. 31, 2014
Going Concern (Textual)
Accumulated deficit	$ (20,639,745)	$ (18,041,208)
Stockholders' deficit	$ 2,997,385	$ 1,074,788

XML 28 R24.htm IDEA: XBRL DOCUMENT

Summary of Significant Accounting Policies (Details Textual) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2015	Jun. 30, 2014	Dec. 31, 2014
Summary of Significant Accounting Policies (Textual)
Deferred revenue	$ 0		$ 0		$ 0
Depreciation expense	3,478	$ 5,155	6,820	$ 9,786
Impairment charges for patents			0	0
Amortization of intangible assets	7,557	7,558	15,114	15,066
Amortization expense of other assets			42,034	37,562
Research and development	297,456	275,974	510,801	277,515
Stock-based compensation expense related to stock options issued to the employees	58,611	0	106,911	17,588
Advertising and promotion costs	329,393	154,044	$ 794,139	241,993
Effect of dilutive securities			18,268,932
Furniture and Fixtures [Member]
Summary of Significant Accounting Policies (Textual)
Property and equipment, useful life			5 years
Computer Software, Intangible Asset [Member]
Summary of Significant Accounting Policies (Textual)
Amortization of intangible assets	$ 9,654	$ 9,654	$ 19,309	$ 19,309
Property and equipment, useful life			3 years
Computer Software, Intangible Asset [Member] \| Minimum [Member]
Summary of Significant Accounting Policies (Textual)
Property and equipment, useful life			3 years
Computer Software, Intangible Asset [Member] \| Maximum [Member]
Summary of Significant Accounting Policies (Textual)
Property and equipment, useful life			5 years
Machinery and Equipment [Member] \| Minimum [Member]
Summary of Significant Accounting Policies (Textual)
Property and equipment, useful life			5 years
Machinery and Equipment [Member] \| Maximum [Member]
Summary of Significant Accounting Policies (Textual)
Property and equipment, useful life			7 years
Leasehold Improvements [Member] \| Minimum [Member]
Summary of Significant Accounting Policies (Textual)
Property and equipment, useful life			3 years
Leasehold Improvements [Member] \| Maximum [Member]
Summary of Significant Accounting Policies (Textual)
Property and equipment, useful life			7 years

XML 29 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 30 R7.htm IDEA: XBRL DOCUMENT

Notes Payable

6 Months Ended

Jun. 30, 2015

Notes Payable [Abstract]

NOTES PAYABLE

NOTE 2 – NOTES PAYABLE

Future principal payments of the Frisco Note payable are as follows:

2015			52,000
Total		$	52,000

XML 31 R3.htm IDEA: XBRL DOCUMENT

Condensed Balance Sheets (Parenthetical) - $ / shares	Jun. 30, 2015	Dec. 31, 2014
Preferred stock, par value	$ 0.0005	$ 0.0005
Preferred stock, shares authorized	25,000,000	25,000,000
Common stock, par value	$ 0.0004	$ 0.0004
Common stock, shares authorized	100,000,000	100,000,000
Voting common stock, shares issued	31,224,000	28,438,631
Voting common stock, shares outstanding	31,224,000	28,438,631
Series A convertible preferred shares
Preferred Stock, shares issued	518,750	593,750
Preferred stock, shares outstanding	518,750	593,750
Series B convertible preferred shares
Preferred Stock, shares issued	900	1,145
Preferred stock, shares outstanding	900	1,145
Series C convertible preferred shares
Preferred Stock, shares issued	770,000	0
Preferred stock, shares outstanding	770,000	0
Series D convertible preferred shares
Preferred Stock, shares issued	1,050,000	0
Preferred stock, shares outstanding	1,050,000	0
Series E convertible preferred shares
Preferred Stock, shares issued	531,666	0
Preferred stock, shares outstanding	531,666	0

XML 32 R17.htm IDEA: XBRL DOCUMENT

Notes Payable (Tables)

6 Months Ended

Jun. 30, 2015

Frisco EDC [Member]

Debt Instrument [Line Items]

Future principal payments of Frisco note payable

2015			52,000
Total		$	52,000

ZIP 33 0001213900-15-006402-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001213900-15-006402-xbrl.zip M4$L#!!0````(`'6+$T=;XT-?MG4```1=!@`1`!P`;WAY)-NI.I=!Z]N=/=R23I>^_4[E:*@&QK&H.O@,2^6[5_^TK@AW#`QB"( MB>GJZDX00K_ST-'1T9'T\>^3D2L\0QP@WSLY`(?B@0`]VW>0-S@Y^/YPU3,. M_G[ZYS]]_$NO)WR&'L16"!TA"DBY.F@T,?"+[,V0=RF1#_U,(QPX%C3GX2S:!`%H2")/PD+$.JQHA`0 MLW8F3]A%Q_1?@3#`"X[]R30X.1B&X?CXZ.CEY>60/H@P#*9!"$?!H>V/8H)$ M328L2NJXR/N1JD._=^CC`7E3E(]H\1.A<_XZ+770H@+[LG:4%"Y>??7I%SE^ M%YBF>127+EX-4-:+Y*/@Z+>O7^[M(1Q9/>0%H>79*2QH#?;5]U'@*Q+0U]5( MWIA7\'S/BT;9[SLA/@JG8WA$7NJ1MR!&]J+>YDKI"C'CPDRNJ@E7P_FKMA]Y M(9ZFWPV@?3CPGX]FA53(S% MQ[/@\:;_*(N/9V/\2*A2'D3Q,?G[<)/Y_&#Y06*843A=_HX<^H28:2S$[$A3 M/Y?^^?4_#DY%8I<4(.NF_O%HM3+]X%%V"X19R'>8%F/[%)('%&./_)7%9>UE MZ?S)LOY1BB?KF71.1A%_]"B"EG*)<`&'%V3$9O@D@F5]MGP!VEFIP#)V65J- ML8GV2=+C5XOR#X`47S.??_&]00CQZ`(^A0^DBYQ-4/!XA5%@^[?8'Z$@\/'T MFQ_"KW#T!'$SL;:HGR3T@$=>#?T^2OUXN!R3P:D#Z.?+2SW>*12NJM^V` M1"MHM0Q(VW+U\<[R!HE%^HH\-(I&[3!""]@'I_-'*?P-V)OW(71KTFZAL_@[ MH:\3^GU(FJ74?X;^`%OC(;(M-U:"[_>[+OE<[`>GLWC'\??[3OSEQ'_GO[2C M_Z_1@MC]7!#2:4)I32#.NQ/9X;WEPN#=:,5KHCH-6:)OYO#=9K0S>$Z#>GF M<.V>P[55L>Z'/@X?5M>SR>>>:2(0X21=]0UNK:E%?FZ'"F62Q"K-&MKV2ED6 MV5:OU:(-4_[4RO8K)O%:V5Y=_E]A4L;S76923<2M93^&NHZ^3/R__2NY9])72=_1O[G M[UK^F=1U\F?D?_&NY9])72=_1OZ7[UK^F=3ME?SO8!#BR`XCC+S!N1_0X!QY M!O%SVNM/>/!>I@0;J)X%M-.TKU&+;BK2A"I^\[U<1NV78J[C1*>FVZAI.NM. MS8F4JKL9!%R)0*O;IIRIS>0R;N9JEQRUYT+ODJ/V1>A=R[T+JRX+T+OPHJ=^+NP8J<)75BQTY`NK-CNL&);%:O;<]GTGLL6 M*TNW3ZX3?MN3%7[7/]]RO5_3WKM MDG:=6X)W^D#?809\QMZUKYEL%.]?0SV-([=;O=T2!V[3^O^L*W.4B\%3@JPA[B'C^D)1? MH0G]J25#]U9ZFD]FIT)55>BK90^1!_&4+=^C07P-_=T@_HX4^-T.XF^@P-T@ MWGB6R%[8XJK9(YU5;J]2OUO[_*9*O;>6>O7T\I9MGDD=6_2*29Q/U]J"2=T% M]S5UI)T5>)>.6'LZXL[*OLLN?*^R;&VVPR[D&>RLC+M3^)L_A;=-\N]R/_=; M_MV)-/LM_^Z`F?V6?W=>S/N6?Y?*OV^I_*U5Q2XS?Y\R\W=83;M$^YU(M-]9 M#>GRYAO(FV^7]/-7AMJZH,U[&:RX97J#->OWJ&QM2@G:*66K.^MG9Y5M,:VF MR2OAE&:I^![Y-9BG[XQ\CYE'O_.UA2PFI%)XTMS@H8W=NL:;Z6J[UT%V65?? MY1H,,![/HL%K73_CNH5"XA_'D41!ZO?GS/__I^O_` M?U_]GU\,?\/GR!\*3%_W85A3%5E75?OC?X:EJG!@_ M?_R@`N/#QP_DGZL/X.K#9Q/H5Y<_GQCDX97R<=9`@B2B35/1!$,+0Z)WL^<=[%(3[ M:4!L7"!<>_;'H[PV*=!EV3G!BBWWVG/@Y!]PR@D0V_ESVYH#.2/\6W,L%[X= M47QT(L&I?2#V_IDTSGY\M<';V%;RI7PYE*7;3[6U"B1A3?+*%7D6<`+S3RD- MXE4[V4"HC'C"H+]F`5FTD^Z25\B%^)RP:4"FCYP@W(\LEWQ5N(-C'X?(&PC4 M^;*\*=L_4PVOF(FE2Q:/"L%-%-*AUZ&?RH)8PNT0J!F-/S(;(`4'VH@`#TX. MKK]='9S*DBC*HJRD;,H:8)2$A4]I!<,SSZ'_4>?SV7)COS,\MS">DG=_L=PH MNP^LWM\LY]S?+&=10@=FA@PB"4W5-5W^>+05,*Z4+!1$R5$*?(DFJ M"O)QQ:'5+\@FLWIX!>&2K0WJIJ+)LDADO`E+5;S<>*H8A?$NMP7"L86,#FYC<8&B@!>V4?<$"*+R>V&U'G^[/O M.R_(=9OQ&B1=4]C18S,NGG3P$H.LZ)HJEJ>#L2C??,]NSG9(BB:Q>I\)I!)2 M7BR63$T3U2V0)F6-,%$E/F3*B8R;W@X,+SZIDB&IFKX6S,S'G>76$#M!GN`( M.E^0]81<%-(-#0WZ#*HARQDN>`%X-5#%S3(#43<4WE0Q.7/-"@FHBL%:N"*X M>-+!S8R(]$]Y.LZM,0HM-SZ]\.;)10,KSF9L4A**R<8)UL'A`[P"ZRW(0$DT_.&+QL)E^39Y\9T$@`3M1,66+4 M,1M*1;3'!VQN5E8Q);$$[K=A M,I!-">A,<(TG2&XLE0P5&%)AD+XWH,>,-&T1%.((,UY/%HPJ,.L9B^8H:%9H M''7/'"K?D'WK@?$EI286+[6U&2=)ULA\,;.WE(#51"=.#Y*C$0KC([&I$`D8 MY`V@9]?'O36B*PFF'CU*Y_CQ7&DLF66\(6:1"B.O(M\1PK)34M=VKS:0E7WB M1"M4+?NPA%9`S][G7QOT^H\H6A_Y,^KJ"?6?O?,F';S^(V763J<,M0V$%>K^ M*U'?5A!6R#BD>YA6?`AE4LH:2T$"0-9U-J20AE`6'B^'$]"9>#%XR8**XR`Z M0[#7=S>QR\F-4#D@PT5N&RL:3BVHO"6PLYUUZ];$O+U@2B(DN,>'/` M5,3++RADJ(JAF5OAO8.AA3SH7%K8(]..X,RVHU$4!^DO8)]NZ&F"U3U@B`J0 M1&:TWPR,'QG<%%P2-=G4%;4L&;'EH)@UC/(@^:U/ MFWK*O5@/DIGXDTGUV_#UU;KU)E"\"*AMK7L;`M+.Q*V%;W#LOCCQR'@+<9R6 M7HL7AY$O5:6%\UZH:FA[>@'>2<3V';+K*/O&N0(3 MUVS.Q:,&3\XE>U3.HG#H8_0'=/C;A9R],Y(JKJ0LK`?&AX1R1J"M)#3>XU\S M*E[K)=Y\.@FU"I>N@R#BIJPBN26M$Q#5=M);TD:I*T'<\N06VRO?%C\J9X/]CA!>FT>UVV37XUOM M-LWU>%F[37,]_A9_FEOB>>TVX77Y8+M-=8W>V&X37J=?MMN4U^BAY1T'M(S% M[="2#9.R70`@1WIJ6JSA0L^;A:[2<(WJN(:4"<7Y#D0U- M!FN`OYYWE0#-E=TRD"1E/;<+@.;O47)A]V8C6M?0P87Q.?#O+1<&=_`9>A&D MIRD$>8=MR,EQ>V=CG,'S;4]-TW0#`(;962A*H4P?"E@1)1!E15;$&F"FF5DU M+U%4-!&8M7.S*DQ-%U59+@Z3WK1TTX]+[GTWVXIQU4I)4PQ58_M0"L"VV+CJ MHJ*+BL(/&U<%5$03&')-?*MZ)IVBBK)9"-MG[`?!+?;[.0F$7'5-`;*D,M$V MIO%M,''5,563#5.IC(FK;FFR9L@:9SY5W?LNJ4H!/M$KXBQLT[,G+XB5<_WX M]*C9T6<-6#-=-74&Y5HXU7!SU4))UU6@-H*;JZ9*-!E8>P-^5TW\!*(A@A*X M[Z'K$F^2O/?5PC\@W-+Y&*I@)BO6BO`9,_7K04Q5X66)5.N M'3'?P=XDPZJY+>)X8\IGZ$%LN?0H*6>$O/BJ`'K&1G/F6C4EF9EK%$'%A0JN M6JZ)BFFLGH'7!!5\G0X)B*^V+C4OB^K[U619K:)28WHSR;+39!]1P#-% M-J"\)B`P#)J;RAFJ::1/Q&7;WQ8:7X-HRBH[X#>,[?%^Z./P8?6RU?/LT^@* M[)'GQV:N'4G5`#'K-;&YZNFLIF2RB6,-8^.N`IIL`+.8'GSW,+1 MM1,WWO)\OGJ&JC7;_5E1TY266/K]L".W-" MY,IK32ODEDAJU,5*/*E\3K(BZW]$3#]F%R@W(JA)134?7$B$W1D0U?5Y+A/)&DN!*A%F*B%\A M&@S)L[-G8J,'\%M$8PHW_;@:DV=98M!&?W4]^ M=B']@:Z&CNB=X'_$SYO(!B'#+SN_W@RJ!B*J1@F`R3HWVQ+!/K_IT^#M!0KB M&Z1N,1RA:-3`ZH4$`)O@O1$2;_Q50^^B;.AE\=/B:R\(<403O"Z@C>G-%E<^ M'J!GZ,&:7/>U,;KJ@*HZQK*N@Y1.;X"42D)=AAINO,L)G;Q%*!C2FHDP&D@3 MEU*G5V]$Q!O^]NS/T(?XKN;+B4W8NPPTWA"+?XM]&T*GD0G2+`*Z$4MVR#8K M1E_7GI5"4>_R@#BO8VR$Q&A`D@]"SS.^\3[!H>7V;_KI6P6;8BA/0%49*NN` M9G45AI2)_].T`4:F39-,L]$W`N&%EHLE6BP!!T%D>3:<[]KVG%\MC"TO#,A0 M<`_Q,R(&X@:?NQ8:-3YL\@97U20/GFK1A::I]G?1RMO(E2,XLAC8T3L[TVV=%\$6'B M+]V2@1=?LBU'\J:K"JLM2N`J@8JJF[T4("JQ8L=F!'0V8+LED[Q'?B(@W?*X!A&\P/+>"X2WVGY$#G4_3 M[V1F03K6/,GGS`[1NI9'[P"G=UK$^^'K%Y,N:BI[=6AA:+415'4$3Y_)R8>> M:R^TO`'=Y5'C"+ZRX\E80\4J'M[@F[!*=-X1-&Z5=-%0S(T=.`-;;1157DM, M*7PY@N;+3%?8'RUCJ4SPI(ECT#1V+\!&1+SA5UXC%T50$OYJS#HG4I4^3!X(&S\H%?8B&863;F?+D/M9D4$$G1U?1)V+E@^&&N'`O55J\8+`3Z M#HYGXJ`FO&%&@YE:%`###W-51NMJ.VSY=*NEW@YJS&K)A8'9#5>O2D#KT:RJD9#)('EO^^;YYCS%V\$>K$F2@O4F#"B!@"L/DB$Q2(QQ/.\8T3!Z,D4! M3?.C,IJJ'2M]`/4Z,*MIW$\ON@XB'H(EDL[SK4W\Q]6/+Q?43A<-G,%K3#*N2&E1BDTB+NRE(@' MP(R6O)`SF1#D$Y8;ASMHQGW39Z54!5'5"]94B"T`?H2;VM;/G1A2,;^7C"VJ"_)/$<> M[`U77O;Q>&AYP;%@1:'_0:#T]2PR1_"."5P+A[-'R',@;5@<3V9/0DRJ])*_X60?_T`Y'/T6\2"^7_@#U2*1S. MRF>\P#"TARMT]ZT1SN_]O[TN:VD231[X[P?\#K=>_:$2!- M\*:],Q&T+'NTSY:\DGK\YI,#!(LBQB#`QB&9_>M?9AU`@01X@B1(U<9LFR*! MJJR\*BLKCW]I-Y^TNZO/UU>?KB[ZU_=:_^+BYH_K^ZOKS]JWFR]7%U>7=]KK MBQO\YH_+CV]PG+<#,>+;*7YZ^>*TJ'QJ!$SQ)BI/>S2;Y\YJRW8YI:]^)YA,+5J')S\+4H>:---.R MHDE$G:F:*64P5K54/BOAY5@`>>EAGLQ`>U4W])YA:*8[U%X9-;W6,NB#\!S\ MOT^(-H&UC[4I/?4%&@'"##70\T1KU'0-E3U]%_=,'8`-I@1/\,29;01%LZ[7 M&DT&1:.CM]KU&(K`_K4]#*/`IL$'"-/4 MG/F>X]!U#6W0UZ'XJN*SJR[^&CQ+)E/'FQ$8\FGLX>(\F!RII85>YGJS,*AK MH#*?"$X9:`@JT)&!QZ>GTU6UJU!L"S`?#!X0`0@?'_&`A!C&+Z57!!`:H$_;K]P([6GMUO<1F4?]VXHYP!B M]/1&K<=M=O;YF5O+9\&4REX^/9JE3_2B!QP5,*D+G(;M,P.)C(D).G_PQY\O MF/T0!!Z6A0+II?9LAGGH1;XP!YB]88T!8'@!3`6A1TPT7RU,0AI6YR'`3RF8 MY?'%`,Q-T.OHS5:;Z9QZIZ7W.L7IO_5`:!DUO5LS!`@=O05#/G.]I[P$Y:;/ ML]!Z&!P2SC016)S0K9*EW+[CN0?0T:*MI!/*/82ZLH*%0;A:-+P=R MXX643>M9N(1&>3&=:"7WA+!(L)3@U)OM"6AV:I4ZZ`$:+RB]&]!0-50,'O5* M>E,:(J:+HQ8KG#4"#-%OZ"1@E^'9SG$\BZKG^!"'3]`S/QZ+1R:RPU] MVPUL:\Y5L?#@E(?2"72//6<(3Z18CG*`Z01>(?A>0M%[NJX%R(EIC3-`QVW= M,AU+W&$$S,:Q1R,``MDN\3<1C<"WEKA1%P--?=MB'L5LQI;UAZY-@.[VU+%1 M9&=L);00*G5L,KT#P'N2)P=7BF25>$%9"\??CI2U4&KR++46:-!;A9:(TE*U MJN1#49J8]#W48.QR@1K]5%XK;.<5L?CRY<$#T^8HV=1XX/LZ/1D))[Q./?F@ M%-C>!UH$D%R)?X:E>3Y!#:C#CL]VZ)31PA5R:@3A\I^R]);*> MX0P])J_4A.F';*(8$&YW#/%M>)PNG+F;4ZJ0OHJZ#'2F:]E3YM:'[>K!I8YO MT+Y"Z?MF:`[@UUCY4TCI14G`:DJ)4Q;=6,;FH^S:SEA!B@(IX,UXHTK!#^*! MY]]HPC:**/;??W!,X)X["W8Y-*O$%F@CLP.YAL0Y8?U\UO*?(0>*4F6DU*>M MO3I,SIFFLF35+OMQS"E8K+^HK@`5\ZK5U=LB_J26]LOH\?4>O6Y%I>K#>[Z- MJHEKE'(GR_1WK!$C6*RO?>[WOU6U3UOZF;9!B5%K M2S$Y';W5[2J'5=DD1YF@I2;/9LIY:@!?-X$SQVHV''K%#FS<%8/9_EJ_.P`FJ,);Y]%BP@7/3<,.1.!.H- M"JBO0HRA9/_XS*5DO]3D62K[_2%UY`2QQ&N5+)F7'TO">:3K-=YG$,V)IS%Q ME]^Q?2>)@+]JU'MZH]?@VWNKJ=>:31JH)$V)OX%-,/%X%6<$8$A+>Q03<+#^ M5)L9/,PS_JK3:^I&@T._0ED&GF7V).[LDT6KC/>N*MPS23]0Z3?.;" MN\ZO[)(^8E7M']X3H8ZS`9T79Y,F([^H@80GKM"N#+';&#KV`P(ZDB;_5S71 M+RV&>$^@ZNP>A@ZS<"D@W7GQ-\,Q1IUZD3-D;J\!7D](P\&W0Q[-&@(7VM3+ M%B\P#05]EYU%=7[V'$;6DLN)4`Y/3F#PB;@]'287E>FKR_@BCSO;,J%CLU2U M;_D_RJCD=[*4DADN/G:=*A_2N?.2.OCBXW7N*7[JF'PD/C7.:X?\0#\@6K)H M-I)\EN?PQ+?*.!AL>Q3^],Z%4!*V;1E=O=[NZKU&_>6+I1A2NK&4NO&L/(S/ M(!,U3C/!DO!NJ"7)R-HWWW/ALT7OQX,DV>0VF'S2>HYA]=<3T,/MX^Q,RR8`RTY](-;86+#C5@E*+2X0GB:`Y&.VQE% MM'*%.63VAK0?2^4QURIR,%_7!-M^@JT*HS_O.@CG+`/I2@CU5#X@?G6G?>O_ MJ__ARZ7:;$I$2;79E)H\RS:;^7!?$;,?G\Z2$RX/^\401-^VV/7(\@A@WV1N M3,*"D%D&P2`4^PAW<.*4[$`*V]L(\T'9H9YW2,N-94S'L2P$ZP9Q@BB[K)D/ M/+[PAG0/HN"&WM2V>!SR"1\ASX(_E4XY/9HM'AXC&J[B8_PRGA@G():>/].N M:3`XDB^:.S/&Q+UQM:\TXZA>IWX@`P/\:((Y%60P84U7ZT_850 MOT'%B.XZ&D$//A[ M/*,98.0-?='F]CD,)";S"="1Q_]C#0*7QF2;^,P#;\+H>":M&_&J;C1T$!?M M-;XH+YXA#&F6PD'H/1"JL"E`4VD%%M#(%E4,6JSZ@$[W"<(4OK=`7`H@\\_R M8P:\Y-CH-(3#BF5%Z&5]I[VVW[`U1HXC@DK%6A>)$*#TP3OP$INN8=#IVDJY M*^6NE/L6ROT^4:"H#T2`=("U0&;,E',CS#\2$B'O1PQCTK47HK0D> MOUD4M#PB6&P8XAVGN0Q`#\#`[[6QN*^*?P++E-_0\*LF,]2,>K71_)U>12$H M$S9!Y,9E/J1DFG#NHH'FL'91!R9A0!@<9-*:I$+-R,":P<(H"0>SLEE-'$_I M&Z5OE+[9)M*9^1$SU$F&-$Y9"TA6U@2!]B" MW6%%,+YE$3(:O9>'&8IA!!8;G=Z\A#ID%+*7Z(:'Y`N'R\9HXP@<[`J#![ZM MMJ9A)B^L,=@".((F;'2QP@'F(LW_)@:B\\_]QH4]\!Q[N`5L36,>.!^E?'_0 MM>IH7JP!62L;:]L1Y6WH[\9Y5&EE\]T\1,UIF,=]]UYH.DO6GC74^C3=F&3- M7((-O0A46MXR7AT/",:=ZW'2!H19EW7>4E5_BCOS:6[#JM7H-Q9OTLL4#Y6+C%4XEKU]XC]SFT1%"AIWTU M9UJ3_MEA@S&WI><'[%*,%B-EZ(3E$&EF.01W$*=-$:*ZS`KL\*Q?!U M4&]UZI:,PQF7Y(7A%T-CDZHD/.\ZG808CFT?%CXEOL6.2M5E"G8K',6F MI@5+L,8UC/&J"9NAT6OKN>6^UJDI);+SG^8K2VU81BHI3B;O:N)%?NO(G.04 M@%?M1A>@K_&2`7$TR4I+)3L9+BNF!)A5XB,A2OB+Q$AF*)DCV?0=L49506:` M8DZXX4);4_;KY\ MO+R]DRPK[?)__[BZ_Y>*3"R1\:0.N*4FS\HH(II8\@WV6$+SL^]8).(M8NC, M,D_.@H!*Z$Z/9JEPX'J+>F/0Q9-$_4YC^6,^#%C(V/-9$Y>I*6)P7]6J\%HK MR04^8=^!VO_*39]S%L4[>!C>[VM2GUU-V@)1!-])1907\Z;UE(L1D]X3B66' M5"GCO*$;S89>;W22(?,E?T@"`%@4!%X'TE0P;?Q"_)`<5LICANVTI.:NM'M+FF\M:%B7I?%7KXH'Y.5FZ4*U]%*&QQ4&W")O"C`^NQT M5GG0,^W/I5-GV9\7.]J?%W/V9WT-/YI8&VJT6M9`93`_3U=TRF8,Y5LYC79. M3L5^J52*>)52!*<4;]APF5U47SDZ8\%IEO%,EE6C?&7E/[B9:]\G%'>^7C%O9*LCIFL60JM?3`RF^FU-L)T.>;/ES2+@NP85JP^[;;[4TMF*539UDPESM: M,)?;1"[QM2VQ7RZ5_:+LEU.CSSFKMAWMET5UEB/L>=;+Y?.P7LJ4-U885YV; M@+]\<<+$V"1-Z8()%34>SBLW26VEY:;/Z2N]Y75GDU2&0$YE,%BFTMQ!G^4A M-:7,I//=[4Z3S$H*2TV>'0W:$ZZZ>A;T.FL9.W,*+:N'&]?S[#;S%<LI M`9`;**$]B1+@8"]2N5S::%6X_'LE,V7D@M<-)3-;;1IZO=76FZW<;6-!:E+" MLE#8M_3BD7'X.`89%T'?T#!>\-R_;KZ9-^.?P=*75A;:-*X8323\_[B&)3;" MMA_AEU>=6LIRHA=@27%.+BM!-`@LWV8E-]F[]"`EJE'Z9&+:+JVVR<=;.'F5 M4%I>M]YLJ$T7=,S:45'42*W'SE6![3%Q:&%7`NCUGG3410-:)Y;0NK'1%+51 MY,,'QPY8250/J.+2MHK86?R7-<;2W&542,]TOVZK_7JC_3I6-J]:7;UM&+%2 M@=V:M:)+MR46982Y#((\D,G4\68$A\9V=^)/;6C#V%B#GE4C@2T=JQQC05N= M]J+#;1Z+-CF.&<:EGF'V$;%I(=OW^$41VSXVAU!R5K"<=92<;2EGO"!V5BWH M=2H[KR<,JA_-:7C$%5U*0I=GE]1>_EBSA:-H1L2T")A.-Y1I&'J=M:O-Q`VHE7-+:%^:"R\(`UK\^0.>-+[Q5J#Q4`76 MV!_:CT+QI([G*UM1KBU3\X*QZTU>!@,M93LCCX%67>"EPMZNL1I^$ZOAW]]< M_%_MYMO]U]J_O[[)"WXK!ZS8HI,JK)$C,T)Z*X58P7!QG MR92*=N5B]ROL3_/-@:4LC[A4;*?8;B-<7;E:?^K;#NR:M:9.O5H?/-.G78L^ MBI-ZW"L^D/8\UK@'_X.=>^A&^\CK+IM#W@<(6[II__2HBXPE&]VP'Y"54XE' M^!I^*:<;B>X^O!-0$/L@Y+K.O-T<=S^@WP'(0R\()`=$RLG`UC>AZ4!L:?WA MHTT[):5_FNMAASX^"V32)UHT91Z_B0FV133!)[,*RN<$9"HA54*Z$:YN,J52 MB,>0`(03L.\#UC`JHGENDD^.2NF3[3CHQ7[`WE%8"AB?):,1RX!+=Y>DS_". M:ER2:6.U(-$$CX0YO@-K3(:1@T)F#@$(.PA1=(0XT^YN5"4,`L(EUD3'.OHA M[`#>%>T<)?]B7A=)!E"&>IK#`/5,\F$3!^5\03FNB@+M@;C$-QTX'Y!?4Y3N M`0F?L/3Q"!%#%PQ_S(CI2VWEAKQC)445:XP)IQPX9Z"#$7M74H#PH5X-'IX! MYD8A)D!&0#&&4P*+Q0N%@-\O(%Z$[@(>M$'G1<#U$;"C'R.4-[T#DKK:8*;Y M,`#3LT-BAC"RCRW;S('M@.F@5(Y2.=OB"M,1IMA,CW&74"5<>S"58@=X"0]2 M0WP+F0[XEK=4I-*1:(_M.%UB[X3G*9OKN,=B?[Q8R%``!T1<$R1-`\7>+<.% M1@-*(>HS>OBN:GTW@123+UR/-0['=&)3MGJ8/Y9G#E,;("F+:6�>S#-Y.6 M+J',T\;V!!89@K5EPNR`W)&-_2AAO"D,@%8^:E2$+:XN)UVH8-]()=)*I(L[ M8@,9>8[C/='X"!;A'TU@U?9?J-E<7(/)>H\/1'-=;KNB-E]H M%LYMP;11BSG?B=('ZX>9<,/YO<0,%EI^OU/,O19SIY(S%I$#YJX]\&T=@V8> M"9J_@!U8*2.?(0`DV0(9'`?V..0T`+>)3!F*`]RKF$"5,3+T= MPM;)\5@>XC/P0C@O))J97=EFAA2D[\WY+!4V`*RMVHKOC59>A>7'+>1?SJ/[ MD?AK7[9QXAM]V^_M7,C`-:5 MV4R"IS?(2^XYFML(,Z[8CT`:1?^]T__: M-'8W?$I>%$5_)?F*\DKR%?UWHO^]%YI.B8B_B1&I#0#3#[X7N4.!_/^P+$)& MH_>_+0+-2="NTPO.^24T-UW`GA6RW"LAU+Z:OC46/1%:FY)+,%^[D(6OEJC4 M?+)X.62T]F2;"U05UO&0V]V^AN2X!#L\!S M9[E7I\IIM6K34$QV&DRVB5XS2LEME96`MX[.:JT#LUK.BDNOSYX;ARV-"U`\ M]AS5V?IFVJ'5VHYG+!K;FG7"V@"VSRS;X@CW-YLP]S;C;\1[*[32ON$N$9;S M]Q2%7,7")X%EQ<**A6%0LK%C[^:7CW2])/ M(F/V[06KM+QDGS[X5?E^G41K7)3OFQGW!O0F#'Z>81:EX)T][!**9>[B$WH?0O7RQYYOG$[QK/DK4 MS(GRSWYB8TK'-$NC^Q2_E";.I72,L\L6K[CFF6D9Q2S'IL`IJIA2&33262)I MS(9_J6*4>ZNT>O)%59/Z_NG6%W(9[OGSF?9D!IJAM^L=O=YKEZ*(=&EPJE@M M$RW?B18%O)]+4L?7#()H(O5:"4+:6RUIN[#0$%:4/Y\KR"O:/81CG[#R[8'] M2YL`N&-@91<[8J8Y&!^!#TU5MG>+LKT%%^%=M??1;V)L;UVR]QA%>%.!$5)? MQDT"*@IPNA4[46XF^L+DARZTF]_B;`-O8BEQKHA[$L3=LK;4(=7$LLN,8S'8 M'BYYRL&TPBZYIW;)5V:/7*;LD7UR\+%I?>SYGR6OW8'E>\*;4+V-9F77TG/^>NFB&G_G7^4KB\M?V,,6;WB(/PFTUS;O6@QMR=XWB]Z)6Q:@5O_$<$:>*;Q3?*+Y1?*/X1O'-87"ZSZ)UZRZ$'WQ; M[:1BW_:&W3\]QPQM!^]>7\M=M*O%6':I8K4'X^%U2N0>$(YZK;FL-F0F)-U& MM=,[+C)^5QQP3`YHUJK-EN*`L^&`1@ETP+(BNP?@@-91.&#C19>'`XK7`3MS MP)DZN&[MX&=EA&$\-EY$D"#4?#,DZMAP.L>&:K?UNU;1C&JG^?L!C@\O7ZB# MYYEQD%%MU1@+=6N'8"'%0&?&0`=608I_SHQ_C&JS678%5`87V/[N-X?VHPV# M#)7UMS?1J1U\M<6<8A4A%2$5(14A%2'7+E2Q\,O5)`'`'-#U*OL/TS0>B30%1'JM,D'[1].6Q/1AH M8MJNYB65"ZO:XOQV`#8MECKP7#JF-P!*/.)\8#,FCP*]:,D#WMF$_CKU@K#R MB%40W`?-8K7430:+5`)A,.,?"0FJ65S#:BUH8QN6XZ/-K3TF=[BP@"$L^!&G M\"(_@4AZ)BG+H`V(9>)@=@@?'9L`=+`J,]1&41@!?J2WO$=>D4$,F4`D"+.( M8\"6ZX6:8_\DS@P1,K1'(QAG!&Q,'Y^:05B*"B,G4*1!*8@5"B(^NTD<+LLK M"@03FYDDKE0$D7WCUZ?F#+5`IO3=+]0NH5P_!FU"Q=CR)A,8CHD!+6/BS%`8 M%V5C;`:2$(-X#`A!Z45ILEV`�!OC7P3'_(X/,!7,\/JMH-`.S#"T`AHGTB M`S\R84WUFE'7`=F$+34%"OY!0.6`;O)-6I95*#`AUQ:5W0S>,4-;%2.6)E&*HSD#?X- M8&#)`5I8)HK_')D,.MNUG(BB#$&(V05`F)H^+9Q"/[HVEC'Q8+\QJ8;'T4:V M"WK>!@F%KU&<4.LS-&!*"P[CV']&]I!J6!C3G-HA/,W7!2,\$!<&=.AG$#\0 M6B!T`'QKCP#U!!;E3>`#\*OC>3]US02T/`2P?"276$(F)RNMJ[3NEKCZU+_[ MH/7O+K2.T06["1@8M=^(-8J)\#-L]0,25WP:9HLH\K1/'K'SFZ[9(T"D18(` M-)F.=@Q((M<`*G*/+B.;&)@(!'3+W)*U@&Z("(ZA8W4MBXG"&N$H?S;4H#&Q9(UT]W0YCQY8N8#00'F+`51J02 M3>/Z8@QFW"81\=0^%:<'SL`E.P3&"+T%&OH=2!*O@+Q4"8G%3-!;!$1/JC M;0EYTR5MVF*)9KHVC*CI!BBQQAHQX3^(:VM,-Q1N@,,\\#":C:__(KX'YIB+ MYM:3I[/:@3JSRE`(6?I:KHT?6YNIF6#\!#+0Q'[(%@28`![S3?0]5!RP6YD, M9X[^*57,<(TBAEQ!:DO4"U;L-*=3W_M%=2H`]ZK5U=N&00=Y!2,"=J;,KD4[ MG"&1;E0!:LFI#^_YMC.;WUX"P!^:LK/H-3EMKBZR)*#.:V&UJ6P)*:H M&M@Y,2TBN::DSKP6[.28_)H8"?1&FCGXV.$8'UTEJXFHHXUD@GECA8DO8KF0 MHVI'$W3$C_YHG,KVG&PN#4CXA%X!;MI0[TIL_,^M`,5GE-K-)(@;K$V`IK M#B\!@A]L_/#=])%1`\9R=GQAEI0&40C="*$2'M.,J3"ZMAL]J=O-JT%'$[0) M_\+3*=C+3XQG4&V>PZN+9C?%>^LRSO7U--0,LXI^42E)6:?Q0F5C)I*#YP` MZ]R,2L8U)9^HM(2\Y([BDI'S!)3`&9607>C73,$I5Q%9X3C:)Z,>FZ3'GO]9 M527^YMO67M7><_PM6A9#CM^YWHA/+3P?!GUF"JH`AUW/OH3QV'QR[/F/ MS:=[T^N*/4_+=!4K;);'6N[&Y4Z_53YO22U8U[%FF: M)YTQ<9]*^>79*7'.+TV;F+$'DDYN1G/]YRU(0+[P@#.XP[_P#IB!^,V=8PB.X!Y@_.)[U\^\O7_RW&(J_ M\LWTP]D](ABS:#PW2*:(7\.L;%SW+1G][;<+]OE'^^OECYKQXW],]P_FE?W_Y4?O6 MO[W_EW9_V[^^ZU_<7]U<[<3%0P$,G*4Y1[40S,?1`I MR5AL!PLWS*LIFW[-\O&"PI/G3AK%:^7)K86:N>RV8E/KMDZ68YBQ_R(55EE( M3+T=QO:96K<'W]`A/!&WLDANZGK(]B2MZU(\4&#IH4-(_R=R;-/5;KT@2)#P MVGAS".3NSR$GT-WH]&+U3BNOY<(OAZ6MRQ++0]E6.'=7!4+1U^NUF@YJ?N4@ MV5%'Q[E1RP;C+J2"N[P]VQ:BN,9"LU^4L)R/W^R9]M]4#S]]-@IF>^Y6'@E5.&I+7,%&J-U$OG9Q>:-K7_TJW2>UJ>]AK>E`BP)6 MNF[L.5@OS3*#L68.'_$:GYT26!U?45*4%4)B531YB7GQ[PCT`2[M)ZLN3^L( MKW1Q;."70'>&]VL6O+L9C3Z8#D)X-R8D[*/CY8%0WT??':+'PF=5H&X&0$A6 MHU-Y-P[FW4B$LYUR<]Q\^J1]Z'_I7U]<:G?_N+R\U_JWM_WKSY=?+Z_O[[3^ M]4?MXN;Z_K9_?^GMT@A8F[4HXGR;C?L9[\(T%7B$8/1,R^ M\S0LTQM*^HA5%XU8D%F4])NK'8?^37%$M,1K7$M*@[S5R+4 MO;X=_(31I$'@?#3`)AJL0+Q/5\=F\F(5R0MFFMJC"0.B,R,V=&U:&SAK\3,& M4KR;Q!XF/2DKKXOZ_`@7SFX!EFW^9Q!-L5(A+B4*+W=6^[`N_([36]2VA M-1+=A_WZP*=9UE\L/8DL:G,RJ&=(X#)EVTTIV[O+SZA6M:OK3S>W7ZD:S=*B M+U\4#6*67LQ52\5/+Z0:"UQZ_H/)JCB:`:N[RVIV(V?3PKS8N@=8@'GN&%.\ M8V6XR2-QO"E^H6M#.V!UAVU:(QNL>=-A)7^Q"8+IA#-:V]:&D;&O!\C",++" M@!>79\Z>"7`\5F$7/^I8N)@$@>=3D:2CL@+$V%L#>UB,;3*2>CD,8:H``*A, MS)\@I38KB79!G[K\1:R(-HP`$8$A?#9$SH^TX#UY"B0E9;NT,P1=(.]EQ(IF M:M/(1V5#BV42WGP"H,GL*D%783H@/NPA&`A@M`A;+&]009N*R/.9`R_"HIJ/ MQ(T(_OA`O`??G(YM"[Y]0"%FRS&#@(2L:5)2+)A.QJK4(]W^<#$(5:,'=0IS M?T*P_+UP=POP6(%.U()Q(PLV%WT0M/C0HX]/B(EJ011BCU>*)7X!I$50>8GD M:(I#(<"\.NB$``M9K!N`3YNFZ/+;,D+L0*)!7-*5(PBL]R686N@-%8SM*5WI M<`A#!J+\NP6RY4U0^Z,/3U:[YZD/TL4%DVY=M-SK,M;+*C`8]X)85A#ZW=[7 M=$#TS4^061*P5OM]V17#6C7N'N6FM)PLZXI\S_U:/5-2^1ZY=XU@>^]K;`N85X MK?;E'X^LBH%6$/'._J789VXF[MQ5*J\HCEUUU;@1WZP7%JY43ID)V%0$/&T" M*@D\<0*64`*/NNT6^.9:9;T5Y`KRPT&^F6BM"B*9AX;[&5KUW_.R\=?7#VDW M845X9:EC-UB"$>'K^'TO>EX:?=<%OEH]3>_WK(BM#>YU?P:Y@ MW]Y\WV`_W0-?'40T"I#W7JN1,<'+%[NL8T,+\5EBOEW+POM!U_!L<9_']0K[ MA\!^HZ-W&LMVKS)O64N/ACD^HV+V,L>V:#?:$2'!6QZC(V(&3M`]N#?^W`R, MK3BXLCF^#[)T16M%ZV,C6=%:T?H4:&V@+VJ9%7)X@N_S/)U;KV@MR. M^'N,7%QVLMYMWATY!B:+"T?MT[FST>1;^[?;>LWH;8KJH^@G1>0M_>-=W4C5 MIU!T7DDR=RK='4&\U-K(M]$SEE6R1)_$G^\QJY:''> M\V93.N/QV;;O!.,Z/02Q,K"$U?T"^56YJ=@[HTC92-GI%\NB*--"?YE'X[ M,B>V,WNW9GIM.GSJ&NO$]5(Y?9]OKJX_8X[TQ>7M.ME\ITC&4R/:+NE-I:?/ MZ(DEC]GPQM2!J1^( M2WS3<68TEW.Z5AKB=.K`OY@^A5EYVH-':V4PE:XC,JTQ4^B3J4-?9D7\8`%_ ML>Q`&$PD0M),U-`.1BQ%'7^2\KP%+#S#'Q;@!S1Q<8!K(D%0U?YA!Z&'<.$: M1.KZ@!!7"Z+1""#&3$^L].$3*_+IGP[6#J'?\=14FIXILNA-%U$132*6]#HD M(]NR0YST5;VFMQL]O=-D.7*OC"XZW7T1E=,J] M$WDDOHZ\`%#`L*Z''!3Y-)&59N]C'NP<^#C=D^TXP`Z:^6C:#O)L?IZHTF1' MU&2G2Y6SWO\55115%%7.G"KGO*]5*KRX2'_XW50]"GP2Q39L=:Z`0:,@M6,VDU4RP_YSVYPEP5E4)F M:(&DK;,!*_X#SQ-"#:0AF1**?U9O@U=`(D/)-A537[!!A8F-DT6^FS&(]+!D M48(QQE>'5AV=/I2*'0F#D!T@L/2'7(YI8`9VH#-[T':QZI,H02&72T+[$!YA MAXJ0L$)\U-(>1=2`E`WN^S'!D!2P$#T?RZM,/)B'%G2"OWS3#M*V*;K80EYI M!:U.:3$":;0,>/H\0J?)/B/Q\BAP%'*B(>$&)#(/^YE6O<&1L#H@)[S$(=04 M=H`)L/!*?*S)X0ZL5L4_9K\GGWFH.3M!L47#U2588@>KH0.+10XM[`)?1ZXX M@,6+!Y*07W`:(K!PRB6;"\"BG/. MT*+B##Y#?F%7#QAX&-$#=NH=5FFFJO5I63,\AT8.#&%19A[:>$;GI3C'6!$N M7C"37%J^S9[D$86+KN.D1)?J1STA.">`-[5=3N,$TSKUE212!L]2)W],@5SL MT-I*=N`0$T^:0\4)?18$9' MNT.'$Q/WRES7&6G^X,P/;8!VTU%+N+B]2*^'"QPIMB!ZA0*$B(KE&::BB#)=%T4RB[N9]'$CXK^"500'*!U41/.2R/:R M1*T-B&.#X@CFA$Y4J!J9MB_L"E.RNFS9S3GU`NKET6-=XHTDPP)K1DY@C#&` MBQ7CJ+>/[KK4&,%F(/%\H@I67*M,*!T)I>&B-TUH]"ST\.J.VATS\)B&XGL` M;$I_1G#T(;XSXPJ2-E,"=0.0#H4:!%F+AE0TE@TF3]]GA&07<&B["<[]O_%2 M9\3T>;6OQ?6,;`>^C^4`^0,&^6KZ8&;RAUI5[3OUOB7N7WT."CK4$E!LRB?$ M]UGENER4F,QC+,G&XLA525:`9EG#<'MI0'W/0[Z#_SMRF:,Y7FS6V)+QM)EY ME.Y617?(6S`)'US*L1_YZD7YN[U4<<9SEOL@_D)EK^%A4V1-"QCB&GPH&E`*Q0Q/5=A\]##(WY3I]\E^XMZ*U M/F4-OR1;0SZ%)':&GZ`QJ79+MY@)B,9KNTJJ*,Y!9%*I)UC*E55 M&U:B\$A/DCJOW587Z M5KGZ*>TR*I:OX$V9D:]<^`K+@N[O+%!H%?+SJ_`'[@`N4^9047.87.E-8/,H;,A^]T1$%9>'H^(!7:3,X5DYH/ZTG@EM\0-\" MW*"!+]>*E2K"5B48,SZ)I=C<&L`!HS"^KD3>A[V:]26TO"!$86,UF(4#!'8B MW_LECD?L>,&>1.?%R/8#I"7_@&X#ZL2H:E<27N*ETQM3V$%`,6#Y?WBQ`J/C M8IA5!4>'8`S0/7@@C56T@J2_Z=O)*2F(48^+P^W"8;(,9W!ZDQC:(1[>*?>Q MHP;^+'1CWE%B:X%0M>"?C:9(255&4[S,+4/H!]S1N#M`%)HMO&]>82@_`09= MT4[/`C0,?%O7QL1Y)!BG#RB#-5=4-[UUDAB2)]?MQ+3>S4)^.&1^JJE6V[=`J+[Q-=SQ;ZL;H]!@4VZHFTN4TORR\I`['-H#;E>%@M]#AEJ2)S1F0XG[19VY!_L!-> M<@A>[)PY#U@[C@8I3&TL[PF[R61KM(ZM9[>.W606HVOHW7;C`.O9`'FM_=$E MNU-NP73):>F[$5T:#;W9Z1Q@/?M2#.LW""Y<#WSW_)\:#16BGK0C'`WV(1V[ M,533T'N]YM&`?V:H-HQ#HWI_V_@F\CIG^^TFQFEG=WF.`YL0;2^'@7US\=Z` M-GI=O;V1%CK/`Z7BH*TYJ%;7.ZU6.3BH#!92*AM_-WU+*^/(=X@+6$YJK.;6 M75@7I\+3D'FC?'P9:N8R(Z^YD%[%JPV!W[,P;0A]LU[76RUC*P(>_21UGY0CH7\M!#KEQ2[)\4T79C#&YMOPS^6?D?UH.A@1@@2O;*G'R3@M,JB*U@:*T;A=QJ)A^W/:T M;BUNDMGODVG[_S2=B-R,XMCJJP15[$T5:W?P6#NDBT8)@W1/PMXEVBQ$S-(7 MTU4Y9*[G<38BFX%F.R`?"C&G'TC"-;I(@<`@4HO`UR+*-/Y^:LY868-LB>0! M]TS>4OF+V`B=Y2'Q9`*4+)I^EP.\%&XG8O(10WR<`;',*"!)P+YKQB4CDH!4 MC#S$I(@933ZBB7'#2,X(E,84,#F@U2H89,OJ0M!T1Q9SRU(;6+R@R!L:"E5& M0W5AT'YV#A3OBC[$$"EI3AJ)",,\@-W]%XXO.I$_C0G%#4",D<'`^AT*$-0_)`_8?CLF0^2[#0#Q]1D::3`_4TGPRWM0>0Z-MXF/8 M_BQIHQZGA&(X)3"?`_S@,%4&,#"0X.$`9)CF)++LLS!-"XXNJO MIKK\174T?1M72V<*M-=T/_E"IVT`H\CAG4'XAI98<5G<)(L["PJ/.CO3`#.E MO[/UMXT?&,.QPQ3]XEV"1E#BL?S%(OYGY"WH#Y90AFM$5X)(J(3OYJH4F4*] MX;MQAJ4D-53A%1[9^YRB*4N$K;(R>WTILXMT6<[G$H,'8!P[IK\^>[,Z38L# M)9*RSJAB.);*[+.<'CZ5B_EJ2H:4#!U:AAJ2#,U+3I+)FJJK,4"S2AB@:%D] ML;17MH^8Z(8&8Y_:;#0E$>UD>BMN6\(68O4B)!&9Y>XA/$4UWK\B=ZGUF6'7 M)59D:AFQ%:D24)0T;8NKQ3,SXOK!.[AZ2#+D^#3HYUPB:3DH"%/28(\+^$H'%HL`2-)Q.?BL3!J71X5I6;AB8;\!#^BL4**:Q^Q-SY? MT\Q3-]SFG,VJU[#*BV/,AEYV\$YS]:)+:RT/E>S2^N9C/GXX^^:`UNF[0W2$ MT5S;,CA5!7"L*H.`;+W49SG%,C4.$>/P5$!1!BAD&8GT!#PD4_C!3DHUF!.L M+<7/^4!\S%D&KG\DS/*AA&,)D(RML/02+6`*6P+P"+I$>'9_XOT`WAA%#FPC MHUCX[`F.S7803(..2Z*R4SIL"@$F_=(2`2!,MP2TENDPE\F`ZI14,0>6.@J, M!<0BW+TAIL-4:U;YB/I1IG9(RX0.J]HEUH@9VLBKS%2D=:2(2^L;,.:=`IOQ M7-`Q*$E6)8#7EF&)Y;`/TV3LJO8I\ET[9OR1_8L-C"_':!:X'*%`\,5]-:TQ M:!A_CFK+WIS'SYTW"C%'G!?>2K_!4,J>S'+)?4'28;57F2JY";!S')!!Y4<2 MEP=+S&Q*D9A'L@'Y*#-CC&3,0<=XQRZK--O2C58K+B'!UC8!R1BO3$O/*CJ; M/V5;[]9K;,J>WNFVXRD#^]?V$V8KLW5U4RH#?H*\B0_=^!_M8.H%IG,S^@)* MX0L6[F`NQBMJ)`+IKMP0I0RV'O;#O@MI*8?^>@[]&[KY(M4JE&S<-2Q=,\[) M"=/SHC!T^.316Z"`^4X%C87DLM0RUM%5>O+&X>0))29[(F9D'7T5JO#A`P_=@N3ZZV@,5H8F\D+6K?T M6KL8H523(.-C6)+?6+Q MYJ'9(\V"O0,G?@ET$)PJ/&S_,AX;WW;%G8D4IC<1C\34IM478<3XNOS]? MWQ3O_\54W'4PO_Z,,FE2\7^I.AM>MN,SHC)'7-%0V"5!0&%BEDH03X#HF8., MVGEH;C%3QK)]4((8#V#1XQO%%)85FGJH6^@9*L$D*^TC8>MJE$)T,H)TQ.25 M?WP[2*J\,O@D[PA5TK3T'3^'B8L]K#,?4$00N<28+BQO,34FJ9N$DT9 MEPPXYZS;`K([83^K-^HKISJ+Y,[=6:J=BZAR9.@<)JMP!<^4DDTVRBKIH5H;4MHG1&V=7E8FWU\M*RS\`E"Z!KM'LZ.U6;0>&+HR>FZ3&%7^I M&7?YIE=M\H/[N/?<7P,A=E.8?3T87PJR(`]-?G:'F[O4,/2&K&[H/:M<+O)Q?YK<[C3 M2DU5DA2NN&>-"SL.QG:)-RGNGL@@P.NG(8:A>2S&"*^)`YV'I8I@$?D!?K^# ML:YT(>OI.^SN'`^=^DVH/(P7Z!/%"&(PB MXPUA!)BFYLSW'%9V?FC[V#&&?U6A`6MXA>+Q.O78/=J;$8+MG#QCI=5;L*A9RR2ZN`"$!X,);MYT3?B"NO<#;E M3:AIIPD,G'K"[A1QC)4A&E8WK\)5N*G93*9C(8F7OW$C[)53<%*B%#IJHO"0WF=XY_WX$E>I[%E<3:;Y^9%8`\LE*8(L<*/>]]+<@`Q M>GJCUN/;&OM<\(;".Q[FVR#I+CT!P3S&OCO\F"B42[:.?>9>KXA2%7#QBOV) MJKM`B;+493]0[+;W7*8X_UP.A!196MV8($,#0,5H%\F5&`YZ5;!<;TQBA M&,Z^TQY&Y:A+P2#2!$@)O3<(7."?@RS,],9B*QOH%B<,%AB!,0(7^`L>!_L)I>,;)J]D7`/9QEFM\4M M@!>PP=LDBAE!=;+$KNRQW-"WP7JVYBRPA0?CS`&.;`POQR;7,L-1^M-"*(5A M.YN>+#EM`7(:8[0(.NI>L)HM<59F44VL*RQMWY:8T6`2TF:W*%;20*PCFXC& M6F1K67OH&AS*0WOJV$F73C>BO1GPO,:T#JU?D!BHN%(DJ\0+%T0]$!F\&5BS7N88T8GJYJOQPK5/P.V:5"R:3)=))/Q%FE M7[['89$LKQJ)76%;`V]TF#JV/S"%@\Q'=S=/]';VDN.O3L_0P+>FB(4"%%;B MGX$FGD]02'7:=Q&WD-2NRG5&:@1QV*:YJ4L4LT^28RC")%)<%T5-7JGYA*6; MF/-"`,(W1M%RFBZ<'?32T8OX*J\H$E?(X:T?_V(*0N@EWPQI2\58/U%(J8L" MLV%1*W!KK1J'\">'RHP5I"B0`MZ,=6D*?MK1,N[(+:7M?$"/L,GRR*(*75\;5Y^V/BLQKF=R:\F*3CX=29FI('"O6EV]+1S3 MM?1I1X_=3**A'+`](-]FA:[H;)4ELPG%A#EW*7GDIC'79XEOD&FS6#]$+K9N MQV;75>W3EJ>W;5!BU-J2LQY.C]WN4G_WXH%P"[L@;5;8TRFP&CSZ#P#"@8]X MT"_#85&`1I$C@%MP8RPY-U:TU!!C,82(:P>F$*TS>0:%U"@;;V1X#V'NJ^11 M\L+]P3R0PHN13M^E)[$@E/H0!SGG^?7P+U.L/Z3V9,"?+,6Y7H*)$6C=EM#R MBXE+5W(8)?W9YS)YWN@U1*984Z\U:0-V4YH2?P-YG'A43AD` MP\@7^_'.+L[UI]I,V?`TC$ZOJ1L-[A.MTP81C;6\2"MX2&:W2]-'UWSPC?A4 MU9SBM>PUR#)O5?[ZBQ<$;S18C4:7DUV)$9NV6W#V9$O77COT):`,LU?9N8YG M7:<<.$\$XPI0'6!JTH-\3!0'2NZCBD):K!3&KVK_\)X(-<0'=%Z:\I-,1GY1 MK81[5FA7AK83T;-L4IVBJGW$+V'6&.(]@:HSUP,=9N$<+#EY^)LT\9^5KJ%F M-&V[+@T'WP[YO11/RH(],5Y@&@KZ+MO-=;Y[#R-KR7D\E"\:$QA$MR%P\0S ME_;5Q9XKT4H]"SHV2U7[EO^CC$KNA&3E@!:/#,Q_*)LY_#!$#PRQ@9)K!TUQ M=V=E>]C4.*\= MH[X4/_+MRIHJ1=8^U^2I'Z<+?H-=`SY:1*H>2+TY$8O[!/^FZ;XCQ5%]H0Y M+RHLS:AU26RJ;&G-P"0K&6W-R-<&Z(TA`2^'`J^Y7ERZACN2<4O%(YT5)IMI M4ID)]K90`)&^,QA%K.[,D"G^E2>[375?ZEAGC6%[=,C-*"YD?\&*0MWC:DNO M+\^/A]/45FF5JL-[&7J,JP[OJL/[OF1*=?G>.P.I#N_/FO:JPWMN9H_J\*XZ MO)>AUH3J\+[=T"=0`T1U>%<=WE?N`9M,H#J\JP[OJL/["22BGW.1!=7A77&0 MZO!^NAW>"ZO\X:@&VZ6!7O5W5^RG^KL7V=]]W0OR5,-M6L^=%KF9KVHC)[/S M9-S3N&A7=^KJ3GV/?F55JOCH;DI5JEB5*E:E156I8L4HJE2Q8A-5JECY0%6I M8E6JN!3N(56J>,^EBG?QV&2G4WQE[;!M$K"2Q_?$GV!9L#UX>W[@^*$8?S8E M_5]V\.,:*RA],V)9Z2#:%VRMN@[ROJTW:1MRE,!ZH;>N&QDNVULD93`U]@3# M"MXIPIS=63I`'5KZ]?G+5+A,=)Z^ML.2UYYYB_9U7 MN=J4\8O!ER*S(G-Q9-YONOYS99UK6CCN.(SSW''?9Z4'%?(5XS\OW"O&/R+R M+[S)P':/8RRHDCLG7G;E9G1"9VA%^2+]:+^(;]G!*?E0%/V5Y"O**\E7]-^) M_LG]?SF(O_=Z8.UZ)RMZ9IO_GBR&NHZRVCH7<;^1D8*TAP:"9X[DRW]VIZ^P*\5FT: MBLE.@\F*B*T\[@HJ*P%?,_ARCZ1O'9C5=DI>/J(^4QRF..Q9*[/UC;1#L]R^ MPLXW@.TSZ_UUA/N;\F40Y^ND9U06=0_Y@@JYBH45"Y$6%0LK%C[^:7CW2])/GC\B,/KP[07V[':<)?NT*J!4-#/N M#>A-&/P\PRQ*P3NEJ%"D6"9CDIKF8+RS/P?; M:<4.BC[H6X4./L/*E>62N:+NFH\2T?`,N:<4FWP!L7V*7Y2VV3R(2G&-TC** M64K&+*>H8DIET&Q5>7/;ZIFK:G%^,V<3XH;])],?RJ/]TW0B.D4_"*()^T[5 MY2Q=72N/Q6![\.*6 M@VEA0]3",='NQSXAVE=X81QHE[`I#F.7YCXY^-BT/O;\SY+7[NQ?I\QI2H6> M#%L?I+C'-C<^IT3,8\__W)BIJ9A),9/23":\]=)-%.NM7ENN++!#JQ7"61/[H0;::]O59L3T@S>G MZ_R4;CT//;5\>YF[:Q2_%[4J1JWXC>>(.%5\H_A&\4V9^.;E"\4YI[Y&I7'V M:.`MK4NU[D+XT;?53HIR;6_:_=-SS-!V\.[U]1-OXZ69CZ1:C&V7JD9Y,!Y> MIP;F`>&HUYK+RK]E0M)M5#N]XR+C=\4!Q^2`9JW:;"D..!L.:)1`!RRKHWD` M#F@=A0,V7G1Y.*!X';`S!YRIB^O6#GY61AC&8^-5!`E"S3=#HHX-IW-LJ'9; MOVL5S:AVFK^7]/B@^*?$_&-46S7&0-V:8J!36V,)&$@IH!->8PGXQZ@VFV57 M0&5P@.WO?G-H/]HPR%#9?GL3G=K!5UO,&5814A%2$5(14A%R/>?0-FGHVR>. M9Z>DWX1CXF=GN6=GMJO\=_5@SUS;>MO2J]XV3?[B^Z M2M#7Z!G+0\SG%KS1I=N^K99TB?FOIF^-M8:Q78WY;9#7SNJ1?F@Y7Q$%>SB1 MW^/:FO67^:X0%*59B,M+DYE^ZB4SV@%K^A[7.K#;YGO2@V]W>KI[5[[U%==2LH6 MHP0W(VC5R&\5IV6\IKHGE=CGO%-; MTUTT0W,U%@89'#`H#*`"5,7*)ERE6>"V6J20%3;U7KNA]UKMO5.P=$Q6.H#* MPO6OSI79C6J]?LI\OE5ZQ,9)#-FY$+?$,4-,L?#A>8RF-ZT3:L!WKKD.:R%D M+D.AV/2(K1,>XKBKBCG$G!0Q]79XVF=ZQ![L^T-8DUQB02&!R&YJ/F:?!M8] M%AXH/.C0@4#_$SFVZ6JW7A`D2'AMO#D$D!X]^'*1>.#VJ0?9OS'?=B4TRP$Q0FQ"9&T.>+H&3;E*M-,J)M:[?=E M)E$I$SN7^`)S$)0V,M>=)[6W9S9YPC)>^<'Y>N.@!MQ"O;7#@H!5,6TFW< M*4Z1KBRD4U)WLJ0KF=2I/HP*9@7SEG/OW=G:JO^>%Z^YONS_X6(THT:]A8%6 MT::^-XPL4&6F0X)<3`B_Q.][T-[2V+LN;J4SN/=[;I#M^K,8>JW9U&OM_#2. M`I>T&0(5<=J=CMZJY2>.*=(<46[:[:[>ZJZ^;5'$.3AQ>IV>;AC') M2TI,'-;W7F@Z^0?6W6;=B4M@JC@39W]>DHVFWMHAW-9K1G[?Y$PD'T$3*>)N MX5#NZL:2,C^*M"=+6D-O=VIZJY'O,U#$/6'BUAI-O=%_-="A\QO>_ M:9%KLT'^N/OXFS8DECV!X3'8_.]&H]'L=)*U9`*R$Z09P?FY0?M+(>T:W79C M&TB_>_[/*_>;[UDD.`A2F[#I-#,@30&R&ZA%8;5I]'K;@?K)=NT`&/^SYPT/ MPZJU>J?5RH`U!K*DW0#>?NG_(J9__^25?L4< MSAT72C-/3F*I".ENB_WD1?Y)K!4!W7ZI_1%L5G08>.$0ZZW7VYUZ8]L%I\!= M<]77)#P((9N==JNVUL(`(AGVCV1$?)\,;]GES44$?[A+82YJ%Y/`S09B-S"+ M0NV&8$Y]>)ER329P#9:]V9_Z&1B,05L3@RU#M@+DN3>"*9U1NB-,O4ZW70!, M:3SM+AW=PO&T(TSM;KVV&J:KR=2T?3PLW8SF!9G)N(,ROG^R2K"N"=-^EE&< M,&^Q#'E/6'QI__(.1K_$Q\NA.3#7?T;V%+'[878_ MFY+^+SOX@168(MA#[[Q1^&3Z9`Z2KP3;9B[7+NU6\T`8*%1\C%:MW2XIX`D<)^[U.WJ>VBEO$^E`KRL4N?]F@7O,@X_O)S>H11F MH]-JP\ET+6B*!'M7)V*]UFAN`'9,%\?Q+"PJDUVND+^^?PM#LH_6`ZF@112[ MV79:W>Z1%E+HSM/JM@VC%!3951'7VKT=5S*DL2F![3X<3!B,5K/6E/>/!1BV M@+!03J_CI46C8`B+/7K7>XW"(2R4-SN]IM'HK0VA&]I#VXE".!O>$0M+K]DD MN/QE.=&0##_YWH3MV7R'O31]%P8*OO%"M*R\8-&+"G#H0%[7U?4GO">LM[L] MV<%;"/0R.G*-F#\",HJ<+_:H&`H6:"W]_5OC7PE&UEA`:=?[A8#B''O.\&HR M];U'@C\';)4_;F'E[*FOMFM/HLES7;WY*[7ZSIFL_E,$HAE&()/N\)/]"S\% M\2);9[+(KZ8UMEWBS^3?5S+X,UO]F3+X6LK\&:BYC?$PQP\[2,,7SWVX)_[D M(QF$O,PL6`NW9&K.J+*]&7WS;=>RIZ9SY>XI#N,'`A%R(&*D7'LA";Z9,XQ` MHR=J_CE8PR/2JM=JTC%WIT7F8>L4%R][42*\%+DE+GDR'>237R'8P6`2?O+\ M!_L1)_OBF=F79&R5]3HP(CT_&*E59GZ?N`@O'*#T(^0_M\8&R"2LEGZ(@I";P(KVN."__[:?J,!I3404D?C MG*EY(_H=`:C@'4L#+H6OP;(/WFN>K[VVX268VQIK#8-V4FI7Y0O'O%7&?`!6 MO^T-@?^)3V,W87C`6BY['P015)VM@"Y>`"4[&::7>L5+B]^:X;*0DP,Q\!3L M-IF#F[_]O58UZK$/<>42"EGL[CHI?[&Y6U,^$NH,"6>)@I25L@H%M4U0D"W9 M?[@FA^!#EU$:S$JACK*#0C:>[_7KE#?T@Q#&:G98,K0S`G@$K M%.?-9FV=90"TU*4'7Q=HG*VX,6VG0)L#08;NN^G[8(X'8)W<8HI((/="+`CI M=V-@O_MYK$M`R:A;A7BJFVJ2-W_9"F+ES"9#T^MFBMY%4%]@5P>V]4_3B0HZ M3Q6Z3.2O6LWHM;D27KZ`17ZC3X[N0L_Z29VG`8>##(V"5HO5#U&]7#AF$/"I MZ(KOP#8BP8=O/H]7I+\LK#?':]QIS;/MDI7$Y*6_7@5!!"H.SE#N`[//V//L M>S#/+LQ@?.,61>W]K+_1BL\/&RTJC0J0!2$6>0.DP9->*#5ZZK6F@;>KQ2PU MU21E&;;I0;>8F)E5B+G84FXZM93*7[V<,B[^XW:+-VJM M=Y#%ET4AR/O%>@NGJN,#G&E&MF6;3K+)?"+H@#O`G6]J8U\"R=IDDC=*R=Y( M[E@/=>5;;[6;K<::%%D)=4RM3Z;M4SOG9L2L'Z[J[[W+R=3Q9J3X%>:&PZP+ MT%JV26H7+SH<(H](#?R_-6R,%'"KED.Q$>QU/=FGWA764@9DPOKR+ M!H'EVP,R_!#!X=FF[^:?$[8Y$.UH`V2$D=32&^!FZRH_1E89!AFN^-K.*&&> MWHS78G:B)[I;8A'FS#\1)MEN7:G=*+NM-5K5#X1=(2:/=)#Y[G""_#N&[XC_F,:P]Q=K]!_6/1?>VXNDG<@QJ_`?N?:SM]^ M@\G);V^/AJI-MIR=M&>SUV[T6NUS9+?M<:C$=U=\*NU9:O2?M/;\3O#"B`S[ MC\0W'\CE+^);=D"^^5A/_*`6*1CK/Z:`,0KYW'674:WOAPV7+?^$,;YWC;&, M6+5JTU#$*JUU-D>Z[L^^ MEU.N--)R$\?89-J2FCO[(JX,S1_3@TE M)[8#'7]W+Y-Q=/K8/*ZM-%B-V\$\;N,\FSXB<1NH]-[=DC=ZVG MC=@UBW]RQ':?%V(+.]>N1*SD4"&NO]I$#NRD0Z4J<&8UK;XGE/0!OPC>WY,_(#NR0 MW!'_T;9(@2%T,KZWAD06]#CDA#V0+2S76"*@25H(LM+C0&K5JV_5.OU66*7I^['I+LYY,,3%Q=@.M[:\UBVWQ,%>V]],'VLZTV*F M]L@&4"+?)\5UTY&FF=W#P@+3HA!^F,F_L)8<8YN,`'*+=B*^&8U`\OS5PJO9 MP[_]]LGS0A=65S%^&*+(;'8/F!7KSF\Y))\"+TYG#1^.WO[ELS#Q4Y M*Y)1<$L>B1OE5#XOM!-]N],UY,1Y,?/>H$EJ'W\FWH-O3L>V93H4Q7_4K5261,H>$+9OOC>,K/#.7*]W9[O6V`&M.SA#,CJ(U1K-1K-V M0'"V9\A>IV<8)0$UER'3V$UW9SLRP!MR::/3:>P"?*'M"8Q:LUTS>@<$9WL^ M!5B;-;F+S#%AW;/FW!6V#7G2Z+6*4YV[LF2[4VLU#@G.#BS9;G=;W>)44;E8 MLEC8"F?)V%6++4,=+\"\IGN`^X/C63\+<^_:))F^UI;,-)`*>0 M8'RRA]Y3/-23YP\3(.A8`.K@IPW#X9AP7/!^D@J\%([Y[WSA/@FM<3+LQ/0? M;%<&QW3L!_CBWU$0VJ/9^]_^\R%\CP09X(?KF_M+K:/]ISF9OO^/;MTPWFN? M^E>WVC_[7_ZXU+Y>]N_^N+W\>GE]?X>OO!V(E]].\=/+%XJR9:,LI:31KFU( M)H7X7,2O8F/.O^O1YV*,KKA`\YE+00L]4-B^_6BB(R&`N7PM'!,ML']I$YAW M'&@$L#'40*L2K5'3-52MFND3S<2G'0=7K"3R#"52D:DD9`JI0Y^3BD]GP.$Y M?W6+6,C#Z6:4SD#)`+Z"@8&#'',:`#+%IY78^DVSB./PT:C;&_^>FL,A_UO" M@"^63WLW@CDJ4#CPPM";`!BF]?/!]R)W6!',;%F$C$;OY6&&.%Q"/:-^0L1+";Y#1N$9D//5A@2K-TY)W%(4\W&@,R`9B%K- MJ&TJ:(U3)=N9"-J<;9!+N;>AO]NF2]UUZ9^E"Y6_^'RW[[,XY\XS;9WJI-,G?OJ2-16WLS=] MWLS5YD,O&CA$J?/3N*A5A#\OPM>;/;U>6_N^-ULEJIV\_+9X:DM_2R/&SC_. MK]Q1?7-1>-66[6;25(5(ERQ$FO5#38=!:U-6T`2_Q-(&ICO3?&+AQC=,!5!+ M%_2+-_%@C[WBUX;X&3!DC;57]5I3K\,WY!=8U6R*J>_A9_H&_KTXE.D.M2\\XH=\^A@R4#:`[\NH3/3>'&\,,&_1J;M M)SW)H6ZY['%J;CO4R:?BOM6<=\J[ENI2AF]%%<@-)&VWM?PV-=J_9J?,N:IL!EVX$`!QJ8Y?3"S,8]UWZ#_96>S0= M[*K6#R],WY^!K%-Z+NOP9?SX2*R,QBH9WV_4J:`P`+=K8[>(^OI\]]0-88QY M2O(]'(#IZUTXJ'&&D68&:`">_U.I:*(%F'9':!\QK5)!4$%!_7PWXK]]@3^T M7_2K<#8%)0EPTGK?O_%O?0]5YS@,I^_>OGUZ>JK^&OA.U?,?W@+:&F_QY[?X MX&_QT*`94B/"WV;H^6+`L8_K^8]4=SO^DV,."#`-_/,C]?/;!;#[?GH.T[?$ M(/!Q!Q@5#%Q*]C.)H4P"<:_ MOS;>:#>1KUU6 M5.)AXTW47P$\SWH;:[AB:J1@U([X=Q1A"HKG_\1D&X7/L=_A?^_/]02P,$%`````@`=8L31P'/(:(J"P``8Y@``!4`'`!O M>'ES+3(P,34P-C,P7V-A;"YX;6Q55`D``\WTU%7-]-15=7@+``$$)0X```0Y M`0``Y5WO;]LV$_X^8/^#7^_K',=)NW<-U@U.G!0!DCI(TFWOIX*1SC91F?1( MR8[[U[^D+"6219&4?\A4AJ)HXO*HN^T7&[ M!<2C/B;CC^TOCU>=7]M__/[C#[_]I]/Y^_S^IC6@7C0%$K9N19L1!K^UP.&D M=?F]<^GCD++6GZN^6KVCTZ/CHY.6^/%Q$C'NH^7/K7XTCGC8.CG^6?SMO6\= MGYR=OC][]Z[5OVUU.O(Y`2;?GA"'EM"+\(_M21C.SKK=Q6)Q]/S$@B/*QMV3 MX^/3;MJPO6IY]LQQKO7B-&W;Z_Y]>_/@36"*.ICP$!'O54IVHY+K??CPH1O_ MKVC*\1F/Y6^HA\(8*:->K=(6\K=.VJPC/^KT3CJGO:-G[KS0*H=?S9A,/K8IL]+WI$X'O]R>BRE?[J@Q`?"P3]'@33S80(0 M\G9+]OCE_CJGMI2.&/`E#V'*CSPZ[%,00W`@]T8@\:)/,=(1[XP1FG4E/%T(0IY^$@/6 M.>XE@/^4?/RUS[EXZD7$F/#N]`$!>H(@?NQ7=;MNS5I>(#[I$U_^<_E/A.D19='TVG<6P<+ M_E/Y$:-3'<#I<^DF=K0H\X&):4W,:A$72M*95``%[=8"\'@2BO^JG<)[X"'# M7@C^MF16[+IFLR%;I0MA:(:7G+-W.85(?A!)AMO&,C[2YCE3!(R/O%)?)6*AKC M4:'7@0DH71>4&!LBLGJ'!YT!"Y=W8O,1"L^0X<9,;G'URX)6S%DV],;:15/U MKM%BNS[&8HI=V274O'SV@DCF)SY1ZB]P$&C7;@MQ9\FR,]XNM*J3M,S<^ID2 MS[C$J-L[2TN)>7:A5IT\W&#TA`,<8K!8YQ6-Z]4VW4#2X!P;P6^0#,ZMP!>4S$6X+4.X MK,:Z45,BT0A62LVU2XO4R`KC`P'EC*P+;.TZ.(Q5EK."LODAW:T2*>LNJ#;>O=@U,T#L-DZ.S`"EN&^^ M8W#9*DM?="^T?@BI]VU"`Z$7EXFX<*EQ,T7CNO.D,`+A-7ZLB>EL6M7Z@'Y4 M#K7BI*!HIGMSTP6=3BFQHJ+0M!$\%`UT;P"O,H&^CU>*)%./,=-9$&@$(67& MNK<'?E7R#F'_FIAY*9-H!#&EYKJW'[Z'$&$"_B5B!),Q[WM>-(WB3-@`1MC# MNKV7A7`C^+(!P;T-X'`:U\R)F)B24'@: M$$^_E=%)-9`C+0B6T433;%:UM%RANVO5W;__^$/VSQ9EZ0^AF-QB'H:CX0S8 M:DOVA:!(K%RR8KQ*?;JIL_T5JIN>7'-IT"=&.;]C=*1=-;.MZBY>>D`!\'N8 M`XE`%BQP?4F-LOE!:\L4$!<&G-)&%PO/+R@/AZ-8QP MW#OUXY],&62<5"'J5N)BV[H#=0Z"*%F"/Q"^'="X2"Q11ANCZ^0.N)Z6@J]X M!4%GN7NAW@,$HL^QT/<6L6^0L5$WU98+-8$DG$Q$+PHU8CVRF[DQK%]@I*K_.3VZE=?Q@J()9 M"O^TC`_J+=PA-&^3>68HEZF]2AO$?LDB/EAO>4`/,@*N*,?.6VD>(K5[T1?" M``7X._B?$"9R5`S):\6';MHR23:)*2,*[L4(F;*<-77MJI'6A9I$E\YV76FO'5IE$DT@JM=J]4Z;/$%I%:OEVAR1#I7!I&)-MZGB49F68QA4M MYVE-YGI'66MY#\%50!>[2%HK^JHG9ZUX<,TI,'DE@%!"[#'F6%ASOOS"P;\F M+Z[=]\2L;RJXJ]!)W2F^36>>`Z97JU-2&+]YHUU,?0]@QL##,1[BYP!BF(G? MGU(6XN_QY]HXRT*\X2S:0>3D?2L9#8J.P11'4PVS9MF&TVH! MCHMWLTA%KPD/67S9W``\)NMYKT1?8E=`0#NYFF4;SJD%.+N]]V5'Y]6ONX8A MN7R6MD:83Z0-*\_4G6(;91O.J04XYIJP2H>:)9?Y7#Y[PH->M^##.3!AEP?@ MJP:=6::AQ%B`87Y9Z@"GS*_*JG)?^@(,LVQ#R:P`3D+J?_<]RE9'$;)B=TC. M88*"T7"4?RF\?+19R#:4J`K@)$3]NM>KS;*JG"^K\U.0>2N\%,%(^/C@4LAQ MS7DDKY0=CN*Z2+&=^0LQADC(1;3T`&R.Q?P^9!D-M/HLOE[NS1&:`R5E4I.>V<4FHZC%!C?U5NNDH;QM`E=* MXJ[R,?L:COFK;WEAD\/6N54D MLG#M4`6P'*P[+ZB_?G=Y%8H+LF^+V2(T+KZ.HK;["A-$O"VG)E4GM7_G0WR& M>R7X?DUW9Y)N.G6`?GMB0HE!YN/-$URS2:7PT4.WWSIB1#^;HVVAVME[9O)`D&",PU?/6' M>9G%(7/9MZ%X3R?52.*LX'#O"K=[F"7.)A=T6_9T4HUF3PN'96U?O?3YD;>J MXWZ84!;*2X^K7X=>I9>&TUL!+LNJO\-_U?,JZ%I/>&GXKM3-`0G?Q%S%FTC6 MF43'WYS<(QS*W(7CUR'N$0[EE++ME8G;O'8J(6%+,6OA,<$C[,G\W^K@0FZZ M:(#E!98#>8ELP"N^A5JIZSV^E%I)CZ9\+?0A=+Q'BUNQ:6`8!?H#0%7[@Y[Z MJ&`N_2[KO)DNOF'ZHNI?E'V3U034T[^E5B+0'$[6#'7QS=`77:_D16,3\.,K M(FU(R0LTAY0U0ZU?[50L9'4M8;T]KF$]5Q:Q7MVKF'2$$&[P7(8XA:\1U@P! M@V#=0UBC3O;5YJ1LZ[-@\W$!P1QN*0DGNJ&^9<<'G1+LR%V?)+:%TL5EMYI- M_P/$'A=T9UZ1]O?FG>$%.!=7^0U,$8_7Y4PV[?'?X0-%$-5OZ([&QC`W27[:X3:]OWB'60+0[^]KYOB/[A:(;)QO!Z%Z6LU#)?OEF1K?SS6K>SAG'WZ+PHC%.=KLZ=T=P\3#,Q1B05M&F^U[4#6"SCO950[@K-7I"',0O_P=02P,$%`````@`=8L31_2)<[7[ M&0``]](!`!4`'`!O>'ES+3(P,34P-C,P7V1E9BYX;6Q55`D``\WTU%7-]-15 M=7@+``$$)0X```0Y`0``[5W;D#2MOKK%R`IB9)PXP7*E)L/,^VR`3!/'EP2B4S@G_]Z MGX4'KX0F01S]3P@$1>[`?1\R^'/QZOCGX^_-?__O=__?-_CH[^?3:^ M.;B(O6Q&HO3@EI69!,0_>`O2Z<'EGT>7?I#&]."WHJV#TT_#3R>?!@?LQ\=I M1A/?G?_]8)0]9TEZ,#CY._O?Z9>#D\&WX9=OGS\?C&X/CH[X=\(@^N/)3<@! MDRM*?CFW3^]/-/P4T^?CPT]"=9*OPT794^/ M_WU[\^!-R>FN::T^\'LN"QS[(8A^Q*7X5LZ?R&_'";!["4DB]]-*9E((2Z^SR7_ MPF7^&V_MN(4T[&<2\4YSY).)FX5IA[)MM]V1I/',#2([@A9-MY(S;^)H1F9/ MA'8IY%J[;22<,F&HESV1HR7P#N44M=Y&VBA.1YT.F;+!7*:%0+K&X_=Y.Z,DF2FK*]/X]!G]M7E?[(@G3?2G;R9MO*EL?='_,*MH\2- M_#>74M:7$K^1D.JVNI#TKFA]%/F_EZV7>CAM(*JB,:NR#KJ4=6!7UF;3DU&3 M+>4>D]!-B?_BTG2>LO83U\L_V*CKZAIKJV/RS'=?U]$DIK-\*])L%I`VD\O' M3.4@"OBO;Y@P:V(RE1.V$OL+07ES;>R,?,\7>VO?"/DN*Z9"TRHWJR9N\I3; M5EER].RZ+\=<1\;6VC=.:#PS4-?BD[%& MV(.8LB7IET-6(TN8),7LS^>+PG3^YL51RCK?99A78^.EZ,*KOXB\$4/"6LY/>\60#,."H0$2ABX:,22LY?QCKQB285@P-$3"T&4C MAH2UG)_WBB$9A@5#G\$9&B4)V\./GI*4NEZJ(&6]H/,5D(9CB*?_X?[U%_=D$F:C-)SE])Y M$#W_YH:9RG5C5-\YM>+2J466B`3)3L<4$AH2QX2!"KR4^&WIK-F280(_A>0[24OLJLE34,?LL.>#@D>^_PZ>F4RQ73. M!%104RWFG$+Z&>I2L2EY%X;W]H$1_XUS$WC\Z.6*D!7O\EZOJ^*<0GH+3-5L M@@*/)$KF%5#`*#VLXII`.A[M@P!+3@[PLX?Z9, M;4"`=!G47CHV15]H_R=P[=_3^(70='X?\O"ER.?FR`O?XZG7#E4UYQ3266"Z M-=(AP&-Y74>I&ST';/XML#$!+]^],..!YK_&L?\6K(Z6A2ZPR]WZ/(T\[QPG+.X-]<#5(16V#JVN&RXC'%;@+W M*0B9Q@@/.%9$*OI*7JJ!*6=`:3+HA$_$A1X+/KS.'IEFWB^):S*JAI#XAK.`-)GT6SP MR)'@V1%<$!J\LE']2FH9(*IJS@#25]&(*AT(F-#2;,C.DK8>E,P3UGW1-IQXLHL&XFHO,UD)GB,0ETH&OBV/!LP<[ MCV>S()WEL5*L]\3Y30LD\M34*&HY0R3^CJ94:;#AV:DU.@Q0J&2(Q-G1E#@U M-#P;N/5`>EWXIJ"T,X1T>VC4+.9&@@*-S<$'?1P9$;)9U!E"^CD:L2&"@,`R&E7CW;N!?1WIZ)#6HS`-]9>C$6UFH/`8 M"-L@:QETSF?8.(X&#(E!H/3A"JW3%M$WSN>/$\8A!:AA\GC]BJ?=7OJT?FMC M?P.4J<3]#5#]#5#]#5#]#5#]#5#]#5"69[/^!JC^!BC,!/4W0&%GJ+\!"CM# M_0U0V!G"?P/4NH!L8W]'S]4'=X,P>`Y(ZH( M7&/94M2"O4"J(5G]#I*4IJ9'IA*:@"HG=&"Y#BU&W[PG:96%_(\X+C\.=&ZLC4U04]5Y>-#S)<>"QK"^&/Q M?L;$G-RZ:4;S2+N[237O+Y_0^?N39TR,/U2'$36;`CV'K6U_-$"G<7SOR+9N M].XQEEM-30QQ?66(2,9E=Y&*IXUQ-&P"P'HW4KEV(&EA[;=U+X5W-CN8@=D(MEOV&<5WU[D*J-, MU\PD8B)?!>_\)_TV1%X)=`=B.+#$_"DQH:'K/)Z]9&R7]1!/TC>7DHW;P[7, M&=4'W7.T(M$4'IYHFUO7FS)SD,ZK4+4T*FJ!AH6V(D\-"D_,37ZS#T^PNYZ] MT/@UMZKUE->/!IWW\TT7BT'&^UJIO%->;N8RR6O`IKYP$OGM^*BL^:-P<:T-O'7ML.* M9V&^*$-TQ^251)G!7?#B"C#!K2U)$(\\.4`TD]X%>:'$"_+[1954K8K!1+1: M(F@=%I[!Q#9#;D#YS'$WV7S>[8IKG83!JS+FU;`%F!A8*VS60(S'$S":Q30- M_LR[X+;8"G[5%6$"9ZW0J@=J\9GCZL?+IV/O)I4G_62VBZX>S#NMG?)CC!-/ M9LZ8)(2IBC\Q?\'6Y##.;;-2;M465U4/YEE7*T--BQ-/HLXHS!LG?AYM?^8F MQ.>>>R9HM2^JYD^C!F`>@+4SCQH#QI/J,_+SIWP2!MB`T:W","_$VF%/"`Y/ M\L^(X?*#,../^3P0KPS<*YXA)OX54TYQL%8NXXM;/!=9@&P=R=2O]'71/LP+ MMG;Z0U?ZT"0F88@2^9&021;>!!/UK0_:VC!OXUJAWQ#M@MRO:++.ROC7/NVL M3SOKT\[ZM#-H2OJTLX]%"Y+SYS[MK$\[0T&8+(?*X)$I7=7]2BLS0(/G]*''#Z^@[LW\>WTCX2FZ9,30U?5.Q=KN@4:$F],DG MUS:8T0SE*A!#CD&C0KNAK!(#"IO>*=C$`B5Q]GO9?B\+;J'W>UD4"T*_E^WW MLG^YO:PD5N.*!HD7WS,`09+$=,Y7;.F^5%-C+_:C>@QH!L7#-*;IH_GZ(2QO M9\=I;P&1@<"ST=R24#M926I8VAR:OV$=, M1WET!IL-JMM$@U1J13W0S;MB@(C9TD%!P]6^Y7'66G%$*9OP,+,D6?PIFYOR6DS97+L2W"PQ4U$%-OW2V%-K`L.F MSC..XVZR:31)%2XI#Y@KJ5.>2-\*%/:\0D6DZ]UD3"+RQH2,_$M^!,07I2L& M/GCE"&YB5[2SJM<`8&)D`S9JP<+CL5@?XO?%(2[?J)B??U4K`:8_UN/,#$H7 M-K]D'-T3&L3^W83]=Q+3F1MYA/43R6&TI@9@=F*#D:+&83'Y,!^:Q%^G_#I* M"25).G93T=&I647`],,&!!C!P9-EN"[GC\@MY:.L"9AMV,6%) M$.')*ZR"5/!4+0:8(]B,DDWA\>3[54Q#39C31DG`3+]F'`CDQY/,QR4J!.3F M8"DJ\5?#^'>74I<'S]&[7,;R/;)3S M2GQ'P)\X,0RQ+_<,?82YVF_I;*#9*.H,]<74HY%_R(/%Q M[.J!);Z.\INB6:_A^>[I'"B9O)Q0\L=>;PS"[X7E0=]*RD4YF^>"F3^/M%4+ M(!A?IDM);U8+O]\A^TJ2+K5350Q"DK^%,0K0&%)HSZPWY MM%%]PO+0,?M:;8M)DF'Y:.0@":GIEB5\`3>ET:X-_U@K!QK9+QT`RJTIOG#^ MRFOW)N\%K9<%31ROR8!(>#R'X-"!+6LA3U;XL@&08\:TXAYWDCAH2U8(/5ZU,D!8$G M-Z80]*(11\):L.'M]3F2@L#S]%\AZ&4CCH2U8*/DZW,D!=%%T)WL*:DM;[_I MLU&ZBC!1\S4=V.90\*PWZ[VD"'L89>DTICS>3S%4U!4A'QPR(D`\=/2@T)AR MZZ+>N_2.YOL*/S^*7=P9;DR@K`'(MX8Z(U(%#O=0+"*0:@[#HA+D1-%ZG5B.0#PDU(*H90)L68^[ZBOQ%+)=,K/59H5)!R6*;AB%?$6K% M;%O0>/(Z*@LB&T2R6IZ1B"G,"]QP96E=$7YGL]2:450!C/IO MO,)IX.#)TE#VE:J=7$DJ6[T)UG1T:1L&3`2P-O*,0'>2$2*[Q-0-:#Z9WTW6 MDL,>X\O92QC/B?R6$(.J@!D"C8>I(:Q.DC4LV9I:SXND!F#R0*%1D5S))CS=87\NS_\;$(\5-7LJTTMH-.<.]\ITT![FD#]Z/(I+? MS&31U'2&>^E!,4"U9$_B/]E5XBH7L/ARPH1[*QWD/DSV:JZI,SK$[\1"9_C2S:=M\`R+GMA%29 M-Z9#O>QW.N^8\`MCO#0W'\_CA#_KSGY'Z*OVNGIU35PIO>U9%G6VM]YN0\9#6'/(*4^3?AV[TW9V9//O5_>>@TXVWR)5L'NQ`1V-]?(B>A,3F M`>U2^-*KZRS^VCJ@J=6V)@%Q_U#I``VYC1TV98#%R/>#0G1^27L8YUY-1=[= M3KX+FAYNU05F66M[9!EID%;<^\5C0A;[XM:W8)/?K7<2.WU3J,4/,T]6T/U. M^+W!Q!^]$NH^D[7KA7?32U42P%X*L/]]5Z?;CS/%_EHD^T1%_,JO-$ZL'/?) MOP9[-\*>=E6)'O%DN#8WTH4(;\D$UF[9N-:#98$+?%:L)0C,)2#0?77G*L:3>=U6Y5PE(5%NU3[;=A+D;!WIN[T"J>3'3K<(%\!ZWD@KE5YJ-W?)W& M-5G]NXQG7FAR=>%'^1K/:1_0W`BGM/JL:2?A,79WCBWBY98J;93.M]M?*@88/;W1BL=8W MQ<6C;_?=3-_5FS/_$CH3'51KKV/6HJ6MMPOZ_4=1<>U MI5,T*UFG*EZ@_"T.63-AD,[';FK%S6?^==SQN]8[L'7E(IMYN\([#I(_KB@A MBR?#=]F11=_>SPAA=-U8HMH]"B9J,F@O@M?`)Y$/,1M7O[VG8<;H>K%,MYJ@ M(11'*(/^"*4_0NF/4/HCE&;YWW^)HY1-R/NS6]R#I%W@`YXM;KN.JE-"[WM2 ME^I$#^!:0Y'<#/?0@)+=CAT%"OAHIN8.P2%/2H9[+`&VSVF4\G&F-/AD M8K@G'P"ZF%@!>^2W_W!)P'`/6=CH?ITJID_>76:EPCV%T:27-`+8I]V"I]W" MO=@!,1?55DZ?,+N3;\-<[P)FDAGIHT]U19[J"O>V+<8N:WHM"^8DU?*9H3[. MHH^SZ.,L^CB+/LZBC[/HXRSZ.(L][DE]G`7&.(MNK]G_Z\1?J'1@,19C];7* MEF'C25)I6(9)Y0\:H6$(_0.<;!;Q`J6]E8RR=!K3X$_UD4#7WP(,UC`ENF/7 MA$(3%I^;6[H^"K_'W:21R0,G@.VE[R.?)YSE;FAC)FZ[0">H[>@ MJ@'*+@[%5;9-==KE"7)10L;$BY\+I8[)?[(@"5+R0.AKX!'I:5&[!B$/O%O0 MV0HOGO/OI65=B"A>DK_'T2M)N(^?K[[)8YRZ8?7O_,W8[W'Z?R0MT:LM(&O? MA#S5;F<*654)GK-L:S"+H<5FTLKP4]W^LEM!($^YD?9+J9ZPGW[7WME!GA?; MV)\9G.F"DV1^O%T>5_-##^MI%EO?@GFH`W3KKE+%HE?];,'<;2KO)3/ATOEU MQ-\2S]V:=^F4T,>I&VTCD9K&N_@XS$,:[EFT;F^@H:AC$GHLH7RQ:7I MG*F%P?5R8?TB#F77`2BE./=5.";A);JJH,$C$N&2L_G:7XP#16JT!Q`4 M8D"%-N2C'L+]#N\PPZJ[JMRX$52!(35Y%G>;6MC1'+Y69=.>RF\7AH[.J*=T M/7'X`B]:$X0DZ,$64_CB&%.Z MQ.370XUFO;L@3^G*Y5"]$?=R,B$>7PKNF57._N8^JW:6M=H!O8Z[6]KKXL8S MV-3F,YR M#^0%E$/NE4092;C*+QD:RC1QGB5I/".4YZW=Q-'S#1LE_BA)2)J8.>J:-0GL MP*LE=!U/7OV&05QZC4DS4C;U<'%^)?$S=5^F@>>&&A>?M`XR MCUXS.B7=1($9C1E63M=5$?5I-K(ZT'X]I<8E)"FP?%22D/CVNF7+ED#@)C5'V&SC50=?EWK:Q+;\\.-X[=[ M&ON9ESZX(4G47CAA8=C<'W.%*A%8#/-GG]1JM90#]"'`^II<2HWG+KZ5^"-* MW$1M4^C=F$V:`_9N=6UO-U0!'H_'0F*#K26HAZJIHF5>Z24D]>(A\$P<\Q:? MW(2P?_P_4$L#!!0````(`'6+$T=IOI7O5%```%[G!``5`!P`;WAY&UL550)``/-]-15S?34575X"P`!!"4.```$.0$``.U]>W/C M1I+G_Q=QWZ'.>Q%C1U#N;K?M'7MW9H-ZM36C%K42VUZ'X\(!$44*:Q+@`*`D MSJ>_>N!%`J@7'IGJN[C'M+LK$_4KYJNRLK+^_3]>-FOR1.,DB,*_?/'NZ[=? M$!HN(C\(5W_YXM/\\N3/7_S'7__G__CW_W5R\E^G=]?D/%KL-C1,R4?D.ENM4M2\LW; M"?M_[[XC;[_Y\?UW/W[[+9E^)"?QW%JS??O'W[_DT^\`LY\L>7)#@8_?P^'_ONS7]]O+Y?/-*-=Q*$ M2>J%BY**LVFB>_?##S^\$?_*AB;!CXF@OXX67BI62CLOTCJ"_]=)/NR$_]7) MNV].WK_[^B7QO^!K$$=K>D>71'S^QW2_I7_Y(@DVVS6?MOB[QY@NF^>PCN,W MG/Y-2%=>2GW._P?._]WWG/^_9']][3W0]1>$C_QT=]4*YX<#7I+HS5_)&#.\ MI7$0^1>AVU2/J$>=\WWJQ6F'65?H1YKW/$J]M=.,*Y0CS?6&NJUM03?6FC([ M2-W6M*3L<:YI?9[6"UFN(+?4_,_7[/L',Z,O*0U]ZN=SXY0*:RD8"RLKC'^T M.&"VYN8VB@]Q1B_[Y(1[C[??OW\KD/"_^3UW3-.0J7T:I/NK^M]",H MUY_???_NXW??_IDMY[?OOKUB_^=OW[1/J"YPF8R5XP@?.+;^C(-B#!6Q$Y`C MS;!;AC$4XHQI9>RMKY@G?/D[W>O\3COAV'Y&!:%%>K*!1(PD;"BH%QD"P.@^ M0BM(C3Y!)T5#B?R4^2"?^Z'+M;>R,?Z'A)!6_QC"L:04_T[X`#1FOMNT0>UZ MH]!H#7J3Q`PEUF>[..9?"I*%M_Z5>O%%Z)^S_9F),6^EA;#G"B#'`I,-)7(L MX8-9..T3/ASVZK7TD@>!<)>()Y9\L@1]+[*FWY@6.3$@I M31/`XHXAP!5D)%J2@I#DE,!U'MUESL3O.0@Q@+;.O8>U-J/60C6VZVN=?+OX M_2:&P%<3J=>]T MK`UFBSB>(5&P(9!A4S1GR;+W9"H)'5OQSKM[LF86L)ZL#5:+.)XC4;0^$6%3 M,&L),O=D*@D<6Z$N^O-DS:QP>+(VF"WB>(%$P89`ADW1G"7+WI.I)!0@R7X= MA/2*_5%;M*:@!#^6J8)0',WP842,PY-/:_\AS,YHCG^%\41HFB0T35Q/VH^H MH2UT#4SMQIP8@/747#_]^_N+^3TZT]HL0T;6M%&`QI;^[-*5:1L1-3&4&6V# MTJP"$Y+?H4/2'L061CY]3XQ'XPB4`J7T!2II&O&,T4L>IZ'/_^?B'[O@R5NS MV233],R+XWT0KG[VUCOC&X)V3*&=ARGTFB0R`M&81ORA0CHA7DIR:B+($<7\ MKG!%2S"RX%AI28?*CW;^)0='MZUUD@-&*&3U@:Z",.3"&BV)G.)`R,N^?QAP M4_8/K8C!HRLKDVP4=-G8X_%,2MU&(1[=@\[NB"LCD]K.D-33-ALTXK MJ'A!QXD:H+7]5C:&B]1H2^-T?\N67+S6\(]=L.6!E,6V7,D#SH)EL=[QI?\0 M1?YSL*[)@,X'&O&$#O0,@=#:KL8&_88MGE;YJ)H:+--BC'\G>8CRF'H@@N[4!`[",' MFS985*'4`64XH5*`L5-`;KD?\%B@F'QSM@>5(V^=ZWPVGUZ3YNL5X%D=R_F" M.]Y#<;;(WXRN>->!]Q"L@Y0W60GE3;[':.W3..'[BG1O>R/$F!^4B[4`7#NT MNYJ>7EU?S:\N[LGTYISR M+HG0^3B].!KY/:TLCE^_>^OM>74"TW[V-_&.^O4YFKI#&Y9@UR:M8+?6OV;D M(A>;,2!-"HIBC]H3YFT%LY=ASFL*$&QINZ&4!R6>"U:XRZ?V*JR^DFJMOV#F MZHZNO93ZMUZLME-&1>)*GM`Q@B%PG:6:D(R29*1(RS+-87&S9LIE+J1MXDVC6\=JR7X6_ M<\5D+#Q$AK'`0F&UC:+5=I,]8G!:MK"L3LUS*D#-Z7`C:I2Z& M%^G?/<:8SAU6?BK3_TO)79MB66+*7]+TQ$--YW0A>OB2]^\FA#\,C*SS52=P M?]N%E+Q_*X!]ARZ.,+$E1@&%@2&!/+!VJ"*!3F\9R1K:,.'0I9+T;-4#`&)YP# MX2RR_G0MZ7"TE2R]+(+(O*"N;W$2?+.:%Q>I'U_E7=(!C;1@OKL9B";]/.!U M"H<23C,(T\T@V5BGD,-FT2&2KKW->D+"`47%/E0R@U!:7ZM<:V=`/ET&8<`_ M^&$7^'QKUC,P&06N"WC*M#Y<)*@PKNI8L-VR8HL&AXD"7TGTUS'J>X6AGH$N M@FTJP>&]DCAV@/@5,M_DD&C"D&%2IY9PA'?*V97+0QCBHFXSQI`SLDT6 M`1PB;S9!RKN0\$M39U&8!N&*AHMF550_]J!@!1T!J&'6#V:+T=+G5\>C\O.6 MN&8?/U[-/U[7JI'//-RZZW=!'>R[6Z MG5H=3.1H,DW3.'C8I:)B;1[QHG[8ZX`]P,1\Z;;C-5M$%VL/'[)U>M^MB06T MLVJ&U=`*M_HV\T2^TC8A5TFRH_T_?M7%2]D"2L1CTT]-K\Z!^R6%S!GYHW:! M&S?HBT*ETK14?QW1P=4*U@`TQ7!1B$(W.D)()(2M%TN5(/_[[==OW[[]EC_Z M)E\L_S?R[NW;R5OY_[)'S(FW2Q^C./@G]?_M_;O)-]]\6_W':$F>(AX)D47E M(R00ZR.;:N_2)/5D*\:&2APQYIL_3[Y]_^?)]^_?Y7R5#+1U2H!EC9+A:[S4ZT"SBGRV`16!,0-=;24@BDE.1+RMT M)"/$U;#:"6@5E2]'(3JM1@NIZZV5OH"1D\/WVUE(B/,-]QX!9P^W#P'U!PDU MI"O^350B"[YC,7<>1KL78\\!>?6VJ2^7>#L<`.WJ(SKV=3SN M1=?JW':[I^4'O=DS`*RH-BP>U1K`]O;42-D45:W&S[BE.>!V;U2B(8((C%G9'>L\B!6=A31Q&M]_!3ZG!!OJAMH9.Z1[7-%1+* MZH@Y)-.BG,,VW-%P@PYVM&"UUD;2D)((4;,B:W29A9G6+4RMK@=5=-?A9S3% M!Q[KF.FE0QE@BU+"6AQ9+.<6VQQPP!'/'($RM2H#E0QVC5ELT1S4YR$,431X M"JNXJ/1,W+98D(%`NCQPWIL`3HBXNHHT"&LR&!:!5X.U@#5]L[)VM8]HJ\H. M8[AU"-=4,"M4R`,N-3XKVQ(-"+KO\,OT9QT/8=>"@T&$%T4I&@1L^!JU3I:T M:[A=M\H@-W"Z)A5-6"&XIV.1@SJ\NC-N+K'C51Y[E&C3;!8B:GI-!DV"K3*G MKMDU%2OH6$\-4ZUVPR?5NO8]L$;V:O),!N)IW/M`+9N`*F>77FHC1^#9-/OZ M)K4:[":JPWMIMD"2`_N`**%DCN3G^M57?,FC?B0,6]Y(8P9,(PG0C%%M'AW2 M14I>Z.(']::S60YQIHGE\RV!U@;.50HW`[G6"#E2%(,Q=;C:Q`D8*&61LR4H99: MQD:\S.2M:7)'GVBXHQ^BR$]NJ/7MWD8>T*%5"[#Z#5XQ(AFFL[M[^&0X?=EN M.\SM8)+.EN+S]]':(J-U2`:7R3J> M?CV.3%(R6Q(QAO!!*+RUX<2C)5F)B2=#3-PEK]-]VH#IFT99UZ1MF@1]//W\ M$$=)ST=U/J&1XX7 MEZ`K%+EJ(=I#=X+FEQ2HW'U?H'+C@8>\@O>*-F&FC:\9SQ2;ST8O_ MH!4[9^J$%1S`V@BI0-7KP,5@(8G%\,'LAE,/'BLX/#YM),N!NTWF7B6=W:;2K1.'#3*8NCXTB[482('O; MY_3Q[(/=]K]PFBN/IZ^CQ/J1PB86X*ZT$5:[/F?%!U_R@;B:-YLAX7]-N(B" MJ_C(8.`=?+L"F?GS5NT9SPC<1&%T.(W,'MDFC?6,H-R["<1C.:S2%!8B(_L* M6S[9!:",IH,,6:YB-?L'YE2-Y5+I9$V%%G'P/3?'Q3'\.^!.`!S$M!LDH@&FV1N,9TT]A3+TUOX#Y MP0M"'C_-PG,:!T\B(V*T)'Y!0-9EIULT$8RA<"KC%S/)'$_ARF\?S\4VD%%P@HYIE""/ MY;+\QPD1F]<#74/EF$T-P04F8$&)3'.!]0U!$'6S=:-MC."]J(J MB%;9-E0)`QM4V<&56:(-,(\P&";P"$&K9D8!@D['1C0;-%6>U37;RP,BL%C@ M:.HU$T#3PY,XO$_/F4!9LW_"$;E`3=8A0H&:*G\8,!2/,7_8!3YOW=#WE"?$ M2TA,MU&IF2EX-&(H MOD8QB9GLHE%-L:4\#Y(%^Z5VL?V--%?V4-&.^W(XJ?2$R#U[A26V&H7^5N07 M&JP>N>9[;![>BAXH_4&/K1_1>-J.ZJ'TR=UT8SP3D?]N4_FSW>PV#S2>+<6< M*_VC.CIUQZ]`^WKGQ6G5CHP3D:SX>5ECKW[$T4%O:U(+&M"%!MUTPRABZ*08 M(UZK:,%)0^PRW-J8/6WW_->:$QS.0$1%!@[HYG\9)I' ML;6_UZ@Y-CZ)VSAZ"GSJG^X_)=2_"HM:W>DB#9[DF[KM8JG.2MI_`=H].2U* M4S)$2'+.ACSLR9><$PG"KTA9D5]R&S**=7=,O:S&V?3^)W)Y/?OEGES>S3Z2 MV>W%W71^=?.!3,_F5S^+=ZM!`MB^9=ZJ&N/9AZG_W[LDY=8JF4=WE"]F ML*8'B;%YU-V"-%K:0;X-Y1`'6LAC/:M\AI\B%!\B]1,']L^OQ3XA6M&X6-$B M% M1'$:_%/\O7UUH`%/Z*#($'B]LJXDFY""4-[>KY`B"GAZ0"HO[%?&(RXK-)=G MPP)#8V$>,8RI?'RV/*M7NUU!TQ_2E#\SW,T>^XT'!.5W$U$OH)>,5/+%?QOZ"OIXAO!?50ZX[E@<> MN^=$W(M*L@FI$*)RH/8@Q04>KGSEJ%QG$?I,0[DU=)AF0CMBT^.R5G@67KSP MR'L7)(\R9\FG:^HM]8R@O*4)Q"81+2OUN;`>$N8>%,4)M"M`(F+58UA-:N@. MR^QV#Q`L,"]OK'5*+V^J@ M2EXKN_4"?Q:>TD=OO9PM[^B:_[*W7LP//2R#*P.&P$&6$>2ZB\O>N>!T9!82 M2MIZ/_BQ;$7ILEE%-_3^"E@&ZU9?+;V@HWU MT8P=<^AC&MNEJ/7!R^C%103.01PWYCSX(0?)N1#V9\D'19JHKQ4HL`:,$=-: M#CG)R-!X\$Z2;]8ST$'L1[Q^D-V@HOY9M.&6J*U\J;D2OID:[,I!&YC:90,^ M\.2!CR35H0C*',PQ"*,B,2PJ0P=KW.KTY)`IFJJYS.\W"H#<:BP&_8FL^S9T M!Q5M.86H&Z6;[3K:4_[64C(L4/>N#YUE$CQ0,S-WZDL[*EO782MV)@1#K-R5 M<)3GNS@(5[.657I7[#6?>-F#QB.U%*0N.4,&Y%>AZ5WE)1+[,R;_BK;'+*TH9"VQ=0#J! MEBW`$PZTU8$-J\70ABJF3.[J@P1/OXV>= M(S/A"9X:,P-NJ,,Y+2F)4;CGCF@+6'$K+/BDEX4$&[Z/82R^D'IZ%3ZQZ#2* M#0Z[S)C@\:F'T`Q5L$*$HC+%'E;K_!'YP0:ILW1]=9'KD'>HL[]FP7"8T$M* M2VT]V\6\"ZU5QL&.,VBNP7816A4J9\!TB60L".-1<6HDXX*E)*4K]!SEDN,)*5E[&2+'\F07+<_ M68DD->^X&`7J;06UEZ'&^%!G-YVP]-,6"@%I%<[IDC([Y=_1)QKN>LC;'S/$ MY['KD`W5/" MDPS:(UWU!>B(PFE1+"U9P0Q##^+A5^.X1_K5S<\7]PC4OV_1M8E7G#5C///` M]C993^/IXA^[(*9LLLQJI?M;]NNF;,MSP?YVNVD^1VTTK18"I"J?TO9XAM-\V@6RBKR59[RG[SM[8"6-%/X,26W/Z'O0X M8G!TX#&%L5H:A1"F.HEQ0]$QY='$$5G*HQET#QL%%,<,W4`?YP-,-@1XDAX# M@L26]%!HKDO2HUUMP6W491!ZX6+(I(?J"]#!D].B6-JR@ME(28\N34)Z68_C MM,?EU`/0MO#VD/?2Z,>+>*6NQ>LD6K.QR4KF`:9SMT#("2W(80*P7 MZDD:^1)8M0=$]4XZBN#$!=[!7>-D]Y`LXN"!OTX>^M6KQ_PM-#1.VUA2U6D, M0S$=\_'@PXY"+3>>;^/LA/=XO*W#[OP]:/?=PX(U]SPY:.[5U&YB(OM-3$C! MNZ$M&*HLPP!K56*OM2H0;R?RM7AN60MPA]^7LAFY_YXT;3Q3E!6/<-MHUTY4 MSP#*^:L@'4MV-E;Z_,%:B78XNK`!(_8F\CH0UTX.2=-,%,RS:\5.Z=%U,M?A M>F69<^S0P;N5">BE206TUG.#>82U-;<+FHWG4_D4,-8FW"ZHZH`0774<\&>" MO=ZH,Q3ZFXP:*P&3$#@3KVFF_(S%YKTX%0L,28`Z+/7VOS)^F)?A[,LP[>`T MQ`*+"J8P2FEQ\P%-5&`@B,8[_68I'#.PWF;ZS7,-.J52[F!4K*!WYFJ8]7`[ M'RWS:D,I60_;:#M@A[XK"G$IF[-TV6Q]]5(ZIO+YNX5\+OG^,8K3.8TW6=^Q M:WYY8O:P#E8B.K/8YYJSA-OYVL"N*V=&+7K?<_H3YJ4V18\^P8)4>"!PBMT0 M%UK+%39#N>9D6/;^XX`#S`)8JZDF+V"KHQB/Y8<[C@>/%JP6H8?C=P3)BGZ@ M']?:F!RU=P>K*BA"!A8\C++7[Y[K"4:W:'Q>T]#G_\,+P9^\-7+F.GJ_"911O1&CH6A5I MRA8Z!C.'7RN9J%!*X\5I2848YQW/GA#[0;)81\DNE@\#.]5`:HP5Q%.GAX_@0.E9/X!$0T1? M`DH?*=E*4$R"X!]$,!:\]K=!#:1NS)Y)[`>E2Z\ZG'KW M(SE"J,V$L$&(7)'Y]-%YDA9!,FQ>U"1%HS8.BS9T[KW(!WN;]:"MZ=HQ)6`; MP#J(AMY?;!`1HZ`TH//L4SX*W!/HA4?74Z]95M])"OT@<7:5T MXWX#S)@QM+^P68+:-E[25BZI\EU\F6<6]#BW/%U@'VQZPB@\$8L0'"S"LE@$ MKTA`XMO\6,N_64K64OA'S,B*8_=$'H")RO(-;^(IB]#?&>=@U5S`LJXZ%K&*UK**66E M+OQ0AFF]*/N5TVO2-Z6U,N8+[5,M%J#>M/4A)27MA!34I"3/M121/^T`^5!A M7T]=F*V8&_E.2QD?3ZFG_G_ODC1O-^/[XL%U;\TC]ZLPJR$YJFK[)4@?2RR7 MU$MWL?%!9V_?@W+'/2Y8K3-[R5HTKBJ8RTQH$.8E:9-:"2EY9M^H&!B2?06! MIQ]PP4YI2)?!(F`KM"BA+YNA@T4"?:N8,F;H6;\Z/=C'ONVMQ;W/V?*4RO M+U"U2V70S\NIU\BW-OA94;1F9ES9F:G9M+9S`(L/5*#J*:?- MQHOW8I\>K,*`.3.//RE5\"`Y$VPOQ5O!M,,#YZBU\JAVO3IA'+'4IQ2F^JSF M]"4]73?W.U+75)AQA=ZF&X.O::-.!3DQ$=2XNIJY(_[T\>/T[ENN MS"'=S.87]^1V^NOT]/H"G0O22)YQ8KA=[,;3(EZNGNYMGC%]C-9L5Y_\B&9+__'0U_Q6=7[(6;O,6 MCQ:2/6($6,Q!M+?=TC`1">.LO=19E*2)\``/7L*[3!+BH84"#UW/ZJCWB;V MH3<(C.-/%$+Q_K`$7+!ZX] MEQ9@O2=7V7QW3ZI$V(*,L<`!-JLR$T]-ARHCV817NAY2`#:LH=VWW3)8"/)K M2`1T!']Q/9U?G)/;Z=W\5S)G?O>>MVEBKAB=]W40=L/6E[:2WJ&><+9BX),<2S=B1C!\1 M#$F5HVS=5/*L=L3$XI1?S:K`M'?H0X7:VS_TH#\CFP=K%]_#ET`+E[LN4I^Z M@2TJ&&:!+B_)Z?1Z>G-V0>Y_NKB8$[%#_W#Q\8)MT\6>_6QVPX*'L_FGZ369 MG5Y??9@V!A&=U\2]EKKO1:FF4?GEL"5YR&0H$3+D'#&]_W0G'30:GV$EH$9[=Q/I'+$>AZZXB;NCVR@6 MO44LK7XK/93%5P"J'>/(H6/U$W5)<@^&!LQOZ01.Z;,TT@:G-GT4L!FPA/9= M9K#;)+,@>Q5):D>L%Q^X`R-7-Y>SNX]B1XG.EUD(KUF!FK'D=D@S?8@8YS.. M.E9US*[GWAH)0;+&+1".14@,(]DX+`X))0!=9J4?!"`)#$,YUN:&%=+?DS*Z MY7*;.8#F:-M`:<0;F_^RPS+C=TW/9C=G%W=X')5>QO0).)6`C13C;&0:X/Q[MLQ:^WOKLD=Q-CWK2@PE,_"2#`U4Q3DX MVRD6I)4VWJ@4=RCL40MV-/[42I3-*E0,Y'@\5;V-HRV-T_WMFK28M'?H!3A$CL[MVLJXD>>U%/`1-YF; M+;,T?":S^#Q(ME'BK6?+ZRA<70=/U)\F"4V3JW"QWOG\Q9TP9;\H[^$M_Z%3 M1G>(3X-M;0=9QMH&LO@*B6*2?X>[1?ZE$_$I(EE.2/$U4GZN^$<\U@9P.6?I M(XWK2X(^FG0WL)1D5O&;!E:,QZ'"OL+Q& M)1R\7J(G#(?=>KRRH?-6_DI+9KACNHAB89G9D*@"FH0TS&'1 M/\6TL5TGT:JDP5T1G3Z.>3B64+8F/$-R3I_H.A(!VL4+[^5![;(0)JS@&F.8 MP*P?B4DJ$;Q7Z$A&B#ZDZ!FV:.B")E*P$%U-QPQ3N>W@R64?O[Q_6Q=GKN8$ MZL]U(%OZK!9=[4;4)L<7?#HB1.3@;9%4?#QWYW4GSUPXE6B?,Z;(/+>1"NJ= MMXG^C7@OH6BO56W`)7M&,H/&-BS\FNX3Y3D8RU,%%]9@EX"776YJ[* M9Y(UX M\X5@\5AHDDW'8)?0\@JJF@W<>[XZ>/5G>@N*O!,M'LT<"B,:EVHHCII'0:^3\SL1U/*V_H<^722!R%[(\+6JGY*@%N*-\*]:^!FC\JJNT*QVMHZB/N$E=/%)_MZ:S95%"?[:+ M8_:G.7^QT7V;:LH7VA=;+$!MNY:1\AQKY9)(1DY^$PS0^N6>@`<9<4`1[E$M MA=MLEVHGV2/6K@=AD%)1%G-=SF;./35^"Q-0A-])".=H6(, ML7\88)Y,)5I*#Z60*SC%.(\V7E"KI]&9B!8NT/ZG%9R9G,GAN#S.,)#`?8Q: M#(W+7T+*<@V;`) MD57_.17Y3=*-7.;8$[3+.$@6$;DX/QL.AU-.V16)>%]]*P>W0H)+'YNIECI; M;*174#N_ZR"D5RG=-,6F%C%ZR0;:`[?#J[>B.M@.D=_X8")&X_+`PT`"]\`: M0738Z1U+(<2)RTL7TZFBS1X"M)]7R>PSE^$=M"]+%JK[9@M2?O-`L$ZNU^03$C.'8%!`5BQ MW6;CQ>(J491=N,A(T04*_:F9Y5EP1QV#-42WTG5,G[W8KTZ9-WT2.*9)LMO( MO^L:G/3R5?C0I:?%,S5.V4>(^$K-.A6?(I5O(3!50&M8FBNOLAQI1&B2!AN/ MQ43\5GVQ5"\K5%JE["+V:XBBG%7(,GQRU1\(LW)'13><6R]F MDV(_9,)_QQXB(T.^\+&/\0*HK$3&A`@NI,H&@5T8;`%*(\!#D#A;@ZU8@Z7L MKOEE\'WD.P%IFF:5JTR.TK MH+#\#IYHPGJ!5+G=DAFI<"->2BJ=F$7^(WP`=^O=7?OEE"8&_H158[#\T<6W<6!MS:^#]!,#/[*VA$4A:JSD:08.B$?XBCIOS]C MI\?5-%CXWC4IKL4B?%^M2:S,'E=KD"D`M?@EBO^X"F_C:$$3ZUK$%BYH7.(Q M.(6F\*%,SD@V&$A7^H&58]G*$7@]2Z/PV?F6)LD#4"-^!S5AD?"'*/+MWRLP/>&+RF1G(EDC?HT`)PEH@1R?XO"A/)?7WE<4%.) M`0*"8WW`;!XNF2`.%PH([J\G%L@6HT=;P#F^TFB@93&8Y/WY%8<#57GO.1ZH M"#M6C9\NF1L1EQAM;1*'096SV&* MU>_5_V\4I=YZ6"AS_HG7$%I5S()K"%7:!(B:V-LXVM(XW?.GV])IZ/.'';?. MG6>-^4('018+H+I6DQ-/Q#.(J;A)4C!`V::V#^"1(W#PF,=6["T+X8UD?CPE M;YW.Z=ZV[ZT)*ZBXQ@QFK6Y,)<#XFN2.#1+,UUH(K=+AFDLL`H5T[[9KPA+: MUYK!=I)=C&UYQX<+[E@^\;+`0SGPXKG:W0P*"VW]J14^]]]3)W7A*Q._&[5(:WT?+]-F+Z=%> MN%6?E-;'C"FT%S2%WG2=D-.1G'!2R\6!J>`@@//QH'K8@\#9.#P;$1Y/6S]Z MB\<@I/&^ZH+M?)Z*!9334\,Z%L=B]'&.`Y/;&Q82F.,S$$"EY]-+WXBOJU`O MH8_1VK_:;./H2;Y*ZN;P5*R@W9P:9NUEDGPTJ0['Z<\&10;NTPS$T^SI%:UL MCJ=R=[QKBTV:LR2`\DW5*=?>=N;_ABDIZ3I9,']2$PBE]SB6AI$%U\TW5$FA M?<$AC!8)P9C"ZS)Q<$O>(#Q&EKLN.2/N-((PV.PVEGN+`R*PW<31U&O!MOQW M9/N%CI.&VQ$T"8IZ#]`@)6-NH5^4@JW4Y$-B:&M^#*6^JWP!%?1!)P]NU1L% MRP3H6!OOW__5J@7_YO?LSYAL^5]L`J#9;#@GUHLHEW(V^O=1NM@ M$="$M]3;>6O;GG8=O@#EJ3HM2EL3-OXT2,F)E*Q(SHM\F7'[:LBN>2[>;Y`% MB2P6I/=5\*.%>%!0W!F`7H:DL@Q>N0S;C-?7:(*([M9"&6ET-A5COK&ZI'%, M_3O9EO5LQ_XC-+[9T4(-%7:T@JF_/BH'DFSDA&1C4406]C"RIKH(;C;T-G>P M>$>M$D',@\_9\O@.E[S>):X4FL82INS` MFCT:PZUU?RPH^>:IX>)H]:(B@ANDO2!EVX':75(4T54OZ!:/7LP?0%E&,=EZ M*3_31Q/`6.JENC&FE5*.9WNJ-^7K,[,->C3>\S5&5R#+P2[Z=[%0MC$;$;&ID,2O*&)2/;`9:MQ/'`C9DS&CL), MH2DE+J,I7XD=R!K:A"6]`,NVD>(E:0%L(%.ARS:/A@PDE>R@)JH8RT;11HRL MUH(Y]9N?P\WF:!UAF7$%C[1,P==D-B?,'IY^J#T\G1L?3*&7*UKQ!'N&<5'% MF&MKY5W(A(\MWKL>?L[VGBUTL7K.]>%FL=S[U+QEL>5''(WQ"_I;%0:!;?[!K/D]5VII>/@D<3/2U=3>@K?$G)F.2<"1=&4N'-H^>< M.[GE5Z1^%J3N/-.7UP?C5:RP_:L1L`KM^GR$FX%^)$)TQ--H23 M8:N2[0"S4@RZW(E.0MLX"!?!UEN3K;??Y*_`7\9!LHA(&*64_[W7T)87W`V; MBK7AI1,CF1ZQ_4)E$N7D[FC^*_'NG=DO=Q4:/#78:/6Z?03*X79=FEKK@P-M MGY"2YX247&47V5Q9@G",EP7M/77?:\.D\SV*=,,`P$#>21Q`#TWBDCXT'<;X MV48G![30D<@1$+7E0;31U\S[IA(7M)0$@$9&5LL^%`#WNHWNJP\>G#5IL%D_ MGKKZ=BBVD'$LVY1M@B2)XCU?.K.F#3IRD`(+)9Q:MU`9PY>CB1`<%'T=[-&, M!L.^AJ*'7P5)O81>7=HK);2Z,N)K(8]1G.9&Y+@+NVD^PU+;>`W5CP4H=ZT]\AMW`6WD4/OL=CB&T@;8<PR:V,`UT[4:N80=LZ'=1ZY^EBO'"J"^NXC];!)10^R3U`#:MI/EN*$H3G(0(@0[!4L<7AQ[(ER MB"TO0Y:5(J$`E^W_D6P<##2H?>>@5Y\NNKWC-F*V/#8AIJY2S02T^?>`E:E6G&$5U4@Y/:F`70\!UNE*UEAHD40/UHJKO*]EI;5C M=OUY2*]"%M8(<;B5YZX\H6"=F51P@MZR*T'6>[X\I*0"((4!THVN,* M*KBR0W:2-N$"WZ;K!=.PUXU&*CMX]EL:!Y$_6[+_919LXS&P3)M;J@/J]D5! M#N*[E7!J!U]BL'B\NQQ.V/AA:@:LG;,+&.:?MA4PO$N+/P08>^?;(QHDSE6O M.^W>5*LX'71:>&CJ'YJ-JY#92)JD=UYJ?(?9D!OH5MT$;.W9#DE#CMPDRF2]]!CGN+#+O!Y]#,D MQK/CU.^D^`'Q7)0W-J":1LQFUG,\QU`]@[+-QQS00F=@CH`H3T81'/T83MO& MB*,(B2U^CM+YA#0E7Q:FNO_C:O>*]`%_'O#\5Y/J&V6\&O0>I`[,)`_61@85 MI=:GKW*'X)DNMVEG7GSA)8_DR5LC>D2A17J43KM9=,;=N\DY\-.<;#;4+^.( M7WBU#+_+%L]DWZXKT;;KG^N(LLV-ILHE%WCT#FXSHIC?/[316L0&1+1-$=A/5IW1A9< M(=-#5N`=[8)D`V(*AL'-_T6<[S!U?\Y$&8T_=Q-I[1[=6I['4^+:+P($M&Q M9H%O%VDBCT9^U$`81]QEKKTDF2VS.*AL`TMP2R_+I:N1!BE5,BG_QR9?, M0,MLP"X,F!%;Y/'R5WRMH^P;R$H]S"R!OL[#R`R,>`U_\4C]W9I93]'Q_W0O M#.V\Y6BO^::X@@78=7PEK-J5_&RT>`]>/&9PNBZNP(*LI!/6A` MP?4:T`NANM^`5@)'5"AFQRDWY[R;;;KGO::CD'>-<^JKHF0&O=O60:WM2L4P M4HYKZ;$">@AM"ZH8/R&F^,#WWT8R:M9+QD!`Q].]HTG8=91I)H9R8&U0=#K5 MVD@&Q&/UC@+,12E%2^F<5'(U>@K8K?7-(3&TVSF&TI+5Q=C(QG#J"7\]:\NF M]>BQG93JO!3458+_$$8UIX-"`'?EC7IMDSL':CMX)H1:A.MF/4;;">'*LNH0 MZMDDH;MR_P5CD+K.'<3N]++@B&K<;=<;U.`8ZIU1VKY%6T<_E1-3N`Y">L7V M*];[\&8FT(%0&[3F4[0BM_4;'TO$8%Q;;SL\D0D>MPLB4J M4AZCM<]\A]RBN'3STW,!:1I@`J[>E[6DR5,Y./O[=47WIQH\!,T$.O]D5!`A M:21@K%WM_01,56OL:Q3BZ$J:(UG55I2[61>/ZQF"NU@#R*H3Y,Q'%26>!2&B MI(0+QELF5C2.J9^%J\41KCS!19NR<,%Z3V/^U-TIZ0`:/@XQU5V+'L-ZQ>T2 MGW"VLF#V?!<'X4KV5ZD6TEY&\9F7/,Y"[5&U`T>8N,42=/TPBLNE'$@D!Y(U MWCFH,1)H5W\BB/_ZL MWCJ@.W&EAO^4O)=20N.G8$%%34T:!P\[;IV8;4H?*6&3Y@$2J?,+Q=O(R82P M\8P[OXO'6&\"23PY^F[K=Q[VY(F&?A3+@NIE).J&8`IYNJJ_/CQSL"9=S>$T M]/,3@K8O%S[JF,`T-NOI:Z#EC'TL5K-IY;U?BT,:E9TM8X4Z(8+8;[!E.DAB M9@9CMV5_LSB(BJNMF[>'854>*Z.(&X<3I[K3DFO&+>=1>;>PN-S$#[8T[B6H M@ZQ-5F.Z5"^.6)6ZN"&K&^W-<.M+2_NRVF,6RRF_9_GVB2B@:`#U[X!X?OK6(J:LU0'$8Z M@6[/(!SE#]HL/5R)KK&FJBMU3=6T0ZA\2D.Z#!:!MR[3%)>4O^-L=V%'Q0Z+7Z>7 M<$?_%92AD,GBN(1)A^5 M3\3[W4.RB(,'ZI_NTD^A_`7; MVD0U[G(MN4(E<:S!MY^"9,6Q8B"+K"03&?XB.-?J$6AVJ(.KL;F;%"NS*$XB MW.6QRX;O%:9!O#EP1Q=4OF1KW[+-GCMHY.&R&!K=;"@;E:^BE)P&ZO?FG&[I M=Q6D.ZX70,IG.N*"$Z+@!&8!I&U#%I8XFP=]=.)J&T!:N_'9G7H)]7D;$AHF M0JBFO.AG)2HJDM-].29[CGCZ[,6^:R.XCA]$T#:N\Y(I^[%QRI,'3DJJ_$GU M`[R>NCHP?_%;?`5K8[I7NFP86M_UHZ2FC?)ZT=#QC-D=Y:WT%ZG8")Y%23`K MNRYT[0R@?*(*4JV"B8L=,]2'PHBNF9OV5U(:4=U/U&$[FY_UV;5I:R(%W8C6 M8-12H-F`X5HB.6\?N\\==LO3+$+Z_4RC_'00Y9LHS%F*'9(\U3;K]:5G`'*B MK(%4?Z\T+,I1LFQ*UBL?02,P1T`G(P.R[HW2!=)P?0JM3[P=1"TOD\DR-K*. M!LE!MHDQ:#^[-K`$XT5X<@_$ON*R[3@DAMYD'$.IO18A=LR*K02(E^YM]N`; MH491,MKV-,G1B(E%Y]Q!.>_0OV6_UHVWH7;[HT&^#99N'&8A59J`J3LX'OAP MZ;\!54F="1Q.CT;L]V^QP5!:8M"-AM+2VT2!F#8;O8&J8DEPY0M$4;9_7;4(-.!CJ<&GJI M:[J\VVR\>%]>;"-L7/`4I'M$X=AGO"B=7H)#NRS@0>$H%LOL`;H1S-7K\02S M79JD7N@'X4K>J1D\5FW]\*L+715+V'N$-LDWM.P/Y?K!6F:-&^9^Q2,E;:/>I%Z?HUK(R)E^4-[E`3<@#705AR/_MP5OS M-YP&6IN+T']E*T/E/PRU+.ZO9XVB@)53\V2@"Z=;1I27`6!<`Q>+_/KR";I8 M:9CT@B90>I4QYB\T6#VFU)\RK^JMZ,4+C1=!0F_CH"[70V\I3*?UVC,0YLL_ M6HB1SX-D$R'Y3(B8RF>4Z7!?_(&7!#+/\?\ETB0:1OH3J"-"S3JB"*8_SX4= M.!8WC$21KFVQ6-LF;7[UV5'+"&N4/*E=>/5ZHMD/\J6$4/:6^<#[+H^5,VWZ M]&O-FC8OX['>BE%COWT(C_?SRF9V^JE?;;9`82<&S1>T&PE$-K:U5K01Q*A9 M@QZGACYST.O/T*+0E=#5RT)7JHS&,._V!UVPO-+S<'EX^S[93>=UY0!&EBVS M?3O^2+]_R]A/M-^[643RP$:EOCC)I^D;!_3VG%$^I-&V"$.FW_+O\-=DLXZU M&,+\/I:I^#<V$/(^\RP`-GGM7)R&_L7+-H@%AP+M6'ET_41>:U;=9(F'#.HKWQ=/;U=F M@"O,!UCGC(;Z;\[XX>EZ37VHE^LQKPF.O03.M7BUAR'&IG_0HQ%3N_\9N51, M!9?=)HM^KS/P3V7D3CZK31"&!?WL=D=C&)11ZHOZL":OP-`7SWQ.DV2WR:Z@ MAOY'FCY&?K2.5GO%O?U^?;G%5%[=_LEJF9MW4*?J'=1IOH,Z;=I!55XIKLQ` M[*$J>U]V?@2\"JKHGJF,?.`21IL/.$34_$/;#42LHE\NG[]\;>]^1@F`K>V'2.;Y@<]I@<33,P/ MT043MCF--^^<`NQA9H(B>AYJD4>SQ_S46GZ:\&_C"Z?'6N%B&5(V("%?!B'9 M4R].OL(9$`^JW>;1[I"J_4I#V1S*S]&:L5D'Z?Z.N6>04+9E*I]%*-NZS!"F MLYP$X;/X_")9X]6NK,27U=3-UR!V%$S%1H\\E:K^2BWI79#\<1E3>L6V/DQK MTA8[.DSVR'A"*.+0@9=\1)O*9T#X%$@^!Q"3BF[)^;"3)5^7(%^7N&%=<$2G M8UB`85.RENK_2BUL[C7.@Z?`IZ$/'JD>3.2SBE./EA@B2LVG\)G'J)J5+I;# MSY<#RHX"J158;-J@W!T>URO?\]:Q`7T_4@FO]8'HV;*X:`UXLM(7 MJO)4Y#D'A:X=L*$LZA^?U`IB%UTI+SI,0S_G/Z9K2%*3J M=15Q/%EHT)<9\5=83BE[P!F5.)]K.!&\^M@[.B3//UJI8/L[D#;Z]PHV);+_ MXVPIBX:GN_0QBH-_-EY7'6;7V3J!5YO642SI`'7RM7:IY0=11!UC+N='[R78 M[#8D+-8DD6OB+?ZQ"V*V>#O>2Y8\12FOT*B^44NVC!.:F&9PM1XV=Z/1Z2YO MTQ;(@;[;,WO&2O[Q1!*7C`1([Z8$U;*,SBNP.#-][9$%41@4?*G6");LN MEE58D\%PV4=)O0(C&TF%)%(R5++V&,E,PX8P`T'88@;:MXXZ7J!)"#U0*[,@ MJ5#$!=WA-9B'@?#IS`,T0-C>,P@EKIB#QA0/T8\FLL*B;%L:&E'Q(R0@^!ND9>LUY+QGTH(0> M#`?=/DP!PXXDE''5^/;8QE'=N^:.JSLP?IP3)O2.+J*5?,OFCK+];1*D])[& M3\&"MO8^4&30G;\">TK387&:,Y@'>9B,&ZFP(P4_DC$$Z4$PYI(LJDM"LR6) M*TL2%TN29$NR'69)W",Q1(("8AN'T'SSH[6.QF6\1'KQ1KR<17,*["8*GVC" M[X'R;%V>LF\5&M=6 MUC,AQ1=E)CV9$/'10[7FGV4C4\(^3,HOHZC=&7-=/X5Q\<^'[F#!&"3,`:S% M?<@T(F$4GF0+6TVP@\>#HVFXLJYG:/7^#"REM/PLG*YX!^M[CR//#OJPUC3<=^*KW_X MU16[*Y9PA";K_'N?T5OQ)JM8EMI4`]OB<0U.BR;*'4PQ!^VFUZ:57;*GKE.Z M^,/7EB?K%VF=909P69E1UKT1CM'#"_QD(9+/$1. M@%1F0,04")]#;@2K-A!-UA=HR4NC6%0S*^PA9`(8:(%^:5@6;!G@,6VD0;9X M1`,Y8JA<7"^YD\FR6R].]W,&*N%W:MCL3O<'_]+B6)K=O1-SL)#7<2E:;UTQ MZY.-)X*`5'E->&1[^,^_"8Y(&MXA70RXT+6+HJC#TPY:,IZA,)O;]"5H>B18 MF2>QX`R=T+1:A%JKAD/YYJ-P7,$<#1UX2LY>B(W2:=82#*.VYQ'/G)HZ[P9* M*,_<"$(C@'(<#F?:X_S!_%^[("F=6ZL4C:<"9X\!7;(8>[%+@R?F99?!@L8? M:4M>5VD_5*R@?9,:YK&TB=&D&$ZR\>0W2=&_WKB_56P'[&^[=>"%9/[U790D MP\'IXF>=`"GA@#M6`QTS\J1Z!>N0=!7[[JI!:C4"]9+=-EJ0LOEV(+67MD66 M\,BU`.E$=QR#S=R^A-UVZGDITI:/15*&KM&']FISM3*`[TFO@Y!>I733UTZT MY`?MXPT`J\/*"A'YC9,108?+/XZ&$MQMF@IPEUWHL?2"J^?YCEZRY9E'!YMC MR[==G'ACV+]:+(2B\16OC#IP*609A%ZX",*5?$LEC%(DKRWV#]X>.(I=LZT* M&.^K+>5_/`-PPW^+6V_/$]:5"04T.5M[21(L`^J?[>*815ZVKMJ&-;37MEN& MVE$VIR89^>0@EF<<)B2C1+1A[X9WNHEV`\#I$I"@!+1E1/F6Y<,N\/E3?A#` M2+1+DY297F:"T058#A;(*-:R-S_C6=US^I"6U0;5KM07RR7EC3+Y-;8%EYV5 M\5&^'5.H0,L6^K%$<_I*E=7DL-G\A!1<2,D&09EI5]CWJ7`IR@[R(+%C5V#E M[Z5\-0`L/'12565/D\[XE286IO%*?A[!&1W]6+($.1&RAEV+ MY7,&Q09S'I&2!^^I5.%";@9)+YE'/GV#KMP4YT<9OL\?@BC11TNRJ*`7.282 M),EN@$OW]F=1*-8!R9F6F_ZW'W4Y*?^8`54^F0]>$,["\K_MHZA63O"ADP)D MW>GF_S@A?#B)PHH=0Q976.#*L?AT$5,OX5W-RO?`*RJZ#KP'_M!?T*=]_D&" M#>F*Z\"K`(L@A-*IIF'-NG_3Z> M$4/0"[Z&D(^%IO)"7I609)0H7\SJ&6KK4S^P5T!M9%A_@]-"@&$N8#[1<$<3 M?H!_\<+VPJ&W/MLE:;1A-F$:^M=1N+IF?M^?)@EE$W>]B>GP%0Q7,IT61_4B M7LZ2<)XD9TH*KJ*QM'X,%,X`.-S?;&4&G#%00:YO-RA",US)[Q@*^,=:*G]DS M4!K9&U&=Z.IX'G8W+=L9@/E=!:2:RY!C)^10]C#=OQP.#IQ7TPF=VF%I),Y6 M>1*Z^'H5/3$DNS"-]UQWWN?_P=7F?45MLK_^G2VVH;NI4$#YE8-)U]M;!OS, M1%BDT3-/':=+XCS*0W>WL"XH2L=0DY(.N9.[Z/DVCOS=(KWWUC2QN"?83`F2 M+&T#4;L[$SV3;"`1(X$N`;\*!/;)56,0LU_(-@.1\)'@OD:O"NVI3)4>=%-, MNYO[1U2@ZD'6P$"^,+"E-WN3/K&0^!9]+:98A?>;P M6(#&O$-GE5"X5EQ];;F@Y,@?[BZ=\X+4+XVZ)0"OX>[-CK8DECD_Q9(`WKWK MICJ:^W>=]&8\`U+N\::\E$(];\MCP4[?@$X1.BY,>\:-"#X3?=XKE&UL M550)``/-]-15S?34575X"P`!!"4.```$.0$``.U]6W/C.)+N^XG8_^"M?=VZ M6';W3G5L[X9\JW4I"=_ MK_HZ.?UT]NG+I\$)^WMT_M+&GU*TLGGP9L=J=?OW[] M7/Y7\FF&?\O*]G=)X.>EI*3C.N%^0?_MX^JSC_1/'T\''\]./[UGX0!WG.%_+LU>-I'D:)LD>5HEGT*DMEG^MEG84^?FXWR M,HE#%&^MGT)DK>;`R5T5?3D1:SF9\N1N,G M/(G)0A?X9"X$05*0R1!/'I((!QAIZJQBGPU'_CW)$=&PA?]"O]49WU;+IO*; M$AV?)E%(MH/K?Q9D`=&4U7[[QKJ7!'^.YJ5"DU7M#S]-B?QU*>1TTG!LCR@B MRAR2=2%?/),>,S\H?T)O<-Q>&HYN-![7EZ\AQ3RIIAZ1`5GB\I3\4N%'HY<( M3WR#D1O]0D-4-SY._^Y'!;I'/AU4^6MZPV9WT51/T83V8[QS,]HW'-&WA"Q/ MA(0`I9ICV6IYD!6YS979U@JM]FO/=!EN!<>R9XO[C,E8&>W;6>&-!"GLJJ75 MWF2@DK[:6"--ABGJR/IZ:40XKY>#S/4KE/LX:F6RK[H^)([3%H&<'A3),WJG M9D>+>%:_8'$U-M(F5@?VQV0D3T$_UD\I9C.1VXV-'2VIMB$_#M^6VU!H-$AQ M7^WLO88+@J2S5LE+JT8^/,J5V2U^P2(]65==:&E6.T$`A[ M:G&41GJ@TJ%UV\QL?>5V8_%D:S0R5@=:8V+=$D1I6O4>HPG5>WI'\)7>$9S^ M6HYZ^><[_P5Q**]?.'S=ZJMJ]/F_3@XQP@>4XB2\CLV&NM/ZH&-^RLE:TV#4 MM?8'&O=SDON1T8AK+0\TUN_(3+;K=H>2*;'GD)E,-RTMCC7?'Z>V(#<2)*O4 MG"QI9&$ME]0[,HRM`9(M`,4AO9:I_DH[:'YW6%[R)L'6+T7T6C5)9:LU_8LG MZGSXDI6.XE5'$85:=N\IM_6^5`NXTAB7PB@%G:'@TR1Y_1PB3`1^>D[_@8[_ M_..7T^7M[K^1/WG5+S^B":8_&.??_1EB#)CWJ; M;]O7TF(8A@1%2*#>1/^&(?^L; M[ZR/8M^%L!+WX,#BOBQ2BO(&9X$?_0/Y*3&MKLAFQ9$\[W/OO(\D"-"L^#@[ M,!\K,,^D6PX']4^\7_HH]QT$*UF?`\EZ?:80*#[S6^_7/DM_%\J*AE^`:*BF M836J&_*W3$+%WO?>?_29#A:<%26_@E)"5T9U0M9?>W_K/QUU,"LR_@/$,+W! M$4HOR4R=)*G8+-WZTOO:1Q+80%8$_`WF9)#,9DE<^LG+JYUL5.0T;IA&18N/ M"8*&WNF7_O(C`[;BZRN;K\^[CH9=.=AS/G`"@XVT9NQG+Z6XB^SCQ/?G5'5^ M^8RB/%O]I710U'1H^6=O'9PZ&M_@F(P#D_4^R;#$2Z'3W-A180'5'3^08@++A MPVJH);9[-'M!J6A.\EL!.6C$%'%FIA"%+5[S^F4,!+D71N0R6P%Y@)G-V>2CX/NZ^L7MEQ"ZS%9#3RIQ='@J^Q[QO[%X;L0#,V>7AX+OH^\1NRO3\@['Z)9Z"%3.-^N/@5QIQ@>;^L"M;:PPYO`PRU"> M*?A(MC^$\JZ)J6#3MC]R6Y;N*TI?$J@Y5\%:7K0J$[CSO7<*ZRQB<",BD3%Z M)[BD"?4T\Y;\#TUH>/4C&AP\S"_]-%W@>%+M\#2KMO5-8_Q&?0H[S0164 M$RKPB(A`<)"CL*DR:/;DG<*ZI735P@">"X??949;]H@"1*`20^4[RI=2$ZWZ M@F;>*:SK2I=Y&19KIV#0A>`V?B5XDG1!P`F(K7_FG<*ZJ72)W!V[M0.N(7&< MV.<['-"KS1N$-AK'GW&R)MXIK+=)E205'-;.K*`SC1S(YSX.K]_G%"O924;Y M%*5;S]8E]59YWX,.ZG;2WS-W!\^/>=$VA>AK3 MH>=M,D=IOGB(_"K$AAA_<^H,$.^8HF;>*:P+2OD<+`-AS=0%MH%R/YY@LNE4 M@B'@KM^#J*#Q3]^2)'S#422TC>3-O0&L!TN9<54P;EB_M1WG>Q('TM69^;TW MZ(E7BSMZ:(O8YA8KW5N]01<<4\I.2#I<>Y`-8%Y6$4['#41&?BYI1*WAHHA+,YMX`UA-F0Q>X MP-PX@%WZ]T].-.-K;P#K'#-B MEX/#C0/891*3W\^I\V"[3CU__K);>`-8_YC9Q.5C<>,"XPJE^)50\8JTS#91 M,^\,UBUF1+0,D+4+BTX=T[2.9]X9K$O,B%N,.Z2>/*,TMD5>LG+$!:F MB:%R$-?JR#N#];39.)QK`W;#(E_A5MS'69][9[!>.`/JQ#JP"\Z)`[B:E!HO M"=X9L)_.MC+(X=KSUG;"::^V_WMGG7&\6?#'4C3VDMW@:*0%/G!>?W$)QQ,4 M!V):!:V\L\[XU$QIEJ!SXT1N=,TF$.=99QQJIK2+P;EQ4-]._9,%\#.^]LY@ M76L2DMC,[ M#;QSZ(Q(`U;Y4-RXTMA`>_!Q>!O+R>6T\,ZABVH9L"O`XH8Q]4B?`(E1>.VG M,;$5LV$0%+.BO)B]0F,<8)%1)6_LG4,7W#(@70V6&V;5OH"TC&CO'#HJS8!? M-@Q[-QR=<&TPSQ(-XA"]"TK@06],"\(*B#Z68IRC'`4%SK"YJ$]6QNFAO M:QD>JXL>JXL>JXMVB,-C==%C==%C==$>LWNL+KJ/XEA=]%A=M`_L'JN+[J,X M5A<]5A>%,X>WE?+!3T=I"3,L[Q`?4%J^;J-\%<[KH$_52-41.7%/O@VW>LQH M6.33),5_;;R#4N9W&T+7+35GG(7$C8MT%L[;+"NT::X:09WE0:;,6M(*N M36K(-`N&&W4/]T!*]VA."^B"IHV8W4"PED[8+5;5-F?Q0Z.P+JY&_.[@X+\P MW)CD`\9&K"62C<:C.4JKU*8?L5^$F&Q)AXZ+N(W)R-!Z4`JA$)P6$-$/?H2R M1_2*X@+1*HJ9N'8HZW/@2`B^+'D.)C8&)]P,ETF6C\8EJJTF0LC-FM?04<[J!-W/;07"1%$B/2%E2NR:41)669Z"5<85R]H!QSQ(&2-3;0,CA-Q+1'I MRA3,*9WOH0. M>U#CB,TO`TICV_EK16:,)O1*#H;,'W&*_(C>$7WS<4R7IU&\*4@I6IPE+:$# M()J0K0#-A9CQ6N'1'8@"VOF-H&,AFC`N1M7@^4$P8XRI5.45O?08<]Z!O6NZ-WH8#RJKS) M*@+KPL]P0'VT."IR832+I"5TU(,VO0IXK$4_`)I:$IBE*^\*9T&4E*$3"D=H MPQZAGX"UK2`BG"O%^5NO-_0_$)Y,"=(A&84_0=\+FALU&I?"J,4)J2\A9AU" MOS';1`_8FF4NA[9NS8""L2[];'H3)6]PL5BUNBCKP>C5IMEK!A"514P5.HR' M-'G%A).+Q8\,A;?QV@4\#,B!LJJ!I.`BU>ZL.[5M6&3PS3M]F`[<6IL9[\`N M-2.N5,QZ>\5O@`MV_K\BJVJ`/R>/*$CB`$=H"^IS8F^):./G@`/3;*I82^)Q MP_-+AAK@DEWRSQ$J:8[#X2Q)<_Q7^7>A#UC>'#@DKBWR>>YC)8$XL&_5$8W& M]-42:G33MT4?4C3#Q4RT7LG:`L?7'59G5*3AQEKS0@1(I%%0R5ZA(*6/V]R0 MOO`KBI'0^I&V!8[6._0J(Y>&"]G:M7N947S]3L54X&Q:G2VH$$0Q]K*VP'%^ MA]48%6DTO_9J=KE)/12E)GSY]>Q+J0?T+][U>T`T>G,/.R*6/9%)@%#(6C&D M;8!C``_#NXH4FE]]=>$R>P./%:(A3H>3M@4.,CSTKB*71O/`M9;6B"HXECX0 M,8HOT-2/QJ/Q]N/V_+5"WA8Z"O&@BX::..S=OIK8%PIZ<+'0YW^W#72@(A#O M+#&TF'I^R)#5+"MH.?Y58> MLEX?;8@\2\?.RL%3D^#R#32U6B6*G8#'>%J\\M%#[49FY#[F85"ZD3,R21$Y MQHG?QU%IWH&@41U:576##=2)M)Y]L+?Q*Y%TDHK?Z!:VZT!P:1MJL(.P^9U+ M*[Z._7'?D7V/'-UN$-HH\&614DGRS`ZM3CH0*FI.MQE<-Q)]]F$_I&A.#OBK MPWX9+*FU"K`Z@(X(;6DYX$&%OB=IS;BD`)=S8)AE*-?;'_:;>P/PW.TV]((- MU(W;%+YM].`OZ!I)8UF"("5GKMI+GD96I:A#;P!>E+!-.U,&W97R`+OXKY9C M7U9OU%*;G;;>`+SB81L:PD`)>]%RZ(!X*X'P]/UA5SP9>JA=*`W$04Q/9YFM M[`E!9]Z@(S7];:1/2'"Z$%9(-M.E+WH8_+/`*2(R(),C7SQ$/C'0XI`^+%Y6 M.Q2HB7HGWJ"37E(9T6RMT8/MA$-L#_(MX3">8&J/R0X]TK;>`-8_VJYRL-!" M.\D.O>58V6J\`:S_U*J:Z,%VH6(T!_$-COTXL&2@"#KS!K#N6*L&B@2G&S=S MJZ#;&R++37A,[7);M.?(VGH#6.^K(;&-G5$B!+Z*I!S#;RQSM7" MG'G?>V>=K"6@1Z04H1MW=O7=\3(A!C;!1TYCDDPX02OOK)..TN:V`P.G"T_( M/Z+Y4LFI4:2J`()6WAEP!4^[R[@0)W3NDBT5"(N@2A5_FB9I_HS2V?+&Z8[> M(8U>(CPI:13OZ\J]>&>=='B:JH@6[N9W;UU0&74)6O%3>&>==(*:*8P>;'L5 M*N&\6Q0N.?_0_Z'>_U<_HBMJ=53:O;`6Z(M.-]Y91YYHU?)HZ2)TX6Z6C7E( MYDB:+LAT*,_2VEJQT]X[ZZ.#4QF:-4-T7JH:&6V:.ZT-L/[-5K7!1D;]EC9< MQT!&QE,QGT>EG/QH):?;>)RDLXHPA2*>:CUXY[#>23-]T`#7RSIR8#@!(4T M(??9?Z_*.LA8W/W8.X?Q#C8CDH7"A3BW[TD<$)ELXBKB<'T*O:4UO=6>VU/K MPSOO91"D#CP77I.HO)Q9Y<\J+RYG-,&@NN,\%5G>PH;>.?AK/QH\<@QP*4(' M%GCJVMX`7?J\J7]J51NR`BW2!-4NO'-@KYX%G=#!ZL*6L56I8QB&N$)`-\;; M>.GVWKDH^0/GTXV(;I"?%ZGH"&_K)[QSX)!("^IE4Q:PY5NYJ><$DA^5O@M: M-E3P2J3P>^\SO1&HO(W`;03P,(Q0G,^$KHM('`VJU@'P`S!"D?/\8ZK`V@O^/.#\ M^I[D:)4%?.A9M"HP7[V/I3"#V`T`9L_V0%2F"Z<%\/S@"E1@MK)1.#$9RB*` MTR0B2#)Z5Y(O#CTEJE]5>6MQZT.(#82>9+=D19<2O4FAW`?P--D3-F_KT,#C MQH2A@$?ER+-Z1L"AE^.UA,L,C77YSF7T[662Y5DYMU]H@<]5=*[*AM.H8XB- M277`%_4!*VU@S7J&WNB:$LG;$!M+Q8EUH!;FOG@F2T#F!U7#2A4Z46$'?PA^"K$3RB.7T<,YZHQ(]RFD"X:7:&HNF@D;>&?N*=+VJ>DT8) MDQ.;SK>$%H%,R,Z;:DP;CIU4[TQFT[&^M6&KU?N5VF#,CR%M*XY46#83;^Q. MJ*7:G>[Q;M<4P86?X6PTWAG3HOK_*LN^6@<]O-M5!N9$89]E,1'Z,-*D>GA* MO>RQM*T'_)*<`?LJF*P%VP$7O*[>#]&8\[PF'O`K<`8\"Z"X4<6-D^^KS+52 M>P_X;3<#XE5Q60N,`]6"]>E_-%[&#/K1)H!X"5O%'R)J[\'&WYMH@2HN:]G/ MT!4=V762U9<#U2X\V+A[$UW0@.;(4Q>S.5'_,E\IO<+9/,G\:#2^2^+)'7Y% M854N^38.HB*D(<8[=91U#PHM_)H'&WUO9&^T(@5KR=>&^LB[+J-O#M5'+K\+ MX[;P8(/O=;B6(W'C6?)'P@21(C6CKLBA*$K*U7+Y\IC4I%!H[<'6T#`[-ZJ@ M@GX\G#-?JSC$562>XI05-O).8:$];*1IK3WP#9MBQ'S"O8C.)XI+MAXB6 M;$?4$I*?#0QZ\T[[YP\TA&GA5>\NK/5/4SR?5TEG_^/'851>.60:!P>U#KS3 M_KD*U9&M=:'?'L-A6":#9DN@&LXD24OOM'\.1`5(:]K[[4F\]M.8H*2U`LNU M4)UV24OOM'_N0P5(:]K[[3K\CMYJ`DJ3F/QC@&KN,74]T.V*/D+9-\4PP;C6 ME!;W]1K0G+BO MO\$QSE'I,]QU$@YG-%CMKY*UI>-!64.:=-O#6_Z&<%L,``!*ZX=9G/N=W+^Y M+RRE)QGVSM?0N8X&2?W["&RMJ!'(4DHO7W*4SBBV9_)CPWE*`]3GPTL=A MA4TA9_QN<7B5S'P<:[!8-0`.8.)1HT;D&D*_J:QO1^4EVO*?LWLT>T&I@%-) M2^`@)3Y=G(.D%(TCI2`W*Q>Q:5!9R4QY#UVW`(X]TEJ!^1"L&90P4W=S"+NG M)0'+!V:JX(;GE>+K'U75N@*.-Q)0*CNO*N-S(Y^#704&Z-QQK`6SIX[L:\XM MVJK'HQ8&<]FT<^A34DL58:P(Q@EW%DL22SD.W_PTK$N"QNM6&I!EQ:SZ6R-= M-/\AZ'/?`?6RD9#M-7K6N>ELURP"H$^<59BT>F$GH1D6>C2)M"M#?8?\%1]7CMOEZ MO`:34*_+7M;Q:0#6R1(_,'.QYX5^-O;]SJ!J@KU8+/^CYK%*I\?^%00RQNG$ M;J@6X76%&XO8)'#Y@2%\U<'M/MR6Y'_7`L#P] M6I;:OB.M0.?OA,?G-Q2]HOLDSJ>BU;!9QSVT5AL#=L(0TI/"/Y"?/K\EUM1H MV9_S"0<;G&[86@;HR<^+(NH->^QAH4)SI+"/\D)ISDU2B&*%S3KL89U#8Z". M%#[4@C\<$QTO9LE3$'C',ZGQ+22W\J8LH5*UBQZ>,S6@]3O?BPOO8J&0C:G0&OB8J$,D6Q74 M,#JJ!4K9G`JM@8]\BAQJ*H!#:9\W14HL"YJ$'H%*[8&/6(VX5P78\TS1>Y$,4;IHBX? M*?N"5L!'J4:SN9I\EH%4$N9%K0"+OK>B&DQ+&L> M-QBF'^E3O1)S??T-<#GWYD9Y'4G/%^,2BG1*UKX"KLN^)7H!.^O!]MMFNLY8_PZZ\/H.`9R-;W?$/2?*?U6PE[U+;-09=`5S1=ZV26\&UXEXIIW'/9>E M8P6+`+L!5"7SA@RRUP`^1$/=ZNKJYCNC-M2@H7*T'[Q3&W]2*)FA@=B-!H!ZUL@]9='\N;.B=PKBF6E$* M.51[>0=NA6_QB3Q=HG;>*8SS MJY5)+D5J+YH+SB@81F7G*&07DI+K@UH'W@#&X];.ZJ\,V=K3LY`:LGG#2T$; M]C[V!C`NO':89$SX\':(9%)B*."ULQY0L&R[.[U.WUM&84W1+#5]?O2Z-E] MXXOLG(70*6"E?V\`XSQL1YML2<3:B[F`RPS7.?%31.'(3 M=GR$QYU'>'COR2C8=+*F?7MD1P&/$Q.XCFV#^1'-ER7W:1P0C@,\]Z/;6*.X M3Z-^@>.T5;CG;^I-4#NG4HH:`AS2;8=PF]'<@!GL#(\"4)[ZT;%P="QTYU!Z M="STG\.C8P&`2DZXS4U*%ICD@:#%648KDI)]A^LDD+3HB7-`CL()`_!IFJ3Y ML_K2R?R^3PX!'H">NP/V8$F73TX+X,,_EQY%-M<@^KT97B9Q&9]!5+ENXRL4 M3A"T`SZJ"[ABDRL#X\##Z'U*IM9:9EEYTSTM;7#,F^XT/8;IN'W(F]X=L1,6 MIV&>>Q_2IW='[$8Y;WOWAL#YTE8N#FOYT`-(\6L9T$3Z-QFD>`9 M1W0)$N`ED\=809<(^ISVMH7+I8OS/6@BLDSR++($.$"M>7Z:64'3)1]1C-X( MO#B\IEP M'H#(\[' MDK8%3>:UL=1R,%E+VP6EOBX@Q9ACT"1<,T)WAV\MH1:4NYHA+PDAV_D2-)G6 MC$$&`C?R92F:"APUWY;!MJ0J>P!;2WP]H'ZL]'\8AX]X,B43H(EUE)9(K]]1&N`,/:0X0.O_ MF"W_:R9:$8SZ\P:]<:8UQKG6&IB"?IPS_&:-JW8\9EPF9?'%(E@#J-\T[H*2QTLSO@3--I`RQ MB>5!Z3>A2]-8&E2V]1UP)@J7">'QT:WT$X)^EL3ENJ3R*.#VM\!I)YK\L89O M+3`B1&-:P9NT_5;@D-[SPFV=RZ-LB51UV]QM`YV%TFC+9(#I>791'9%TL]S_ M&#KQ1$2,T!VSC:'?6^032NF+Y`^KH:HMNH)6P.DH;(HX4U.(P@5>+XQX9;8" M3E_1YY6'HN>+;@7NTHA89BOHI!=]9KDP>IY25J&[,J*6V0HZ/T:?6BZ,GC^/ M6Z&[-J*6V0HZ:T:?6BX,:Z&*\%;PG4(:%/-[Z/0:HZ,-%TE'8[[W;S-47X.4 M-83*N)$SP;B!5$+CA!]I>\6I@FB&13Y-4AHS*YBCXH:P+P$JL<>>L')8#M+^ MX*>CM#SLA^45^^IY"67Z>1W`/@-H30U$\-Q(T6*I?15+I[D$5(U@7_JS//TW MD*QMVI!Q9IO@FG$-Y#JB4AA3)FL+^PI@`]Z5D'7R0<=RM)6*7A4I?4FF3%VK MJ^Y-DE[ZV704<^/'M#J!?>'/@&0SB-;.7-;9'L;A*J*1!VA[':LU$&I`DXYA MG_=KI!5-8;OP"&3MDE7C$"!H!?OH7Z.M0(C)E?2S-4@#XU^A->PK?7;H%V%S M(X%-N"F6+[H(8Q!DC6'?VVN@!&K0K&6@V?7A7:`8C7&`_6ACU=X@6OV?:_\) MFH#F"QGOZQ)`+N2&"76T?IZII=]NGA@UG=?2CD%3B%J;\TJP[>6AV5T0;GR< MEAO8:+R51ON<7,_F4;)`_/I9"DU!LXN,%PA%8/:2Q+IB[BGZ]C@M0%./K%KU M&SQ.))/MX5/+%!8U\P:]=>:)0=G+/#N4(V_+/V7BQ-OJP!NXYL#;@[>FN'O> MNWT(Y3Z4->&8T8-WUEM_G#*^-BI,2^"\#'"S MCKRSGOKG]&&NU:2QS\[F8L"_:B0:7F99/Z(`5?5`A4ITF9 M/I5=+#;?+(<^)$2&&C4/FOT&]%.;3PLRJ??R4R/B!9""_+2:*;RI,6R M"-?IJ_25)''+[M1@:,XP6XGD`NBW:M`7PVB]^1I*:2HJMPUP[08%KM@DBP!U M[,W0E0-:_$[H]E?`%1F$TF78\GN#[^AK(TF\&FEIA54W!6)>1&V`ZR[HLB2! MXD;D<[5#+*3OMVY]UYTJ"VUMBKMP^YX2;"RGC2#B\"'RX^_^3.6)6/L_!UP+ M8D\A.!9Y.\C[;8'I;"+2-L#5(]HBF*U.(BDX\(JM5)@\6=XI9-$V[QRXH,4! MMCDK,NI[3053&2P#9X9AB"N\&S>/BL>OU=^%+MEA1[$L*ZVJX/J]VS853^T: MH7IVL44=WOLMZ'HD[>M6.SK-%*0M/9Y7D2:YG^8]LQ/VI?,'HB7P43@DIVY_ M@K8JY1]&T44C@*[9XH#ZR\1K[23?^UGQK4KYBZL8HV]IDK5B3O-_#;RD34^U MG2-*Z)HZT*XJIG3:6N_MC0*Z,E!G9X%=$4,_6GN`K*>:ERA;X1AW!E77 M"%Q7C20%6T*A(\OQ2B+@*[+60*`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`/.;.S%99_%BV=+U6(W*_QLI?B`/DZ'JS6 M2L1RK##4G0I#D"_]`2@I6P0_R2V.>X6!()\P;$-[[HSB/49S'*,YC%.'XJ.;^6LS(;%ODT2?%?XLMVV[\%&@BJJB66 MUQR!+(`5DK,0;1S[E5=_-%YNX56%-MX2)&D&&DUI1KTB+.@Z&KHT5F41M6FL MFH'&&[9!XQH6=`PAAT9:M0C'C)'?).EMC"(\P<16NHU#FM-/':0<7G7[@8W- M:\"T"5#H0#N125C?;F@!ASA#CRA()C&N/(K_+'"&<_2$TE<<(&X<2+,.88/H M&FA#(\0NQ-2MS^(5.+89\SV)7U%&[YBHQ9(])[D?U?\[=5A_3_)_H'PI-['= MV-IOPD;*-3,@6Q6*&_%QK8FHFM)D`ZA->U%5Q\,.!#9RKJ-:S964RQ%UVF=Q MV!BT-D[45N/$^N@DW@Z1IH[0UJ/$]GX+-DH,R%$C$H:U@#$CC>0=#TR17A.# M-U_F''^53E#Y/_7A?!MRCQ"%^'#;LJ\FQXU#2L1;\M:N8!PS\6D;% M$$KR!1$J$5900@VKR*]#AWPMA_-`A_-<&XY"4)>L*6C8%F]P%XNM_Z(O:TL#L0Z2 MRY7H<^@GPA1(D@P?^AJVU:WW3B%R3-84.OSG(-OLG3O/=G$07A7HA@CW.=G: MI8S/)L+N@!_64N%82SMD8)V($/N>Y"A[\!=T_M1P8I1=1GZ6X3%&X6614@($ MZJ+1"_!+5:9[*J.+W-J^U!FMN??S(L7$=".8KU`6I'@NN@/@S#,HHA6RX;S\D&"DT3CHG5F-/8Q-($X9W? M]7H!=JWJ,6R&SXW==`7QFX_C4;SY=Z69O=L(V+':=%XSX'0T.+M2QXRJ*V^^ MUCX!=H0:3,;MP4-'27=W'X5UGK:PC_YB+_89N*J,R!`%JBD#;8]R%C.FI!3S M3U7:]LK:U$'5S7NAG\C43%)_/L4!6:?$,:G<-AT*036CDJ,B`KP]9[^:+G5<\OI^O#;`_E(A2QQB M!5"Z0&R&@D^3Y/5SD!1QGBXHKV>K?Z&4GM4H7?[9^_'$X&[S'Z$KZ(DDODW2 MUIB[Z1QX3-[(H2@L@OS)CU`F#AEE?@Q=94Z=#B$&V-LC/CM21I8(@&,Z]5E8 MCQOZ2L=6D*;6?GVG%,=KUB5PL&9;-DP#!$8/`*K,+:`QR?:`6IA5[:Y_&`?JAO"8XGETD<$$%H>Z`X M)D>]3]EE'^M;&Q>0]7X5[QT%38#\.2()L4PB,0)'UAVBHS$*K_TT)F"S81`4 MLZ*\:;M"8QQ@<=J*K#'DI:.$/=YZI`#)">;+$AK3)")(LJJRA=`YM_LQY!6D M$;-,"*T=,9E;SF'ES+3(P,34P-C,P+GAS9%54"0`#S?345`L``00E#@`` M!#D!``#M7>%OV[82_SY@_P.?O[P.F.,X;KHE:#HD33($2.L@<;=^&VB)MHE) MHD=2B;V__ATIR:(D2I;L%%6>\J&M+-X=[WY''N\H47W_V\KWT"/A@K+@K#<\ M..PA$CC,I<'\K/=E/^??O_KQ?TMNF1.Z)-`HD]`,Z/$14]4 M+M#5O_TKETK&T1^1+#0\&!T<'APAN)PL0BYH\.C MT]'QZ=NWZ/P3ZO=5/\)9$!\CB?F#MAJ+4). MQ%I(XHL#A_D#)>SPW4@I[Q&EWC7C_B69X="39[U_0NQI77L(K`W$J9)07Z3F MR9`_C0X8GP/)X7#P]=/M@]8Y$>[1X.\,]6K*O81^-%#-4RQ(0JY:7;EA,(F/ M!U'CAM2KD/OU%@2;0FD%,0V$Q(&3*E%0.C9Q>')R,M"M"6E`YE@2MU3XR8`S MCPQBLH0K%/TYQLL-UPR+J>:(&S3<_<-A?S3,L?2QE.5LT,CI-)1$)&P."P/) MUUE`!7$.YNQQ$#>JWD;9WIR0M5A@ MH,$C$=+.$K59K`DP=82=1S3_(2TB$AH*XX^"#O@8W"9"A.53$BKEB$AM'*K`>O8,])_3* M.QAD4-X/]H\L<$D`HB^PI^+IPX(0*2+`2]KL4!\!O@^`"HFQWC"CF!M%[*\@ M)T#>88C(2[4\E?_A)#HQ4.Y>-\.Z:^%86MP_A=%O)U$5C+G[_%2KV*0B?^).8?IFT2* MDD8[QB<%C!4[BOEUDIY(Z"+2]\13Y2#D:W(]`10$%'D*F`CJTE8KUL/#/-8Q M/]("D"FABUB/9S,SY3Y7HVX>Y0TPCB&9EAS0";$WGGITC@T_[,1I]]$P[R.0 MG4W?D2E>3Q"C`V3TT$4?7F/*_\!>2#X1K`@T2)&3[$UV+QSEO:"8D>9&)GL7 M(7X@0YJY8P?S;1Y,S8-BIB[" M6*]2V:6ZJ:YRAL>[5SGH37+U6HB6PC]1A4PCA\4<=G?M492B-Y'D3CK+K$5- MEUCNVX&OKE0[C6U)[909^94D=L2+A6QID=5I^,OJ*1/_+31V!Q2JW/+*J],. ML.;H)OI5!%;HCPI%;TDJWVG*E7)SCZ'AJ\^VX3\A*[5YMH/G$DZ[ M_PK%^2[^B[OHI!?-FB(3#VT-=A\4JO)/V96^M-D.>:&:MCVD[/8PU]4NBXI=J'6?XE+7S36/'OE%=W7D/%#-#;G,,K&-R.Z+0N5=M?W7Y77"NKV728\J*>SH%ZKHTAW` M5^CMP&:"4AU"NR,*Y?`V1W0Z'A5W7;-U0FFS'?SBTVG;KFR79X#YMD4&:EN# M'>1"_9MY&^/_!E[UESK]>4]F2!^K/%5GP\YZ@OI+]\E)$IRQ0%/[98\"G''B8CX.%SUL4\0PI:$2TK$(%&^-W@&>P#PIO9D M?=0J:SP\;6H-L!"O=8;`N&YJ2&XJ/*\Y@^1X)%REAR:A`2QA7*+`>D2\[+1S M=+K\ECE:3`6+^M5/^/KJ5G]XU!\-#U;"C11KT/_&HH;])WS-^K>?(*_9<\*@ MNCRNT5GE.>Z2/G5_5L8!\:1([O13476MKC@77:6+A2V^[J1PF3 M+_FQCQJVD^NU]#`9-[_ZJ9BFFA3.M]?18L.DK_88$L5C[W6Z3[FBRWXJH*D" M^6/T=;I/>-3%/EWG#]?7ZCMATE?->M_V38@ZPID&;*57Z@HLZH2'C41;-84/U1A%HPY+GV<(S]4P[- ME&#!YUWTJ/Y0QNYKII9EC9#Q-W&T+M4?@CB?"GT>)JK>5&;X5SWR*+W4GYTY MA7M0NMU`B:A*GQ[",=593_)0)9^:"M(]RMR)YG-#'A^'"*CGJ0>>":T(@9G* M4+7^SEFX3#JA(!ZL0P7S;JFC3NY?$TA"'4(?E;2/>O4RK:JD,HWQ&40`S-CV->,/A#_"K#7-WXG[ M)0S[FP!D0>5W2:)_;X)Z8:TAWTN`X@ZOHU>56>DL*"=Y"0:JKVJH^6N.7%N?;F]OC5%,_F[-*VEOFA+%<$'XNA/H& MF'HW>&T==Q5$+;,G>B$Q>?6DW*0M="VSJN9YU.AQMF4N[PR']/@ M>_DN`.O`O5I)F"P@`"K!>50$W3(<9*=679YOMCWTC$63[FT\@W_U9AV( M!RLNR=0P8[5YCU5]VU=7XI';)NS*7WIL33(Y0RWJ M9S3[VT[IS,RL.9US/"T:L%5;YZ*AJ5:F5ODU&T1RD5;GL>D>>7X)WH'W!>2) MR0PLU%_YAE;57$&BG7'*IV!!-5F+[%'_>XP;>A`>DS7-EA)5$+4L%XJ`-C^P M5)[HU:-OCX%7JR6-I"7%4SRL\(KZH9]],EM-V:H*JU1;&M2U*Z%LE5T3PGT: M6-2%H'T3$(_.U1;&3>#21^INSNEH0YNSMLIR/;4^,E]M$IK[A;!*L7GT$OT] M@=I*@(3XV7AD9GYZ[B:C75BHU?H""^*:QAB/F"[6*4G\,/G\"7,W*C[3?02A M]UHG"QS7X>)J1;A#1?JY^;1^_?;][9E'/N-&AE;3_+Q;834NI6C10GSNNGI, MBUC/"3/>G*K:%6W*^!)JO+0T%=:-J!?RK,'ZT;O2?*0>>7O2D7OV=,>9&SKR M`7M$%&9=27N+YAQH:-.ZA9KFGWG;1U`EU?<<.(/HQ>(//_[P/U!+`0(>`Q0` M```(`'6+$T=;XT-?MG4```1=!@`1`!@```````$```"D@0````!O>'ES+3(P M,34P-C,P+GAM;%54!0`#S?34575X"P`!!"4.```$.0$``%!+`0(>`Q0````( M`'6+$T'ES+3(P,34P M-C,P7V-A;"YX;6Q55`4``\WTU%5U>`L``00E#@``!#D!``!02P$"'@,4```` M"`!UBQ-'](ESM?L9``#WT@$`%0`8```````!````I(%Z@0``;WAY&UL550%``/-]-15=7@+``$$)0X```0Y`0``4$L!`AX#%``` M``@`=8L31VF^E>]44```7N<$`!4`&````````0```*2!Q)L``&]X>7,M,C`Q M-3`V,S!?;&%B+GAM;%54!0`#S?34575X"P`!!"4.```$.0$``%!+`0(>`Q0` M```(`'6+$T>E'ES+3(P M,34P-C,P7W!R92YX;6Q55`4``\WTU%5U>`L``00E#@``!#D!``!02P$"'@,4 M````"`!UBQ-']G25UKH+``#S`L``00E#@``!#D!``!02P4&``````8` ,!@`:`@``+"4!```` ` end XML 34 R1.htm IDEA: XBRL DOCUMENT v3.2.0.727

Document and Entity Information - shares
6 Months Ended

Jun. 30, 2015

Aug. 18, 2015

Document and Entity Information [Abstract]

Entity Registrant Name OxySure Systems Inc

Entity Central Index Key 0001413797

Amendment Flag false

Current Fiscal Year End Date --12-31

Document Type 10-Q

Document Period End Date Jun. 30, 2015

Document Fiscal Period Focus Q2

Document Fiscal Year Focus 2015

Entity Filer Category Smaller Reporting Company

Entity Common Stock, Shares Outstanding 32,003,034

X

- Definition
If the value is true, then the document is an amendment to previously-filed/accepted document.
+ References
No definition available.
+ Details

Name: dei_AmendmentFlag

Namespace Prefix: dei_

Data Type: xbrli:booleanItemType

Balance Type: na

Period Type: duration

X

- Definition
End date of current fiscal year in the format --MM-DD.
+ References
No definition available.
+ Details

Name: dei_CurrentFiscalYearEndDate

Namespace Prefix: dei_

Data Type: xbrli:gMonthDayItemType

Balance Type: na

Period Type: duration

X

- Definition
This is focus fiscal period of the document report. For a first quarter 2006 quarterly report, which may also provide financial information from prior periods, the first fiscal quarter should be given as the fiscal period focus. Values: FY, Q1, Q2, Q3, Q4, H1, H2, M9, T1, T2, T3, M8, CY.
+ References
No definition available.
+ Details

Name: dei_DocumentFiscalPeriodFocus

Namespace Prefix: dei_

Data Type: dei:fiscalPeriodItemType

Balance Type: na

Period Type: duration

X

- Definition
This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.
+ References
No definition available.
+ Details

Name: dei_DocumentFiscalYearFocus

Namespace Prefix: dei_

Data Type: xbrli:gYearItemType

Balance Type: na

Period Type: duration

X

- Definition
The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.
+ References
No definition available.
+ Details

Name: dei_DocumentPeriodEndDate

Namespace Prefix: dei_

Data Type: xbrli:dateItemType

Balance Type: na

Period Type: duration

X

- Definition
The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word "Other".
+ References
No definition available.
+ Details

Name: dei_DocumentType

Namespace Prefix: dei_

Data Type: dei:submissionTypeItemType

Balance Type: na

Period Type: duration

X

- Definition
A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation 12B

-Number 240

-Section 12b

-Subsection 1

+ Details

Name: dei_EntityCentralIndexKey

Namespace Prefix: dei_

Data Type: dei:centralIndexKeyItemType

Balance Type: na

Period Type: duration

X

- Definition
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
+ References
No definition available.
+ Details

Name: dei_EntityCommonStockSharesOutstanding

Namespace Prefix: dei_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Indicate whether the registrant is one of the following: (1) Large Accelerated Filer, (2) Accelerated Filer, (3) Non-accelerated Filer, (4) Smaller Reporting Company (Non-accelerated) or (5) Smaller Reporting Accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.
+ References
No definition available.
+ Details

Name: dei_EntityFilerCategory

Namespace Prefix: dei_

Data Type: dei:filerCategoryItemType

Balance Type: na

Period Type: duration

X

- Definition
The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation 12B

-Number 240

-Section 12b

-Subsection 1

+ Details

Name: dei_EntityRegistrantName

Namespace Prefix: dei_

Data Type: xbrli:normalizedStringItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: oxys_DocumentAndEntityInformationAbstract

Namespace Prefix: oxys_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 35 R18.htm IDEA: XBRL DOCUMENT v3.2.0.727

Stock Options and Warrants (Tables)
6 Months Ended

Jun. 30, 2015

Stock Options and Warrants [Abstract]

Summary of option activity
Employee Non-Employee
Weighted Weighted
Number Average Number Average Combined
Of Exercise Of Exercise Total
Outstanding at March 31, 2015 2,513,838 $ 0.41 - $ - 2,513,838
Granted - $ - - $ - -
Exercised - $ - - $ - -
Forfeited/Cancelled - $ - - $ - -
Outstanding at June 30, 2015 2,513,838 $ 0.41 - $ - 2,513,838

Summary of assumptions to estimate the fair value of options granted
Equity Incentive Plans Equity Incentive Plans
for the Three Months Ended June 30, for the Six Months Ended June 30,
2015 2014 2015 2014

Expected terms (in years) 5-10 5-10 5-10 5-10
Volatility (weighted ave.) 83.79 % 40.45 % 83.79 % 40.45 %
Risk-free interest rate .85% - 1.74% 1.50% - 1.80% .85% - 1.74% 1.44% - 1.80%
Expected dividend rate 0 % 0 % 0 % 0 %

Summary of warrant activity
Weighted
Number Average
Of Exercise
Warrants Price
Outstanding at March 31, 2015 3,304,260 $ 1.28
Granted 1,659,696 $ 1.11
Exercised - $ -
Forfeited/Cancelled - $ -
Outstanding at June 30, 2015 4,963,956 $ 1.22

X

- References
No definition available.
+ Details

Name: us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of the changes in other outstanding share-based compensation awards other than stock options or nonvested awards.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)(2)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ScheduleOfOtherShareBasedCompensationActivityTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of the number and weighted-average exercise prices (or conversion ratios) for share options (or share units) that were outstanding at the beginning and end of the year, vested and expected to vest, exercisable or convertible at the end of the year, and the number of share options or share units that were granted, exercised or converted, forfeited, and expired during the year.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)(1)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (f)(2)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 36 R4.htm IDEA: XBRL DOCUMENT v3.2.0.727

Statements of Operations (Unaudited) - USD ($)
3 Months Ended 6 Months Ended

Jun. 30, 2015

Jun. 30, 2014

Jun. 30, 2015

Jun. 30, 2014

Income Statement [Abstract]

Revenues, net $ 1,046,019 $ 678,111 $ 1,670,533 $ 1,034,340

Cost of goods sold 409,183 264,856 745,039 470,446

Gross profit 636,836 413,255 925,494 563,894

Operating expenses

Research and development 297,456 275,974 510,801 277,515

Sales and marketing 329,393 154,044 794,139 241,993

Other general and administrative 621,066 259,230 1,243,350 604,987

Total operating expenses 1,247,915 689,248 2,548,290 1,124,495

Loss from operating expenses (611,079) (275,993) (1,622,796) (560,600)

Other income (expenses)

Interest expense (561,791) $ (85,980) (892,945) $ (193,587)

Change in value of derivative liabilities 119,933 122,584

Derivative expense (204,272) (204,272)

Other income (expense) (1,225) $ 42,465 (1,108) $ 58,360

Total other income (expenses) (647,355) (43,515) (975,741) (135,227)

Net loss $ (1,258,434) $ (319,508) $ (2,598,537) $ (695,828)

Basic and diluted net loss per common share $ (0.04) $ (0.01) $ (0.09) $ (0.03)

Weighted average common shares outstanding:

Basic and diluted 30,215,788 25,996,642 29,587,327 25,956,948

X

- Definition
Total costs related to goods produced and sold during the reporting period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.2(a))

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

+ Details

Name: us-gaap_CostOfGoodsSold

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of decrease in the fair value of derivatives recognized in the income statement.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 10

-Section 50

-Paragraph 4A

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=56946850&loc=SL5618551-113959

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 10

-Section 50

-Paragraph 4C

-Subparagraph (a),(c),(d),(e)

-URI http://asc.fasb.org/extlink&oid=56946850&loc=SL5624171-113959

+ Details

Name: us-gaap_DerivativeLossOnDerivative

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
+ References
No definition available.
+ Details

Name: us-gaap_EarningsPerShareBasicAndDiluted

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.1,2)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

+ Details

Name: us-gaap_GrossProfit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_IncomeStatementAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of the cost of borrowed funds accounted for as interest expense.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 835

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.9-04.9)

-URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882

+ Details

Name: us-gaap_InterestExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Net Income

-URI http://asc.fasb.org/extlink&oid=51831255

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.19)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.18)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.22)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Other Comprehensive Income

-URI http://asc.fasb.org/extlink&oid=51831270

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 19

-Article 5

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 20

-Article 9

+ Details

Name: us-gaap_NetIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The aggregate amount of gains or losses resulting from nonoperating activities (for example, interest and dividend revenue, property, plant and equipment impairment loss, and so forth).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.7,9)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

+ Details

Name: us-gaap_NonoperatingGainsLosses

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.7)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

+ Details

Name: us-gaap_NonoperatingIncomeExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_NonoperatingIncomeExpenseAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.
+ References
No definition available.
+ Details

Name: us-gaap_OperatingExpenses

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_OperatingExpensesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The net result for the period of deducting operating expenses from operating revenues.
+ References
No definition available.
+ Details

Name: us-gaap_OperatingIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The sum of expenses not otherwise specified in the taxonomy for managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.4)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

+ Details

Name: us-gaap_OtherGeneralAndAdministrativeExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 730

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 985

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756

+ Details

Name: us-gaap_ResearchAndDevelopmentExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Aggregate revenue during the period from the sale of goods in the normal course of business, after deducting returns, allowances and discounts.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.1(a))

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

+ Details

Name: us-gaap_SalesRevenueGoodsNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The aggregate total amount of expenses directly related to the marketing or selling of products or services.
+ References
No definition available.
+ Details

Name: us-gaap_SellingAndMarketingExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The net change in the difference between the fair value and the carrying value, or in the comparative fair values, of derivative instruments, including options, swaps, futures, and forward contracts, held at each balance sheet date, that was included in earnings for the period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

+ Details

Name: us-gaap_UnrealizedGainLossOnDerivatives

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).
+ References
No definition available.
+ Details

Name: us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

XML 37 R12.htm IDEA: XBRL DOCUMENT v3.2.0.727

Fair Value Measurements
6 Months Ended

Jun. 30, 2015

Fair Value Measurements [Abstract]

FAIR VALUE MEASUREMENTS
NOTE 7 – FAIR VALUE MEASUREMENTS

Changes related to derivatives for the six months ended June 30, 2015 are as follows:

Balance as of December 31, 2014 $ 31,010

Additions related to embedded derivative of convertible notes issued 369,472

Gain on decrease in value of derivative liabilities (122,584 )

Conversions (28,698 )

Balance as of June 30, 2015 $ 249,200

During the six month period the Company recorded derivatives related to convertible notes of $369,472 of which $204,272 exceed the proceeds of the convertible notes and was recorded as a derivative expense. The Company also converted $28,698 and recorded a gain on the change in the fair value of the derivative of $122,584.

X

- References
No definition available.
+ Details

Name: us-gaap_FairValueDisclosuresAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 820

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=36462937&loc=d3e19207-110258

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 30

-URI http://asc.fasb.org/extlink&oid=6957238&loc=d3e14172-108612

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=6957238&loc=d3e14064-108612

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 21

-URI http://asc.fasb.org/extlink&oid=49121117&loc=d3e13537-108611

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 16

-URI http://asc.fasb.org/extlink&oid=49121117&loc=d3e13504-108611

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 10

-URI http://asc.fasb.org/extlink&oid=49121117&loc=d3e13433-108611

+ Details

Name: us-gaap_FairValueDisclosuresTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 38 R11.htm IDEA: XBRL DOCUMENT v3.2.0.727

Off Balance Sheet Arrangements and Contractual Obligations
6 Months Ended

Jun. 30, 2015

Off Balance Sheet Arrangements and Contractual Obligations [Abstract]

OFF BALANCE SHEET ARRANGEMENTS AND CONTRACTUAL OBLIGATIONS
NOTE 6 – OFF BALANCE SHEET ARRANGEMENTS AND CONTRACTUAL OBLIGATIONS

We have not entered into any transactions with unconsolidated entities whereby we have financial guarantees, subordinated retained interests, or other contingent arrangements that expose us to material continuing risks, contingent liabilities, or any other obligation under a variable interest in an unconsolidated entity that provides financing, liquidity, market risk or credit risk support to us.

X

- References
No definition available.
+ Details

Name: oxys_OffBalanceSheetArrangementsAndContractualObligationsAbstract

Namespace Prefix: oxys_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure on off balance sheet arrangements and contractual obligations entered into by the entity during the period.
+ References
No definition available.
+ Details

Name: oxys_OffBalanceSheetArrangementsAndContractualObligationsTextBlock

Namespace Prefix: oxys_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 39 R23.htm IDEA: XBRL DOCUMENT v3.2.0.727

Summary of Significant Accounting Policies (Details 1)

Jun. 30, 2015

USD ($)

Summary of Significant Accounting Policies [Abstract]

2015 $ 30,232

2016 30,232

2017 30,232

2018 30,232

Thereafter 226,723

Total $ 347,650

X

- References
No definition available.
+ Details

Name: us-gaap_AccountingPoliciesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized after the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.
+ References
No definition available.
+ Details

Name: us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 30

-Section 50

-Paragraph 2

-Subparagraph (a)(3)

-URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16323-109275

+ Details

Name: us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 30

-Section 50

-Paragraph 2

-Subparagraph (a)(3)

-URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16323-109275

+ Details

Name: us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 30

-Section 50

-Paragraph 2

-Subparagraph (a)(3)

-URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16323-109275

+ Details

Name: us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 30

-Section 50

-Paragraph 2

-Subparagraph (a)(3)

-URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16323-109275

+ Details

Name: us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 30

-Section 50

-Paragraph 2

-Subparagraph (a)(1)

-URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16323-109275

+ Details

Name: us-gaap_FiniteLivedIntangibleAssetsNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

XML 40 R19.htm IDEA: XBRL DOCUMENT v3.2.0.727

Related Party Transactions (Tables)
6 Months Ended

Jun. 30, 2015

Related Party Transactions [Abstract]

Summary of the related party financings and notes payable
Related party Julian Ross (1)
Amount $ 200,000
Stated interest rate 0 %
Maturity n/a

X

- References
No definition available.
+ Details

Name: us-gaap_RelatedPartyTransactionsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of related party transactions. Examples of related party transactions include, but are not limited to, transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners and (d) affiliates.
+ References
No definition available.
+ Details

Name: us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 41 R15.htm IDEA: XBRL DOCUMENT v3.2.0.727

Summary of Significant Accounting Policies (Policies)
6 Months Ended

Jun. 30, 2015

Summary of Significant Accounting Policies [Abstract]

Basis of Presentation
Basis of Presentation - The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reported period. Actual results could differ from those estimates. The interim financial statements include all adjustments which, in the opinion of management, are necessary in order to make the financial statements not misleading.

The accompanying Condensed Financial Statements have been prepared in accordance with United States generally accepted accounting principles (“GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X promulgated by the Securities and Exchange Commission (“SEC”) and therefore do not contain all of the information and footnotes required by GAAP and the SEC for annual financial statements. The Company's Condensed Financial Statements reflect all adjustments that management believes are necessary for the fair presentation of their financial position, results of operations, comprehensive loss and cash flows for the periods presented. The information at December 31, 2014 in the Company's Condensed Balance Sheet included in this quarterly report was derived from the audited Balance Sheet included in the Company's Annual Report on Form 10-K for the year ended December 31, 2014 filed with the SEC on March 31, 2015. Where applicable, the Company's 2014 Annual Report on Form 10-K is referred to in this quarterly report as the “2014 Annual Report.” This quarterly report should be read in conjunction with the 2014 Annual Report.

Deferred Revenue and Income
Deferred Revenue and Income - We defer revenue and income when we invoice a customer or a customer makes a payment and the requirements of revenue recognition have not been met (i.e. persuasive evidence of an arrangement exists, shipment from a company warehouse has occurred, the price is fixed or determinable and collectability is reasonably assured). Deferred Revenue was $0 for each of the periods ended June 30, 2015 and December 31, 2014, respectively.

Inventory
Inventory – Our inventory consists of raw material and components for our portable oxygen systems as well as completed products and accessories. Inventories are computed using the lower of cost or market, which approximates actual cost on a first-in first-out basis. Inventory components are parts, work-in-process and finished goods. Finished goods are reported as inventories until the point of title transfer to the customer.

Inventories as at June 30, 2015 and December 31, 2014 consisted of the following:

June 30, December 31,
2015 2014

Parts inventory $ 181,863 $ 133,477
Work in process 41,994 41,114
Finished goods 198,694 102,755
Total inventories $ 422,551 $ 277,346

Cash and Cash Equivalents
Cash and Cash Equivalents - We invest our cash in deposits and money market funds with major financial institutions. We place our cash investments in instruments that meet high credit quality standards, as specified in our investment policy guidelines. These guidelines also limit the amount of credit exposure to any one issue, issuer or type of instrument.

Fair Value of Financial Instruments
Fair Value of Financial Instruments - Our financial instruments consist principally of cash and cash equivalents, accounts receivable and accounts payable. We believe that the recorded values of all of our other financial instruments approximate their fair values because of their nature and respective maturity dates or durations. The fair value of our long-term debt is determined by using estimated market prices. Assets and liabilities measured at fair value are categorized based on whether or not the inputs are observable in the market and the degree that the inputs are observable. The categorization of financial instruments within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement. The hierarchy is prioritized into three levels (with Level 3 being the lowest) defined as follows:

Level 1: Inputs are based on quoted market prices for identical assets or liabilities in active markets at the measurement date.

Level 2: Inputs include quoted prices for similar assets or liabilities in active markets and/or quoted prices for identical or similar assets or liabilities in markets that are not active near the measurement date.

Level 3: Inputs include management’s best estimate of what market participants would use in pricing the asset or liability at the measurement date. The inputs are unobservable in the market and significant to the instrument’s valuation.

The fair value of the majority of our cash equivalents was determined based on “Level 1” inputs. We do not have any marketable securities in the “Level 2” and “Level 3” category. We believe that the recorded values of all our other financial instruments approximate their current fair values because of their nature and respective relatively short maturity dates or durations.

Property and Equipment
Property and Equipment – Property and equipment are recorded at cost with depreciation and amortization provided over the shorter of the remaining lease term or the estimated useful life of the improvement ranging from three to seven years. Renewals and betterments that materially extend the life of an asset are capitalized. Expenditures for maintenance and repairs are charged to expense when incurred. Furniture and fixtures are depreciated over five years. Machinery and equipments are depreciated over five to seven years. Software is depreciated over three years. Leasehold improvements are computed using the shorter of the estimated useful lives of the assets or the lease terms. Depreciation expense was $3,478 and $5,155 for the three month periods ended June 30, 2015 and 2014, respectively. Depreciation expense was $6,820 and $9,786 for the six month periods ended June 30, 2015 and 2014, respectively.

Other Long-Lived Assets
Other Long-Lived Assets – We have two types of intangible assets – patents and trademarks. Intangible assets are carried at cost, net of accumulated amortization. Amortization expense for patents and trademarks was $7,557 and $7,558 for the three month periods ended June 30, 2015 and 2014, respectively. Amortization expense for patents and trademarks was $15,114 and $15,066 for the six month periods ended June 30, 2015 and 2014, respectively

Intangible assets with definite useful lives and other long-lived assets are tested for impairment if certain impairment indicators are identified. Management evaluates the recoverability of its identifiable intangible assets in accordance with applicable accounting guidance, which requires the assessment of these assets for recoverability when events or circumstances indicate a potential impairment exists. If impairment is indicated based on a comparison of the assets’ carrying values and the undiscounted cash flows, the impairment loss is measured as the amount by which the carrying amount of the assets exceeds the fair value of the assets. Impairment charges for patents were $0 for each of the three month periods ended June 30, 2015 and 2014.

5-Year amortization expense for patents and trademarks is as follows:

2015 $ 30,232
2016 30,232
2017 30,232
2018 30,232
Thereafter 226,723
$ 347,650

Other assets
Other Assets– We record Other Assets net of accumulated amortization. Amortization expense for Other Assets was $21,911 and $10,051 for the three month periods ended June 30, 2015 and 2014, respectively. Amortization expense for Other Assets was $42,034 and $37,562 for the six month periods ended June 30, 2015 and 2014, respectively.

Capitalization of software: The Company accounts for internal-use software and website development costs, including the development of its partner marketplaces in accordance with ASC 350-50 (Intangibles – Website cost). The Company capitalizes internal costs consisting of payroll and direct payroll-related costs of employees who devote time to the development of internal-use software, as well as any external direct costs. It amortizes these costs over their estimated useful lives, which typically range between three to five years. The Company’s judgment is required in determining the point at which various projects enter the stages at which costs may be capitalized, in assessing the ongoing value of the capitalized costs, and in determining the estimated useful lives over which the costs are amortized. The estimated life is based on management’s judgment as to the product life cycle.

Amortization expense for websites and URLs was $9,654 and $9,654 for the three month periods ended June 30, 2015 and 2014, respectively. Amortization expense for websites and URLs was $19,309 and $19,309 for the six month periods ended June 30, 2015 and 2014, respectively.

Research and Development Costs
Research and Development Costs – Costs associated with the development of our products are charged to expense as incurred. Research and development expense was $297,456 and $275,974 for the three month periods ended June 30, 2015 and 2014, respectively. Research and development expense was $510,801 and $277,515 for the six month periods ended June 30, 2015 and 2014, respectively.

Equity Warrants
Equity Warrants - We issued warrants to purchase shares of our common stock in connection with convertible notes. In accordance with ASC 470-20, Debt with conversions and other options, the proceeds from the notes were allocated based on the relative fair values of the notes without the warrants issued in conjunction with the notes and of the warrants themselves at the time of issuance. We record the fair value of the warrants at the time of issuance as additional paid in capital and as a debt discount to the notes. We amortize this debt discount as interest expense over the life of the note. Additionally, as a result of issuing the warrants with the convertible notes, a beneficial conversion option is recorded as a debt discount reflecting the incremental conversion option intrinsic value of the conversion option provided to the holders of the notes. We also amortize this debt discount as interest expense over the life of the notes. The intrinsic value of each conversion option was calculated as the difference between the effective conversion price and the fair value of the common stock, multiplied by the number of shares into which the note is convertible.

Stock-Based Compensation
Stock-Based Compensation – We account for share-based payments, including grants of stock options to employees, consultants and non-employees; moreover, we issue warrants to the consultants and related parties. We are required to estimate the fair value of share-based awards and warrants on the date of grant. The value of the award is principally recognized as expense ratably over the requisite service periods. We have estimated the fair value of stock options and warrants as of the date of grant or assumption using the Black-Scholes option pricing model.

For the three month periods ended June 30, 2015 and 2014, stock based compensation expense was approximately $58,611 and $0, respectively, which consisted primarily of stock-based compensation expense related to stock options issued to the employees and recognized under GAAP. For the six month periods ended June 30, 2015 and 2014, stock based compensation expense was approximately $106,911 and $17,588, respectively.

Shipping and Handling Costs
Shipping and Handling Costs - Shipping and handling charges to customers are included in net revenues, and the associated costs incurred are recorded in cost of revenues.

Advertising Costs
Advertising Costs - Advertising costs are charged to operations when incurred. We incurred $329,393 and $154,044 in advertising and promotion costs during the three month periods ended June 30, 2015 and 2014, respectively. Advertising and promotion costs during the six month periods ended June 30, 2015 and 2014 were $794,139 and $241,993, respectively.

Net Income (Loss) Per Share
Net Income (Loss) Per Share - Basic earnings (loss) per share is computed based on the weighted average number of common shares outstanding. However, basic loss per share excludes anti-dilutive securities. Diluted earnings per share is computed based on the weighted average number of common shares outstanding, increased by the number of additional shares that would have been outstanding had the potentially dilutive common shares been issued, and reduced by the number of shares the Company could have repurchased from the proceeds from issuance of the potentially dilutive shares. Potentially dilutive shares of common stock include stock options and other stock-based awards granted under stock-based compensation plans and shares committed to be purchased under the employee stock purchase plan. As of June 30, 2015 there were 18,268,932 potentially dilutive shares.

Recent Accounting Pronouncements
Recent Accounting Pronouncements

We have reviewed recent accounting pronouncements and concluded that they are either not applicable to our business or that no material effect is expected on the financial statements as a result of future adoption.

X

- Definition
Disclosure for accounting policy of equity warrants.
+ References
No definition available.
+ Details

Name: oxys_EquityWarrantsPolicyTextBlock

Namespace Prefix: oxys_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for recording of other assets net of accumulated amortization.
+ References
No definition available.
+ Details

Name: oxys_OtherAssetsPolicyTextBlock

Namespace Prefix: oxys_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_AccountingPoliciesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for advertising costs. For those costs that cannot be capitalized, discloses whether such costs are expensed as incurred or the first period in which the advertising takes place. For direct response advertising costs that are capitalized, describes those assets and the accounting policy used, including a description of the qualifying activity, the types of costs capitalized and the related amortization period. An entity also may disclose its accounting policy for cooperative advertising arrangements.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 340

-SubTopic 20

-Section 55

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=51677389&loc=d3e8384-108330

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18780-107790

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 340

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=51662920&loc=d3e8275-108329

+ Details

Name: us-gaap_AdvertisingCostsPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).
+ References
No definition available.
+ Details

Name: us-gaap_BasisOfAccountingPolicyPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 305

-SubTopic 10

-Section 05

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6375392&loc=d3e26790-107797

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4273-108586

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Cash

-URI http://asc.fasb.org/extlink&oid=6506951

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18780-107790

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Cash Equivalents

-URI http://asc.fasb.org/extlink&oid=6507016

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Financial Reporting Release (FRR)

-Number 203

-Paragraph 02-03

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 1

-Article 5

+ Details

Name: us-gaap_CashAndCashEquivalentsPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3630-109257

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18780-107790

+ Details

Name: us-gaap_EarningsPerSharePolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for determining the fair value of financial instruments.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18780-107790

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=49121117&loc=d3e13279-108611

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 820

-SubTopic 10

-Section 60

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260

+ Details

Name: us-gaap_FairValueOfFinancialInstrumentsPolicy

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for the impairment and disposal of long-lived assets including goodwill and other intangible assets.
+ References
No definition available.
+ Details

Name: us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for major classes of inventories, bases of stating inventories (for example, lower of cost or market), methods by which amounts are added and removed from inventory classes (for example, FIFO, LIFO, or average cost), loss recognition on impairment of inventories, and situations in which inventories are stated above cost. If inventory is carried at cost, this disclosure includes the nature of the cost elements included in inventory.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 330

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=28360613&loc=d3e4492-108314

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.6(b))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18780-107790

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 330

-SubTopic 10

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=28360613&loc=d3e4556-108314

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Financial Reporting Release (FRR)

-Number 206

-Paragraph b

-Subparagraph i, ii

-Chapter 2

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 6

-Subparagraph a

-Article 5

+ Details

Name: us-gaap_InventoryPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.
+ References
No definition available.
+ Details

Name: us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for long-lived, physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, basis of assets, depreciation and depletion methods used, including composite deprecation, estimated useful lives, capitalization policy, accounting treatment for costs incurred for repairs and maintenance, capitalized interest and the method it is calculated, disposals and impairments.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 360

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18780-107790

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.13(a))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_PropertyPlantAndEquipmentPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 730

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18780-107790

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Research and Development

-URI http://asc.fasb.org/extlink&oid=6523717

+ Details

Name: us-gaap_ResearchAndDevelopmentExpensePolicy

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for recognizing unearned income or deferred revenue related to transactions involving the sale of a product or performance of services.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 605

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SAB TOPIC 13.B.Q1)

-URI http://asc.fasb.org/extlink&oid=27012821&loc=d3e214044-122780

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18780-107790

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 13

-Section B

-Paragraph Question 1

+ Details

Name: us-gaap_RevenueRecognitionDeferredRevenue

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for stock option and stock incentive plans. This disclosure may include (1) the types of stock option or incentive plans sponsored by the entity (2) the groups that participate in (or are covered by) each plan (3) significant plan provisions and (4) how stock compensation is measured, and the methodologies and significant assumptions used to determine that measurement.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5047-113901

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18780-107790

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (b),(f)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for the classification of shipping and handling costs, including whether the costs are included in cost of sales or included in other income statement accounts. If shipping and handling fees are significant and are not included in cost of sales, disclosure includes both the amounts of such costs and the line item on the income statement which includes such costs.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Shipping Costs

-URI http://asc.fasb.org/extlink&oid=51575562

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 605

-SubTopic 45

-Section S99

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6408413&loc=d3e221937-122793

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 605

-SubTopic 45

-Section 45

-Paragraph 20

-URI http://asc.fasb.org/extlink&oid=51671805&loc=d3e60635-111653

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 605

-SubTopic 45

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=51667946&loc=d3e61069-111654

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Handling Costs

-URI http://asc.fasb.org/extlink&oid=51575068

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18780-107790

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18726-107790

+ Details

Name: us-gaap_ShippingAndHandlingCostPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 42 R13.htm IDEA: XBRL DOCUMENT v3.2.0.727

Segment Information
6 Months Ended

Jun. 30, 2015

Segment Information [Abstract]

SEGMENT INFORMATION
NOTE 8 – SEGMENT INFORMATION

We are organized as, and operate in, one reportable segment: the development, distribution and sale of specialty respiratory products and related medical products, accessories, and services. Our chief operating decision-maker is our Chief Executive Officer. Our Chief Executive Officer reviews financial information presented for purposes of evaluating financial performance and allocating resources, accompanied by information about revenue by geographic regions. Our assets are primarily located in the United States of America and not allocated to any specific region and we do not measure the performance of our geographic regions based upon asset-based metrics. Therefore, geographic information is presented only for revenue. Revenue by geographic region is based on the ship to address on our customer orders.

The following presents total revenue by geographic region for the three month periods ended June 30, 2015 and 2014:

Three Months Ended
June 30, Six Months Ended
June 30,

2015 2014 2015 2014

United States - product sales $ 1,044,066 $ 677,508 $ 1,668,580 $ 979,110

ROW - product sales 1,953 603 1,953 37,730

ROW - license fees/service revenue - - - 17,500

Totals $ 1,046,019 $ 678,111 $ 1,670,533 $ 1,034,340

X

- References
No definition available.
+ Details

Name: us-gaap_SegmentReportingAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 34

-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8981-108599

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 41

-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e9038-108599

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 33

-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8971-108599

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 12

-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8595-108599

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8380-108599

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 32

-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8933-108599

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 26

-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8844-108599

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 35

-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8984-108599

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 40

-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e9031-108599

Reference 10: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 42

-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e9054-108599

Reference 11: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 10

-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8538-108599

Reference 12: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 29

-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8864-108599

Reference 13: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 31

-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8924-108599

Reference 14: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 30

-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8906-108599

+ Details

Name: us-gaap_SegmentReportingDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 43 R14.htm IDEA: XBRL DOCUMENT v3.2.0.727

Going Concern
6 Months Ended

Jun. 30, 2015

Going Concern [Abstract]

GOING CONCERN
NOTE 9 – GOING CONCERN

Our financial statements are prepared using accounting principles generally accepted in the United States of America applicable to a going concern, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business. Historically we have been suffering from recurring loss from operations. We have an accumulated deficit of $20,639,745 and $18,041,208 at June 30, 2015 and December 31, 2014, respectively, and stockholders’ equity of $2,997,385 and $1,074,787 as of June 30, 2015 and December 31, 2014, respectively. We require substantial additional funds to manufacture and commercialize our products. Our management is actively seeking additional sources of equity and/or debt financing; however, there is no assurance that any additional funding will be available.

In view of the matters described above, recoverability of a major portion of the recorded asset amounts shown in the accompanying June 30, 2015 balance sheet is dependent upon continued operations of the Company, which in turn is dependent upon the Company’s ability to meet its financing requirements on a continuing basis, to maintain present financing, and to generate cash from future operations. These factors, among others, raise substantial doubt about our ability to continue as a going concern. The financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or amounts and classification of liabilities that might be necessary should we be unable to continue in existence.

X

- Definition
Going Concern.
+ References
No definition available.
+ Details

Name: oxys_GoingConcernAbstract

Namespace Prefix: oxys_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: oxys_GoingConcernTextBlock

Namespace Prefix: oxys_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 44 R16.htm IDEA: XBRL DOCUMENT v3.2.0.727

Summary of Significant Accounting Policies (Tables)
6 Months Ended

Jun. 30, 2015

Summary of Significant Accounting Policies [Abstract]

Schedule of inventories
June 30, December 31,
2015 2014

Parts inventory $ 181,863 $ 133,477
Work in process 41,994 41,114
Finished goods 198,694 102,755
Total inventories $ 422,551 $ 277,346

Schedule of finite-lived intangible assets amortization expense
2015 $ 30,232
2016 30,232
2017 30,232
2018 30,232
Thereafter 226,723
$ 347,650

X

- References
No definition available.
+ Details

Name: us-gaap_AccountingPoliciesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of amortization expense of assets, excluding financial assets, that lack physical substance, having a limited useful life.
+ References
No definition available.
+ Details

Name: us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 2

-Paragraph 6

-Subparagraph a,b,c

-Article 5

+ Details

Name: us-gaap_ScheduleOfInventoryCurrentTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 45 R34.htm IDEA: XBRL DOCUMENT v3.2.0.727

Fair Value Measurements (Details Textual)
6 Months Ended

Jun. 30, 2015

USD ($)

Fair Value Measurements (Textual)

Additions related to embedded derivative of convertible notes issued $ 369,472

Excess derivative over proceeds 204,272

Conversions 28,698

Gain on decrease in value of derivative liabilities $ 122,584

X

- Definition
Additions related to embedded derivative of convertible notes issued.
+ References
No definition available.
+ Details

Name: oxys_AdditionsRelatedToDerivativeOfConvertibleNotes

Namespace Prefix: oxys_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Conversions.
+ References
No definition available.
+ Details

Name: oxys_Conversions

Namespace Prefix: oxys_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Excess derivative over proceeds.
+ References
No definition available.
+ Details

Name: oxys_ExcessDerivativeOverProceeds

Namespace Prefix: oxys_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: oxys_FairValueMeasurementsTextualAbstract

Namespace Prefix: oxys_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of increase in the fair value of derivatives recognized in the income statement.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 10

-Section 50

-Paragraph 4C

-Subparagraph (a),(c),(d),(e)

-URI http://asc.fasb.org/extlink&oid=56946850&loc=SL5624171-113959

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 10

-Section 50

-Paragraph 4A

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=56946850&loc=SL5618551-113959

+ Details

Name: us-gaap_DerivativeGainOnDerivative

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

XML 46 R21.htm IDEA: XBRL DOCUMENT v3.2.0.727

Segment Information (Tables)
6 Months Ended

Jun. 30, 2015

Segment Information [Abstract]

Components of revenue by geographic region
Three Months Ended
June 30, Six Months Ended
June 30,
2015 2014 2015 2014

United States - product sales $ 1,044,066 $ 677,508 $ 1,668,580 $ 979,110
ROW - product sales 1,953 603 1,953 37,730
ROW - license fees/service revenue - - - 17,500
Totals $ 1,046,019 $ 678,111 $ 1,670,533 $ 1,034,340

X

- Definition
Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 30

-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8906-108599

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 25

-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8813-108599

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 21

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8721-108599

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=35741047&loc=d3e13816-109267

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 22

-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8736-108599

+ Details

Name: us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_SegmentReportingAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 47 R26.htm IDEA: XBRL DOCUMENT v3.2.0.727

Notes Payable (Details Textual) - USD ($)
3 Months Ended 6 Months Ended

Mar. 22, 2011

Jun. 30, 2015

Jun. 30, 2014

Jun. 30, 2015

Jun. 30, 2014

Notes Payable (Textual)

Unamortized discount, new notes $ 181,000 $ 181,000

Note payable, net (new notes) 1,147,500 1,147,500

Convertible notes, cash value 966,000 966,000

Interest expense 561,791 $ 85,980 892,945 $ 193,587

Convertible Notes Payable [Member]

Notes Payable (Textual)

Exercise price 0.01 0.01

Conversion option intrinsic value 400,196

Interest expense 638,190 $ 0

Promissory Note [Member]

Notes Payable (Textual)

Amount of renewal and extension forgivable loan $ 213,000

Debt instrument, payment terms (i) the full payment of the economic incentives; or (ii) March 31, 2016.

Period of performance for debt 5 years

New debt instrument interest rate 12.34%

Unamortized discount, new notes 8,000 8,000

Note payable, net (new notes) $ 44,000 $ 44,000

Promissory Note [Member] | Maximum [Member]

Notes Payable (Textual)

New debt instrument interest rate 12.00% 12.00%

Promissory Note [Member] | Minimum [Member]

Notes Payable (Textual)

New debt instrument interest rate 10.00% 10.00%

X

- Definition
Amount of renewal and extension forgivable loan.
+ References
No definition available.
+ Details

Name: oxys_AmountOfRenewalAndExtensionForgivableLoan

Namespace Prefix: oxys_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.
+ References
No definition available.
+ Details

Name: oxys_ConversionOptionIntrinsicValue

Namespace Prefix: oxys_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Narrative portion of notes payable.
+ References
No definition available.
+ Details

Name: oxys_NotesPayableTextualAbstract

Namespace Prefix: oxys_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Period of performance for debt.
+ References
No definition available.
+ Details

Name: oxys_PeriodOfPerformanceForDebt

Namespace Prefix: oxys_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
Renewed debt instrument interest rate.
+ References
No definition available.
+ Details

Name: oxys_RenewedDebtInstrumentInterestRate

Namespace Prefix: oxys_

Data Type: num:percentItemType

Balance Type: na

Period Type: instant

X

- Definition
Including the current and noncurrent portions, carrying amount of debt identified as being convertible into another form of financial instrument (typically the entity's common stock) as of the balance sheet date, which originally required full repayment more than twelve months after issuance or greater than the normal operating cycle of the company.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-03.16(a)(2))

-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.9-03.16)

-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 19, 20, 22

-Article 5

+ Details

Name: us-gaap_ConvertibleDebt

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Description of the payment terms of the debt instrument (for example, whether periodic payments include principal and frequency of payments) and discussion about any contingencies associated with the payment.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.22(a)(3))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 470

-Section 50

-Paragraph 3

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=6479336&loc=d3e64711-112823

+ Details

Name: us-gaap_DebtInstrumentPaymentTerms

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of debt discount that was originally recognized at the issuance of the instrument that has yet to be amortized.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 835

-SubTopic 30

-Section 45

-Paragraph 1A

-URI http://asc.fasb.org/extlink&oid=6451184&loc=d3e28541-108399

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 835

-SubTopic 30

-Section 55

-Paragraph 8

-URI http://asc.fasb.org/extlink&oid=34725769&loc=d3e28878-108400

+ Details

Name: us-gaap_DebtInstrumentUnamortizedDiscount

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of the cost of borrowed funds accounted for as interest expense.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 835

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.9-04.9)

-URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882

+ Details

Name: us-gaap_InterestExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.9-03.16)

-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-03.16)

-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 13, 16

-Article 9

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 19, 20, 22

-Article 5

+ Details

Name: us-gaap_NotesPayable

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(i))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

+ Details

Name: us-gaap_WarrantsAndRightsOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Details

Name: us-gaap_ShortTermDebtTypeAxis=us-gaap_ConvertibleNotesPayableMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_LongtermDebtTypeAxis=oxys_FriscoPromissoryNoteMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_RangeAxis=us-gaap_MaximumMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_RangeAxis=us-gaap_MinimumMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 48 R5.htm IDEA: XBRL DOCUMENT v3.2.0.727

Statements of Cash Flows (Unaudited) - USD ($)
6 Months Ended

Jun. 30, 2015

Jun. 30, 2014

CASH FLOWS FROM OPERATING ACTIVITIES:

Net loss $ (2,598,537) $ (695,828)

Adjustments to reconcile net loss to net cash from operating activities:

Depreciation and amortization expense 21,934 24,853

Amortization of debt discount and beneficial conversion features 803,870 $ 121,140

Gain on forgiveness of debt $ (37,714)

Gain on extinguishment of debt $ (42,525)

Excess derivative over proceeds $ 204,272

Derivative liability fair value adjustment (122,584)

Expenses paid on behalf of related parties $ 137,150

Expenses paid by related parties $ 4,374

Warrants issued for services $ 8,883

Stock based compensation 106,911 $ 17,588

Common stock issued for services 62,670

Changes in operating assets and liabilities:

Accounts receivable (341,573) $ (363,543)

Inventories (145,205) 1,804

License fees receivable 15,000 36,692

Prepaid expenses and other current assets (38,159) $ 62,509

Other assets (50,368)

Accounts payable and accrued liabilities $ 282,345 $ 304,405

Deferred revenue (2,976)

NET CASH USED IN OPERATING ACTIVITIES $ (1,691,105) (531,507)

CASH FLOWS FROM INVESTING ACTIVITIES

Purchase of property and equipment $ (3,900) (70,651)

Purchase of intangible assets (198)

NET CASH USED IN INVESTING ACTIVITIES $ (3,900) (70,849)

CASH FLOWS FROM FINANCING ACTIVITIES

Common stock subscribed and issued for cash 80,001 $ 10,672

Preferred stock issued for cash and warrants $ 2,650,001

Cash received from related parties $ 9,800

Payments made to related parties $ (92,000) (108,300)

Cash received from convertible notes payable 1,461,000 247,500

Payments made on convertible notes payable (175,000) (192,000)

Payments on capital leases (149) (1,008)

NET CASH USED IN FINANCING ACTIVITIES 3,923,853 (33,336)

Net change in cash and cash equivalents 2,228,848 (635,692)

Cash and cash equivalents, at beginning of period 647,093 657,673

Cash and cash equivalents, at end of period $ 875,941 $ 21,981

Cash paid during the period for:

Interest

Income taxes

Supplemental non-cash investing and financing activities:

Conversion of preferred stock to common $ 246

Conversion of convertible notes payable 804,138

Beneficial conversion feature 808,532

Initial value of the derivative $ 165,200

X

- References
No definition available.
+ Details

Name: oxys_CashPaidDuringPeriodAbstract

Namespace Prefix: oxys_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Common stock issued for services.
+ References
No definition available.
+ Details

Name: oxys_CommonStockIssuedDuringPeriodValueIssuedForServices

Namespace Prefix: oxys_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Excess derivative over proceeds.
+ References
No definition available.
+ Details

Name: oxys_ExcessDerivativeOverProceeds

Namespace Prefix: oxys_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Expenses paid by related parties.
+ References
No definition available.
+ Details

Name: oxys_ExpensesPaidByRelatedParties

Namespace Prefix: oxys_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Expenses paid on behalf of related parties.
+ References
No definition available.
+ Details

Name: oxys_ExpensesPaidOnBehalfOfRelatedParties

Namespace Prefix: oxys_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
License fees receivable.
+ References
No definition available.
+ Details

Name: oxys_IncreaseDecreaseInLicenseFeeReceivableCurrent

Namespace Prefix: oxys_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Initial value of the derivative.
+ References
No definition available.
+ Details

Name: oxys_InitialValueOfDerivative

Namespace Prefix: oxys_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Payments to related parties.
+ References
No definition available.
+ Details

Name: oxys_PaymentsToRelatedParties

Namespace Prefix: oxys_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of increase (decrease) in additional paid in capital (APIC) resulting from recognition of deferred taxes for convertible debt with a beneficial conversion feature.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 55

-Paragraph 51

-URI http://asc.fasb.org/extlink&oid=51663037&loc=d3e34017-109320

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Beneficial Conversion Feature

-URI http://asc.fasb.org/extlink&oid=6505963

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.3-04)

-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

+ Details

Name: us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 835

-SubTopic 30

-Section 45

-Paragraph 1A

-URI http://asc.fasb.org/extlink&oid=6451184&loc=d3e28541-108399

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.8)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

+ Details

Name: us-gaap_AmortizationOfDebtDiscountPremium

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Cash

-URI http://asc.fasb.org/extlink&oid=6506951

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 1

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6676-107765

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3044-108585

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Cash Equivalents

-URI http://asc.fasb.org/extlink&oid=6507016

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.1)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_CashAndCashEquivalentsAtCarryingValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Includes effect from exchange rate changes.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 24

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3521-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 830

-SubTopic 230

-Section 45

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=49171198&loc=d3e33268-110906

+ Details

Name: us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The value of the financial instrument issued [noncash or part noncash] in the conversion of stock. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4313-108586

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4304-108586

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 50

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4332-108586

+ Details

Name: us-gaap_ConversionOfStockAmountIssued1

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4304-108586

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 50

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4332-108586

+ Details

Name: us-gaap_DebtConversionConvertedInstrumentAmount1

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Decrease for amounts of indebtedness forgiven by the holder of the debt instrument.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(f))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

+ Details

Name: us-gaap_DebtInstrumentDecreaseForgiveness

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

+ Details

Name: us-gaap_DepreciationDepletionAndAmortization

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 10

-Section 50

-Paragraph 4A

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=56946850&loc=SL5618551-113959

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 10

-Section 50

-Paragraph 4C

-Subparagraph (a),(c),(d),(e)

-URI http://asc.fasb.org/extlink&oid=56946850&loc=SL5624171-113959

+ Details

Name: us-gaap_DerivativeGainLossOnDerivativeNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 470

-SubTopic 50

-Section 40

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=49170532&loc=d3e12317-112629

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 470

-SubTopic 50

-Section 40

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=49170532&loc=d3e12355-112629

+ Details

Name: us-gaap_GainsLossesOnExtinguishmentOfDebt

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4297-108586

+ Details

Name: us-gaap_IncomeTaxesPaidNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

+ Details

Name: us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

+ Details

Name: us-gaap_IncreaseDecreaseInAccountsReceivable

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The increase (decrease) during the reporting period, excluding the portion taken into income, in the liability reflecting revenue yet to be earned for which cash or other forms of consideration was received or recorded as a receivable.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

+ Details

Name: us-gaap_IncreaseDecreaseInDeferredRevenue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

+ Details

Name: us-gaap_IncreaseDecreaseInInventories

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_IncreaseDecreaseInOperatingCapitalAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The increase (decrease) during the reporting period in other current operating assets not separately disclosed in the statement of cash flows.
+ References
No definition available.
+ Details

Name: us-gaap_IncreaseDecreaseInOtherCurrentAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of increase (decrease) of consideration paid in advance for other costs that provide economic benefits in future periods.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

+ Details

Name: us-gaap_IncreaseDecreaseInPrepaidExpensesOther

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The amount of cash paid for interest during the period net of cash paid for interest that is capitalized.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4297-108586

+ Details

Name: us-gaap_InterestPaidNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Fair value of share-based compensation granted to nonemployees as payment for services rendered or acknowledged claims.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

+ Details

Name: us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 24

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3521-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 26

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3574-108585

+ Details

Name: us-gaap_NetCashProvidedByUsedInFinancingActivities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 24

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3521-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 26

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3574-108585

+ Details

Name: us-gaap_NetCashProvidedByUsedInInvestingActivities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 24

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3521-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 25

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3536-108585

+ Details

Name: us-gaap_NetCashProvidedByUsedInOperatingActivities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Net Income

-URI http://asc.fasb.org/extlink&oid=51831255

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.19)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.18)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.22)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Other Comprehensive Income

-URI http://asc.fasb.org/extlink&oid=51831270

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 19

-Article 5

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 20

-Article 9

+ Details

Name: us-gaap_NetIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_NoncashInvestingAndFinancingItemsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 13

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3213-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Investing Activities

-URI http://asc.fasb.org/extlink&oid=6516133

+ Details

Name: us-gaap_PaymentsToAcquireIntangibleAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Investing Activities

-URI http://asc.fasb.org/extlink&oid=6516133

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 13

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3213-108585

+ Details

Name: us-gaap_PaymentsToAcquirePropertyPlantAndEquipment

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Financing Activities

-URI http://asc.fasb.org/extlink&oid=6513228

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 14

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3255-108585

+ Details

Name: us-gaap_ProceedsFromConvertibleDebt

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The cash inflow from the additional capital contribution to the entity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Financing Activities

-URI http://asc.fasb.org/extlink&oid=6513228

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 14

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3255-108585

+ Details

Name: us-gaap_ProceedsFromIssuanceOfCommonStock

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The cash outflow for a borrowing recorded for a lease meeting the criteria for capitalization (with maturities within one year or the normal operating cycle of the entity, if longer).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 15

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3291-108585

+ Details

Name: us-gaap_ReductionOfShortTermCapitalLeaseObligations

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The cash outflow from the repayment of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Financing Activities

-URI http://asc.fasb.org/extlink&oid=6513228

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 15

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3291-108585

+ Details

Name: us-gaap_RepaymentsOfConvertibleDebt

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of revenue, fees and commissions earned from transactions between (a) a parent company and its subsidiaries; (b) subsidiaries of a common parent; (c) an entity and trusts for the benefit of employees, for example, but not limited to, pension and profit-sharing trusts that are managed by or under the trusteeship of the entity's management; (d) an entity and its principal, owners, management, or members of their immediate families; and (e) affiliates.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.1(e))

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Related Parties

-URI http://asc.fasb.org/extlink&oid=16382449

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 946

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.6-07.1(c))

-URI http://asc.fasb.org/extlink&oid=6488393&loc=d3e606610-122999

+ Details

Name: us-gaap_RevenueFromRelatedParties

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

+ Details

Name: us-gaap_ShareBasedCompensation

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Value of preferred stock and warrants for common stock issued.
+ References
No definition available.
+ Details

Name: us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

XML 49 R10.htm IDEA: XBRL DOCUMENT v3.2.0.727

Related Party Transactions
6 Months Ended

Jun. 30, 2015

Related Party Transactions [Abstract]

RELATED PARTY TRANSACTIONS
NOTE 5 – RELATED PARTY TRANSACTIONS

A summary of the related party financings and notes as at June 30, 2015 is as follows:

Related party Julian Ross (1)
Amount $ 200,000
Stated interest rate 0 %
Maturity n/a

(1) Our CEO, Mr. Ross provides us shareholder cash advances and other consideration from time to time to fund working capital.

X

- References
No definition available.
+ Details

Name: us-gaap_RelatedPartyTransactionsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 850

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 850

-SubTopic 10

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39622-107864

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 850

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 850

-SubTopic 10

-Section 50

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39678-107864

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 850

-SubTopic 10

-Section 50

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(k))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph b

-Article 3A

+ Details

Name: us-gaap_RelatedPartyTransactionsDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 50 R27.htm IDEA: XBRL DOCUMENT v3.2.0.727

Shareholders' Equity (Details) - USD ($)
3 Months Ended 6 Months Ended

Jun. 30, 2015

Jun. 30, 2015

Dec. 31, 2014

Shareholders' Equity (Textual)

Preferred stock, shares authorized 25,000,000 25,000,000 25,000,000

Preferred stock, par value $ 0.0005 $ 0.0005 $ 0.0005

Common stock, shares authorized 100,000,000 100,000,000 100,000,000

Common stock, par value $ 0.0004 $ 0.0004 $ 0.0004

Beneficial conversion features $ 400,196

Common stock issued upon conversion of convertible notes, Shares 1,256,453

Fair value of options issued to employees $ 58,611

Common stock, Shares issued 31,224,000 31,224,000 28,438,631

Common stock, Shares outstanding 31,224,000 31,224,000 28,438,631

Number of stock issued for cash 133,333

Number of stock issued for cash, value $ 80,000

Series A Preferred Stock [Member]

Shareholders' Equity (Textual)

Preferred Stock, shares issued 518,750 518,750 593,750

Preferred stock, shares outstanding 518,750 518,750 593,750

Series B Preferred Stock [Member]

Shareholders' Equity (Textual)

Preferred Stock, shares issued 900 900 1,145

Preferred stock converted into common stock 75

Series B preferred authorized 3,500

Common stock issued upon conversion of convertible preferred stock, Shares 204,188

Preferred stock converted to common stock, Shares 75

Preferred stock, shares outstanding 900 900 1,145

Series C Preferred Stock [Member]

Shareholders' Equity (Textual)

Preferred Stock, shares issued 770,000 770,000 0

Preferred stock converted to common stock, Shares 770,000

Preferred stock, value $ 700,000 $ 700,000

Preferred stock shares issued for notes receivable $ 700,000 $ 700,000

Preferred stock, shares outstanding 770,000 770,000 0

Series D Preferred Stock [Member]

Shareholders' Equity (Textual)

Preferred Stock, shares issued 1,050,000 1,050,000 0

Preferred stock converted to common stock, Shares 1,050,000

Preferred stock, value $ 2,000,000 $ 2,000,000

Preferred stock, shares outstanding 1,050,000 1,050,000 0

Series E Preferred Stock [Member]

Shareholders' Equity (Textual)

Preferred Stock, shares issued 531,666 531,666 0

Preferred stock converted to common stock, Shares 531,666

Preferred stock, shares outstanding 531,666 531,666 0

Common stock [Member] | Series A Preferred Stock [Member]

Shareholders' Equity (Textual)

Preferred stock, shares authorized 3,143,237 3,143,237

Preferred stock, par value $ 1.00 $ 1.00

Common stock [Member] | Series B Preferred Stock [Member]

Shareholders' Equity (Textual)

Preferred stock, par value $ 1,000 $ 1,000

X

- Definition
The total gross value of stock issued during the period upon the conversion of convertible securities.
+ References
No definition available.
+ Details

Name: oxys_BeneficialConversionFeature

Namespace Prefix: oxys_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Fair value of options issued to employees.
+ References
No definition available.
+ Details

Name: oxys_FairValueOfOptionsIssuedToEmployees

Namespace Prefix: oxys_

Data Type: xbrli:monetaryItemType

Balance Type: na

Period Type: duration

X

- Definition
Preferred stock shares issued for notes receivable value.
+ References
No definition available.
+ Details

Name: oxys_PreferredStockSharesIssuedForNotesReceivableValue

Namespace Prefix: oxys_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Shareholders equity.
+ References
No definition available.
+ Details

Name: oxys_ShareholdersEquityTextualAbstract

Namespace Prefix: oxys_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Shares of preferred stock and warrants for common stock issued.
+ References
No definition available.
+ Details

Name: oxys_StockAndWarrantsIssuedDuringPeriodSharesPreferredStockAndWarrants

Namespace Prefix: oxys_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Number of new stock issued for cash during the period.
+ References
No definition available.
+ Details

Name: oxys_StockIssuedDuringPeriodShareIssuedForCash

Namespace Prefix: oxys_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.
+ References
No definition available.
+ Details

Name: oxys_StockIssuedDuringPeriodSharesIssuedForCashOne

Namespace Prefix: oxys_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Equity impact of the value of stock issued for cash during the period.
+ References
No definition available.
+ Details

Name: oxys_StockIssuedDuringPeriodValuesIssuedForCash

Namespace Prefix: oxys_

Data Type: xbrli:monetaryItemType

Balance Type: na

Period Type: duration

X

- Definition
Face amount or stated value per share of common stock.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 30

-Article 5

+ Details

Name: us-gaap_CommonStockParOrStatedValuePerShare

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 30

-Article 5

+ Details

Name: us-gaap_CommonStockSharesAuthorized

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 30

-Article 5

+ Details

Name: us-gaap_CommonStockSharesIssued

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.3-04)

-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 30

-Article 5

+ Details

Name: us-gaap_CommonStockSharesOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 50

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4332-108586

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4304-108586

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4313-108586

+ Details

Name: us-gaap_ConversionOfStockSharesConverted1

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.28)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29

-Article 5

+ Details

Name: us-gaap_PreferredStockParOrStatedValuePerShare

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.28)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29

-Article 5

+ Details

Name: us-gaap_PreferredStockSharesAuthorized

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.28)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29

-Article 5

+ Details

Name: us-gaap_PreferredStockSharesIssued

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.28)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29

-Article 5

+ Details

Name: us-gaap_PreferredStockSharesOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Amount of subscription received from investors who have been allocated nonredeemable preferred stock or preferred stock redeemable solely at the option of the issuer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.28)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29

-Article 5

+ Details

Name: us-gaap_PreferredStockSharesSubscribedButUnissuedValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Number of shares issued during the period as a result of the conversion of convertible securities.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.3-04)

-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29-30)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21475-112644

+ Details

Name: us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Number of shares of stock issued during the period that is attributable to transactions involving issuance of stock not separately disclosed.
+ References
No definition available.
+ Details

Name: us-gaap_StockIssuedDuringPeriodSharesOther

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementClassOfStockAxis=us-gaap_SeriesCPreferredStockMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementClassOfStockAxis=us-gaap_SeriesDPreferredStockMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementClassOfStockAxis=us-gaap_SeriesEPreferredStockMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 51 FilingSummary.xml IDEA: XBRL DOCUMENT 3.2.0.727 html 82 200 1 true 23 0 false 4 false false R1.htm 001 - Document - Document and Entity Information Sheet http://www.oxysuresystems.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 002 - Statement - Condensed Balance Sheets Sheet http://www.oxysuresystems.com/role/CondensedBalanceSheets Condensed Balance Sheets Statements 2 false false R3.htm 003 - Statement - Condensed Balance Sheets (Parenthetical) Sheet http://www.oxysuresystems.com/role/CondensedBalanceSheetsParenthetical Condensed Balance Sheets (Parenthetical) Statements 3 false false R4.htm 004 - Statement - Statements of Operations (Unaudited) Sheet http://www.oxysuresystems.com/role/StatementsOfOperationsUnaudited Statements of Operations (Unaudited) Statements 4 false false R5.htm 005 - Statement - Statements of Cash Flows (Unaudited) Sheet http://www.oxysuresystems.com/role/StatementsOfCashFlowsUnaudited Statements of Cash Flows (Unaudited) Statements 5 false false R6.htm 006 - Disclosure - Summary of Significant Accounting Policies Sheet http://www.oxysuresystems.com/role/SummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 6 false false R7.htm 007 - Disclosure - Notes Payable Notes http://www.oxysuresystems.com/role/NotesPayable Notes Payable Notes 7 false false R8.htm 008 - Disclosure - Shareholders' Equity Sheet http://www.oxysuresystems.com/role/ShareholdersEquity Shareholders' Equity Notes 8 false false R9.htm 009 - Disclosure - Stock Options and Warrants Sheet http://www.oxysuresystems.com/role/StockOptionsAndWarrants Stock Options and Warrants Notes 9 false false R10.htm 010 - Disclosure - Related Party Transactions Sheet http://www.oxysuresystems.com/role/RelatedPartyTransactions Related Party Transactions Notes 10 false false R11.htm 011 - Disclosure - Off Balance Sheet Arrangements and Contractual Obligations Sheet http://www.oxysuresystems.com/role/OffBalanceSheetArrangementsAndContractualObligations Off Balance Sheet Arrangements and Contractual Obligations Notes 11 false false R12.htm 012 - Disclosure - Fair Value Measurements Sheet http://www.oxysuresystems.com/role/FairValueMeasurements Fair Value Measurements Notes 12 false false R13.htm 013 - Disclosure - Segment Information Sheet http://www.oxysuresystems.com/role/SegmentInformation Segment Information Notes 13 false false R14.htm 014 - Disclosure - Going Concern Sheet http://www.oxysuresystems.com/role/GoingConcern Going Concern Notes 14 false false R15.htm 015 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://www.oxysuresystems.com/role/SummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://www.oxysuresystems.com/role/SummaryOfSignificantAccountingPolicies 15 false false R16.htm 016 - Disclosure - Summary of Significant Accounting Policies (Tables) Sheet http://www.oxysuresystems.com/role/SummaryOfSignificantAccountingPoliciesTables Summary of Significant Accounting Policies (Tables) Tables http://www.oxysuresystems.com/role/SummaryOfSignificantAccountingPolicies 16 false false R17.htm 017 - Disclosure - Notes Payable (Tables) Notes http://www.oxysuresystems.com/role/NotesPayableTables Notes Payable (Tables) Tables http://www.oxysuresystems.com/role/NotesPayable 17 false false R18.htm 018 - Disclosure - Stock Options and Warrants (Tables) Sheet http://www.oxysuresystems.com/role/StockOptionsAndWarrantsTables Stock Options and Warrants (Tables) Tables http://www.oxysuresystems.com/role/StockOptionsAndWarrants 18 false false R19.htm 019 - Disclosure - Related Party Transactions (Tables) Sheet http://www.oxysuresystems.com/role/RelatedPartyTransactionsTables Related Party Transactions (Tables) Tables http://www.oxysuresystems.com/role/RelatedPartyTransactions 19 false false R20.htm 020 - Disclosure - Fair Value Measurements (Tables) Sheet http://www.oxysuresystems.com/role/FairValueMeasurementsTables Fair Value Measurements (Tables) Tables http://www.oxysuresystems.com/role/FairValueMeasurements 20 false false R21.htm 021 - Disclosure - Segment Information (Tables) Sheet http://www.oxysuresystems.com/role/SegmentInformationTables Segment Information (Tables) Tables http://www.oxysuresystems.com/role/SegmentInformation 21 false false R22.htm 022 - Disclosure - Summary of Significant Accounting Policies (Details) Sheet http://www.oxysuresystems.com/role/SummaryOfSignificantAccountingPoliciesDetails Summary of Significant Accounting Policies (Details) Details http://www.oxysuresystems.com/role/SummaryOfSignificantAccountingPoliciesTables 22 false false R23.htm 023 - Disclosure - Summary of Significant Accounting Policies (Details 1) Sheet http://www.oxysuresystems.com/role/SummaryOfSignificantAccountingPoliciesDetails1 Summary of Significant Accounting Policies (Details 1) Details http://www.oxysuresystems.com/role/SummaryOfSignificantAccountingPoliciesTables 23 false false R24.htm 024 - Disclosure - Summary of Significant Accounting Policies (Details Textual) Sheet http://www.oxysuresystems.com/role/SummaryOfSignificantAccountingPoliciesDetailsTextual Summary of Significant Accounting Policies (Details Textual) Details http://www.oxysuresystems.com/role/SummaryOfSignificantAccountingPoliciesTables 24 false false R25.htm 025 - Disclosure - Notes Payable (Details) Notes http://www.oxysuresystems.com/role/NotesPayableDetails Notes Payable (Details) Details http://www.oxysuresystems.com/role/NotesPayableTables 25 false false R26.htm 026 - Disclosure - Notes Payable (Details Textual) Notes http://www.oxysuresystems.com/role/NotesPayableDetailsTextual Notes Payable (Details Textual) Details http://www.oxysuresystems.com/role/NotesPayableTables 26 false false R27.htm 027 - Disclosure - Shareholders' Equity (Details) Sheet http://www.oxysuresystems.com/role/ShareholdersEquityDetails Shareholders' Equity (Details) Details http://www.oxysuresystems.com/role/ShareholdersEquity 27 false false R28.htm 028 - Disclosure - Stock Options and Warrants (Details) Sheet http://www.oxysuresystems.com/role/Stockoptionsandwarrantsdetails Stock Options and Warrants (Details) Details http://www.oxysuresystems.com/role/StockOptionsAndWarrantsTables 28 false false R29.htm 029 - Disclosure - Stock Options and Warrants (Details 1) Sheet http://www.oxysuresystems.com/role/StockOptionsAndWarrantsDetails1 Stock Options and Warrants (Details 1) Details http://www.oxysuresystems.com/role/StockOptionsAndWarrantsTables 29 false false R30.htm 030 - Disclosure - Stock Options and Warrants (Details 2) Sheet http://www.oxysuresystems.com/role/StockOptionsAndWarrantsDetails2 Stock Options and Warrants (Details 2) Details http://www.oxysuresystems.com/role/StockOptionsAndWarrantsTables 30 false false R31.htm 031 - Disclosure - Stock Options and Warrants (Details Textual) Sheet http://www.oxysuresystems.com/role/StockOptionsAndWarrantsDetailsTextual Stock Options and Warrants (Details Textual) Details http://www.oxysuresystems.com/role/StockOptionsAndWarrantsTables 31 false false R32.htm 032 - Disclosure - Related Party Transactions (Details) Sheet http://www.oxysuresystems.com/role/Relatedpartytransactionsdetails Related Party Transactions (Details) Details http://www.oxysuresystems.com/role/RelatedPartyTransactionsTables 32 false false R33.htm 033 - Disclosure - Fair Value Measurements (Details) Sheet http://www.oxysuresystems.com/role/FairValueMeasurementsDetails Fair Value Measurements (Details) Details http://www.oxysuresystems.com/role/FairValueMeasurementsTables 33 false false R34.htm 034 - Disclosure - Fair Value Measurements (Details Textual) Sheet http://www.oxysuresystems.com/role/FairValueMeasurementsDetailsTextual Fair Value Measurements (Details Textual) Details http://www.oxysuresystems.com/role/FairValueMeasurementsTables 34 false false R35.htm 035 - Disclosure - Segment Information (Details) Sheet http://www.oxysuresystems.com/role/SegmentInformationDetails Segment Information (Details) Details http://www.oxysuresystems.com/role/SegmentInformationTables 35 false false R36.htm 036 - Disclosure - Going Concern (Details) Sheet http://www.oxysuresystems.com/role/GoingConcernDetails Going Concern (Details) Details http://www.oxysuresystems.com/role/GoingConcern 36 false false All Reports Book All Reports In ''Condensed Balance Sheets'', column(s) 3, 4 are contained in other reports, so were removed by flow through suppression. In ''Statements of Cash Flows (Unaudited)'', column(s) 1, 2 are contained in other reports, so were removed by flow through suppression. oxys-20150630.xml oxys-20150630_cal.xml oxys-20150630_def.xml oxys-20150630_lab.xml oxys-20150630_pre.xml oxys-20150630.xsd true true XML 52 R20.htm IDEA: XBRL DOCUMENT v3.2.0.727

Fair Value Measurements (Tables)
6 Months Ended

Jun. 30, 2015

Fair Value Measurements [Abstract]

Schedule of changes related to derivatives

Balance as of December 31, 2014 $ 31,010

Additions related to embedded derivative of convertible notes issued 369,472

Gain on decrease in value of derivative liabilities (122,584 )

Conversions (28,698 )

Balance as of June 30, 2015 $ 249,200

X

- References
No definition available.
+ Details

Name: us-gaap_FairValueDisclosuresAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of derivative liabilities at fair value.
+ References
No definition available.
+ Details

Name: us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

Fair Value Measurements (Details)	6 Months Ended
Fair Value Measurements (Details)	Jun. 30, 2015 USD ($)
Fair Value Measurements [Abstract]
Balance as of December 31, 2014	$ 31,010
Additions related to embedded derivative of convertible notes issued	369,472
Gain on decrease in value of derivative liabilities	(122,584)
Conversions	(28,698)
Balance as of June 30, 2015	$ 249,200

Document and Entity Information - shares	6 Months Ended
Document and Entity Information - shares	Jun. 30, 2015	Aug. 18, 2015
Document and Entity Information [Abstract]
Entity Registrant Name	OxySure Systems Inc
Entity Central Index Key	0001413797
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Document Type	10-Q
Document Period End Date	Jun. 30, 2015
Document Fiscal Period Focus	Q2
Document Fiscal Year Focus	2015
Entity Filer Category	Smaller Reporting Company
Entity Common Stock, Shares Outstanding		32,003,034

Statements of Operations (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
Statements of Operations (Unaudited) - USD ($)	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2015	Jun. 30, 2014
Income Statement [Abstract]
Revenues, net	$ 1,046,019	$ 678,111	$ 1,670,533	$ 1,034,340
Cost of goods sold	409,183	264,856	745,039	470,446
Gross profit	636,836	413,255	925,494	563,894
Operating expenses
Research and development	297,456	275,974	510,801	277,515
Sales and marketing	329,393	154,044	794,139	241,993
Other general and administrative	621,066	259,230	1,243,350	604,987
Total operating expenses	1,247,915	689,248	2,548,290	1,124,495
Loss from operating expenses	(611,079)	(275,993)	(1,622,796)	(560,600)
Other income (expenses)
Interest expense	(561,791)	$ (85,980)	(892,945)	$ (193,587)
Change in value of derivative liabilities	119,933		122,584
Derivative expense	(204,272)		(204,272)
Other income (expense)	(1,225)	$ 42,465	(1,108)	$ 58,360
Total other income (expenses)	(647,355)	(43,515)	(975,741)	(135,227)
Net loss	$ (1,258,434)	$ (319,508)	$ (2,598,537)	$ (695,828)
Basic and diluted net loss per common share	$ (0.04)	$ (0.01)	$ (0.09)	$ (0.03)
Weighted average common shares outstanding:
Basic and diluted	30,215,788	25,996,642	29,587,327	25,956,948

Off Balance Sheet Arrangements and Contractual Obligations	6 Months Ended
	Jun. 30, 2015
Off Balance Sheet Arrangements and Contractual Obligations [Abstract]
OFF BALANCE SHEET ARRANGEMENTS AND CONTRACTUAL OBLIGATIONS	NOTE 6 – OFF BALANCE SHEET ARRANGEMENTS AND CONTRACTUAL OBLIGATIONS We have not entered into any transactions with unconsolidated entities whereby we have financial guarantees, subordinated retained interests, or other contingent arrangements that expose us to material continuing risks, contingent liabilities, or any other obligation under a variable interest in an unconsolidated entity that provides financing, liquidity, market risk or credit risk support to us.

Summary of Significant Accounting Policies (Details 1)	Jun. 30, 2015 USD ($)
Summary of Significant Accounting Policies [Abstract]
2015	$ 30,232
2016	30,232
2017	30,232
2018	30,232
Thereafter	226,723
Total	$ 347,650

Fair Value Measurements (Details Textual)	6 Months Ended
Fair Value Measurements (Details Textual)	Jun. 30, 2015 USD ($)
Fair Value Measurements (Textual)
Additions related to embedded derivative of convertible notes issued	$ 369,472
Excess derivative over proceeds	204,272
Conversions	28,698
Gain on decrease in value of derivative liabilities	$ 122,584

Notes Payable (Details Textual) - USD ($)		3 Months Ended		6 Months Ended
Notes Payable (Details Textual) - USD ($)	Mar. 22, 2011	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2015	Jun. 30, 2014
Notes Payable (Textual)
Unamortized discount, new notes		$ 181,000		$ 181,000
Note payable, net (new notes)		1,147,500		1,147,500
Convertible notes, cash value		966,000		966,000
Interest expense		561,791	$ 85,980	892,945	$ 193,587
Convertible Notes Payable [Member]
Notes Payable (Textual)
Exercise price		0.01		0.01
Conversion option intrinsic value				400,196
Interest expense				638,190	$ 0
Promissory Note [Member]
Notes Payable (Textual)
Amount of renewal and extension forgivable loan	$ 213,000
Debt instrument, payment terms	(i) the full payment of the economic incentives; or (ii) March 31, 2016.
Period of performance for debt	5 years
New debt instrument interest rate	12.34%
Unamortized discount, new notes		8,000		8,000
Note payable, net (new notes)		$ 44,000		$ 44,000
Promissory Note [Member] \| Maximum [Member]
Notes Payable (Textual)
New debt instrument interest rate		12.00%		12.00%
Promissory Note [Member] \| Minimum [Member]
Notes Payable (Textual)
New debt instrument interest rate		10.00%		10.00%

Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
Statements of Cash Flows (Unaudited) - USD ($)	Jun. 30, 2015	Jun. 30, 2014
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (2,598,537)	$ (695,828)
Adjustments to reconcile net loss to net cash from operating activities:
Depreciation and amortization expense	21,934	24,853
Amortization of debt discount and beneficial conversion features	803,870	$ 121,140
Gain on forgiveness of debt	$ (37,714)
Gain on extinguishment of debt		$ (42,525)
Excess derivative over proceeds	$ 204,272
Derivative liability fair value adjustment	(122,584)
Expenses paid on behalf of related parties	$ 137,150
Expenses paid by related parties		$ 4,374
Warrants issued for services	$ 8,883
Stock based compensation	106,911	$ 17,588
Common stock issued for services	62,670
Changes in operating assets and liabilities:
Accounts receivable	(341,573)	$ (363,543)
Inventories	(145,205)	1,804
License fees receivable	15,000	36,692
Prepaid expenses and other current assets	(38,159)	$ 62,509
Other assets	(50,368)
Accounts payable and accrued liabilities	$ 282,345	$ 304,405
Deferred revenue		(2,976)
NET CASH USED IN OPERATING ACTIVITIES	$ (1,691,105)	(531,507)
CASH FLOWS FROM INVESTING ACTIVITIES
Purchase of property and equipment	$ (3,900)	(70,651)
Purchase of intangible assets		(198)
NET CASH USED IN INVESTING ACTIVITIES	$ (3,900)	(70,849)
CASH FLOWS FROM FINANCING ACTIVITIES
Common stock subscribed and issued for cash	80,001	$ 10,672
Preferred stock issued for cash and warrants	$ 2,650,001
Cash received from related parties		$ 9,800
Payments made to related parties	$ (92,000)	(108,300)
Cash received from convertible notes payable	1,461,000	247,500
Payments made on convertible notes payable	(175,000)	(192,000)
Payments on capital leases	(149)	(1,008)
NET CASH USED IN FINANCING ACTIVITIES	3,923,853	(33,336)
Net change in cash and cash equivalents	2,228,848	(635,692)
Cash and cash equivalents, at beginning of period	647,093	657,673
Cash and cash equivalents, at end of period	$ 875,941	$ 21,981
Cash paid during the period for:
Interest
Income taxes
Supplemental non-cash investing and financing activities:
Conversion of preferred stock to common	$ 246
Conversion of convertible notes payable	804,138
Beneficial conversion feature	808,532
Initial value of the derivative	$ 165,200

Shareholders' Equity (Details) - USD ($)	3 Months Ended	6 Months Ended
Shareholders' Equity (Details) - USD ($)	Jun. 30, 2015	Jun. 30, 2015	Dec. 31, 2014
Shareholders' Equity (Textual)
Preferred stock, shares authorized	25,000,000	25,000,000	25,000,000
Preferred stock, par value	$ 0.0005	$ 0.0005	$ 0.0005
Common stock, shares authorized	100,000,000	100,000,000	100,000,000
Common stock, par value	$ 0.0004	$ 0.0004	$ 0.0004
Beneficial conversion features		$ 400,196
Common stock issued upon conversion of convertible notes, Shares		1,256,453
Fair value of options issued to employees		$ 58,611
Common stock, Shares issued	31,224,000	31,224,000	28,438,631
Common stock, Shares outstanding	31,224,000	31,224,000	28,438,631
Number of stock issued for cash	133,333
Number of stock issued for cash, value	$ 80,000
Series A Preferred Stock [Member]
Shareholders' Equity (Textual)
Preferred Stock, shares issued	518,750	518,750	593,750
Preferred stock, shares outstanding	518,750	518,750	593,750
Series B Preferred Stock [Member]
Shareholders' Equity (Textual)
Preferred Stock, shares issued	900	900	1,145
Preferred stock converted into common stock		75
Series B preferred authorized		3,500
Common stock issued upon conversion of convertible preferred stock, Shares		204,188
Preferred stock converted to common stock, Shares		75
Preferred stock, shares outstanding	900	900	1,145
Series C Preferred Stock [Member]
Shareholders' Equity (Textual)
Preferred Stock, shares issued	770,000	770,000	0
Preferred stock converted to common stock, Shares	770,000
Preferred stock, value	$ 700,000	$ 700,000
Preferred stock shares issued for notes receivable	$ 700,000	$ 700,000
Preferred stock, shares outstanding	770,000	770,000	0
Series D Preferred Stock [Member]
Shareholders' Equity (Textual)
Preferred Stock, shares issued	1,050,000	1,050,000	0
Preferred stock converted to common stock, Shares	1,050,000
Preferred stock, value	$ 2,000,000	$ 2,000,000
Preferred stock, shares outstanding	1,050,000	1,050,000	0
Series E Preferred Stock [Member]
Shareholders' Equity (Textual)
Preferred Stock, shares issued	531,666	531,666	0
Preferred stock converted to common stock, Shares	531,666
Preferred stock, shares outstanding	531,666	531,666	0
Common stock [Member] \| Series A Preferred Stock [Member]
Shareholders' Equity (Textual)
Preferred stock, shares authorized	3,143,237	3,143,237
Preferred stock, par value	$ 1.00	$ 1.00
Common stock [Member] \| Series B Preferred Stock [Member]
Shareholders' Equity (Textual)
Preferred stock, par value	$ 1,000	$ 1,000